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Abstract 
This grounded theory research explores patients' experiences and the 
supportive care implications of living with the incurable and progressive bone 
marrow cancer multiple myeloma. Patients (n=17), family members (n=11) and 
healthcare professionals (n=12) participated in the research. A total of 46 semi- 
structured and recorded interviews were undertaken and transcribed verbatim 
(three couples were interviewed twice n=6). Some participants were interviewed 
individually while others were interviewed as a couple or small family group. 
The methodology employed aimed to generate theory in an area of limited 
qualitative exploration and findings were determined through the procedures of 
theoretical sampling and constant comparative analysis. 'Contention' was the 
core category that emerged in the form of 'struggle' with close affiliation to other 
prominent interrelating concepts such as 'battle' or 'fight', 'disruption' and 
'disharmony'. The findings are described within four categories of 'Ways of 
communication', 'Nature of the disease', 'Impact on life' and 'Supportive care 
needs'. 
This research provides insight of individuals' life experiences living with a 
complex haematological malignancy that is poorly understood. Implications for 
practice relate to development of collaborative approaches to healthcare and 
the identification of supportive care needs. This work contributes increased 
awareness and understanding of multiple myeloma and the impact that the 
disease has on the individual and on family life. It also highlights the value of 
effective communication and collaboration between patients, families and 
healthcare professionals to identify supportive care needs at specific times 
along the illness trajectory and inform service provision and the development of 
effective care pathways. Indications for further research are included. A Family 
Self-Assessment Referral Plan and Model of Supportive Care, based on the 
research findings, are currently being developed in collaboration with patients, 
families, professionals and Myeloma UK. 
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Glossary of Terms 
Allogeneic Stem cell transplant 
Also called an Allograft. A transplant using stem cells collected from a matched 
healthy donor, usually a sister or brother. The risks associated with the 
procedure increase with age. 
Alzheimer's disease 
A progressive neurodegenerative disease characterised by loss of function and 
death of nerve cells in several areas of the brain leading to loss of cognitive 
function such as memory and language. 
Apheresis 
A procedure in which stem cells are collected from the blood using a machine 
which separates them out, returning the remainder of the blood components to 
the donor. 
Bence-Jones proteins 
A characteristic protein found in the urine of some patients with multiple 
myeloma. 
Bone marrow biopsy and aspiration 
A procedure in which a needle is inserted into the centre of a bone, usually the 
hip, to remove a small amount of bone marrow. The aspirate is smeared onto a 
glass slide for microscopic examination. 
Bone marrow biopsy (trephine biopsy) 
Removal of a small core of bone marrow under local anaesthetic. It is used to 
assess bone marrow structure, the number and distribution of all the blood cell 
types. 
Bone marrow harvesting 
A medical procedure which involves collecting healthy bone marrow which is 
stored and kept for a future bone marrow transplant. 
Chemotherapy 
The treatment of disease by means of chemicals that have a specific toxic effect 
upon the disease producing antibodies or work by selectively destroying cancer 
cells. 
Haematological malignancy 
Blood cancer 
Haematologist 
A doctor who specialises in the treatment of blood diseases. 
High Dose Therapy (HDT) 
High dose therapy followed by stem cell rescue or transplant is a standard 
treatment for patients with multiple myeloma. Very high doses of chemotherapy 
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is given, usually melphalan. The high dose melphalan destroys bone marrow 
and re-infusion of stem cells (transplant) is needed to replenish the bone 
marrow until it recovers and produces new cells. 
Immunoglobulins 
Immunoglobulins are proteins in the blood plasma which function as antibodies 
and play an important part in controlling infections 
Lesion 
Any pathological or traumatic discontinuity of tissue or loss of function of a part. 
Leukaemia 
A progressive malignant disease of the blood forming organs marked by a 
distorted stage of the disease proliferation and development of leucocytes 
(white blood cells) and their precursors in the blood and bone marrow. 
Lymphoma 
A malignant tumour of lymphoblasts (blast cell) derived from B lymphocytes 
(white blood cell) most commonly affects children in tropical Africa. 
Monoclonal Gammopathy of undetermined significance (MGUS) 
The most important differential diagnosis in multiple myeloma is MGUS which 
means a paraprotein level exists in the absence of multiple myeloma. These 
patients are monitored as this can transform into multiple myeloma or other 
associated diseases (e. g. lymphoma). 
Monoclonal proteins 
Proteins made by cells which all belong to the same clone are identical and 
called monoclonal 
Multiple myeloma 
A cancer of red bone marrow characterised by an abnormal increase in the 
growth of plasma cells in bone marrow, osteolytic bone lesions which may or 
may not be present, and the appearance of monoclonal proteins which may be 
found in either the blood serum or urine or both. 
Neoplasm 
New and abnormal growth of tissue that may be benign or cancerous. 
Osteolytic 
Characterised by or causing osteolysis or dissolution of bone applied especially 
to the removal or loss of the calcium of bone 
Paraprotein 
These are abnormal immunoglobulins or antibodies produced by a clone of cells 
of the B-cell type for example in multiple myeloma. It's presence in the blood 
acts as an important marker of disease. 
Paraproteinaemia 
The presence of abnormal proteins in the blood. 
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Plasma cells 
Normal plasma cells are found in the bone marrow and produce antibodies to 
fight infection. In multiple myeloma the malignant plasma cells produce large 
amounts of a single abnormal antibody that does not fight against infection 
(cloned cells). 
Plasma cell leukaemia 
A classification of multiple myeloma where there is a high number of circulating 
plasma cells which means there is peripheral blood involvement. 
Plateau phase 
Stable stage of disease in multiple myeloma following a good response to 
chemotherapy. 
Progressive disease 
Myeloma-related organ or tissue damage continuing despite therapy or its 
reappearance in plateau phase (Smith et al 2005). 
Radiotherapy 
The use of high energy radiation (usually x-rays) to kill cancer cells while doing 
as little harm as possible to the healthy cells. It works by targeting cells that are 
rapidly dividing and damaging them so that they cannot survive or reproduce. 
Radiotherapy is used for lytic lesions which are at risk of or have fractures and 
is highly effective in treating local symptoms such as bone pain or spinal cord 
compression. 
Relapse 
Reappearance of disease in patients who have previously had a response to 
treatment, including the detection of paraproteins in the blood or urine, or a rise 
in levels of paraproteins following plateau phase. 
Remission 
Restoration of the blood, bone marrow and general health of the patient to a 
relatively normal state induced by chemotherapy or radiotherapy. Patients with 
multiple myeloma must be monitored in case the disease returns. Remission is 
usually referred to as stable disease. 
Stem cells 
The most primitive cells in the bone marrow from which all the various types of 
blood cell are derived. 
Stem cell rescue (Autologous Stem Cell Transplant) 
Rescue is the preferred term when using the patient's own marrow or peripheral 
blood stem cells which have been collected and stored at an early stage. Also 
called Autograft. 
Supportive care 
Supportive care is general term for all services that may be required to support 
patients and their carers. This includes self help and support, user involvement, 
information giving, psychological support, symptom control, social support, 
12 
rehabilitation, complementary therapies, spiritual support, palliative care, and 
end-of-life and care of the bereaved (NICE 2004). 
Sources: On line Medical Dictionary (1997-2007) University of Newcastle upon Tyne: 
The Centre for Cancer Education. Haematology 13th Annual National Conference 
Advanced Haematological Nursing (2003) Hammersmith Hospital, London. 
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Chapter 1. Background to the study 
1.1 Introduction 
This grounded theory research was an exploration of the experiences of 
individuals living with the incurable and progressive bone marrow cancer 
multiple myeloma, which is poorly understood outside the haematological 
oncological arena. Chapter one commences by providing a definition of the core 
category (Contention) that emerged from the research and its relation to impact 
on life and supportive care needs. The impetus for the study introducing the 
researcher's background and clinical area follows. This is pertinent because the 
experience of working on a chemotherapy day care unit inspired me to 
undertake the project. An overview of multiple myeloma is then presented 
describing various classifications, clinical features and common treatments, 
aims, outcomes and implications of treatment. Justification for the research, 
policy context, study aims and objectives are also addressed and finally a 
summary concludes this opening chapter. 
1.2 The concept of contention 
The findings that emerged from this research are associated with the impact of 
a cancer that is physically and emotionally incapacitating due to the presence of 
bone disease and immunodeficiency. Contention was the core or central 
category that emerged from the research data identified through its frequent 
appearance and explanatory power. Contention is presented as a concept 
relevant to nursing that enhances understanding of the difficulties encountered 
by individuals and their families particularly during stressful events or when 
supportive care needs are either not recognised or not met. A concept analysis 
was undertaken in order to develop a theoretical definition of Contention, 
discussed in more detail (5.3). Contention in terms of living with multiple 
myeloma suggests 'struggle', 'battle', 'disruption' and 'disharmony'. It is a 
multidimensional concept encompassing sociological, psychological and 
physiological manifestations. 
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1.3 The researcher's perspective 
At the beginning of the PhD journey I wrote an account of my clinical practice 
area entitled 'Chair-side nursing' (Appendix 1) which describes the 
chemotherapy day care unit, the patients and staff who provided the inspiration 
and impetus for the research. My professional role is that of a clinical trials 
coordinator. The majority of trials I have been involved with relate to the use of 
single and combined chemotherapy agents for patients with multiple myeloma. 
Although the nature of the work lends itself to huge amounts of necessary 
administration with a focus on data collection and record keeping there is also a 
substantial nursing component. This means spending several hours during a 
working day with the patients attending the day care unit administering 
chemotherapy, and collecting various specimens (blood, urine, bone marrow) 
for local and central laboratory evaluations. 
1.4 Dual role of nurse and researcher 
The boundaries that normally exist between the roles of researcher and nurse 
appear to overlap which makes this particular post (clinical trials coordinator) 
unique. This is partly because clinical trials in oncology have become the norm 
and there is no 'treading on anyone's toes'. Being there as a 'research person' 
is acceptable and it is implicitly understood that while attending to the patient I 
also take on the responsibility of a trained nurse because I am invariably looking 
after very sick people. Patients living with multiple myeloma may arrive on the 
day care unit depressed, distraught or extremely ill and barely able to walk. In 
these circumstances the role of the nurse supersedes that of the researcher 
and research activities or'run of the mill' procedures are put on hold. 
In a previous job as a clinical trials coordinator in thrombosis research I was 
involved with trials which focused on prophylaxis for patients undergoing hip 
and knee surgery. I was often made to feel like an intruder and did not feel very 
welcome on some of the hospital wards. One ward sister finally accepted my 
presence when she saw that I was prepared to stop collecting data and get 
someone a bedpan. The fundamental difference between oncological and 
thrombosis trials is that one aims to extend the person's life while the other aims 
to reduce the risk of a post operative complication (albeit a deep vein 
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thrombosis which could potentially lead to a fatal pulmonary embolism). The 
fact that some of the trial medications are considered to be experimental has no 
bearing in the field of oncology where it may be looked upon as a potential 
miracle cure or at best another reprieve. Patients informed of treatment options 
can choose between not participating in a trial and receiving a standard or 
traditional therapy, or participating and receiving a new combination of standard 
therapies, or participating and receiving a completely new therapy (unlicensed 
drug). Some patients simply run out of options having had several lines of 
conventional therapy and the only path left open will be the new treatment. 
Spending much of my time on the day care unit administering chemotherapy to 
the patients has meant that I have become 'part and parcel' of the day care unit 
staff although my role is that of a 'research person'. I wear a nurse's uniform. 
Wearing a nurse's uniform was something I deliberately chose to do so I could 
'blend in' and not feel like an 'outsider'. It was important that I did not appear to 
be different from my nursing colleagues working on the day care unit. It also 
prevents any confusion as to who I am. For instance, a patient I met for the first 
time wanted to know if I was a "proper nurse" because I was not in uniform. 
Furthermore there are the practical aspects of the job, issues of hygiene, 
infection control, health and safety when obtaining blood samples or handling 
cytotoxic drugs and the need to wear protective clothing. 
1.5 Attending the chemotherapy day care unit 
Patients coming to the day care unit for the first time are usually apprehensive. 
They and their families are not only coming to terms with the diagnosis of 
cancer but are trying to get used to the idea that they are going to receive some 
form of treatment and this will mean making changes to their normal routine. A 
newly diagnosed patient is given huge amounts of verbal and written 
information in a short space of time often during one or two visits to the clinic. 
This can be extremely overwhelming for some while for others it is welcoming 
and reassuring. High levels of anxiety can arise because of the adaptations 
they must make to their lives. It can be particularly stressful when patients have 
dependants prior to the onset of the illness such as young children, elderly 
parents, or a spouse who needs care and would normally rely upon them. 
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Receiving cycles of intravenous chemotherapy may involve travelling to the day 
care unit twice a week for two out of a three-week cycle, for example. Other 
supportive medical care may be required between treatments such as blood or 
iron infusions. The illness, the treatment, and the associated travelling can 
cause extreme tiredness and fatigue. Getting to the day care unit, receiving the 
treatment, and getting away to spend the rest of the day doing normal things 
becomes the main objective, even if this means resting for long periods at 
home. The main focus for all patients is whether or not the treatment is 
working. Newly diagnosed patients often assume that this will be so. However, 
for those who are 'fully trained', that is they have already received several lines 
of therapy, know that this is not always the case and are familiar with the 
unpredictable path of the disease and its response to treatment which is 
discussed in more detail in the next section on multiple myeloma (1.6). 
The chemotherapy day care unit is often overcrowded with people. Nurses and 
doctors are seen walking in every direction. Nurses may be cannulating 
patients, taking blood samples, or setting up infusions. Doctors might be 
examining patients; phones are ringing constantly; bleeps are bleeping; patients 
are having treatments or they are waiting to be seen. Patients are treated and 
then go home. Alternatively patients become too ill to go home and are 
transferred to a ward. Amidst the `hustle and bustle' of the day care unit 
environment a patient left waiting may start shouting or burst into tears and it is 
not until there is such an emotional outburst that anyone is aware that 
something is wrong. Some patients remain quiet while waiting to be seen, while 
others talk together often about their illness, their treatment, and whether or not 
they feel they are making any headway. There are patients who will tell a nurse 
without being questioned that there are problems such as the physical side 
effects from the medication (chemotherapy), or that they have depression. 
Sometimes patients do not want to make a fuss; they see how busy the nurses 
and doctors are, and as a result of this they remain quiet. However, it cannot be 
assumed that there are no problems. Patients participating in clinical trials are 
usually keen to report any side effects or adverse events because they 
appreciate the importance of collecting information and how it will affect future 
patients and the way in which the illness is treated. 
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1.6 What is multiple myeloma? 
Multiple myeloma is a haematological malignancy or neoplasm characterised by 
an abnormal increase (cloning) in the growth of plasma cells in bone marrow, 
osteolytic bone lesions which may or may not be present, and the appearance 
of monoclonal proteins which may be found in either the blood serum or urine or 
both (Hoffbrand et al 2001). The 'cloned' plasma cells (myeloma cancer cells) 
produce immunoglobulins (antibodies). Their normal counterparts 
(immunoglobulins or antibodies) are thus significantly decreased resulting in an 
immune system that becomes compromised leading to recurrent infections. The 
cancer is complex and diverse and can be extremely debilitating due to bone 
disease. Sirohi and Powles (2004: 875) describe the activity of the disease as: 
"Intricate interactions occur between the bone-marrow microenvironment and 
the myeloma cells, frequently causing bone destruction which in turn stimulates 
tumour growth". 
Numerous bones can be diseased with myeloma cells hence the term 'multiple'. 
It is not something that can be seen or detected easily unlike other cancers, for 
example a breast lump or an obstruction (blockage) due to for example, a rectal 
carcinoma. Several areas of expertise may be required during the course of 
managing the disease for example haematologists, haematological nurses, 
orthopaedic surgeons, and chemical pathologists (Bradwell 2003). It has an 
unpredictable path with numerous periods of relapse and remission. A patient 
can die within days or weeks of being diagnosed on one hand and on the other 
can live for many years with a 'smouldering' myeloma that does not require any 
medical intervention (Bradwell, 2003). Despite the modern treatments of 
combination chemotherapy, high dose therapies such as melphalan and stem 
cell rescue multiple myeloma remains incurable with a median survival of 
between 3-4 years. 
1.6.1 Incidence 
The incidence of this uncommon form of cancer has more than doubled since 
the middle of the 1960s, which is almost certainly due to the wider use of 
specific diagnostic tests namely protein electrophoresis (blood serum tests) and 
bone marrow aspiration (Foerster, 1993). Multiple myeloma represents only 1% 
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of all cancers and has been reported in all ethnic groups. In the United 
Kingdom there are approximately 10 - 15,000 people living with multiple 
myeloma at any one time and there are about 3,500 patients diagnosed per 
year (King 2003). In America there are more than 45,000 people living with the 
disease and approximately 14,000 diagnosed annually. Interestingly it is defined 
as the "orphan disease" (Dalton 2004) implying that it has not received the kind 
of media coverage favoured by other more common cancers such as breast or 
lung cancer. It has a higher incidence in males and the majority of patients are 
over the age of 40 at the time of diagnosis. The median age of 63 has 
decreased (Schey and Pallister 2004) in recent years and there appears to be 
an increase in the number of younger patients. Myeloma is more common in 
the Afro-Caribbean ethnic groups than Caucasians or Asians. The cause has 
not been identified but certain contributory factors may be associated with 
myeloma such as: genetic factors; weakened immune system; exposure to 
particular chemicals; radiation and viruses (Morris, 2003). 
1.6.2 Classifications 
Multiple myeloma is classified according to the type of immunoglobulins (Igs) 
involved. The structure of each Ig molecule is made up of two heavy chains and 
two light chains. The Ig molecule itself is normal but sometimes these are 
altered due to disease or separated resulting in a rare heavy chain disease or 
the more common light chain disease. Light chains are also known as Bence 
Jones proteins and there are two types of these called Kappa and Lambda. 
Only one or the other is present. The monoclonal protein or paraprotein level 
found in the blood serum is IgG in two thirds of the population of myeloma 
patients; IgA in one third; IgM, IgD or IgE are rarely found but can exist on their 
own or coupled together meaning Biclonal. Figure (1) displays the percentages 
of these classifications based on monoclonal protein production or type of 
immunoglobulin involvement. The urine contains Bence Jones protein (Kappa 
or Lambda free light chains) in two thirds of the myeloma population and in 
some cases is present without a serum paraprotein (Hoffbrand et al 2001). It is 
therefore not unusual to see on the medical history page of the patient's case 
notes 'IgG kappa multiple myeloma' or 'IgG lambda multiple myeloma'. 
Myelomas, the majority of which are secretory, are also classified in more 
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generalised terms such as symptomatic myeloma, asymptomatic myeloma 
(smouldering myeloma), and plasma cell leukaemia where there is peripheral 
blood involvement. The non-secretory myeloma is rare and there are no 
paraproteins found in either the blood serum or the urine making it problematic 
when assessing response to treatment and progression of the disease. Another 
classification and the most important differential diagnosis is a condition known 
as monoclonal gammopathy of undetermined significance (MGUS) which 
means a paraprotein level exists in the absence of multiple myeloma. This can 
however transform into multiple myeloma or another associated disease 
(lymphoma, amyloidosis) in 26% of patients (Singer, 1997) therefore these 
patients are monitored closely and may attend the haematology outpatient clinic 
3-6 monthly for a blood test. 
-0%  IgA 
1% lIgE 
QIgp 
Q IgG 
  FL chains 
  Biclonal 
  Non-secre 
59% 
Figure 1 Classification of multiple myeloma based on monoclonal protein production. 
(Bradwell 2006: 62) 
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1.6.3 Clinical features 
Clinical features vary according to the different types of myeloma. The most 
common of these are: bone pain, recurrent or persistent infection, renal 
impairment, and anaemia. One or all of these may be present however some 
patients are totally asymptomatic and diagnosis may be made following a 
fracture or a blood test for other reasons. Further clinical presentations include 
persistent and unexplained backache, height loss and osteoporosis (especially 
in males and premenopausal females) and spinal cord compression. 
Abnormalities such as thrombocytopenia, leukopenia, persistent elevated 
erythrocyte sedimentation rate (ESR), and hypercalcaemia may also occur (The 
UK Myeloma Forum Guidelines Working Group, 2001). There may arise in 
patients various presentations such as hyperviscosity syndrome with purpura, 
haemorrhages, visual disturbances, neurological imbalance, neuropathies, and 
heart failure which is more common in IgA, IgM, or IgD myelomas (Hoffbrand et 
al 2001). According to Foerster (1993) there appears to be a greater reduction 
of the normal immunoglobulin, in the IgG myeloma, more frequent infections, a 
higher serum paraprotein level, slower growth rates in tumours, less 
hypercalcaemia and amyloid disease than is present with other isotypes. 
1.6.4 Treatment 
Myelomas are often referred to as being in a state of 'relapse' or 'refractory' 
which means that the disease is not responding to treatment. Finding an 
effective treatment is often a challenge. It might only be achieved through 
persistent trial and error. Shain and Alsina (2004) argue that the disease 
remains incurable largely due to the mechanisms of drug resistance. Common 
treatments include chemotherapy, steroids, high dose chemotherapy, for 
example melphalan with autologous stem cell rescue (autograft), thalidomide 
and more recently bortezomib (velcade) and arsenic trioxide. Treatment with 
chemotherapy is indicated for patients with symptomatic myeloma. Medical 
intervention prior to the onset of symptoms has not proved beneficial (Hjorth et 
al 1993; Riccardi et al 2000). 
The aim of treatment is to slow the progress of the disease to achieve a partial 
or complete response (sometimes there is no response) to therapy; control the 
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symptoms and improve the patient's quality of life (Morris, 2003). Treatment is 
aimed at reaching a 'plateau phase' where the paraprotein level falls 
significantly and remains at a level suggesting stabilised disease; or for the 
paraprotein level to fall to zero when the patient enters a remission period. 
Many patients are entered into clinical trials and have the option of receiving 
novel single and/or combination therapies. Radiotherapy is often used for lytic 
bone lesions, which are at risk or have already developed fractures, and is 
highly effective in treating local symptoms such as bone pain or spinal cord 
compression (Hoffbrand et al 2001). Bisphosphonates, such as clodronate and 
pamidronate are also given to control bone disease, hypercalcaemia, and may 
also have an anti-tumour effect (Cavenagh and Croucher, 2004). Transfusions 
or erythropoietin, which stimulates red blood cell production, are also given to 
treat anaemia. 
1.6.5 The physiological impact of treatment 
Treatment can be problematic due to the potential side effects or adverse 
events which can cause extreme anxiety and discomfort for the patient. 
Routine prophylactic medications given to patients receiving chemotherapy 
include anti-emetics, (for nausea and vomiting), anti-diarrhoea drugs, antacids 
to reduce gastric acidity, anti-viral drugs to reduce the risk of herpes simplex 
(cold sore) and zoster (shingles); anti-fungal lozenges and anti-bacterial mouth 
wash for oral mucositis which are all common side effects from chemotherapy. 
Infusions of immunoglobulins, oral broad spectrum antibiotics and anti-fungal 
agents may also be needed for recurrent infections. During treatment cycles 
many patients are treated in a chemotherapy day care unit. The disease, 
treatment and travelling can all add to extreme tiredness, lethargy and 
depression that have been evident in practice. 
Repeated accessibility to veins can be difficult and time consuming when 
administering chemotherapy. Venous cannulation can be painful and phlebitis 
is not uncommon especially after repeated treatment cycles. Extravasation can 
occur if a cannula becomes displaced during administration (where the needle 
passes out of the vein and into the tissues) of vesicant cytotoxic drugs causing 
severe local tissue necrosis. A central line or catheter can be inserted into the 
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right vena cava or atrium for some patients having repeated treatments and has 
the advantage of reducing the possibility of extravasation and preserves 
peripheral veins. Common side effects of chemotherapy and other agents used 
can be particularly distressing for patients. Side effects include alopecia, 
gastrointestinal dysfunction, peripheral neuropathy, anaemia, and fatigue 
(Schey and Pallister 2004). 
1.6.6 The psychological impact of treatment 
Patients with multiple myeloma may have several lines of therapy and many 
become highly experienced and knowledgeable about the disease and 
treatment options. There is a huge focus on 'paraprotein levels' or 'M Bands' 
because these act as 'markers' by which patients can measure their response 
to treatment. They usually want to know if the therapy is working and need 
constant reassurance that it is. Paraprotein levels will drop significantly if the 
response to treatment is good. Alternatively they can remain static in which 
case there is no response; or it may rise significantly indicating disease 
progression. There is excitement and relief when there is a drop in paraprotein 
levels, frustration when the treatment does not appear to be making any 
difference and sheer despondency coupled with disappointment when the level 
rises. Importantly nurses are not always in a position to provide the 
psychological or emotional support needed by the patient and their family due to 
staff shortages and additional pressures or lack of appropriate skills. 
1.7 Assumptions and context of care delivery 
Healthcare professionals make many assumptions about what they think the 
patients are going through and what it must be like for them. In reality we 
(healthcare professionals) cannot possibly know what it is like and how the 
illness is affecting an individual and their lives or that of their families. Two 
publications have been written during the course of the project with the aim of 
highlighting a better appreciation of these issues. The first paper (Smith, Cox 
and Kelly 2007) aims to increase awareness and understanding of this relatively 
unknown cancer and includes a patient case study illustrating the impact of the 
disease on the individual. The second (Smith and Cox 2007) provides some 
insight into the often aggressive nature of the disease within the context of end- 
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of-life care. The narrative content portrays a dying mother and how the family 
coped with the illness and impending death. (Articles shown in Appendix 2). 
If we (healthcare professionals) do not know what is going on in people's lives, 
how can we help them? If we do not know what is going on emotionally how 
can we understand why they are behaving in a certain way? How, in turn, can 
we become more sensitive to their needs? It might well be that a person will not 
wish to share life experiences with healthcare professionals, whilst on the other 
hand patients who do want to share their experiences and emotional problems 
may not have the opportunity to do so. The kind of environment in a 
chemotherapy day care unit may not be conducive because, for example, it is 
an open plan area with reclining chairs almost touching one another; spaces 
over flowing with people and examination rooms constantly in use. 
Assumptions are usually made based upon an outer appearance and what 
people perceive as `normal'. Patients with multiple myeloma often appear to 
look well. It can therefore be deceptive. It is not uncommon for individuals to 
camouflage or hide their true feelings when necessary. For example one male 
patient stated that he could not tell his elderly parents that he has cancer and 
has so far kept it from them. A female patient disclosed that she had been 
invited to a formal luncheon and her one fear was that she may have to take a 
wheelchair. 
Another example, which heightens the layperson's perception, was brought to 
my attention while booking hospital transport for a patient. A member of the 
transport department informed me that there was no room for the patient's 
husband who always accompanied her when she came to the day care unit for 
chemotherapy. The member of staff working in the transport department stated 
that the patient always looked well and did not require an escort. The issue was 
quickly resolved following a discussion with the manager of the department. 
However the situation highlighted the fact that there are people employed within 
the hospital environment who have regular contact with patients and their 
families, and who have little or no knowledge of the illness, its implications or 
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supportive care needs. It can be argued therefore that there may exist a lack of 
understanding and sensitivity towards patients and their families. 
1.8 Justification for the study 
The justification for this field of enquiry was determined by the lack of qualitative 
studies undertaken. No studies were found relating specifically to the 
experience of living with multiple myeloma. Very few contributions were found 
when searching for nursing research and multiple myeloma (Coon and 
Coleman, 2004; Coleman et al 2003; Coleman et al 2002). The body of 
research mainly consists of randomised controlled trials, unrandomised trials, 
the management and treatment of multiple myeloma and quality of life issues. 
All of these are are of paramount importance because the main aim of these 
studies is to extend life and improve quality of living, however, they do not 
address in depth the supportive care needs of these patients. 
The Cochrane Central Register of Controlled Trials currently has 973 articles 
relating to clinical trials and multiple myeloma (key search terms used on the 
Cochrane Database, March 2007). There are 4,801 records of multiple 
myeloma in the title, abstract or keywords in the Cochrane Data Base of 
Systematic Reviews (April 2007). 
Quality of life questionnaires are commonly used for data collection for example 
the European Organisation for Research and Treatment of Cancer (EORTC) 
comprise of Liked scale answers for the patients to choose ranging from a 
score of 1-4 and 1-7 with the highest figure being the most positive response 
and the lower figure the most negative. Vast amounts of information are 
collected in this manner and although questionnaires are quick and easy to use 
they do not always take into account the complexities of human behaviour. This 
research which is a qualitative enquiry therefore, serves to complement the vast 
number of quantitative research projects in existence. 
1.9 The policy context 
The NHS Cancer Plan (2000) set out to improve supportive and palliative care 
for adults with cancer in collaboration with NICE (National Institute for Clinical 
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Excellence, 2004). Key topic areas include: communication, information, 
coordination of care, psychological, social and spiritual support. The 
experience of living with multiple myeloma required input from each of these 
parameters which was particularly relevant when considering an individual 
patient's unmet needs; implementation of service development and implications 
for future research. The purpose of this study was to provide a detailed 
description of the impact of multiple myeloma on that of the individual and the 
family, to enhance knowledge, and to inform clinical nursing practice. The 
ongoing challenges addressed in the Cancer Reform Strategy (Department of 
Health 2007) that were pertinent in this research related to delayed diagnosis 
and treatment; accessing life prolonging cancer drugs; difficulties in 
communication, ongoing support and accessing information. Collecting data on 
patients' experiences of cancer care was also indicated in the Cancer Reform 
Strategy (NHS 2007) which this grounded theory study contributes to. National 
and Local strategies for cancer and palliative care may have a substantial 
influence on clinical practice, however, the reality is that in order to succeed, 
high expenditure, resources and expertise are required. In haematological 
malignancies (NICE 2003), it appears there is a lack of research evidence to 
support some of the critical questions presented in relation to improving 
outcomes such as: 
"Is there evidence of better patient outcomes with early/prompt diagnosis 
compared with a delay in making diagnosis of haematological malignancies"? 
(NICE 2003: 7). 
The evidence presented in this research suggests that delayed diagnosis in 
multiple myeloma may result in disease progression. Multiple skeletal fractures 
requiring surgical intervention (5.4.1) could potentially impact on the choice of 
treatment; thus reducing options because of toxicities associated with high dose 
chemotherapy and serious side effects. The implication is that early diagnosis 
can lead to prompt treatment of bone disease and a better quality of life. 
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1.10 Aims and objectives 
The initial research working title for the project was 'Living with multiple 
myeloma: A study to explore patients' experiences and supportive care 
implications'. The aim of this study was to explore the experience of living with 
multiple myeloma from the patient and family perspective to determine their 
supportive care needs. This was an exploration of the participants' individual 
views. The primary objectives were: 
" To explore the meaning of multiple myeloma in terms of becoming ill and 
being diagnosed 
" To explore the meaning of living with multiple myeloma in terms of 
impact on the participant's personal or family life 
" To explore the meaning of living with multiple myeloma in terms of 
impact on other family members 
" To explore the meaning of living with multiple myeloma in terms of the 
participant's professional or working life 
" To explore participants' perceptions of the health care and supportive 
care services. 
These objectives have been achieved and the substance with findings are 
explicated in this thesis. 
1.11 Summary 
Chapter 1 has provided background information for the study. The impetus and 
inspiration for the project gradually evolved from the researcher's experience 
while working on a chemotherapy day care unit as a clinical trials coordinator 
specialising in multiple myeloma. The dual role of nurse and researcher has 
been discussed from the researcher's perspective. The research explicated in 
this thesis focuses on a unique cancer that is complex and understood poorly. It 
has a low profile in comparison to other cancers and evokes specific demands. 
It is these that form the focus of this research. This chapter has taken into 
account the impact of the illness, the treatment, and the impact of the treatment. 
Assumptions made in clinical practice; justification for the research; policy 
context; aims and objectives for the study have been introduced. Chapter 2 
(Literature review) follows with reference to the literature review that preceded 
data collection in order to provide background information for the initial research 
proposal. There is a presentation of the subsequent updated literature review 
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undertaken after completion of data collection and within the context of 
the 
findings. 
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Chapter 2. Literature review 
2.1 Introduction 
The literature was reviewed at the time of the research proposal in 2004 and 
updated in light of the research findings in 2008. The cancer literature served to 
provide the background information and identified the void that was apparent. The 
methodology employed in this research was grounded theory, and to undertake an 
updated and extensive review of the literature prior to collecting the data and 
identifying an emerging central or core category, violates the basic premise of this 
approach. This is because the research design is aimed to generate theory that 
emerges from data and not from any existing knowledge (Glaser and Holton 2004). 
A summarised version of the review undertaken in 2004 is shown in Appendix 3. 
This chapter commences with returning to the literature in 2008 in view of the 
research findings, defines the scope of the literature search, the approach to the 
meta-synthesis of qualitative research, the meta-synthesis and summarises the 
current evidence. 
2.2 The 2008 literature review 
2.2.1 Returning to the literature 
Returning to the literature towards the end of the study meant that I could consider 
a review in terms of the findings from this research, which are presented in Chapter 
4. The 2004 review was undertaken with the aims of the research project in mind 
and two years before commencement of main data collection. My original research 
question was 'What is it like living with multiple myeloma'? At this time there 
appeared to be no qualitative enquires that addressed this specific question. 
Four qualitative research studies (Carter et al 2004; Persson and Hallberg 2004; 
Mok et al 2003; Thome et al 2003) were identified and considered pertinent 
because they represented the patient and family perspective drawing from the 
experiences of dealing with various forms of cancer. 
2.2.2 Scope of literature search 
The CINAHL search results displayed a total of 1020 hits using the search term 
'multiple-myeloma. mp' and yielded 6 results when combining named 'qualitative 
research designs', (Dahan and Auerbach 2006; Johansson et al 2005; Coon 2003; 
McGrath 2004; Bulsara et al 2004; and Herrmann et al, 1998). Only three of these 
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articles relate specifically to multiple myeloma. The remaining three concern 
haematological malignancies per se. MEDLINE produced 1016 hits using the 
search term 'multiple-myeloma. mp' and when combined with 'qualitative 
methodologies' or 'research designs' yielded a total of 5 hits (Jones et al 2006; 
Stephens 2005; Johansson et al 2005; Coon and Coleman 2004; and Herrmann et 
al 1998). Only three of these articles were found to relate specifically to multiple 
myeloma. Extending the search including the search term 'cancer. mp' yielded 2424 
hits (CINAHL 1982-2008) and 958 hits (MEDLINE 1950-2008). 
Returning to the literature in light of the findings was based on the following search 
terms: 'communication', 'impact on life', 'impact on family' and 'supportive care'. 
The literature is silent in relation to these topics in multiple myeloma. The papers 
selected for the synthesis were selected according to the following criteria: 
" Topic relating to findings 
" Qualitative research design 
" Clinical practice area (blood cancers, other cancers, chronic diseases) 
" Patient and family perspective 
" Healthcare professional perspective. 
The following synthesis aims to demonstrate relationships between the studies and 
provide new knowledge and understanding. Similarities and contrasts from the 
synthesis of pertinent qualitative research are compared to the findings of this 
research making a further contribution to the body of existing knowledge in the 
complex field of haematological oncological nursing. With the exception of the 
articles mentioned above, I was unable to find any further literature relating to 
multiple myeloma. 
2.2.3 Approach to qualitative meta-synthesis 
The meta-synthesis of qualitative research aims to address the main concepts in 
the literature that correlate to the findings. A synthesis is not just an amalgamation 
of related published research findings but the generation of renewed understanding 
or interpretation adding to that which is already known (Beck 2003; Britten et al 
2002). The approach to this meta-synthesis is guided by the use of Noblit and 
Hare's (1988) framework of meta-ethnography and Schutz's (1962) levels of 
interpretation in relation to 'common sense and science' referred to as first and 
second order constructs. This approach was first suggested by Britten et al (2002). 
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Two of these authors (Britten and Pope) facilitated a one-day qualitative synthesis 
workshop at the University of Exeter (10/07/2007), which I attended and provided 
the guidance and inspiration for the approach taken. 
Following completion of data collection eighteen relevant research papers were 
included in a grid (Appendix 4) under the main headings of 'communication', 
'impact on life' and 'supportive care needs' representing three of the four main 
interrelating category groups that emerged from this research project. The fourth 
main category 'nature of disease' consisted of the subcategories 'delay in 
diagnosis', 'living with uncertainty', 'perceptions of disease' and from 'novice to 
expert patient' (gaining knowledge) all of which were found in the selected literature 
and are incorporated under the heading of 'impact on life' for the purpose of this 
synthesis. The grid (Appendix 4) includes details of each article including 
participants and setting to provide the context for the interpretations and 
explanation of each (Britten et al 2002). Listed representations of corresponding 
second and third-order interpretations from each paper are displayed in Appendix 
5. The second-order as defined by Schutz (1962) are the original scientific 
interpretations by the authors and the third-order interpretations generated are 
presented in the form of conceptual hypotheses (Britten et al 2002). The qualitative 
meta-synthesis follows under the corresponding headings from the grid (Appendix 
4): communication, impact on life and supportive care needs. 
2.3 Communication 
The first six qualitative papers on the grid focus on communication issues. The first 
two are concerned with the breaking of bad or significant news, one of which is 
from the doctor's perspective while the other is from that of the patient's. The 
remaining four examples are associated with how individuals respond to 
communication within the home and clinical environment, specific language used 
when ending active cancer treatment, interactions between patients and healthcare 
professionals, how parents communicate with their children and how much 
information is disclosed when mothers are diagnosed with breast cancer. 
Regardless of cultural differences and different health care systems in other 
countries the emphasis is on the experience of cancer, illness and disability, the 
impact on individuals, their families and the healthcare professionals with whom 
they interact. 
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2.3.1 Doctors breaking bad news 
This study was selected because it was undertaken from the doctors perspective 
and although this may be viewed in terms of a limitation (excluding the patient and 
family perspective) it compliments the following studies. From the doctor's point of 
view, breaking bad news was perceived as both challenging and emotionally 
demanding (Friedrichsen and Milberg 2006). The study aimed to explore the 
experiences of doctors when telling patients with advanced cancer that treatment 
was being discontinued. This was viewed in terms of losing a certain amount of 
control regarding their ability to cope in a professional manner when dealing with 
difficult circumstances. Informing the patient that there was no longer going to be 
any further cancer treatment was perceived by the doctors as a reversal of the 
healing role to that of the role of the 'assassin' and the subsequent ramifications of 
guilt, helplessness, inadequacy and failure. This may have a fundamental impact 
on the relationship between doctor and patient/family particularly when the 
relationship is a close one. Patients with haematological malignancies, for example, 
establish relatively close relationships with consultants and nurses who are 
managing their care and treatments over a prolonged period of time, which may 
last for a significant number of years (McGrath 2001). 
Friedrichsen and Milberg (2006) reports the difficulties doctors sometimes have 
communicating a negative message when complex relationships exist among close 
family members especially when they are unable to communicate with each other 
about the situation, for example, avoiding the reality of an imminent death of a 
loved one and protecting each other because it is too distressful. In some cases 
'hope' or'denial' can have such a powerful influence that individuals are reluctant to 
accept that there is nothing more to be done other than palliative treatment. The 
setting for this study was Sweden and doctors discussed interactions with patients 
from outside the country and for whom it was necessary to communicate through 
an interpreter. The doctors felt they had an ethical and moral duty to disclose all the 
information but believed that the patient's cultural backgound determined the type 
and amount of information likely to be delivered during the translations. Thus there 
was a potential for deliberate misinterpretation and the patient may not be informed 
about the gravity of their illness. Communicating bad news to individuals that 
doctors were seeing in clinic for the first time posed problems because of 
uncertainty, not knowing how they are likely to respond in the absence of prior 
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personal knowledge, which could only be gained through previous encounters. 
Doctors in Friedrichsen and Milberg's (2006) study felt they were not always able to 
rely on scientific evidence and therefore relied upon their own clinical judgement 
and frequently considered their individual clinical experience to be more 
trustworthy. The scepticism was a result of inconsistency among published 
findings from various different papers and the knowledge that there was no 
guarantee that any one treatment regime would work effectively or successfully on 
any individual patient. Patients who gained knowledge through the Internet were 
sometimes more informed about novel cancer agents available than the doctors, 
which created frustration when family members demanded a specific treatment that 
may have been available in other countries. These encounters undermined the 
doctors' clinical judgement as it was considered virtually impossible to keep up with 
all the ongoing clinical trials and research worldwide. It therefore appeared that 
their medical competence and knowledge were being called into account. 
Questions relating to existential circumstances were sometimes a struggle to 
answer for example giving an exact period of time that an individual may survive or 
stating why that particular person had cancer. 
Time and environmental disturbances during consultations were additional reported 
factors that contributed towards losing control of the situation when managing the 
breaking of bad news to patients and their families. Finding a balance is reported 
as complicated in a highly specialised clinical area because patients and families 
need the doctor's undivided attention when delivering significant news; while at the 
same time others (hospital colleagues) may demand immediate access to a clinic 
consultant for a critical situation concerning others. Lack of time implies that 
patients and families may have felt rushed. Unexpected interruptions sometimes 
disrupted the consultation exacerbating the experience of giving and receiving bad 
news further. For example doctors reported finding it difficult to return to the same 
level of concentration having been disturbed. 
2.3.2 Patients receiving bad news 
The second paper concerned with the giving of bad news from the patient's 
perspective (Randall and Wearn 2005) focused on six main themes: the character 
of the doctor, available time and attention, type of information and terminology 
33 
used, the ongoing process and regular follow ups, ongoing support and the setting 
or place where the news was given. This paper was selected for its relevance to 
the haematological clinic setting. Two out of fifteen participants were concerned 
that the information they disclosed during interviews may have been interpreted as 
criticism towards the healthcare they had received implying that the researcher 
(medical student) had a significant influence on the data collection. All participants 
were Caucasians which excluded individuals from different ethnic and cultural 
backgrounds which may have enhanced the study. 
The findings suggest that patients prefer to have an honest and direct approach 
when hearing such information but it is also important that it is done in a friendly 
and professional manner by an individual known to be a cancer specialist. 
Contrasting experiences with consultants are reported. For example one patient 
was discouraged from asking questions because there were no answers, while 
another patient received a 'good' response to all questions. The majority of the 
patients (10 out of 15) spoke of the amount of time given to them during 
consultations and how much they appreciated not feeling rushed during busy clinic 
sessions. There were exceptions when patients felt that consultants hurried through 
clinic appointments and so did not feel that they were being treated as individuals. 
All the participants in this study stated that they wanted to know what the diagnosis 
was and it is suggested that information was not forced on them allowing them 
choice regarding amount of detail given. Those individuals that were given 
information leaflets reported having some control over the situation and could 
access information when and if they needed to, which was perceived as helpful. 
Abbreviations used in consultations such as "CLL" (Chronic Lymphocytic 
Leukaemia) and language that is commonplace in haematological terms such as 
"platelets" (Randall and Wearn 2005: 597) had a significant impact on individuals 
resulting in confusion. However nurses were said to play a principal role reiterating 
and further explaining what had been divulged. 
In this study (Randall and Wearn 2005) the main concern for patients during the 
ongoing process following diagnosis was that they would continue to be followed up 
and monitored. Due to the absence of visible symptoms they were unable to 
establish any significant changes or deterioration associated with their illness. 
Continuity and seeing the same person who initially diagnosed the individual was 
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viewed as advantageous and desirable. Alternatively there was a strong preference 
to see someone who was familiar with the medical history and whom they had met 
previously. Although treatment may have been non-curative it symbolized some 
semblance of hope on one hand, while on the other some patients felt they may be 
abandoned at some point in time. Participants did not feel qualified or appear to 
have the knowledge to participate in decision-making regarding treatment options 
(which perhaps is not surprising when individuals were newly diagnosed). However 
some participants who felt unqualified to make decisions regarding their treatment 
had been diagnosed for several years with haematological malignancies. This 
represented a complete contrast to patients I interviewed in the present study who 
were living with multiple myeloma; some of whom appeared to have developed 
from 'novice' into 'expert' patients. 
Randall and Wearn (2005) addressed the provision of emotional support at the time 
of the diagnosis and during the illness which was provided mainly by the person 
accompanying the patient to the hospital. The majority (10 out of 15) had someone 
with them who also took on the advocacy role and kept other family members 
informed. Having someone with the patient was also perceived as an invaluable 
asset as the assumption was that an additional 'listener' was often able to take on 
board the content of the information provided which could be repeated at another 
time. This clearly indicated that there might have been a need for emotional support 
at the time of diagnosis for unaccompanied individuals. Access to nursing staff at 
any time was perceived as supportive and reassuring. The environment or room 
used for breaking bad news was not apparently an issue for the participants but 
when prompted, the key concerns were that the conversation should take place in a 
private but normal clinical consultation room and face-to-face sitting down with the 
person disclosing the news. The issues arising in the present study mirror at least 
some of these findings. 
2.3.3 Responses to bad news 
Byrne et al's (2002) paper centred on clinical communication which may ultimately 
affect the way individuals respond to a diagnosis of cancer and its aftermath. The 
main categories that emerged from this research were 'concealing distress', 
'accepting' and 'rejecting the cancer'. This research also excludes participants from 
other cultural and ethnic backgrounds and does not reflect a realistic proportion of 
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the population from a multicultural society living in Liverpool. 
The majority of participants (28 out of 30) employed strategies enabling them to 
masquerade their emotions which were considered to be too burdensome or 
distressful to share with others. Therefore the emotional needs of family and friends 
superseded those of their own. Family members often collaborated in going along 
with the facade. It is suggested that doctors may encourage family members to 
conceal their distress so that they do not display any signs of weakness in front of 
their loved ones as this would only serve to exacerbate their suffering. 
Conversations with doctors during clinic visits concentrated mainly on the physical 
aspects of the disease. There appeared to be a reluctance to disclose any 
information during consultations associated with personal concerns or emotions 
because patients perceived these as potentially undesirable and embarrassing, 
implying that it would portray unacceptable behaviour. 
'Rejecting cancer' was associated mainly with negative emotional responses that 
the illness evoked and the effort or struggle to suppress these. There appeared to 
be a struggle or conflict between the suppression of emotions and the desire to 
liberate or unload them. Suppression of emotions was sometimes determined 
through individual coping mechanisms, uncertainty and ambivalence, or because of 
constraints in the heath care environment. The setting in one hospital, for example, 
was described as more conducive when compared to another enabling patients to 
sit at tables and talk which seemed to have a beneficial impact. The emphasis on 
staying positive has been encouraged by healthcare professionals but perceived as 
being discouraged from expressing how they (patients) were genuinely feeling. 
Thus they might not legitimately speak about issues that were considered negative, 
frightening or distressing. Maintaining normality or returning to familiar routines 
was considered imperative for individuals especially following surgery and 
treatment. A minority (6 out of 30) appeared to minimise the seriousness of the 
cancer and its consequences, which was demonstrated through nonchalant 
expressions such as "it was only a boob" in reference to mastectomy, and "there's 
plenty of people worse off' (Byrne et al 2002: 18). 
'Accepting the cancer' was categorised in terms of various responses such as living 
through phases of shock and bewilderment lasting for days, and in some cases 
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several years following diagnosis. Others reacted by trying to think of what may 
have triggered the disease. One patient recalled how she had bumped into 
something and hurt her breast prior to the diagnosis, which was where the cancer 
originated. Many lived in fear of an unknown future, recurrence of the cancer and 
imminent death. The "constant struggle with the fear" (Byrne et al 2002: 19) 
was associated with the cancer and the emotional response to it such as how well 
they would cope psychologically if the cancer returned. Others focused their 
attention on preparations and future arrangements concerning the family and home 
environment to maintain normality for the children. Some participants viewed the 
situation as inevitable, accepting that the cancer existed and they just had to get on 
with what ever was necessary. In other words, nothing could change the fact that 
the cancer existed and the best solution was to eliminate it by whatever means at 
their disposal, and as quickly as possible. 
Byrne et al's (2002) study also suggested a re-evaluation of life which involved 
incorporating the illness into a renewed meaning. Cancer impacted in such 
fundamental ways that priorities had completely changed. There was no longer 
time to be wasted on worrying about trivialities, for example, putting life into 
perspective meant concentrating on existential notions such as happiness and the 
value of living. This type of response therefore represented a totally different view 
of life following the diagnosis of cancer. 
2.3.4 Language and interpretations 
The study by Friedrichsen et al (2002) explored what patients understood when 
they had received information that related specifically to the ending of cancer 
treatment. Patients with incurable or progressive cancers, for example, might be 
treated with aggressive chemotherapy agents and radiotherapy with the aim of 
stabilisation of the disease and prolongation of life. Ending treatment was therefore 
interpreted by the participants as waiting to die. This study is pertinent because it 
relates to the issue of complex terminology, one of the key issues in the findings in 
Chapter 4. The palliative context (incurable cancers) and the meaning of language 
were significant in relation to participants living with multiple myeloma. Language 
and understanding may vary from one culture to another. This research was 
undertaken in Sweden and the findings may not be applicable in other health care 
settings. 
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The doctor's choice of words and expressions appeared to have a significant 
impact on how the information was interpreted. The three categories of words and 
phrases that emerged were grouped under the headings of: Indirect warnings, 
Emotionally trying and Fortifying and supportive. Indirect warnings were subdivided 
into forewarning, evasive and ambiguous. Forewarning was generally a 
prerequisite for news that the recipient did not want to hear and aimed to prepare 
them for what was to follow. The message was sometimes evasive, for instance 
when discussions related to transferring from oncology to palliative care was 
apparently done without clarifying the rationale supporting the decision. Ambiguity 
of words used often created confusion and misunderstanding which had the 
potential for different interpretations. Examples of ambiguous terms are 'cost' and 
'progression'. Cost may be interpreted as meaning expensive in relation to finance 
or quality of life and individual suffering. Progression of disease means that the 
disease is worsening but in normal lay terms 'progression' is understood as 
advancing or succeeding and has a positive outcome. Words and expressions used 
that were emotionally trying were divided into threatening and abandoning. Patients 
felt particularly threatened when hearing information that related directly to a 
calculated amount of time given for their survival. Abandoning words were used 
when conveying to the patient that everything had been tried in terms of treatment 
thus the cancer would be left to run its course without any further medical 
intervention. Despite being told about the ongoing symptom control and palliative 
care participants continued to feel abandoned. 
Fortifying and supporting words encompassed the concepts of strengthening and 
confirming. Strengthening dialogue consisted of comforting words that reassured 
and supported the patient iterating a positive message. Strengthening words aimed 
to inspire hope and encouragement dispelling concerns about the incurable nature 
of the cancer; the focus was placed on treatment. Confirming words used by the 
doctor during discussions with the patient suggests that the individual had the 
doctor's full attention, for example, the doctor was listening and verifying 
understanding. 
The Focus of messages category was subdivided into a treatment focus, a quality 
of life focus, and a threat and death focus. The key message was discontinuation of 
treatment for the cancer and the rationale for this decision. Not all participants were 
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able or willing to give detailed accounts of their interpretations but were aware that 
treatment and surgery were no longer an option. Quality of life changed 
significantly with the discontinuation of chemotherapy and associated severity of 
side effects, which was perceived as living a more normal life. There was less 
emphasis on the disease and more on the person's well-being and quality of life. 
Threat and death messages encompassed time, ultimatum, separation and death. 
The main focus relating to time was survival. Patients who were given an exact 
amount of time that they were likely to survive felt extremely threatened and 
vulnerable. It was suggested that doctors may have adopted a 'bargaining' 
approach offering extended treatment providing patients met certain criteria such 
as significant weight gain within a set period of time which was viewed as a 
"threatening ultimatum" (Friedrichsen et al 2002: 327). The focus on separation 
related to transferring of care from acute to palliative and leaving the specialist 
cancer doctor and familiar healthcare environment. This was experienced as 
traumatic because patients were disengaged from the healthcare professionals 
they had confidence in and had been a constant source of contact. The message 
that focused on death was described as ominous and frightening leaving the 
individual devastated with no semblance of hope. 
2.3.5 Interactions during treatment 
Bakker et al (2001) explored interactions between female patients and healthcare 
professionals during the time they received chemotherapy as outpatients. This 
study may have been strengthened with the inclusion of male participants providing 
a more complete 'picture'. The main categories that emerged from this research are 
the nature of the information exchange and relationships. The nature of the 
information is explicated in terms of interaction modes and the power of 
information. Routine clinic visits prior to administration of chemotherapy were 
described as "medically focused" (Bakker et al (2001: 64) with the doctor doing most 
of the talking, performing a physical examination and reviewing laboratory test 
results. The 'doctor' mode of interaction was normally a question and answer 
session initiated by the doctor with emphasis on the physical well-being of the 
patient. The main objective was centred on symptoms and response to treatment. 
Participants felt reluctant to discuss additional non-physical issues or individual 
concerns that were for instance existential or psychosocial in nature. The 'nurse' 
mode of interaction was different to the 'doctor' mode because these encounters 
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included solving problems together and discussions about how the patients were 
coping at home. It was generally perceived that the nurse concentrated on the 
individual as a human being and not just a disease. During some of these 
encounters, the patients did most of the talking and the nurse was their main 
contact who could be reached by phone at any given time. The power of 
information enabled the participants to have more control and communicate more 
effectively with the healthcare professionals. Patients expected the healthcare 
professionals to provide adequate information and share their knowledge and 
expertise. If this was not forthcoming then it was understood as the healthcare 
professionals "keeping tight reins on power and control" (Bakker et al 2001: 65). 
Relationships were discussed according to roles and responsibilities. The 
oncologist was perceived as the key professional providing information that 
specifically related to medical matters such as the disease, treatment options, 
response to treatment and likely outcomes. Individuals expected to gain guidance 
and confirmation from the oncologist when accessing external sources of medical 
information such as the Internet or mass media. The nurse was perceived as 
facilitator, advocate, interpreter, main contact person and communication link 
between patient and doctor. However despite this system providing open access to 
the nurse conflict existed when individuals believed that specific information had 
not been passed on to the oncologist and the nurse was perceived as acting 
independently. 
The participants viewed their own roles and responsibilities as patients to be on 
more common ground with the professionals. This meant that they needed to be 
assertive, kept fully informed and gain knowledge. The aim suggested but not 
always achieved was to be in a position to actively participate when communicating 
and interacting with healthcare professionals. All the participants related to a quality 
of connectedness associated with the conscientiousness in which patients and 
healthcare professions connected and interacted as a partnership. Connectedness 
existed when there was trust, mutual respect, partnership, and acknowledgement 
of patients' feelings, beliefs and psychological needs. If the connectedness was not 
apparent the partnership was nonexistent and the patient tended to adopt a more 
submissive role. 
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2.3.6 Talking to children about cancer 
One of the significant issues that emerged from the present study was 
communicating with young children about the cancer (4.7.1). Some parents 
appeared uncertain as to how to explain about a cancer that they, themselves 
were struggling to understand and come to terms with. Barnes et al's (2000) 
research relates to 32 mothers with breast cancer and a total of 56 school aged 
children. This study also excludes male patients (fathers with breast cancer). The 
majority of participants were biased towards middle class. The findings therefore 
may have yielded contrasting results with the inclusion of mothers and their 
children from more deprived and lower working class backgrounds. 
Timing of disclosure was a significant finding as parents chose to inform their 
children at specific times such as following confirmation of diagnosis or at the time 
surgery was planned. There appears to be a desire to inform the children when the 
diagnosis is known on one hand, while on the other disclosing information was 
delayed until the last possible moment. There was substantial variation in the 
amount and nature of information given to the children concerning the illness and 
potential consequences. For example 32 out of 56 children were informed that their 
mothers' illness was cancer. 
The most common reason suggested for withholding information from their children 
regarding the illness was that parents felt they could not cope answering their 
children's questions especially those that may have related cancer to death. It was 
perceived by some parents that their children would not be able to cope with the 
information and that it would be too distressing or worrying for them. Other reasons 
for nondisclosure were the child's perceived level of knowledge and understanding. 
It was assumed that the word 'cancer' would have an insignificant impact on a6 
year old for example. Information was also withheld when special family occasions 
or the festive season was approaching because parents did not want their children 
to be anxious or worried during these particular periods which would spoil their 
enjoyment. While some mothers talked about protecting their children, others spoke 
of their children having the right to know about their mother's illness. It was 
considered important to talk about the illness and how they were feeling as a family 
and it was felt that children would lose their trust and become resentful if they 
discovered that they had been excluded from this information. 
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Parents also considered that their children would cope better emotionally and be 
more prepared for potential outcomes if they were included in family discussions 
about the illness and its implications. The mothers in this study suggested ways of 
helping parents to communicate more effectively with their children. They needed 
guidance on the most appropriate language to use when comr icating with their 
children about cancer. There was uncertainty about a child's level of understanding 
concerning illness and death and parents needed advice about communicating in a 
more effective manner particularly with very young children. A creche or similar 
facility for the children at the hospital was suggested providing space for children to 
play, socialise or support one another. Furthermore if children become more 
familiar with the healthcare environment, it was reasoned that this would serve to 
alleviate their fear of the unknown, reduce anxiety and prepare them emotionally for 
the experience. 
2.4 Impact on life 
The next six papers were selected in light of the findings reported in this thesis 
regarding illness and its impact on life. The first paper illustrates the magnitude of 
change and disruption to family life from a caregiver's perspective. The remaining 
five papers focus on terminally ill patients' perceptions on the quality of their lives; 
delay in diagnosing disease and how this impacted on daily living; experiencing 
recurrent cancer; the impact of cancer on men and their roles as fathers and long- 
term survivors treated with bone marrow transplantation and their quality of life. 
Each have relevance to the demands of multiple myeloma and are therefore 
considered relevant to the review. 
2.4.1 Disrupted life 
Houldin's (2007) study highlights the apparent disruption caused in the lives of 
people caring for recently diagnosed patients with advanced colorectal cancers. 
This study was important because it provided the family member's perspective. The 
caregivers represented 12 spouses and 2 friends. This study is also biased towards 
middle and upper class families thus excluding other groups who may be 
underprivileged and vulnerable. The core or central category that emerged is stated 
as "Balancing care giving activities and disruptions while dealing positively with 
daily disruptions and personal impact" (Houldin 2007: 325). Evidence suggests that 
total disruption was experienced and that this impacted on all aspects of life. Life 
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completely changed and the change was perceived as radical and abrupt. 
Individuals struggled with undertaking additional responsibilities and change in daily 
routines. There appeared to be uncertainty about making future plans such as 
arranging a holiday, accepting invitations or planning on having a family. 
Uncertainty was also associated with response to treatment, financial income, 
accessing life insurance and a shared future together. The personal impact of the 
diagnosis was immense and participants explicated their feelings in terms of 
experiencing helplessness, frustration and struggling to come to terms with the 
impact of an illness they had no control over. 
Gaining knowledge and expertise about the cancer and treatment was considered 
a prerequisite for understanding how to manage as the primary caregiver and 
communicate more effectively with healthcare professionals 
Young families felt particularly stressed because their children were young and they 
were at the peak of their careers. It was evident on attending the hospital for 
chemotherapy that the majority of patients appeared to be in the older age groups 
or retired which did not go unnoticed by the younger participants. The role of the 
caregiver was described as burdensome with serious emotional and physical 
manifestations such as depression and lack of sleep. The most distressful times 
were when individuals received the diagnosis, when surgery was planned or having 
to deal with numerous different hospitals. Receiving chemotherapy treatment and 
attending one hospital was considered less stressful as was getting back to a more 
normal pattern. 
The cancer was typically symbolized as a battle zone by some of the participants 
such as "we are at war" or "we can use our energies in a more positive area, to 
fight the illness" (Houldin 2007: 326,328). There were reported positive and 
negative impacts on relationships. Couples disclosed a closer and more intimate 
relationship or one where they became kinder and more considerate to one 
another. Others suggested significant behavioural changes in their loved ones such 
as being irritable or constantly angry and bad tempered which proved particularly 
stressful for the families. A beneficial impact on sexual relationships was reported 
where sexual activity was heightened between treatment periods and it was felt the 
illness had brought couples closer together. Negative standpoints relating to sexual 
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relationships included statements that suggested their active sex life had come to 
an abrupt end; lack of desire because of stress levels; fear of physically hurting or 
exhausting their partner, or worry associated with risk of infection and low 
immunity. 
Impact on social life appeared to be more constraining for some participants than 
for others. Not being able to socialise with friends and go out disadvantaged some 
as this was viewed as restrictive, while remaining at home relaxing in front of the 
television was appealing to others. Working life was affected because of 
absenteeism and there was apparently a struggle to find a balance between 
provision of care and other responsibilities or life commitments. Staying positive, 
striving to be optimistic and hiding emotions was described in terms of struggle. 
Thinking in positive ways despite facing the reality of the seriousness of the illness 
enabled participants to cope. The priorities of family life were of paramount 
importance for example being there to look after loved ones and taking care of the 
children. Participants used various coping strategies such as avoidance or denial 
and others were able to draw from their faith or religion. Some participants could 
cope by dealing with the present and not contemplating anything associated with 
the future. Talking to other people such as friends about the situation was 
especially supportive for some individuals. It is suggested that if the nature of the 
person undertaking the role of caregiver had a positive outlook on life, this personal 
characteristic could be sustained throughout the illness and associated challenges. 
Keeping life as normal as possible for the children and maintaining the customary 
family routines was the key issue. Parents were worried and uncertain about talking 
to their children about the illness. The participants were also concerned about 
informing other family members about the cancer and how they would react to the 
news. Some of the participants were able to discuss the illness and treatment with 
their children and kept them informed of progress but avoided using the word 
cancer because of its association with death and dying. Parents adopted various 
approaches when communicating with their children such as speaking in positive 
ways, discussing the situation on a factual level, preparing children for the worst 
outcome, being creative and turning events into a story, or seeking help and advice 
from a counsellor. 
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2.4.2 Quality of life 
This paper (Johansson et al 2006) centres on patients' perceptions of their quality 
of life living with incurable cancers while being cared for by a palliative homecare 
team. Despite the small number of participants (n=5) they participated in three 
focus groups while in the advanced stages of their disease and consequently only 
had a minimal survival time (end-of-life). This research was biased towards a 
motivated and purposive sample selection. The participants were described as 
active for a significant part of the day (50%) and there was emphasis on the 
positive aspects and the meaning of quality in their lives. Participants appeared 
reluctant to discuss existential matters and it may have been too distressing to 
disclose sensitive issues or speak of impending death within the focus group. Thus 
the complete reality of living with terminal cancer is not represented in this 
research. 
The five themes in this paper consist of valuing ordinariness in daily life, alleviated 
suffering, maintaining a positive life, significant relations, and managing life when ill. 
The first theme concerning valuing ordinary things in life was discussed in terms of 
appreciation for a semblance of normality and being able to function in order to 
manoeuvre and progress with daily activities or go out with friends. Having the 
physical strength and feeling able to function meant that the individual was 
liberated from pain and fatigue. These periods of activity were crucial because they 
represented feelings of personal achievement and autonomy. Alleviated suffering 
related to physical and emotional well-being collectively with methods individuals 
employed to combat pain. Physical well-being was defined as being free from pain 
or other symptoms such as breathlessness or fatigue which could be exceptionally 
disabling. Finding a balance between rest and activity; being able to eat and sleep 
normally was understood to be the key to maintaining an acceptable level of 
existence with some quality of life. Emotional or psychological well-being was 
associated with the absence of physical discomfort and emotional disturbances 
such as depression or anxiety. In addition to medical intervention individuals 
employed their own strategies attempting to overcome symptoms such as pain by 
keeping occupied or distracted with specific tasks or offering to do something useful 
for another person. 
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Maintaining a positive life meant keeping enjoyable memories in the forefront of 
their (participants) thoughts and feeling reassured that they still served a purpose 
or that others needed them. It is suggested that focusing on memc ' that reflect a 
positive stage in their lives such as travelling abroad had a positive impact on the 
present creating temporary distraction or diversion from their reality. Feeling useful 
or needed was fundamental to the emotional stability and continued existence of 
the participants. Individuals had the explicit desire not to be perceived entirely as a 
sick person especially by family and friends that had been known to them 
throughout their lives. Significant relationships included essential networks and the 
development of resonance in communication with family and healthcare 
professionals. Family, friends, domestic pets, healthcare professionals, chaplains 
and fellow colleagues represented essential supportive networks. The hospital 
ward staff and the palliative homecare team provided ongoing professional support 
and the participants had access to nurses and doctors. The continuity of care and 
being able to recognise healthcare professionals and dealing with the same people 
was especially reassuring. 
Resonance in communication implies good quality 'sounding boards' on both sides 
of the interaction and being actively listened to. Resonance in family 
communication therefore was perceived as a conversation that involved mutual 
collaboration and the sharing of problems so the focus was not always on the 
person with the terminal cancer. Resonance is defined in this paper as a powerful 
component of interaction that develops as a result of long-term relationships 
between patients with incurable cancers and healthcare professionals. Managing 
when ill related to being in control or being in charge of difficult situations and 
concentrating on the important things in life through the process of reflection. 
Taking charge required motivation, obstinacy and determination to go on living. It 
was seemingly crucial to remain positive and continue to make plans although 
some of these may have referred to specific arrangements following their death. 
2.4.3 Delay of diagnosis 
Denny (2004) reported on the experiences of women living with a chronic 
gynaecological disease known as endometriosis. The key domains of which were 
pain, delay in diagnosis and how their lives were effected by the disease. This 
paper was selected because it provided an example of the impact of a chronic 
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disease. Multiple myeloma may itself be viewed as a chronic illness and some of 
the findings appeared similar to those in the present study. For example, delay in 
diagnosis, impact on life, living with an incurable disease with recurring episodes, 
undergoing numerous periods of treatment and struggling with an uncertain future. 
The period of time between onset of symptoms and diagnosis in this research 
ranged between 3 months and 14 years. The majority of the participants attended 
their GPs while still in their teens and it is suggested that their doctors did not take 
them seriously. The pain women experienced was 'normalised' for example one 
participant was told that she was unfortunate and that she had been suffering with 
unusually severe period pains. The women were either prescribed oral 
contraceptives or were informed that there was nothing to be done. It was 
therefore something that they would have to endure. Normalisation of symptoms 
suggests that GPs were reluctant to contemplate potential pathological causes and 
failed to distinguish or recognise subtle differences in presentation. 
Women were able to make distinctions between the nature of pain relating to 
normal periods and the pain relating to the disease. Although they may not have 
been able to articulate this at the time they first attended their GPs. The pain was 
described as intense, debilitating and in some cases continuous. Pain during 
sexual intercourse (dyspareunia) is a known and common symptom of the disease, 
however this research suggests that the topic was not generally addressed in 
consultations with the gynaecologist. The participants were not always prepared to 
initiate communication relating to sexual activity or relationships, which were 
considered private or they were too embarrassed to disclose. Dyspareunia was not 
always associated with the abdominal pain relating to the disease, which implies 
that it was considered by some of the participants as a separate and unrelated 
issue. The sexual problems experienced had a profound effect on the women's 
lives and that of their partners. Some individuals had a supportive and 
understanding partner but for others the strain resulted in deterioration in 
relationships and separation. 
The participants stated a preference for surgical interventions (laser surgery) to 
vaporise the recurring growth of endometrial lesions and cysts. The women 
experienced unpleasant side effects from prescribed medication such as significant 
hair loss and severe bouts of prolonged menstruation (menorrhagia). Oral 
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contraception masqueraded symptoms and offered temporary relief for some of the 
participants. 
The disease had a significant impact on the women's social and working lives. 
Social activities diminished entirely for some individuals. Family and friends 
provided constant emotional support and practical help for others. In the workplace 
there appeared to be a lack of understanding or recognition regarding the 
legitimacy of the illness, which was apparently trivialised by employers and fellow 
workers. Periods of absenteeism were therefore perceived unfavourably by 
employers who believed that the amount of time taken off (through illness) was 
unacceptable adding further tension and making life more problematical for the 
participants. Not all the women experienced lack of support and understanding in 
their place of work. Some employers were reported to be supportive, considerate 
and flexible allowing the women to arrange their working schedule to suit their lives 
and accommodate their illness. 
Following surgical intervention the women perceived the future in terms of fear and 
uncertainty relating to recurrence of the disease and how they would cope. In this 
study one participant stated that her general health had significantly improved 
following a hysterectomy but two (n=15) women continued to be in disabling pain 
regardless of several years of treatment. 
2.4.4 Experiencing recurrence 
Howell et al's (2003) exploration of women's experiences living with recurrent 
ovarian cancer provided a sharp contrast to the experiences of people living with 
multiple myeloma and the periods of relapse and remission which represented the 
common link. For example the approach and attitudes of the healthcare 
professionals between the different healthcare systems towards recurrence 
(relapse) appeared to have opposing views on decisions regarding continuation of 
cancer treatment (chemotherapy) and sustaining hope. The findings relate to a 
specific geographic area in Canada and may not be transferable to other 
healthcare cultures. 
The findings from this paper consisted of four main themes: waiting for recurrence, 
facing the diagnosis of recurrence, managing treatment-related concerns, and 
48 
attempting to regain control. Despite the knowledge that recurrence of the cancer 
was likely at some point following their first line of treatment, many of the 
participants perceived the 'waiting' as extremely frightening. Follow up 
appointments were therefore viewed in terms of trepidation and fear of what might 
be discovered. The anticipation of recurrence did not, in the actual event of a 
recurrence, prepare the women or lessen the shock and devastation. The 
exception (n=1) was that it was expected and therefore came as no surprise. 
Information given at the time of diagnosis relating to recurrence of cancer and 
survival were sometimes given in statistical terms which was viewed as unhelpful 
as numbers were meaningless to the participants. Thus speaking in more simplistic 
terms or using straightforward language was inferred. It is also suggested that the 
participants may not have been prepared to take on board additional information 
relating to potential survival at this time because it appeared to overwhelm them. 
Discussions relating to statistics were described as provoking fear while attempting 
to cope emotionally with the diagnosis and consequent treatment ahead. 
Waiting for recurrence related to the period of time following the women's first line 
of treatment and when they attended their follow up hospital visits which went from 
three to six monthly and progressed to annual appointments. The participants 
became acutely aware of the tumour markers (CA-125) that represented the 
potential recurrence of their ovarian malignancy. If the level was gradually rising for 
example, this was an indication that the cancer was recurring or spreading which 
symbolized devastating news for many of these women. The follow up appointment 
was expressed as a time of intense anxiety because it was reminiscent of a period 
that represented devastating news of cancer and this was usually anticipated. The 
women were aware of the potential consequences because they had prior 
experience and knowledge. 
Facing the diagnosis again (recurrence) may have followed a period of several 
years but for some of the participants remissions appeared significantly brief which 
meant experiencing prolonged periods of ongoing treatment and unpleasant side 
effects from surgery and chemotherapy such as menopausal symptoms and 
extreme fatigue. Treatment-related issues at the time of recurrence were 
associated with distress and the apparent change in attitude participants perceived 
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from the healthcare professionals. The participants perceived a struggle to elicit 
further information from the healthcare professionals relating to treatment options 
which was not experienced when they were first diagnosed. Participants indicated 
that they were no longer being listened to. The general consensus appeared to be 
that recurrence was tantamount to a hopeless case indicating that there was 
nothing more to be done. 
The women found that they had to assert themselves and act as their own 
advocates once they reached the status where they were perceived as being 
'recurring hopeless and helpless cancer cases'. Some of the women changed their 
physicians for instance while others may have been restricted to specific treatments 
because of the area or location in which they lived. The 'watching and waiting' 
policies adopted by doctors during the time of recurrence appeared to take its toll 
and was an exceptionally fretful period for the participants. Strategies employed to 
overcome some of the difficulties resulted in the women doing their own research 
and searching for information which prepared them for making appropriate 
demands from the healthcare professionals and requesting the ongoing treatment 
they required. It was perceived by some of the women that having had multiple and 
combined treatments such as surgery, chemotherapy and radiation, there were 
very few options left regarding treatment during recurrence. Women also reported 
that their experiences of facing treatment again was daunting and coping with the 
symptoms from the disease progression and the side effects from treatment was 
difficult. In contrast some of the research participants living with multiple myeloma 
had advanced bone disease causing continuous pain that was often difficult to 
control. Similarly disease progression was a real threat and the numerous lines of 
chemotherapy were a constant battle because of toxicities. 
Gaining more specialist knowledge about the cancer and how their bodies 
responded to the treatment enabled the women to become involved with the 
treatment decisions and communicate their concerns more effectively with the 
healthcare professionals. They gradually took more responsibility for themselves by 
becoming more assertive through desperation to gain some control over their 
progressive disease. Attempting to regain control was synonymous with 
development of knowledge and expertise. The women gained more experience and 
learnt about the various alternative and complementary treatments available. 
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Despite accessing alternative treatments on a 'trial and error' basis, this was 
viewed as having control by actively doing something which was considered better 
than doing nothing. 
2.4.5 Impact on family 
The aim of this paper was to explore gender and men's experiences of cancer, how 
illness impacts on family life and their roles as fathers (Elmberger et al 2002). This 
paper was selected because it focused on men as fathers with haematological 
malignancies. The researcher in this study was female and it is suggested that 
perhaps gender and age differences may have influenced the data collection. A 
male investigator, for instance, may have produced different findings. 
During illness men viewed themselves differently. Transition related to a 
fundamental change in the participants self-image. For example transforming from 
an athletic and strong man to a sick and feeble individual. The transition was 
explicated as burdensome and difficult to tolerate because it related to their 
manhood and their father role. The findings of this research show how the men 
reacted to the transition and how they coped spending more time at home with their 
families. The role of the man who spent a significant amount of time away from his 
family home earning an income had been transposed into a sick father remaining at 
home with his family. The outcome of spending more time at home inevitably meant 
participants had more time with their children. The men sometimes underwent 
cancer treatment as outpatients during a normal working week and at this stage it 
was generally perceived by their families that they were at work as usual. Family 
life therefore appeared unchanged and the men apparently struggled to convince 
their families that the illness was serious. 
For most of the men, their parental role was jeopardised by the presence of 
constant supportive partners and parents. A single parent however may not have 
the same constant supportive network. One of the participants in this research 
(n=8) with two young daughters was able to leave his children with his mother while 
he was in hospital stating that there was no one else to look after them. 
The advantages of the changed father's role in relation to spending more time with 
the children included assisting the children with their school work and becoming 
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more involved with school meetings which the men did not have time for previously. 
These activities were perceived as positive strategies to regain some authority, 
motivation and control as fathers. The participants were also concerned about their 
children's changed perceptions of them as their fathers and the way in which they 
managed the situation in relation to the illness. It was important therefore that they 
(fathers) represented and sustained a positive image that would be memorable 
following their demise. It was difficult to disguise emotions or negative feelings 
during treatment with chemotherapy and experiencing some of the associated 
gastrointestinal toxicities and altered body image from these agents. The men 
reported reactions only occurred from their children when faced with dramatic 
changes in their fathers' appearances such as hair loss. Families were reluctant to 
visit the hospital during the men's hospitalisation because of their illness, altered 
appearance and attachments (intravenous lines) with which the children were 
unfamiliar. The men preferred to stay at home and not at the hospital during 
treatment when offered the choice. The hospital environment was described as 
gloomy and depressing by many terminally ill patients. 
Additional strategies to regain control and restore their self-image as men and 
fathers evolved through gaining knowledge and making plans. Some men wanted 
to learn more in-depth about their cancer than others. An ambiguous desire to learn 
or not to learn more about the illness appeared to exist which represents a common 
link to the findings in this thesis. Another common element in this paper was the 
men's use of metaphors in relation to cancer and 'fighting the enemy'. Making plans 
and preparing for the future regarding family and financial security following their 
death gave the men a sense of purpose, responsibility and control. 
Talking to the children about the illness was sometimes difficult because of the 
complexity of the cancer which is also a finding in the present research. When 
parents spoke to their children about the condition they often avoided the use of the 
word 'cancer' as it was felt this would be too upsetting. Children were sometimes 
perceived by their parents as uninterested or unconcerned about the illness. These 
assumptions were based upon their children not asking any questions. Some 
parents worked on a 'need to know' strategy not wanting to complicate issues or 
confuse their children. Others made decisions regarding how much information 
they were prepared to disclose to their children. One of the participants had a 13 
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year old daughter who was so traumatised about her father's illness and possibility 
of his imminent death that she was unable to concentrate on her schoolwork. 
Maintaining normal routines for the children was implicit although not highlighted as 
a central issue in this paper. 
The men appeared to reprioritise and re-evaluate their lives as a result of having 
the cancer. Their focus was diverted to what they currently considered more 
important and valuable such as spending time with their families, being more 
involved with their children's activities, and aiming for a better quality of life. Prior to 
their illness their focus appeared to be on their work, ambition, expenditure and 
material gain. 
2.4.6 Life following transplant 
Molassiotis and Morris (1998) discuss the meaning of quality of life following 
unrelated donor bone marrow transplantation in the long-term adult survivors of 
chronic myeloid leukaemia. Questionnaires used in this study required the 
participants to write narratives. Some participants may have found this difficult or 
tiresome. Alternative approaches such as interviews may have generated more 
information. 
The findings are divided into five main domains commencing with the participants' 
perceptions of their quality of life comparing with their life prior to the transplant 
(meaning of quality of life). The second domain is centred on the differences in 
daily life following transplantation. The third domain is associated with problems 
experienced by the participants at home following discharge from hospital. The 
forth domain relates to concerns about the future and the fifth includes 
recommendations from participants based on their personal perspectives that have 
potential implications for clinical practice 
Responding to what quality of life meant to participants was explained in terms of 
normality and living a normal life. Comparisons with other healthy individuals who 
were fit and able were perceived as normal. Comparing life before and following the 
transplant facilitated the explication of the participants' views and definition of their 
quality of life especially if there was a significant deterioration in their capabilities as 
a result of extreme weakness for example. Being normal therefore was understood 
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as being able to undertake all the activities that the participants had been able to do 
prior to the transplant and in the absence of symptomatic disease. Quality of life 
meant being fulfilled, enjoying and appreciating the experience of living despite 
apparent restrictions in energy levels. Being healthy and independent with no signs 
of physical or psychological sequelae was ultimately linked to living a normal life. 
Sustaining normal relationships with family, friends and colleagues or fellow 
workers; being able to take care of the family; continue working and socialising; 
feeling happy, living in harmony and in a safe environment constituted the pertinent 
themes in this domain. 
Differences noted in daily life when compared to life before the transplant was 
divided into three themes: negative impact, positive effects and no difference. The 
negative impact related to physical and psychosocial ramifications of the transplant 
such as increased fatigue, family problems and loss of employment. Positive 
effects related to a good recovery, re-evaluation and appreciation of life. No 
difference implied that life was exactly the same before and following the 
transplant. The difficulties that the participants experienced following discharge and 
returning home were associated with the physical disability caused by fatigue, not 
being able to work, socialise or make plans. The psychological impact manifested 
itself through frustration caused by the general weakness, memory of the transplant 
experience, fear of recurrence of disease, becoming infertile, impact on social life, 
loss of independence and worrying about financial constraints. 
Concerns about the future included status of the participants' current health and the 
fear that the cancer will at some stage recur. Thus there was an emphasis on 
continued recovery and improvement but a constant presence correlating to a 
threat of recurrence. Participants had anxieties relating to the long-term effects 
from the transplant for example how long the side effects would last and whether or 
not they were permanent. Worries were reported relating to associated long-term 
use of prophylactic treatments in conjunction with adverse events for example 
hormone replacement therapy given because of forced premature menopause. 
Some individuals were therefore reflecting on the consequences of their treatment 
and a future without children. Others focused on concerns about a full recovery to 
their normal pre-transplant selves ("normalisation process" Molassiotis and Morris 
1998: 205). Future concerns were associated with coping financially, unable to plan 
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too far in advance, and caring for the family. 
Recommendations suggested by participants in response to what they considered 
strategies that could be employed by healthcare professionals to enhance their 
(participants) quality of life included recognising their need for ongoing 
psychological support and reassurance. It was suggested that information and 
advice on medication, treatments and side effects was needed and continued help 
with physical symptoms. It was also recommended that more research was 
required to develop drugs with less toxicity. The psychological and physical impact 
of treatment and associated side effects in the present research suggested that it 
was not uncommon for individuals with myeloma to struggle with debilitating 
symptoms associated more with drug toxicities than the actual disease. 
2.5 Supportive care needs 
The final six papers selected associated with supportive care needs are intrinsically 
linked to the findings presented in Chapter 4 and complement the above research 
studies relating to communication and the impact of cancer on everyday life. The 
first paper (Botti et al 2006) explores the views of nurses working in haematological 
oncology wards concerning the existence of perceived 'barriers' that prevented 
them from providing adequate psychosocial support to patients. The second and 
subsequent papers focus on gender specific differences; treatment decisions and 
making choices; categories of support and access to financial benefits. Finally, 
Murray et al (2002) compares the illness trajectories of two different advanced and 
progressive diseases in relation to the participants' support needs and services 
available to them. 
2.5.1 Support barriers 
The study by Botti et al (2006) suggests the presence of emotional and 
professional barriers that existed in the provision of psychosocial support in 
haematological oncological nursing. The nurses that participated in this research 
identified five key concerns: an appropriate time to talk with patients; establishing a 
trusting relationship; dealing with patient's emotion and distress; providing 
continued support and ineffective communication. 
55 
C 
2.5.2 Differences in gender 
Clarke et al (2006) explored gender differences in patients with cancer in relation to 
their emotional support needs. This study only included married men and therefore 
excluded single men or those living alone. These groups may have required more 
psychosocial support. The results from this research suggest that female patients 
were more likely to seek or accept help for their emotional needs than men. It was 
also viewed that women were more likely to feel less satisfied with the support 
services available than men. Women appeared far more resourceful setting up a 
complete support network for themselves including family, friends and healthcare 
professionals. Female patients appeared to be more likely than males to 
understand that the clinics were busy which discouraged them from requesting 
support during consultations. 
Regarding prioritisation of support the female patients with breast cancer had 
access to a specialist breast care nurse which facilitated meeting their support 
needs and provided a valuable contact. Other female patients with melanoma did 
not have access to specialist support and it was suggested that their emotional 
support needs were not usually acknowledged. 
The male patients were more likely to seek emotional support from their wives or a 
close friend and not from the healthcare professionals. Men appeared aware that 
support was available if they needed it but viewed other kinds of information with 
reference to their illness or treatment more relevant to their needs. Unlike the 
female patients the men did not perceive the hospital staff as too busy at any time 
to talk. The male patients also thought that their wives may have benefited from 
emotional support themselves. There appeared to be dissimilarity in relation to 
gender and perceptions of emotional support. The men seemed to equate any 
friendly encounter or normal verbal exchange with the healthcare professionals as 
emotional support. When professionals provided information concerning hospital 
procedures or treatment, for instance, the men viewed this as emotional support 
because the information reassured them. Women may have had equal time and 
similar interactions with professionals but emotional support was defined as 
something quite different to the men. Emotional support for the women meant that 
the interaction with the healthcare professional needed to be more in depth and 
meaningful with a satisfactory outcome or resolution. The couples and families 
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interviewed in the present research indicated that emotional support was provided 
mainly by family members and close friends. One participant who lived alone 
attended a day care center at a local hospice and joined a patient support group 
which she found was particularly beneficial because everyone was in the 'same 
boat'; people had time to talk, listen and understand which provided the emotional 
support she needed. While others acknowledged that they may need professional 
help or counseling. 
2.5.3 Making choices 
Decision-making and attempting to make choices regarding treatment options may 
be daunting and inappropriate especially when patients are newly diagnosed. 
Ziebland et al (2006) explored women's experiences with ovarian cancer and how 
much involvement they had in the decision making process. These authors argued 
that patients might not want to make a decision alone and that they should be 
encouraged and left in no doubt as to what the consultant considered was the best 
course of treatment for them to have. It was surmised that to be offered choices 
without any advice or expert opinion was perceived as a form of abandonment. 
The qualitative analysis was derived from some of the participants' interviews 
taking part in video recordings during the DIPEx project (personal experiences of 
health and illness). Videotaped interviews provide an accurate record of complex 
behaviour, facial expressions and body language. However, the presence of a 
camera or awareness of being filmed may have influenced or altered the 
participant's behaviour. Some of the experiences described had taken place 
several years before the interview which implied there may have been concerns 
with recall. 
The findings highlighted three approaches to decision making in relation to making 
choices about treatment options. The first approach involved the women accepting 
the doctor's recommendations and 'going along' with any suggestion made. The 
second approach indicated more involvement in discussion and seeking further 
advice or second opinions; and still complying with the doctor's recommendations. 
Women utilizing the third approach appeared more proactive and made some 
decisions with reference to their treatment options. Decisions were sometimes 
based upon previous experience, for example refusing a treatment because of a 
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prior bad reaction to a specific agent and choosing an alternative option. It is 
suggested that women did not always perceive that they had been offered any 
choices relating to their treatment. 
Women who 'went along' with the doctor's treatment preference without question 
did so because they may have been in a state of shock associated with being 
newly diagnosed. Some of the participants felt incapacitated, extremely unwell and 
in fear for their lives. Participants appeared to struggle with understanding why they 
were offered choices when they were newly diagnosed and in a "traumatized state" 
(Zeibland et al 2006: 364). Others recognized they did not have the knowledge at 
this stage in order to make any decision relating to treatment options. The women 
who were more questioning and also 'went along' with the doctor's advice did so 
because it was felt that there was no alternative if they wanted to stay alive. Those 
who were able to make some of the decisions (minority) had done research having 
accessed internet sites and gained some knowledge and understanding of their 
illness and treatment options available to them. Women who had a recurrence of 
their cancer and who were more familiar with treatment options were better 
prepared to participate in decisions or negotiate their choices. Knowledge and 
understanding of how their bodies responded or reacted to previous chemotherapy 
agents also influenced the women's decision making as previously revealed. 
Decisions to refuse treatment were sometimes made by women who perceived that 
they were at the end of their lives or felt they could not tolerate further 
chemotherapy. 
Making choices was sometimes perceived as burdensome especially if there was 
conflicting advice from consultants (surgeon and oncologist) who could not agree 
on the appropriate treatment. Participants also implied that their relationship with 
their doctors or medical team was a significant factor and if they did not accept their 
expert opinion it was possible that a sound relationship could be threatened. Some 
of the participants were offered a choice of single agent chemotherapy or combined 
chemotherapy (clinical trial) without full explanation as to why they were being 
offered the choice or providing a rationale for the different approaches. Women, 
therefore, did not always understand if the treatment approach was experimental or 
if evidence was required to establish which was the most effective option. 
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Decisions were sometimes influenced through the appreciation of other people 
fighting and campaigning for access to an expensive chemotherapy agent that was 
not previously available at the participant's hospital. Participants therefore may 
have felt an obligation to take up this option when offered and with gratitude. In this 
research it is suggested that the medical team may have been influenced by 
litigation cases in the mass media which resulted in a reluctance to state their 
preferences when offering treatment options regarding surgery and chemotherapy. 
This meant that the women were informed that they could have surgery but it was 
entirely up to them to decide with no further explanation or information to assist 
them in their decision-making. In contrast some of the participants were guided and 
persuaded with detailed information tailored to their needs of a suggested course of 
treatment and potential side effects. 
2.5.4 Support categories 
Furness's (2005) paper highlights the supportive care needs and experiences of 
patients who have experienced facial surgery for cancer and other conditions such 
as trauma. The aim of the research was to investigate individuals' perceptions of 
psychological support provided by healthcare professionals (Furness 2005). It is 
argued the main concern centers entirely on the surgical removal of the cancer and 
survival. From the healthcare professional's perspective the assumption was that 
facial disfigurement would be associated with psychological and emotional upset 
and that this was to be expected. 
From a patient and family perspective, three categories of different types of support 
emerged: informational, practical and emotional. Information given pre-operatively 
relating to surgery, potential risks and outcomes were viewed as satisfactory. 
However being told the worst potential outcome resulted in increased levels of 
anxiety for some patients. Post-operative information described in terms of deficits 
identified a substantial void in the provision of guidance, advice or disclosure 
regarding the physical and psychological aftermath of surgery and support in the 
community. Patients reported, for instance, discovering that their surgery had been 
more extensive than anticipated which had not been explained and therefore they 
were not prepared. Post-operatively patients received no information that prepared 
them for some of the disturbing physical symptoms and problems they experienced 
with prosthetic appliances. Participants were rarely informed about support groups 
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by the hospital staff unless they had access to a specialist cancer nurse. They 
reported finding the information through other sources and indicated that support 
groups in the community were fundamental for their psychological recovery and 
adjustment. It was suggested that providing information and communicating with 
family or friends would help them to understand what was happening and enable 
them to support their loved ones following discharge. 
Practical and material support were associated with disfigurement, prostheses, 
assistance with mobility and practical help at home. Although some of the 
participants stated that they had no practical help from the hospital staff, others 
received guidance on the application of devices and makeup to masquerade 
physical alterations. It cannot be assumed that practical support was not 
considered and it could be construed that the task may have been too challenging. 
Facial surgery may involve removing teeth and using breast tissue for the 
reconstruction. Patients were not always offered a prosthesis following 
reconstruction surgery. An identical scenario to the findings (4.25.2) was presented 
in this study in relation to the patient's spouse 'battling' to access support on behalf 
of his wife who was physically unable to speak. He was trying to get a prosthetic 
device for his wife's breast following hospital discharge. It was felt that the hospital 
staff could have been more proactive in providing practical support. 
Emotional and psychological support was divided into subcategories of availability 
and need, and components of support. Participants either considered that all their 
needs were met or that they needed help and that it was not offered. The hospital 
staff did not appear to be perceptive to the participants' potential emotional needs. 
In other words participants viewed healthcare professionals as oblivious to their 
feelings relating to the psychological trauma and shock associated with the 
consequences of their surgery. It was suggested that having someone to talk with 
other than family would have made a significant difference to their emotional well 
being. Components of support were comprised of staff awareness and attitudes, 
ongoing support and having time to talk. 
Participants suggested that in their opinion hospital staff did not appear to be aware 
of the traumatic impact of facial surgery or understand how it affected them in the 
long term emotionally and psychologically. It was suggested that the healthcare 
professionals were inadequately trained to deal with the patient's emotional 
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responses, lacked the necessary counselling skills and knowledge needed for 
appropriate referral in the community. Establishing a relationship with healthcare 
professionals was determined through how approachable they were and whether or 
not they were perceived as having a trusting and caring personality. These 
characteristics were perceived as essential and positive in relation to accessing 
emotional support and feeling reassured. Impersonal or negative encounters with 
healthcare professionals often resulted in low self- esteem and feeling 
unsupported. 
Ongoing support requiring long-term follow up was addressed by several of the 
participants. Specific points in time were identified when emotional support would 
be beneficial. These times were following surgery and again following discharge 
when the individual's need arises. The interim period was identified as a time of 
shock and coming to terms with the aftermath of the surgery. Patients recognized 
that they continued to need support during the long term and felt isolated and 
depressed having left the hospital. However, home visits from GPs and district 
nurses following discharge were cited by some participants as providing support 
and greatly appreciated. Hospital staff were often perceived as too busy with no 
time to talk and provide emotional support. This meant that when staff were able to 
spend time with the patients, it was during an occasional and infrequent quiet 
period. Participants felt that it was inappropriate to elicit emotional support from the 
surgeons or take up too much of their time. The ward staff were perceived as 
constantly occupied with the pre and post routine care associated with the busy 
operating schedules. The findings in the present research also suggested patients 
and families perceived and expected healthcare professionals to focus more on 
meeting the physical needs of patients in an acute outpatient setting such as a 
chemotherapy day care unit. 
2.5.5 Financial support 
This paper by Chapple et al (2004) focuses on individuals with lung cancer and 
their experiences of financial struggle and accessing benefits. Only one of the 
participants was from a different ethnic group. However, it is suggested that people 
from different ethnic and cultural backgrounds may have additional problems 
accessing financial assistance. Participants were not always aware of what they 
were entitled to regarding financial assistance. People with terminal cancer and 
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unlikely to survive for more than six months are eligible for financial benefits that 
can be accessed without delay providing the appropriate claim form has been 
completed by the doctor. The findings of this research suggest numerous barriers 
exist that prevent, prolong, frustrate and exhaust individuals during the process of 
applying for financial assistance. 
Patients were sometimes reluctant to claim for financial support because of the 
stigma associated with the idea of asking for 'handouts' despite being seriously ill 
and having worked all their adult lives. The need to provide justification other than 
their illness such as viewing the claim in terms of a replacement for their old age 
pension was one strategy employed to overcome the stigma. Participants were not 
always prepared to admit that they had cancer because of stigma associated with 
the disease, which made them feel ashamed and unable to claim for benefits that 
they needed. 
Barriers existed because of the illness and everything associated with it. For 
example people were dealing with their illness, being in hospital, having surgery, 
and struggling with vast amounts of information. Finances were, therefore, not 
considered a priority during the initial stages of the illness because participants 
were unable to recognize their potential future needs at critical moments in time. 
The crucial factor here was that financial benefits could not be backdated, which 
meant a probable financial deficit unless, claimed at the time of diagnosis. Thus if 
individuals were unable to claim or nobody claimed on their behalf, they may not 
have been in a position to claim until a later time when their financial status may 
have become critical. 
Participants found the benefits system complicated, bureaucratic and confusing, 
stating that they needed professional advice from people who understood the 
process. They did not always have access to the appropriate person qualified to 
guide them through this process such as a benefits advisor, Macmillan nurse or 
social worker. There was confusion over what kind of financial benefits people were 
able to claim for and they relied on healthcare professionals to advise them. 
Participants were sometimes misinformed or did not receive the assistance they 
expected from hospital staff. Rejected claims resulted because the correct forms 
had not been completed. The process of claiming benefits took several months and 
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participants perceived the experience in terms of a 'battle' or 'tussle' getting 
acknowledged regarding legitimacy of their claims and dealing with people from the 
Department of Health and Social Security (DHSS) who were considered unhelpful. 
The participants who reported positive experiences had access to a Macmillan 
nurse or a doctor (GP) who initiated the process and was able to provide 
appropriate assistance at the time of diagnosis. Support groups were found to be 
especially accommodating inviting speakers from benefit agencies who provided 
professional guidance on how to access financial benefits. The sudden loss of 
income and struggling to gain financial benefits had a significant impact on patients 
and families in the present research. 
2.5.6 Prioritisation of support 
The authors of this final paper (Murray et al (2002) hypothesized that prioritisation 
of support services existed which were determined through the specific disease an 
individual had regardless of their own particular needs or requirements. The aim of 
this research was to explore two different illness trajectories in relation to patients' 
needs and access to support services. The participants (n=40) had inoperable lung 
cancer (n=20) or advanced cardiac failure (n=20). Carers and key healthcare 
professionals also participated in the research. The rising incidence and higher 
mortality of cardiac failure when compared with most cancers provided the rationale 
underpinning the selection of a non-malignant disease versus a common and 
terminal cancer. 
The participants with lung cancer often experienced a vague onset of the 
disease and perceived a delayed diagnosis. The illness had a distinct terminal 
phase and the patients were able to plan for their demise. Participants with 
cardiac failure experienced a chronic progressive illness, episodes of acute 
exacerbation, no distinct terminal phase and often an abrupt or unexpected 
demise. Patients with lung cancer appeared to have some understanding of 
their disease and prognosis. There was however an apparent reluctance to 
discuss death and dying by some of the participants from each group (patients, 
carers and professionals). The cancer patients appeared to have greater 
access to printed information and had an understanding of their disease. 
Patients with cardiac failure did not indicate a clear understanding of their 
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illness and did not appear to receive information pertaining specifically to their 
disease in written form. Lack of knowledge or understanding was explained in 
terms of participants' inability to associate some of their symptoms with their 
cardiac problems; for example breathlessness. Prognosis was not usually 
discussed with participants who had cardiac failure. The professionals indicated 
a desire to inform the patients about their illness on one hand, while on the 
other to safeguard them from the reality of acute and sudden death. 
Most of the participants had no input in decision-making regarding treatment 
choices which may be a reflection of their shortened projected survival time. Unlike 
patients with haematological malignancies they were not undergoing cancer 
treatment throughout prolonged periods, thus gaining knowledge, experience and 
expertise. The patients with lung cancer and cardiac failure asserted that the 
professionals knew best because they were the experts. It was generally 
understood that the healthcare professionals made the decisions and individuals 
accepted their recommendations without question. Side effects from chemotherapy 
often made patients with lung cancer feel worse than the symptoms from the actual 
disease. Treatment for cardiac failure was deemed as improving symptoms 
associated with the condition. 
In relation to lung cancer, the prospect of death was a constant and real threat. The 
participants struggled to maintain some semblance of hope and were described as 
battling to maintain balance between optimism and despondency. In contrast, living 
with cardiac failure was perceived as a chronic incurable disease, which potentially 
could worsen. Therefore the prospect of death was not a constant threat to these 
individuals. Cardiac failure did not appear to dominate the patients' lives because of 
the presence of comorbidities. Patients and their carers implied they felt isolated 
and struggled with escalating disability and handling complex medications that 
were constantly changing. 
Patients with lung cancer appeared to have access to numerous services 
available including assistance and information from cancer charities and other 
organisations. These services usually included access to a lung specialist 
cancer nurse during treatment. Very few of the cardiac patients had access to a 
cardiac nurse specialist. Similar findings are addressed previously regarding 
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prioritisation of support (2.5.2). 
Services such as palliative care assessment, day care, help in the home, 
assistance with mobility and benefits advice were normally offered to patients 
with lung cancer and not usually to the patients with cardiac failure. These 
patients (cardiac patients) experienced lack of support and continuity from both 
the hospital and community. The GPs who participated in the research 
appeared to struggle acknowledging that there were inequalities relating to the 
type of help available for their patients. Perceived gaps in the service identified 
by cancer patients were difficulties experienced regarding parking vehicles at 
the hospital for example. Furthermore they suggested a need for emotional 
support at times when they felt particularly vulnerable such as waiting for news 
of laboratory test results or not knowing if treatment was feasible. Healthcare 
professionals, carers and patients did not always understand other people's 
roles (professional and voluntary), which was fundamental when accessing 
support for families and also evident in the present research. 
2.6 Summary 
The above synthesis should be considered in conjunction with the grid (Appendix 4) 
and the second and third order interpretations (Appendix 5). The above studies 
were selected according to the topic and relevance to the findings presented in this 
thesis; the research design (qualitative) reflecting the participants' experiences; 
patients and families living with cancer or chronic disease, and studies that 
reflected the healthcare professional's perspective. The synthesis is a reflection of 
the range of literature in view of the research findings. Therefore the above papers 
provide a retrospective review and supporting background knowledge relevant to 
the research and the generation of grounded theory presented in this thesis. 
Contention (battle, struggle, disruption and disharmony) emerges throughout the 
literature above, for example waiting for news of laboratory tests and not knowing 
whether or not treatment is still a viable option. The next chapter delineates the 
method used to undertake the research itself. 
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Chapter 3. Research methodology 
3.1 Introduction 
This chapter provides a detailed account of the research process from initiation 
to completion. The approach to the research incorporates the methods 
employed and difficulties encountered. A representation of the evolving 
research process is shown in Figure 2 providing an overview of mandatory 
administrative procedures, planning, organising and implementing of the project 
starting with the inspiration for the research study and ending with the writing of 
this thesis. Local Research Ethics Committee approval for the project was 
obtained in August 2005 as by this time fellowship funding had been obtained 
but a university place was not yet secured. It was important that the research 
project was established within six months of receiving the funding in April and 
commencing study at the university in early October 2005. Correspondence 
concerning the application for ethical approval can be seen in Appendix 6. 
Firstly the study site, population and sample are introduced followed by 
sampling strategies, access, research design, data collection, data analysis, 
trustworthiness, methodological issues, management of the project, completed 
data collection, an introduction to the main category groups that emerged from 
the data and personal reflections on the process. 
Clinical experience - impetus for the study 
" Literature review 
" Developing research proposal 
" Application for fellowship, university and ethics approval 
" Preparing administration and documentation 
Organisation and management of the project 
" Choosing recording equipment 
" Employing a transcriber 
" Setting up a Steering Group Committee 
" Gaining access and informed consent 
Collecting the data 
Transcribing the data 
" Ongoing computer assisted data analysis using Nvivo 
Ongoing independent checking of data 
" Validation of research findings 
" Ongoing dissemination of research findings 
" Writing thesis 
Figure 2 An outline of the evolving grounded theory research process 
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3.2 The study site 
Patients (n=17) and family members (n=11) were recruited from a London NHS 
Trust (North East London region). The patients were treated regularly at the 
Chemotherapy Day Unit or were being monitored between treatments and seen 
by the Haematologists when attending the hospital outpatient clinic. Interviews 
were held in a quiet and private room either at the hospital, university or the 
participant's home. The study had been previously discussed with the relevant 
nursing and medical staff and permission for access was obtained prior to 
commencement of the project. 
3.3 Population and sample 
At the beginning of the research process it was necessary to state an 
approximate recruitment figure when completing application forms for ethical 
approval and funding. This proved difficult because an exact sample size in 
qualitative grounded theory research is determined at the time of theoretical 
saturation (which means no new data can add to the emerging theory; thus all 
avenues of exploration have been exhausted). To determine a set number 
therefore at a time when data collection has not yet begun is virtually 
impossible. The figure of 20-30 participants is documented as typical by 
researchers until saturation is reached using two or three interviews per person 
(Creswell, 1998, Morse, 2000). When applying for funding and ethical approval I 
stated that it was my intention to recruit approximately 50 participants. This 
decision was based upon my working experience and knowledge of dealing with 
Local Research Ethics Committees and the trepidation of rejection. The 
following reflective memo highlighted concerns associated with potential bias 
towards significant recruitment numbers and quantitative research: 
Reflective memo. 
Date: Friday 28 October 2005. 
Before the lecture on grounded theory started yesterday we talked about ethics 
committees and the fact that there had been a number of qualitative proposals 
rejected. It's generally believed that committees are pedantic and biased 
towards quantitative research. They are not familiar with qualitative research 
and therefore lack understanding. In order to achieve goals a certain amount of 
'creativity' may be required and it is an advantage to have had dealings with 
ethics committees in the past (having worked as a clinical trials coordinator). For 
example I stated approximately 50 patients will be recruited for the study. My 
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supervisor was clearly perturbed with this and I had to explain that I felt obliged 
to produce a `number' on the application form to appease the committee 
members who (1 believed) would not be familiar with the concept of theoretical 
saturation. 
data collection involved 46 interviews with three participant groups: 
1 =17), family members (n=11) and healthcare professionals (n=12) 
addressed (3.6). Three couples (n=6) were interviewed twice. The following 
inclusion and exclusion criteria were based on the aims of the study, 
professional clinical knowledge and personal experience. 
Inclusion criteria were as follows: 
" Patients aged > 18 
" Patients with symptomatic, relapsed or refractory Multiple Myeloma (MM) 
" Family member living with a relative who has MM 
" Professional health care worker caring for patients with MM 
" All would participate on a voluntary basis, and would have completed and 
signed an informed consent form. 
Exclusion criteria: 
" Patients with an estimated length of survival of less than three months 
" Patients who were cognitively impaired. 
Although the youngest patients I have known attending the chemotherapy day 
care unit were within the age range of 31-40 years, it is documented that others 
have been diagnosed with multiple myeloma in the younger age range of 17-22 
years (Hewell and Alexanian 1976) and 21-23 years (Ishida and Dorfman 
1995). Furthermore I was aware of younger patients at other hospitals in the UK 
through networking with nursing colleagues. One large NHS Trust hospital in 
the Midlands for instance currently had 6 patients under the age of 25 years. 
The age range criterion was therefore based upon the potential of including 
younger participants. 
3.3.1 Purposive sampling 
Purposive sampling in qualitative research involves the researcher making a 
judgement based on prior knowledge about the population in question (Polft and 
Hungler 1991) and was used in conjunction with a process of theoretical 
sampling. Purposive sampling was employed initially whereby patients were 
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selected according to age ranges, trajectory of illness, people living alone, 
people living together (couples, family) and ethnicity. This was done with the 
intention of achieving maximum variation based on the assumption that different 
issues would arise at different stages of the illness or at different times of life. It 
was also assumed that key issues emerging from participants living alone would 
be different to those who had a spouse, partner or relative living with them. 
The first 'patient' interviews (n=11) involved participants known to me from my 
clinical practice area. As the researcher, this meant that I was an integral part of 
the area under investigation and was aware that the relationship established 
with the patients and families had to be acknowledged. However, it could be 
argued that having an established relationship with participants and being 
known in the clinical area not only facilitated access and recruitment, it also 
provided an opportunity for individuals to discuss issues that were significant to 
them. Some of these issues seemed to me, to be disclosed for the first time and 
many appeared to view the interview experience as cathartic. However I was 
aware that as part of the establishment (and known to the participants) there 
was a possibility that I could influence the research process; (this issue is 
addressed subsequently in the section on methodological issues). 
Ethnicity was not considered overtly at the start (with the exception of one 
patient originally from America), the first few patients interviewed (n=11) were 
white British. This group of patients was a reflection of the population that 
attended the hospital. However recognising that approximately half of the 
general 'myeloma' population were of Afro-Caribbean origin I did not feel 
justified in undertaking this project and excluding this ethnic group. Purposive 
sampling was employed therefore to extend the ethnic profile of the patient 
participant group. Eventually this included 5 Afro-Caribbeans and 1 West 
African; all of whom were introduced by the consultant haematologists or 
nursing colleagues via the outpatient clinics. Features of the purposive sampling 
framework included: 
" Age ranges, illness trajectory, ethnicity 
" 31-40 (1 couple) 
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" 41-50 (2 couples, 2 singles) 
" 51-60 (1 couple, 3 singles) 
" 61-70 (3 couples, 4 singles) 
" 71-80 (1 single) 
" Diagnosed 3 months, 1,2,3,4,5,6,9,14, and18 years. 
3.3.2 Theoretical sampling 
In a grounded theory approach theoretical sampling is utilized which means th t 
data is collected, coded, analysed and used as guidance for the next da.. i 
collection phase; thus ongoing decisions are based on previous data collected. 
The data collected from the first group of patients interviewed (n=8) in this 
study, for example, had been used to guide the second and ongoing group of 
participants. This was repeated so that following each data collection further 
decisions regarding selection of participants, sample size, and type of data to 
be collected were based on emerging findings (Glaser, 1978). 
Coyne (1997) makes a useful distinction between purposive and theoretical 
sampling and attempts to clarify some of the common misinterpretations in the 
literature. Purposive sampling, Coyne suggests, involves selecting the sample 
at the beginning of the study based on what is known about the area under 
investigation. Therefore it is a decision guided by previous clinical experience. 
Theoretical sampling is not guided by previously conceived notions or prior 
experience. Instead, theoretical sampling is guided by data that have been 
collected and analysed. The confusion between both terms arises when 
theoretical sampling becomes purposive; for example when a sample is 
selected according to emerging and developing categories in the data. Coyne 
argues that purposive sampling is not always theoretical and suggests 
renaming or replacing the term `theoretical sampling' with "analysis driven 
purposive sampling" (Coyne 1997: 11). 
3.4 Gaining access 
Letters of invitation including participant information sheets, GP letters 
(informing the patient's GP) and consent forms were prepared for three 
participatory groups (patients, family members, and healthcare professionals). 
Examples are shown in Appendix 7. An invitation to participate letter (participant 
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information sheet) was originally prepared with the intention of making 
numerous copies and leaving them with the consultants to hand to patients 
when they attended for outpatient clinic appointments. This would enable the 
patients to read and digest the information at home allowing adequate time to 
consider whether or not they wished to participate in the study. The patients 
then had the option of contacting me (the researcher) if and when they chose to 
do so. Alternatively the consultant could inform me as to whether I could contact 
the patient directly having sought their consent to do so. This was not 
applicable for the first batch of interviews; as stated previously, these 
participants were known to me from my clinical area of practice. I had discussed 
my plans for leaving the clinical area and becoming a full time student with the 
idea of undertaking my own research project. All the patients I had spoken to 
showed an interest in the study and a desire to participate. As a result I was 
given additional contact details such as e mail addresses and mobile telephone 
numbers encouraging me to contact them in due course. 
Having not had any form of contact with individual patients for several months, 
the approach adopted was to write a letter reminding them about the research 
(example shown in Appendix 8) enclosing the additional information sheet and 
consent form. However, there was always the concern that these patients could 
deteriorate suddenly. Away from the clinical area I was not aware of the day-to- 
day developments when individuals' conditions change dramatically over a 
short period of time. Patients were sometimes admitted to other hospitals; 
others may have been due for routine clinic appointments; or expected to attend 
as outpatients for chemotherapy, blood products and platelet transfusions, or 
radiotherapy. 
Being a Trust employee I also retained access to clinical documentation on the 
Electronic Patient Records (EPR) computerized system within the hospital 
closely situated to the university where I was based. The proximity was useful 
as I was able to continue to liaise with consultants and nursing colleagues if I 
required further information prior to contact. It was viewed as advantageous 
having 'inside knowledge' of how an organization functions on a day-to-day 
basis and knowing where to find people on a particular day. Having colleagues 
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who were supportive and being in a position where I was known to the 
department also facilitated my access as a researcher. I was known as a 
hospital 'research nurse' and despite the fact that I became a full time university 
student, I suspected that I was viewed by my colleagues 'in the same light'. 
They were, however, aware that I was involved in a nursing as opposed to a 
medical (clinical trials) study. This meant that there were few barriers and my 
presence in the clinical area was never questioned. Not having to spend time 
negotiating access and getting to know staff certainly proved beneficial. 
3.5 Research design 
The design employed in this research was grounded theory. Grounded Theory 
was developed by Glaser and Strauss in the 1960's while they were 
undertaking a study of the experiences of dying patients. Glaser stressed that 
Grounded Theory was, in fact, 'discovered' and not 'invented' (Glaser 1998). It 
was a general methodology that could accommodate either quantitative or 
qualitative data, the latter being the most popular, (Glaser and Holton, 2004). 
Both two sociologists came from different philosophical and research 
backgrounds, which eventually led to the further development of separate 
methodological approaches. Some of the techniques and procedures that were 
later developed by Strauss and Corbin (1998) were also used as guidance in 
this research. However, Glaser's unrelenting pursuit for 'staying open' to that 
which was emerging from the data has had a far greater influence on the 
direction of this project. 
Grounded Theory is primarily used for exploring a relatively unknown 
phenomenon such as living with multiple myeloma. Qualitative approaches are 
used to discover the meaning of lived experiences. These approaches provide 
the depth, and richness of data not acquired through quantitative measures. 
The central feature of grounded theory methodology that differentiates it from 
other qualitative approaches is the aim of theory development. Theory is 
defined as a group of well developed categories, themes or concepts which are 
systematically interrelated to form a theoretical framework with evolving 
statements of relationships explaining the meaning or the consequences of the 
phenomenon or event, (Strauss & Corbin 1998). The research findings are 
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summarised within a framework of integrated conceptual hypotheses (Appendix 
9). A quote by Gummesson (2002: 132) sums Grounded Theory up succinctly: 
"Take the elevator from the ground floor of raw substantive data and description 
to the penthouse of conceptualisation and general theory". 
The chosen design (grounded theory) is used where areas of limited research 
and insufficient knowledge has been identified. This methodology not only 
provides the best fit for the research question or statement, it is also structured, 
comprehensible, and easy to work with. A further appealing quality is that it is a 
general inductive approach that can draw on any theoretical perspective 
although the majority of grounded theory studies in nursing tend to utilise the 
sociological symbolic interactionism stance. The decision to draw from a 
particular theoretical perspective for this study was later determined following 
identification of the core category named contention. 
3.6 Data Collection 
A pilot study was undertaken with a small convenience sample at the time of 
writing the research proposal in March 2004. A total of five semi-structured 
recorded interviews were undertaken to assess the feasibility of the proposed 
study. The original interview schedule developed from the cancer literature is 
shown in Appendix 10. The aim was to find out what the key issues were that 
patients discussed and whether or not they coincided with my expectations and 
assumptions drawn from my clinical practice. I interviewed two male patients 
and their wives, and a single male patient who was estranged from his wife. The 
couples were interviewed in their homes while the individual was interviewed on 
a hospital ward where he had a single room. The couples were interviewed 
separately although the second couple remained together in the same room so 
were able to listen to each other's interview. The following extracts are taken 
from an early process memo discussing the justification for undertaking the pilot 
study and valuable lessons learned from it. 
Process memo 
First interview and the new digital voice recorder 
Date: 29 March 2004 
The first interviews were held in a private London flat away from the hospital 
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environment. There are sound arguments for running a pilot and one of the 
practical implications that came to light included running out of recording time 
during the second interview with the patient's wife which I had not anticipated 
with the new 90 minute digital recorder recently purchased. One of the main 
advantages of the recorder I believe is the size which is extremely small and 
unobtrusive. Previously while studying for an MSc and interviewing nurses the 
tape recorder was larger and appeared to have a significant impact on the way 
the interviewee behaved. Some nurses would talk freely and suddenly slow 
down during the interview stare at the recorder and appeared to deliberate or 
reconsider what they were about to say or how they were about to say it. 
Others stated that they felt uneasy because of the recorder and although they 
wanted to participate in the study they found it difficult to speak despite time 
spent establishing a rapport and reassurance of anonymity and confidentiality. 
The difference with interviewing a patient living with a haematological 
malignancy was that he really wanted and needed to talk and although he was 
aware of the recorder he did not appear to be threatened by its presence. 
When he had finished speaking he picked up the small digital recorder and 
wanted to check it was all there by playing it back and listening. / had planned 
on an unstructured approach but this proved difficult. Having known the patient 
for several months I was confident that he would be able to discuss issues that 
were important to him. His own words were "You must tell me exactly what you 
want". This is a clear case of 'deja vu' and learning from previous interviewing 
experience where a focus and semi-structured techniques are best employed to 
reflect the aim of the study and avoid huge amounts of data that do not serve 
any useful purpose. 
A disadvantage which became apparent immediately following these interviews 
regarding the use of the new digital recorder was that I had no means of a 
backup system. With a conventional recorder there are tapes which can be 
stored safely and locked away. A maximum of 100 files can be used in Folder 
A and B on the small digital voice recorder which could get lost or misplaced 
resulting in the potential breach of confidentiality and loss of huge amounts of 
data. The best option is to download onto a computer for storage and 
unfortunately my out of date Microsoft Works Windows 95 does not enable me 
to do this. Therefore the only option I have at present is to transcribe the 
interviews in full and erase them. 
In conclusion the main operational issues here to address are as follows: 
" Planning and Preparation 
" Timing of interviews 
" Compatibility of new technological equipment 
" Safety and storage of data 
" Provision of a backup system 
" Identifying and listing new equipment required for the study 
Four of the above interviews were transcribed verbatim. I was disappointed with 
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the general quality of the new recorder and it was not possible to transcribe the 
final one (the patient I interviewed on the hospital ward). This man spoke quietly 
and quickly. The background noise that the recorder picked up was 
overbearing. The location and timing was not very good either as the nurses 
were coming and going through swing doors that were banging constantly. 
Meals were on their way and staff were standing and talking just by the room 
door in the corridor outside. Two or three people entered the room while the 
recorder was on. It was not possible to salvage any of the conversation even 
with the help of a transcriber who later attempted to assist me with the task. 
The main data collection commenced in January 2006 using a semi-structured 
format and recorded interviews. Semi-structured or focused interviews help to 
ensure that specific topics relating to the aims and objectives of the project will 
be covered. This approach also allows ample flexibility in scope and depth 
(Polft and Hungler 1991). Recorded interviews provide direct evidence of 
human experiences relating to the phenomenon and determines their accuracy. 
There has to be a sufficient period of time between interviews to allow for full 
verbatim transcription of the recorded interview and analysis to be completed in 
order to guide further data collection. The proposed interview topic guide 
shown in Appendix 11 gradually evolved into more specific questions based on 
key issues emerging (Appendix 12). A follow up interview of the first couple I 
originally interviewed (P 001. F 002) in March 2004 was undertaken. This was 
done because a period of almost 2 years had elapsed and I thought it would be 
interesting to see how they were getting on with their lives and what changes 
may have occurred over the period of time. The second couple (P 027, F 028) 
were also interviewed again three years later in June 2007. The single man I 
interviewed sadly died (aged 48 years old). 
In addition to the main data collection demographic data was gathered from the 
patients and the healthcare professionals participating in the research 
(Appendix 13). Patient sample characteristics included occupation, date of 
diagnosis, classification of myeloma and family status. The healthcare 
professionals sample characteristics provided information relating to their 
professional status and length of service. This additional collection of 
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demographic variables aimed to provide an overall picture of the sample 
characteristics (Burns and Grove 1997). Background information may also be 
important in understanding participants' responses and attitudes (May 1991). It 
was anticipated that some of the interviewees would welcome the opportunity to 
talk while others found the physical and emotional impact of the interview 
exhausting. 
The following process memo highlights the emotional impact on a patient's wife, 
who was a retired nurse, and had always appeared cheerful, attentive, and in 
control: 
Process memo 
First interview 
Date: 29 March 2004 
Two separate interviews were held one of which was with the patient and the 
other was with his wife. Each person left the room while the other was 
interviewed. I hadn't anticipated the emotional impact this had on the patient's 
wife and her need to talk to someone which was not only extremely 
fundamental but provided an insight into each of their perceptions of the illness 
and the impact this had on their lives and that of their family and friends. 
It is vital for researchers to stay vigilant and sensitive to sudden alterations in 
mood and be prepared to provide support during and following an interview. I 
was able to utilize my interpersonal and specialist nursing skills when needed. It 
is suggested that the development of the nurse and patient relationship is an 
important factor influencing the provision of supportive emotional care (Skilbeck 
and Payne 2003) hence the importance of spending adequate time establishing 
a rapport with unknown participants prior to commencing the interview. At each 
interview I carried a folder with contact details of The Cancer Counselling Trust, 
Myeloma UK help line, and CancerBACUP, which were readily available so 
interviewees could access additional ongoing support if required. 
3.7 Data analysis 
In grounded theory data analysis involves a process of continuous interplay 
between the collection of data, analysis, and the writing of memos throughout 
the research process (Strauss 1987, Strauss and Corbin 1998). The approach 
to data analysis in this study was guided by procedures suggested by Strauss 
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and Corbin (1998) which follow: 
Stage 1. Listening to and transcribing recorded interviews 
Stage 2. Detailed line by line analysis and naming concepts 
Stage 3. Organisation and category grouping of named concepts and writing memos 
Stage 4. Establishing chronological order of named categories and subcategories 
Stage 5. Immersion into data and searching for repeated patterns of events 
Stage 6. Asking questions and making comparisons 
Stage 7. Making amendments to interview schedule based on emerging concepts 
Stage 8. Identifying the core category 
Stage 9. Validation from participants. 
3.7.1 Heading in many directions 
From the beginning of this research the emphasis was on what is happening 
and what is going on in the data. The naming of concepts, or coding, was 
assisted with the use of Nvivo version 2.0 qualitative software. This is discussed 
in more detail below (3.11). Open coding is intended to lead the way showing 
the direction in which to take the research which continued by means of 
theoretical sampling (when the researcher becomes more focused on a 
particular problem or issue). As mentioned above theoretical sampling is the 
process of collecting, coding and analysing data before deciding what data to 
collect at the next interview; thus the process of data collection is determined by 
the emerging theory (Glaser and Holton 2004). An example from a transcript 
and an illustration of how the methodology works using various levels of coding 
and corresponding theoretical memos is shown in 3.7.5. 
One problem with purposive sampling, with the aim of maximising variation, is 
that the researcher ends up managing vast amounts of data and is in danger of 
heading off in many directions. However, making comparisons and searching 
for patterns may help to identify key issues. For example if two or more 
participants discussed a similar issue spontaneously, this was explored further 
with others. Organising codes into categories proved complicated especially 
when one code could be placed under several category group headings for 
example bone pain as a named concept (code) had connections with several 
categories such as physiological impact, communication, and psychosocial 
impact depending on the context and interpretation of meaning in the data. 
There was no obvious sequence or chronological order for example as 
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mentioned in stage 4 as the process sometimes seemed chaotic and 
overwhelming. 
3.7.2 Writing `memos' 
The writing of memos began at the start of the project and were used in this 
research to document reflective thoughts, ideas, and concerns such as process 
operational and theoretical notes recorded throughout the process. An 
operational note is defined as "memos containing procedural directions and 
reminders" (Strauss and Corbin 1998: 217). Theoretical notes are analytical 
thoughts and ideas about theoretical sampling and other issues. Diagrams were 
also used to illustrate relationships among concepts (example shown in 3.14). 
The writing of theoretical memos hold centre stage in the process of generating 
theory; it is intended to assist in elevating data to conceptual level and 
generates the formation of hypotheses between the categories and concepts at 
dimensional and property levels (Glaser and Holton 2004). 
3.7.3 Returning transcripts for clarification 
Transcripts were also returned to participants for clarification of meaning and to 
make sure that there were no errors or misunderstanding. Forbat and 
Henderson (2005) address the potential ethical implications of returning 
transcripts by mail, which could result in a breach of confidentiality if delivered 
to the wrong person in error. It is also argued that it may not be appropriate to 
return transcripts to participants especially if revisiting sensitive material, which 
may be upsetting. Alternatively participants may not have given consent for any 
further contact or follow up (Forbat and Henderson 2005). 
Duffy (2004) highlights practical issues in relation to transcription errors and 
maintains that it is vital to check and recheck prior to analysis and not to 
assume that the transcriptions are correct (regardless of the fact that the 
researcher may have employed a reliable transcriber). The transcriber 
employed for this research was an experienced medical secretary which was 
helpful regarding general medical terminology. However, it was also necessary 
to prepare a glossary of terms used in haematological oncology including a list 
of common medications as the transcriber was from another specialist medical 
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field (thrombosis research) and thus was unfamiliar with some of the language 
used by the participants. The odd word can be missed out completely and 
therefore alter the meaning, or words can sound the same. For example pear 
and pair or I and eye or nose and knows. Other difficulties that may arise 
include accents, colloquialisms and the speed at which participants speak. 
3.7.4 Amendments 
Making amendments to the interview schedule continued throughout the 
research process and were determined by the emerging concepts derived from 
data collection at previous interviews. The first batch of patient interviews (n=8) 
commenced with a semi-structured approach opening with the question of 
"What's it like living with multiple myeloma"? My concern about an unstructured 
approach was that a participant might not know where to start or might not 
understand what the researcher is asking. On the other hand it would allow the 
participant to talk freely so that there was no restriction on the amount and type 
of data collected. The prepared topic guide referred to previously (3.6) proved 
to be very useful. This focused on the aims and objectives of the study and also 
allowed the participants to tell their story. It was important to try and approach 
the research with no preconceptions and allow the participants to discuss the 
key issues that they felt were most relevant. The working example that follows 
highlights a key concern 'delay in diagnosis' and the impact this had on the 
individual: 
3.7.5 The working example 
The following working example involves one of 25 original categories introduced 
(3.14) 'diagnosis' and one subcategory called 'delay in diagnosis'. Other 
'provisional' subcategories included for example, 'shock of diagnosis' and 
'communication'. The category, subcategory, coding with extracts of selected 
data, and corresponding theoretical memos are shown with the aim of 
demonstrating how the methodology works. 
The GPs involved in the following extracts were approached by a nursing 
colleague known to me and to the doctors (Locality Deputy Team Manager). My 
nursing colleague informed me that the GPs (n=3) were interested in 
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participating in the study. They were given letters and information about the 
study. Following that we communicated by e mail and arrangements were made 
to meet for interviews. 
" Category - Diagnosis: 
" Subcategory: Delay in diagnosis 
" Open code (named concept): Repeated visits to the GP 
" Axial codes (link between category and subcategory): Rarity of disease, 
non-specific onset 
9 Theoretical code (conceptual code explaining context, cause or 
consequence): Diagnostic constraints 
Patient transcript (Purposive 
sampling) 
Code: 
014: "I'm just not getting any better - 
back to the GP, back to the GP, Repeated visits to GP 
back to the GP. Finally, after, several 
months of this and it just wasn't getting 
any better, I said to the GP, I'd gone 
over to Canada and my dad said get 
an MRI (Magnetic Resonance 
Imaging) scan done, I came back and 
said to the GP I want an MRI done, 
just to see what the heck this is and he 
said yes but you're `gonna' have to 
wait six months, and I said I can't wait 
six months, `coz' l was almost bent 
double at that point, I could barely get 
to the GP's office, I could barely get 
anywhere, and it was just absolute 
agony. I couldn't sleep, I was just in 
constant pain. So I said give me a list 
of names of all the bone specialists so 
I'll go private and go try find out what 
this is, since you don't know but I 
understand It's, it's rare to see, it's Rarity of disease 
hard to diagnose myeloma in the first 
place and it's also rare to see it in a 
youngish chap so they probably wasn't 
looking for it. But the fact that the 
specialist just looked at the bloods and 
went with calcium levels this high, 
what else would you think? So I was 
disappointed, that the disease had 
been allowed to progress to the state 
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that it had, where I was, well I think, 
pretty nearly gone before I had to do 
something, to find out what was wrong 
and if I hadn't, then that would have 
been it, and as it, as it happens, I've 
had off and on 4 good years and I 
might not have had those. So cross, a 
little bit cross" ... 
Theoretical Memo: 
Date: 5 September 2006 
Delay in diagnosis and repeated visits to the GP have appeared a number of 
times and seem to be a common pattern emerging from data collected so far. Is 
this because the disease is uncommon and GPs do not expect to see it? Why is 
it difficult to diagnose? More importantly why does it apparently take so long for 
any investigation to occur? This is something that is worth exploring further. A 
common presentation is backache and I wonder how many patients are seen in 
the GP's surgery with this complaint and how many differential diagnoses if any 
are considered and at what stage? 
GP Transcript (Theoretical sampling) Code: 
026: "It is difficult because my 
understanding of some of the main 
symptoms you know, well backache 
being the obvious one, is such a 
common symptom, which we see 
everyday really without exception. I 
think the pointers are, may, correct me 
if I'm wrong, but the position of the 
backache, it's a little bit of an atypical 
backache, I think that these folk 
describe to us, thoracic upper 
backache rather than, if you like, a 
'bread and butter' backache, which is 
lower back pain but some of the other 
associated symptoms as well, they're 
often non specific I think if there's Non-specific onset 
say an abnormal presentation, so if Abnormal presentation 
there's a strong family history of Risk factors 
cancers, or a strong history of 
cancers, say the patient had prostate 
cancer, or had breast cancer and you 
were thinking of a secondary deposit, 
you might do an X-ray at that stage. If 
the symptoms were very severe, so if 
it, if a sort of simple analgesia or 
normal analgesia wasn't helping, then 
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you'd do an X-ray. If they've had 
failed treatment, so if they say that 
they'd been to a physiotherapist on 
their own for six months or a year and 
that hasn't helped, you'd do it then. 
So if it's like I started having back pain 
sort of two weeks ago and it's not 
getting any better doctor and it goes 
down my left leg or whatever, then we 
wouldn't necessarily X-ray at that 
stage but say go an see a 
physiotherapist and have that for, I 
mean they'd have to wait a few 
months to see them and then it's 
three or four ... and then a couple of 
months on the physiotherapy and then 
an X-ray, if it doesn't improve. So 
there are certain circumstances where 
we would X-ray early, if we we're 
concerned". 
Theoretical memo 
Date: 4 April 2007 
Both of these GP surgeries are in Essex which is one of our main referral areas. 
Each has one patient with multiple myeloma. One GP told me that out of a total 
of 2,300 patients assigned to him there is one lady diagnosed with multiple 
myeloma. He mentioned a second patient with paraproteinaemia but couldn't 
say if this was MGUS or a smouldering myeloma. The data collected suggests 
that the disease is difficult to diagnose because of its rarity and its non-specific 
onset. There is the assumption that backache is often seen as something 
common such as muscular strain and analgesics are prescribed. Failing this a 
stronger or different analgesia is given or a referral to the physiotherapist which 
can take months. If the presentation is considered uncommon, abnormal, 
severe, or there is a family history of cancer it is investigated immediately. The 
policy regarding backache is to treat the symptoms and not investigate the 
cause until much further down the line when the disease has been allowed to 
progress. I suggest this is one of the major factors influencing the delay in 
diagnosis. A delay in diagnosis ultimately means a delay in treatment. The 
lingering question is what difference does this delay make to the patient who 
has an incurable disease like multiple myeloma? Firstly as shown in the 
patient's extract above it has a huge emotional and psychological impact on the 
individual involved and possibly results in a loss of faith in the GP. Secondly 
patients with lytic bone lesions can be treated with medication, whereas if bone 
fractures have developed, these require surgical intervention. Someone with 
advanced bone disease is going to have a poor quality of life and may be 
confined to a wheel chair unable to walk. The impact on prognosis is highly 
significant in a patient with multiple vertebral fractures, unable to ventilate their 
lungs properly, and at risk of severe chest infections because it reduces their 
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chances of survival further as any aggressive form of treatment such as high 
dose melphalan will be considered too toxic. 
3.7.6 Identifying the core category 
The core category is the emerging central concept that relates to all the main 
categories and appears frequently throughout the transcripts. Identifying the 
core category was a true 'eureka' moment and although struggle represented a 
common pattern there were other strong interrelating concepts such as 'battle' 
or 'fight', 'disruption' and 'disharmony'. Contention appeared to encompass all 
four interrelating concepts and in order to develop some understanding and 
definition, a concept analysis of Contention was undertaken (5.3). The concept 
analysis involved exploring relationships between concepts by defining their 
attributes. The defining attributes associated with Contention for example 
include struggle, battle, disruption and disharmony. The aim was to describe 
and examine this concept and determine whether or not it was associated with 
other words in order to verify its actual and potential utility with regard to its 
meaning (Walker and Avant 2005). The concept analysis was undertaken using 
the framework suggested by Walker and Avant (2005) which included 
identification of all uses of the concept Contention, followed by constructing a 
model case; borderline, related, contrary, invented and illegitimate cases; 
identification of antecedents, consequences and definition of empirical 
referents. An articulation of the rudiments of the theory of Contention is 
presented in Appendix 14. 
3.7.7 Validation 
Validation from participants in stage 9 involved selecting a small number of 
interviewees (n=8) and asking them to look at the conclusions, the core 
category and theory that was developed from it. An example of an e-mail 
communication follows: 
Following your assistance with the validation of research findings when you 
kindly gave me examples of struggle, battle, disruption and disharmony. Can 
you now look at the following list and tell me if any apply to you or have applied 
to you in the past and if so give me an example? Or tell me if you can identify 
with any of the following and in what way? 
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" Communication issues or problems 
" Communicating bad news in a good way or in a bad way 
" Using complex terminology 
" Living with uncertainty 
" Perceptions of the illness (others' reactions towards you and your illness) 
" Novice to expert patient (inexperienced patient to experienced and 
knowledgeable) 
" Disrupted life 
" Physical impact of disease 
" Emotional impact of treatment 
" Physical impact of treatment 
" Social/economical impact of disease 
" Support needs 
" Sexuality 
" Invisible struggle 
" Impact of policy makers/legislation 
" Decision-making. 
Although participants provided feedback before in relation to the accuracy of the 
transcripts this provided a final validation of the outcome of the study. 
Participants who saw the theory generated from this research were able to 
recognize it and provided narratives as evidence of this (Appendix 15). This not 
only provided a test for factual and interpretative accuracy but also enhanced 
the credibility of the study which is discussed next in section (3.8). 
3.8 Trustworthiness of the study 
Credibility, fittingness, auditability and confirmability are the terms used in 
qualitative research in meeting tests of validity and reliability (Lincoln and Guba 
1985). However, Glaser argues that grounded theory is intended to be a 
rigorous and trustworthy methodology (Glaser 1998) and postulates 
inappropriate application of traditional quantitative principles used extensively in 
qualitative data analysis (Glaser and Holton 2004). 
The relationship between the different terms for both qualitative and quantitative 
research approaches are clarified here. Credibility or internal validity as it is 
known in quantitative research is concerned with truth and lack of distortion. 
Completed transcriptions are returned where possible to the participants for 
clarification of meaning and to allow necessary amendments. Not all 
participants agreed to have their transcripts returned and two patients died 
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Before I was able to return the completed transcriptions. Fittingness (external 
, alidity) determines whether the study findings have applicability in other areas 
it with other participants, (Lincoln and Guba 1985). 
kuditability, commonly known as reliability in quantitative research, concerns 
onsistency which determines the extent to which a study can be replicated. 
Thus it is assumed that a different researcher will obtain similar results or 
heoretical explanations by following the same research procedures. It can be 
argued that exact replication concerning human behaviour or unique 
ircumstances is not possible regardless of what procedures or methods are 
mployed (LeCompte and Goetz 1982). Consistency can also be established 
hrough the utilisation of peer member checking or collaborating with another 
esearcher in order to independently check the data. The individual who 
assisted me in this research was a qualified counsellor and lecturer practitioner 
n palliative care. A transcript was viewed in advance and a meeting was then 
arranged to discuss key issues emerging; agreement was reached regarding 
lamed concepts. 
, onfirmability or objectivity is the criterion for judging the trustworthiness of the 
>tudy and for this to be established credibility, fittingness and auditability must 
all be accounted for, (Lincoln and Guba 1985). Credibility was established 
through validating the findings and theory generated in this grounded theory 
-esearch which has been addressed previously (3.7.7). 
=ittingness or applicability to other areas of health care and life might include 
: hronic and progressive illnesses such as multiple sclerosis, trauma, acute 
Surgical and medical events, childbirth and bereavement, moving home, 
business, political and financial change. Auditability, or consistency in order to 
replicate the study, was determined through the methodology of grounded 
theory and the decisions made throughout the process; all of which were 
documented and accessible. Confirmability therefore aims to establish that the 
findings are as accurate as possible having evolved directly from the 
participants and not from the biases or motivations of the researcher. 
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Trustworthiness and data checking were supported by: 
" Transcription of interview data by an independent data transcriber, with 
accuracy checked by the researcher. 
" Multiple sources of data analysis - hand analysis and computer assisted 
qualitative software analysis. 
" Distribution of study findings to participants for validation. 
" Working in collaboration with the academic supervisors, and peer member 
(independent) data checking 
"A clear audit trail as per this written account. 
3.9 Methodological issues 
3.9.1 Emergence verses forcing debate 
Glaser has written extensively about 'staying open' to the emerging research 
issues and not influencing or forcing the data in order to produce results that do 
not truly reflect the participants main concerns (Glaser 2005; Glaser and Holton 
2004; Glaser 1998,1992,1978; Glaser and Strauss 1967). Glaser (1992) 
criticises Strauss and Corbin's (1998,1990) highly structured and complex 
techniques involving preconceived questioning that could force alternative 
theoretical explanations at the risk of jeopardizing the true reflection of 
emerging theory. 
Glaser maintains that entering the research field with preconceived ideas can 
undermine the process and leads to potential bias. In reality, however, it may 
not be possible to enter the field with no preconceived notions particularly when 
the researcher is a part of the area under investigation. Preconceptions 
associated with professional issues may also enhance understanding of what is 
going on in the data. Glaser and Strauss (1967: 46) maintained that theoretical 
sensitivity is something that gradually develops with professional experience, is 
associated with an individual's personal qualities and is defined as: "Ability to 
have theoretical insight into his area of research, combined with an ability to 
make something of his insights". 
However, there are contradictory opinions regarding whether the literature 
should be reviewed at the start of grounded theory research and continue 
throughout the entire process as an analytic tool aiming to identify links to 
existing theory (Strauss and Corbin 1998,1990). Alternatively, to view the 
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literature towards the end of the process when the core category has emerged 
and constant comparisons can be made between the emerging theory and 
extant knowledge (Glaser 1998) is also advocated. The latter requires a 
postponement of viewing the literature and 'putting on hold' preconceptions 
prior to and during data collection. The objective is to allow the researcher 
freedom and openness to the emerging data and reduce assumptions regarding 
what the researcher 'thinks' might be found in the data. This does not however 
mean that the researcher should not read any material during the course of the 
research. Glaser (1998) stipulates that the reading of literature from other 
substantive areas may serve to enhance theoretical sensitivity. 
In this research it was necessary to undertake a review of the cancer literature 
which provided background information on multiple myeloma and identified 
gaps in existing research (Creswell 1998). It also fulfilled a mandatory entrance 
criteria in application processes involving university placement, funding scheme, 
and ethical approval. This literature review was undertaken early in 2004 at the 
time of writing the research proposal. The main data collection did not 
commence until 2006 thus a substantial period of time had elapsed (although 
the lack of available literature suggests this would not have changed markedly).. 
There are also conflicting views concerning techniques and procedures that 
impose devices and frameworks intended to help stimulate analytical thoughts 
concerning development and integration of categories in grounded theory 
methodology (Strauss and Corbin 1998,1990). The use of such frameworks 
according to Glaser (1978: 117) is gratuitous and he argues against the 
researcher using a "ready made outline" in which to assist theoretical 
integration: 
"No ready-made scheme works well if at all. He should simply start sorting the 
categories and properties in his memos by similarities, connections, and 
conceptual orderings. This forces patterns which become the outline" (Glaser 
1978: 117). 
3.9.2 Insider/practitioner researcher 
An account of my professional role was previously introduced (1.3,1.4) within 
the area under investigation. The advantage of being an insider/practitioner 
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researcher meant that my presence in the clinical area was immediately 
accepted. Therefore gaining access and rapport with the hospital staff was 
established prior to the study commencing which can be very advantageous 
and may save prolonged periods of time otherwise engaged with negotiations 
and seeking approval from the 'gatekeepers' who authorise access (Simmons 
2007, Klein and Johnston 1979). Gaining access and establishing trusting 
relationships may be problematic for some healthcare professionals attempting 
to undertake research in establishments where they are not well known 
(Simmons 2007, Klein and Johnston 1979). It is suggested that the 'insider' 
researcher who has spent a significant period of time in the area under 
investigation has the advantage of having access to a broader and more in 
depth range of information (Hewitt-Taylor 2002) and support from managerial 
staff and colleagues (Simmons 2007). The counter argument to the 'insider' 
researcher is that the 'outsider' researcher is less likely to be influenced or 
biased and is more likely to maintain some semblance of objectivity (Allen 2004, 
Hewitt-Taylor 2002). The outsider/practitioner researcher, however, may feel 
disadvantaged because of the amount of time required in order to gain access 
and establish trusting relationships within an unfamiliar environment (Allen 
2004). 
Being known by many of the participants in this grounded theory research, 
however, may have influenced the way in which the data was collected, 
analysed and interpreted. This was addressed in numerous reflective and 
reflexive or 'self critique' field notes, peer reflection with independent data 
checking and memos aiming to acknowledge the potential for bias, maintain 
vigilance and strive to the notion of 'staying open' to the emerging theory 
(Glaser 2005, Allen 2004, Glaser 1998, Field and Morse 1985). Furthermore It 
is argued that 'theoretical sensitivity' (Glaser and Strauss 1967) was enhanced 
having had prior knowledge and understanding of the impact of the illness, 
management of the cancer and familiarity of the specific haematological 
terminology which many of the participants in this current study used. 
One advantage of knowing some participants was that I did not have to spend 
time establishing a rapport or gaining their trust. Allen (2004) argues that the 
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quality of data collected is determined through the strength of the relationship 
between researcher and participants in the field. I felt that most people knew me 
well enough to talk fairly freely and that they were confident to do so in a 
relaxed and informal environment. However there was the possibility of my 
influencing the participant while collecting data. For example I may have been 
perceived as part of the establishment (Allen 2004) and therefore the participant 
may at times have been a little wary or conservative with responses to certain 
questions regarding the healthcare system. How did I know whether or not they 
were simply saying what they thought I wanted to hear, or saying something to 
please me? Participants sometimes stated that they had no complaints and 
everyone (healthcare professionals) were wonderful. This type of response led 
me to believe that participants thought they were being asked to criticise their 
care and needed reassurance that this was not the case. Thus the dilemma of 
the dual role, practitioner-researcher identity can be particularly challenging 
(Allen 2004) for novice researchers. It is suggested that there may be less 
ambiguity or confusion associated with the dual role of practitioner/researcher if 
the investigator's professional status is not disclosed (Klein and Johnston 1979) 
when initially introduced. 
The way in which questions or prompts were used during interviews made a 
significant difference regarding participants' responses. For example the 
question "can you talk to me about your recent stem cell transplant"? proved to 
be far more productive than "have you got any issues relating to the healthcare 
system"? The additional knowledge that I had about an individual may also 
have influenced data collection or my responses. The following example is 
taken from field notes demonstrating reflective thoughts, `self critique and 
constantly questioning the way in which the data was collected and analysed 
(Hewitt-Taylor 2002, Strauss and Corbin 1998, Field and Morsel 985): 
Field Notes 24 January 2007 
P 023 
The interview lasted for approximately one and a half hours and we sat and 
talked for several minutes following this. Dave seemed very relaxed throughout 
and / thought the interview went well. I think I have improved on picking up cues 
and not changing the course of the conversation. It also seemed easier for me 
as / know Dave especially in comparison to yesterday's interview when / met 
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Karen (HCP 022) for the first time. There is always that initial awkwardness to 
start with and that was very much on my mind. I was thinking I wonder what she 
thinks of me? Will she answer my questions without becoming defensive? Will 
she feel threatened? I must be careful how I approach her and how I speak! 
First impressions are so important! I must be myself but make an impression! 
Will she see that I am nervous about meeting her? Will we have time to 
establish some form of rapport? Returning to Dave, I just thought, great it's 
Dave and I know what he is like and he knows what I am like. However, there 
have been occasions when patients who do know me have given identical 
answers to certain questions in relation to the experience of treatment or issues 
associated with healthcare. They have adopted a defensive mode of "Oh I have 
no criticism - the treatment has been excellent - the consultants, the nurses are 
wonderful" and so on. Does the way in which I ask the question imply that there 
might be something to criticise or complain about? Is this because they see me 
as `part and parcel' of the hospital team and know me as a nurse and not as a 
researcher? It might be that they feel that I am part of the establishment and 
that I might get offended if there is any criticism of care. 
Knowing participants on a more personal level in relation to boundaries, and my 
role as researcher created some unanticipated issues. For example I was 
sometimes met at the railway station when interviewing participants in their 
homes. On one occasion the participant talked continuously while driving the 
car and may have been reluctant to repeat the whole conversation that had 
taken place prior to the actual interview. There was also the issue of the 
interview becoming more of a sociable event and transforming into a tea party 
when a couple seemed more concerned about their hospitality and making me 
feel welcome in their home. Was it essential that I made a distinction between 
an interview and the social nature of the event? Did this really matter as long as 
I got the desired data? Finding the right balance was something that I tried to 
achieve. Having said that, each interview was also different. Each person 
interviewed reacted in a unique way and it was assumed they expected me to 
be the same person that they knew (Simmons 2007). I was aware that acting 
differently for the sake of the 'researcher role' when there was an established 
and trustworthy professional nurse-patient relationship could have been 
insensitive to the interviewee, and potentially detrimental to the project. 
3.9.3 Specific issues 
A specific issue relating to time or the timing of recruitment created concern and 
was something that I was particularly aware of. People living with multiple 
myeloma may suddenly start to deteriorate so there was an urgency to interview 
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participants while they were well enough. Some may have died in the 
meantime. There was also the returning of transcripts for clarification which was 
not always appropriate or possible depending on the circumstances. In one 
case, for example, a young female patient died and I did not feel that I could 
return the transcripts to her husband and mother who had also participated in 
the research at a time of loss and bereavement. Even at a later date this may 
have proved to be painful and inappropriate. I felt reluctant to do this at any 
stage and risk causing undue distress. 
The difficulties of being a novice interviewer were gradually overcome. Some of 
the interviews were particularly difficult for various reasons. Interviewing 
couples or a family group together was more complex. Difficulties arose when 
one family member's dominance took over the interview and the 'patient' 
allowed this individual to dominate. For example, I suggest that listening to two 
people speaking almost at the same time, observing body language and trying 
to pick up on important points but allowing them to continue without interruption 
required special interviewing techniques that are only acquired through 
experience. Novice researchers must learn to pick up on issues and allow the 
participant to talk more on a particular topic despite the fact that it may have 
been painful or critical. It seemed crucial to say something encouraging when 
necessary and not change the course or direction of the conversation because 
it was distressing. Any attempt to 'lighten' the conversation for instance and talk 
about something that was not so painful might have constrained the emerging 
theory. 
The emotional impact on the person doing the transcribing was brought to my 
attention during the numerous conversations throughout the course of the 
study. This was a significant concern and one which required monitoring. The 
transcriber agreed to document the effect that the process was having during 
the transcribing of two particularly emotional interviews. A few lines of the 
transcriber's notes are presented below from one of the interviews: 
"What a very sad life experience to narrate. How do people cope, you marvel at 
a human's resilience in the face of adversity, this young woman has certainly 
had to go through all sorts of traumas, emotionally and physically and she is so 
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young, it made me feel so very, very sad for them both. Your heart just wants 
to go out to them both. I felt quite tearful when transcribing this interview". 
3.10 Managing the project 
Organisation and administration were two important practical considerations for 
managing the project. The project administration file used on the computer is 
shown in a diagrammatic form in Appendix 16. This reflected the amount of 
paper work involved albeit on a much larger scale in reality. Examples of other 
files included: 
" Field notes 
" Transcripts 
" Open codes and categories 
" Research and Development Finance (record of invoices) 
" Project work 
" University docs (documents) 
It was particularly important to keep records of the process and to document 
everything that occurred. This not only provided an audit trail but was a 
necessary organizational tool and useful for reminders and guidance. This 
prevented a lot of confusion especially half way through the project when, at 
times I needed to 'take stock' and ask questions such as: 
" How many interviews had been done 
" Who the participants were 
" How many interviews had been transcribed 
" How many transcripts had been coded 
" Which transcripts had been sent away for data checking 
" Which topics were emerging repeatedly? 
These questions could be answered in an instant by looking at the updated 
interview record kept in the project administration file. The implementation of 
collecting, transcribing, and analysing data before the next interview was not 
always practical because the person transcribing lived 30 miles away and 
transcribed 3 or 4 interviews at a time. The mini discs from the recorder were 
posted by recorded delivery following the interview or delivered by hand to the 
transcriber. The recordings were listened to before and following the return of 
the transcripts. This was to (a) establish what the main issues were when 
another interview was pending and (b) to check the accuracy of the transcript. 
Each mini disc was labelled for identification with a number and the participant's 
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initials for example 099 PJS. The transcripts were e-mailed and the mini discs 
collected or returned by post. 
Preparation for the interview was undertaken by using a checklist of items to 
pack in a bag and by routine checking of equipment. Before each interview the 
recorder was tested and the battery was checked. The checklist is shown 
below: 
" Contact details of participant 
" Mobile phone 
" Pen 
" Note pad for field notes 
" Consent form 
" Extra information sheet 
" Demographic form 
" Interview guide 
" Diary 
" Recorder 
" Extra mini disc 
" Extra battery 
" Plug. 
3.11 Managing the data 
Another important practical consideration was managing the data obtained. The 
decision to use Nvivo qualitative software in this research project was based on 
the recommendation from members of the fellowship scheme funding 
committee. Nvivo was being used in the university prior to commencing the 
study and I welcomed the notion of learning a new skill and having the 
opportunity of using computerized assisted analysis to manage the data. The 
main advantages of the system were organization of data, storage of data, and 
retrieval of data. The following process memos reflected some of the difficulties 
encountered along the way: 
Process memo 
Nvivo software 
Date: 25 May 2006 
1 am at the stage of open coding and organising the codes into category groups. 
In Nvivo the codes are nodes and the category groups are trees. The 
terminology therefore is simple. / attended an all day introductory workshop 
which was sufficient to start me off but not really adequate for my needs. 
would have preferred a one to one tutorial and plan to go for a follow up 
95 
session, which they run at the University of Surrey. The whole day was whizzed 
through far too quickly for me to catch up with all the various functions. Not only 
are there various functions, there is more than one way of doing them which is 
confusing when learning something new. On the other hand, having more than 
one way of doing something can be advantageous and often when 
experimenting another way presents itself almost by accident. 
Some of the difficulties / have encountered are worth documenting. I am 
disappointed that when placing the nodes into trees, this takes up so much time 
and appears to be a long-winded process. This is because the node browser 
immediately tells you which section or paragraph to go to but is not capable of 
going straight to that section of the data. On average each interview consists of 
300-600 codes and it is necessary to return to the data checking for meaning 
and context while deciding which category or tree to place the code or node in. 
The system places the free nodes in alphabetical order. The whole process 
involves constantly scrolling the page up and down from say paragraph 4 to 
paragraph 1060 and visa versa. 
A further difficulty I encountered this morning (hence I interrupted the analysis 
to write this memo) is that I have noticed on more than one occasion that 
sometimes there are `double-ups' of sentences. I decided to delete a repeated 
sentence and lost both. Here the situation is that if you come out of the 
programme and do not save the changes then you risk losing the work that you 
have been doing. The obvious solution is to retype the sentence from the 
original transcript, however, the node browser has then become de-activated so 
it is necessary to make a note of exactly where in the text the node or code is 
situated, or spend time sifting through each paragraph until you find it. 
Process memo 
Nvivo software 
Date: 06 September 2006 
Having completed 014 yesterday morning / became frustrated with the vast 
accumulation of nodes from all transcripts. The system allows you to print out 
an up to date node list with or without full description. I like to be able to see an 
individual transcript's codes so I can return to them and the transcript at any 
given time. This is important and is the only way of returning to the data over 
and over again in order to understand the meaning and know what it is that the 
data are telling me. Once the nodes are placed into the trees (category groups) 
the only way to separate an individual transcript's coding is to firstly create a 
node list report, and then delete all except the one that you require. I have also 
been doing this as a backup by the re-entry of codes into another electronic 
system -a spreadsheet in Excel. Although this is time consuming, I think it is 
wise to have a backup on a different electronic system. It also serves to help 
with familiarization and meaning of data because everything is entered twice. 
The more interviews that are done, the more data / am handling and this 
becomes a real chore when attempting to print out selected or an individual's 
node list. This is because of the sheer volume and the desire of not wishing to 
waste excessive amounts of paper. This means that out of 2457 nodes or codes 
wanted to look at 241. The only way to do this apparently is to painstakingly 
and carefully pick out and delete all except for the 241 codes / wanted to view. 
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This takes up considerable amounts of time and effort not to mention the fact 
that thousands of nodes equal hundreds of sheets of paper when printing. 
3.12 Managing the time 
The time scale and work plan (Appendix 17) indicated that by October 2007 
would be writing the first drafts of this thesis. The reality was that I had not had 
the last remaining five transcripts returned by then. Data collection was not 
completed until November 2007 and although I had not intended to do any more 
interviews at this time, a male Afro-Caribbean participant who had not been well 
enough to be interviewed previously contacted me stating he would like to 
participate. 
3.13 Completed data collection 
Data collection involved the undertaking of 46 recorded interviews as shown in 
Figure 3 comprising of 20 patient, 14 family member, and 12 healthcare 
professional interviews. In addition there were numerous e-mail 
communications, letters and field notes. All types of data can be used in the 
process of grounded theory (Glaser 1998). An interview record is shown in 
Appendix 18 illustrating that all interviews undertaken were transcribed and 
coded. 
Figure 3 Completed data collection 
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3.14 Categories emerged from the data 
A total of 25 category groups emerged from the data. Following the 
identification of the core category of Contention, it was then possible to be 
selective and identify which category groups related to the core category. Thus 
there is the process of integration of relevance and fit involving a process of 
delimitation. This is a momentous phase in the process of grounded theory 
research because suddenly there is direction and focus on development and 
consolidation of the main category groups identified. I found diagrams 
particularly useful to illustrate relationships between the core category and other 
category groups. One example of an evolving explanatory diagrammatic model 
is a thematic skeletal ribcage as the central bone (sternum) holds all the other 
bones (ribs) in place; that is they are all closely connected or linked together in 
the same way as the central or core category and associated categories or key 
issues as illustrated in Figure 4. Following the delimiting stage of the analysis, 
the four main category groups identified were: 'Ways of communication', 'Nature 
of the disease', 'Impact on life', and 'Supportive care needs'. These four main 
categories and their subcategories are introduced in more detail in chapter 4. 
The 25 category groups, main categories and subcategories are listed below: 
Category groups Core and main categories 
Communication CONTENTION 
MM The disease 
Support Ways of communication 
Physiological impact Nature of the disease 
Psychological impact Impact on life 
Sociological impact Supportive care needs 
Emotional impact 
Family impact 
Belief system 
Religion 
Adjustment 
Knowledge 
Altered body image 
Understanding 
Decision making 
Impact of others 
Acceptance 
Coping 
Compliance 
Diagnosis 
Life 
Other diseases 
Healthcare 
Memory 
Perceptions 
Subcateclorv Qroups 
Ways of communication 
Communicating with the doctor 
Communicating bad news 
Using complex terminology 
Communicating with children 
Hidden disclosure 
Nature of the disease 
Delay in diagnosis 
Living with uncertainty 
Perceptions of the disease 
Novice to expert patient 
Impact on Wo 
Disrupted life 
Physical impact of disease 
Emotional impact of treatment 
Physical impact of treatment 
Impact on sexual relationships 
Impact on family life 
Supportive can needs 
Invisible struggle 
Impact of policy 
Decision-making 
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Rarity of 
disease 
Shock 
Nature of the - 
disease 
Terminology 
Decision 
making /ý 
Hidden 
tensions 
Struggle 
Family 
support 
Remission -º 
Uncertainty 
Diagnosing 
Non-specific onset 
Breaking bad news 
f Accessing support 
(Communication 
-Managing the 
reality 
Perceptions 
Waiting 
Relapse 
w _-- Treatment 
Figure 4 Evolving category group model 
3.15 Personal reflections on the process 
It was a very disturbing experience interviewing patients and saying goodbye 
knowing that it might be for the last time especially when I had come to know a 
person and their family. There were mixed feelings of sadness and guilt 
because as a researcher I needed information from them and as participants 
they gave up their precious time and energy with little concern for themselves. 
Typically people would say "anything to help others" and I think this had the 
biggest impact on me personally. The following reflective memo was written 
following awareness of Fred's (P 017) death. 
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Reflective memo 
Reflections: 8 August 2006 
It's very hard sometimes going over to the Haematology Department (my other 
world, my work world) and looking on the EPR (Electric Patient Records) where 
have access to patient records and finding Fred's death notification. He died 
on 24 July. I wanted to see his last clinic letter to find out how he was before 
contacting him again regarding interviewing one of his daughters, (Fred's 
suggestion). He showed me his youngest daughter's wedding pictures when I 
interviewed him on 29 June and he was so proud. It is almost as if he was 
hanging on for that wedding - one more loose end to tie. I remember he was 
pale and relatively short of breath when he came to his front door to let me into 
his home. He told me that the past two months had been his worst throughout 
his illness. Looking at his last clinic letter dated 3 July his bone marrow failure 
continued to deteriorate. His platelet count was just above 10 and he had some 
platelets during the week for oral bleeding. His neutrophils were 0.5. The pulsed 
Dexamethasone had been reduced from 20mg to 10mg because it was making 
him irritable and his prognosis was said to be extremely poor although the Dex' 
was providing some symptomatic response and Fred was said to be feeling 
fairly well. His M Band had fallen (not risen) from 26 to 19 on 21 June. I liked 
Fred. He was a nice quiet 'easy going' man and had been diagnosed in January 
1997 so he had been treated for the past 9 years. His wife had died of 
leukaemia at (named hospital) in 1989. Fred had two married daughters and a 
grandson. I am sure he will be greatly missed. 
3.16 Summary 
This chapter has delineated an overview of the research process. There has 
been an account of the planned investigation and how this was managed in 
reality discussing some of the difficulties along the way. General methodological 
issues were discussed in relation to the conflict in the literature between Glaser 
and Strauss because of the remodelling of grounded theory resulting in different 
approaches. Specific methodological issues relating to the undertaking of the 
project were also highlighted. Managing the project took into account practical 
issues such as preparation of interviews, organisation of administration, the 
importance of keeping records and providing an audit trail. The initial 25 
category groups and the consolidated main categories and their subcategories 
are introduced. The next chapter introduces the participants, presents findings 
and the generation of theoretical interpretations from each participant group. 
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Chapter 4. Findings 
4.1 Introduction 
This chapter presents the findings associated with the core category 
'Contention' from the research commencing with 'Ways of communication', 
which is one of the four major categories that have emerged following the 
delimiting process and consolidation from a total of 25 category groups 
mentioned previously in Chapter 3. The remaining three major categories are: 
'Nature of the disease', 'Impact on life' and 'Supportive care needs'. Categories 
are linked through the nature and impact of a complex, progressive and 
incurable cancer. Figure 5 illustrates the core category of Contention, 
associated main categories and subcategories. Contention relates to struggle, 
battle, disruption and disharmony that appears to exist living with multiple 
myeloma. It seems there are specific stages throughout the illness trajectory 
when Contention crescendos. For example, being newly diagnosed and 
periods of relapse. 
Contention 
Ways of Nature of disease Impact on life Supportive 
communication care needs 
Communicating Delay in Disrupted life Invisible struggle 
with the doctor diagnosis 
Communicating Living with Physical impact Impact of policy 
bad news uncertainty of disease ý4 r 
Using complex I Perception of I Emotional impact I Decision-making 
terminology the disease of treatment 
Communicating 
with children 
Hidden disclosure 
Novice to Physical impact 
expert patient of treatment 
Impact on sexual 
relationships 
Impact on 
family life 
Figure 5 Core category Contention, main categories and subcategories 
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This section of the thesis begins with introducing the participant groups. Memos 
consisting of patient and family profiles introduce the participants' background 
stories which follow prior to the presentation of findings. Beneath the headings 
of each main category follow the named subcategories associated with them. 
Contextual and analytical story lines provide theoretical explanation, and 
conclude each of the subcategory group sections. A summary concludes each 
of the main categories and their subcategories. Lastly, in order to illustrate a 
diagrammatic representation of the core category 'Contention', major category 
groups and subcategories within the context of an incurable and progressive 
haematological malignancy, is presented in Figure 6. The chapter ends with a 
final position statement creating an opening for the next (discussion) chapter. 
Selected extracts from interview transcripts are used to illustrate points within 
the text. Vignettes from chosen transcripts are also displayed in trilogies with 
the aim of presenting exemplars from each group of participants (Tables 3-21). 
This provides a way of presenting the participant groups collectively in order to 
substantiate the findings. This approach was inspired by accessing a grounded 
theory thesis about decision making for ill children (Baxter 2004). The 
interviewees are identified by the letter P for patient, F for family member and 
HCP for healthcare professional. Each participant has a study number, for 
example P 001 is a patient allocated with number one, F 002 is a family 
member and participant number two and HCP 005 is a healthcare professional 
and participant number five. Participants in this study attended various hospitals 
and the names of these are omitted and replaced with (named hospital). 
Pseudonyms are used for patients, family members and healthcare 
professionals throughout in order to maintain confidentiality. 
4.2 The participants 
Patients and family members are introduced first. These are introduced as: 
couples, small family units and individuals; using pseudonyms, age range, 
occupation, date of diagnosis and in some cases, a second date indicates date 
of death (Table 1). Healthcare professionals are presented in Table 2. 
Descriptive patient and family profile memos are then displayed introducing the 
patients' and families' background stories. 
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Patient and family pseudonyms. Age range, occupation and significant dates 
Bert and Shirley 
Bill and Sylvia 
Pam and Alf 
Frank and Maggie 
Debs, Mat and Stella 
Geoff and Carol 
Jack and Penny 
Marian 
Fred 
Sally 
Phil 
Dave 
Gloria 
Maurice 
Charlie 
Victor 
Alice, Val, Rosemary 
Mike 
61-70 Retired engineer, diagnosed 2003-2006 
41-50 Electrician, diagnosed 1997 
61-70 Retired printing, diagnosed 1987-2007 
61-70 Retired policeman, diagnosed 2002-2008 
30-41 Architect, diagnosed 2004-2006 
51-60 Administrator, diagnosed 2001 
41-50 Research market, diagnosed 2002 
61-70 Retired Home Help 2000-2001 
61-70 Retired BT engineer, diagnosed 1997-2007 
61-70 Retired lecturer, diagnosed 2004 
61-70 Retired IT Bank, diagnosed 2002-2007 
41-50 IT Architect Bank, diagnosed 2003 
51-60 Retired domestic supervisor, diagnosed 2006 
61-70 Retired mechanic, diagnosed 1993 
41-50 Ambulance driver, diagnosed 2006 
51-60 Teacher, diagnosed 2007 
71-80 Retired secretary, diagnosed 2001 
51-60 Retired plasterer, diagnosed 1993 
Table I Patients and family members 
Healthcare professionals (with pseudonyms) 
Lin, Myeloma Clinical Trials Nurse 
Ruth, Bone Marrow Transplantation Coordinator 
Sam, GP 
John, GP 
Karen, Myeloma Nurse (Clinical Nurse Specialist) 
Ian, GP 
Pauline, Macmillan Palliative Care Nurse 
Ellen, Macmillan Palliative Care Nurse 
Jill, Haematological Oncological Nurse (CNS) 
Maura, Myeloma Nurse (CNS) 
Claire, Myeloma Nurse (CNS) 
Fiona, Myeloma Nurse (CNS) 
Table 2 Healthcare professionals 
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4.2.1 Patient and family profile memos 
Bert's story: 
Bert (P 001) and Shirley (F 002) were married with two adult children. Bert was 
a retired engineer and Shirley a retired occupational health nurse; both in their 
late sixties, articulate and friendly Caucasians living in Essex. I had met this 
couple while working as a clinical trials nurse prior to the commencement of 
the research. They were staying in a flat in London isolating themselves away 
from their family and friends while Bert was undertaking his first chemotherapy. 
This decision was based on the assumption that the isolation would reduce the 
risk of infection, as Bert was prone to chest infections. Bert was feeling 
particularly vulnerable due to a number of infections resulting in treatment 
delays. This couple were interviewed in 2004 (Bert had been diagnosed for 
approximately 4 months) and again in February 2006. They were interviewed 
separately on the first occasion and together for the second. It was during the 
first interview that I saw an emotional side of Shirley I had not seen before. The 
difference between 2004 and 2006 was plainly evident in the way they both 
reacted during the interviews. This couple were initially in a vulnerable and 
uncertain frame of mind. I hadn't anticipated the emotional impact on Shirley 
and her need to talk to someone which was not only extremely fundamental but 
provided an insight into each of their perceptions of the illness and the impact 
this had on their lives and that of their family and friends. I had seen a caring 
and supportive wife accompanying her husband when he attended the 
chemotherapy day care unit. I knew Shirley had been a nurse and appreciated 
that she was not familiar with the world of haematological oncology but she was 
learning at a rapid pace. Shirley seemed in control, always smiling and very 
attentive. During the second interview I could see this massive difference. The 
disease and the implications of the myeloma were no longer a new concept as 
when Bert was newly diagnosed and starting his first chemotherapy. Shirley and 
Bert had now been through periods of 'ups and downs'. They appeared 
knowledgeable, relaxed, confident and in control of their lives. 
Pam's story 
Pam (P 003) and Alf (F 004) two bubbly personalities residing in Essex, were 
married with 2 adult children and 3 grandchildren. Pam was diagnosed in 1987 
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with multiple myeloma when she was 47 and employed full time. Pam attended 
an osteopath for back pain on three or four occasions before deciding to go and 
see her GP. Her back pain became so severe that she was unable to climb up 
the stairs to go to bed. Over a period of a few days her condition deteriorated 
and she was admitted to hospital by ambulance in a semi-comatosed state 
having vomited several times. Pam's blood was described as being 'like syrup' 
and she was immediately dialysed (urgent plasma exchange). Blood tests and 
bone marrow biopsy confirmed the diagnosis. Pam's first remission lasted for 12 
years, which is unusually long. During the time following Pam's first treatment 
regime Alf and the children had discussions about the potential life expectancy, 
which they understood was approximately five years. They avoided telling Pam 
about the five-year life expectancy and made sure that she did not have access 
to medical texts. Alf made a number of decisions concerning the kind of 
information to which his wife should or should not have access. He did not want 
to talk to her about anything that was in his view 'negative' and it was of 
paramount importance to him, that she remained in a positive frame of mind 
and not take 'hope' away. 
Frank's story 
Frank (P 007) was in his late 60s, originally from Scotland and married to 
Maggie (F 008) who was Irish. I met this couple in 2002 when Frank was newly 
diagnosed. They had three adult children and lived in Essex. He had retired 
from the police force and was working part time in an office prior to the onset of 
illness. The day of the interview was freezing cold (March 2006) and Frank and 
Maggie had been to Mass, which finished at 09.30.1 was expected at around 
10.00. Frank was a tall man, good head of hair, wore spectacles, had a large 
body frame and was very friendly. Frank had a strong Glaswegian accent and 
he walked slowly but unaided as if he were treading on sacred ground. His walk 
was impeded by the neuropathy (numbness in his feet) causing discomfort. He 
was cheerful and welcoming and not for the first time I felt humble in his 
presence. My impression of Frank was that he was a strong character and very 
set in his ways. Frank epitomized the uncertainty and disharmony associated 
with living with multiple myeloma by using the analogy "It's like living with the 
sword of Damocles over you all the time". This couple were also interviewed 
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______________________ - 
twice but the second time was a validation of research findings visit. Frank was 
very interested in medical topics and was knowledgeable about his disease, 
medication, treatment options, specialised surgical procedures and 
investigations. 
Deb's story 
Debs (P 009) was a young mother married to Mat (F 010) and the daughter of 
Stella (F 013). Debs had contacted me by e-mail suggesting an interview date 
and informed me that her 'mum' was interested in participating in the study also. 
Debs had broken both her hips and was waiting to have surgical hip 
replacements. I met her and Mat at their home for the interview. Debs and Mat 
were in their mid thirties, both had degrees in architecture and met at work in 
1998. They started dating in 1999 and had a toddler aged 3 (Ben). They lived 
in East London in a terraced house, in a narrow and congested street so 
parking was a real problem, as they did not have a garage. Debs was 
managing to manoeuvre fairly well with crutches. On the day of the interview 
she was dressed in a black Tee shirt, black trousers and comfortable looking 
beige laced trainers. Her body took on the shape of the letter Z. Her back 
appeared bent forwards and her hips seemed to protrude outwards from behind 
which were more obvious from the side view. Sitting down she looked normal 
with a small body frame and a young pretty face. However, Debs she had lost 
significant body weight although she had started to regain a little. Her hair was 
very short having just grown back following recent high dose chemotherapy. 
This family were having a difficult time and the interview was emotional 
particularly because Debs was pregnant at the time of diagnosis. The 
pregnancy was terminated and chemotherapy was commenced immediately 
following this extremely distressing event. Debs described the turmoil to her life 
as being ongoing with one thing after another. She was distraught and 
frustrated because of the problems with her hips, not being able to walk, return 
to her job or take care of her little boy. 
Geoff 's story 
Geoff (P 011) who broke his arm while swinging his golf club was married to 
Carol (F 012). Geoff and Carol were in their early 50s and lived in Essex. On 
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the day of the interview, Geoff was having his monthly pamidronate infusion (to 
treat bone disease) on the Day Care Unit and his wife who worked part time in a 
GP's surgery usually had the day off on Mondays so she joined him. Geoff was 
a tall quiet man with black hair; he was dressed in slacks, blue open necked 
shirt and navy anorak. He told me he had the day off work and appeared 
relaxed. Normally he would be 'booted and suited' like Dave (P 023) and on his 
way to work. Carol was dressed smartly in a matching dress and jacket. They 
were a good-looking couple and both appeared healthy. They had three adult 
children (a son and two daughters) who had now left home with the exception of 
their son who was away at university. I first met this couple in 2002 and looked 
after Geoff when he participated in clinical trials during two periods of relapse. 
Geoff had been relatively fit and healthy before he was diagnosed with the 
exception of pain in his right arm which only caused discomfort at particular 
times for instance when turning the steering wheel in his car. Geoff rarely 
showed any emotion and often appeared expressionless. Getting him to talk 
was a challenge as he was a shy, private person. It took time to get to know 
him. 
Jack's story 
Jack (P 014) and his wife Penny were in their mid forties and lived in East 
London. They met as teenagers and Jack was diagnosed with multiple 
myeloma in 2002 four months after the birth of their son Nathan. Jack and 
Penny were very articulate, friendly and easy to talk with. Jack began having 
problems with his back after they had moved to a new home before Nathan was 
born. Jack was attempting to construct a massive pre/flat packed wardrobe. 
This was a lengthy and difficult job as the wardrobes' parts were extremely 
heavy. Jack thought he had slipped a disc and injured his back during this time. 
The back pain got steadily worse while building the wardrobe and he went to 
see the GP for some pain relief. The analgesics were ineffective and he started 
to feel sick. The GP assumed that the medication was causing the sickness and 
so the analgesics were changed for a new prescription. During the months prior 
to the diagnosis Jack visited his Father (a doctor) in Canada who advised him to 
request an MRI scan, as the pain was persistent and debilitating. Jack 
requested to see a 'bone specialist' privately and was finally diagnosed. At the 
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time of the interview Jack and Penny were planning on (moving home) returning 
to Canada. Jack's condition had deteriorated and he had been unwell for a long 
period of time. He had relapsed and things looked bleak, as he was no longer 
responding to treatment. Penny continued to work as a newspaper journalist in 
the evenings and the couple struggled to find help to take care of Nathan who 
was 4 years old. They had no family living in the UK. Jack's story encompasses 
many issues impacting on family life including his frustration due to loss of 
control as a 'Dad' such as not being able to lift his son up or assist in looking 
after him. 
Marian's story 
Marian (F 016) a bereaved daughter, worked as a specialist renal nurse 
employed at one of the large NHS teaching hospitals in London. Marian was 
also a fellow PhD student. We were introduced to one another during the time 
we were going through the application process of securing university 
placements. Marian's mother died in February 2001 having been diagnosed in 
July 2000 leaving her family completely devastated. Her parents had been 
married for 40 years and they had four daughters, one of whom was fostered, 
and a son. The interview took place in a quiet room at the university. Marian 
stated she would probably get upset and she did start to cry at one point. It 
must have been very difficult for Marian speaking about her mother's illness and 
then bereavement especially when it all happened so quickly in a space of a 
few months. Marian, however, viewed the interview as a cathartic experience. 
Marian's mother was diagnosed quickly as she had been monitored for 
approximately two years. She had originally seen her GP with a history of bad 
headaches and following a number of visits a blood test showed some 
"abnormality" necessitating referral to haematology and a period of monitoring. 
The onslaught of the disease was indeed an aggressive one. Marian describes 
the illness as "hell on earth and no quality of life in between" and portrayed a 
vivid picture of her mother's deteriorating condition (Smith and Cox 2007) and 
the emotional strain on the family. Marian was able to see the physical changes 
that other family members could not and privately regarded her mother as a 
`dying cancer patient'. Despite her private feelings and observations Marian was 
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able to convince family members that her mother's condition was improving to 
maintain some semblance of hope. 
Fred's story 
Fred (P 017) was a widower in his mid 60s who lived in Essex. He retired early 
at the age of 50 to spend more time with his two adolescent daughters having 
lost their mother who died of leukaemia. Fred was a pleasant, quiet, and smartly 
dressed man who I had treated on the chemotherapy day care unit and seen 
during his hospitalisations over the past five years. He was diagnosed in 1997 
which he said "was fairly devastating" as he felt he was "immune" particularly 
having seen his wife die in 1989 of myeloid leukaemia. The interview took place 
in June 2006. Fred, a deceptively healthy, normal looking man was wearing a 
short-sleeved shirt and shorts. I noticed he looked pale and was a little short of 
breath. Fred showed me photographs of his youngest daughter's recent 
wedding. He had two married daughters and a grandson. I got the impression 
he was comfortable living on his own. Fred had a lot of good friends, some of 
which he has grown up with and kept in touch all through the years. It was 
several years and numerous visits to the surgery before Fred's GP finally 
investigated the cause of his pain. Fred had been diagnosed for nine years and 
he stated that the last two months had been particularly difficult because he 
now felt that he was running out of options and his body could not take much 
more. Fred thought 'the tablets' were causing too many problems and wondered 
if it is was worth taking all the medication. Fred answered his own question by 
stating that on the other hand he would not have survived as long as he had 
without the medication. Fred's quality of life had been relatively good up until 
this point in time. 
Sally's story 
Sally (P 018) was a 61-year-old spinster and retired college lecturer. She had 
lived in a small first floor self-owned flat in Essex for 28 years. Sally was 
another patient I met when she was first diagnosed. Her hair had grown back 
(post chemotherapy) and she seemed different. Sally was in control of her life 
again. She was well, confident and appeared normal. Since her stem cell 
transplant Sally had been well for a year. Initially Sally had palpitations and had 
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gone to see her GP who arranged for her to have numerous blood tests. She 
was informed by her GP that there was the possibility of a "suspected" 
myeloma. Sally felt "shattered" despite the fact that she did not know what 
myeloma was at that time. During her first line of chemotherapy Sally spoke of 
not understanding about what the medication was doing to her body and mind. 
She talked about the steroids and said "I didn't understand what was happening 
to my body because of the drugs and the most wonderful thing was being in 
control. Do you remember when I refused the medication? I wanted to tell you 
to get stuffed and I did! It felt so good so I missed that last dose of chemo. This 
was the thing, you were totally in the hands of the clinician and I can remember 
saying to Tom (registrar) please tell me that what you are doing is going to 
work'. Sally needed constant reassurance. She spoke about being positive and 
how important that was. Sally portrayed the aftermath of high dose 
chemotherapy (stem cell transplant) when she lost all levels of concentration 
and thought she was losing her mind during the time she was in the hospital 
room recovering. 
Phil's story 
Phil (P 019) was a tall man with a thick head of white hair and a pleasant face. 
He was originally from the USA and had been divorced four times. Phil's accent 
sounded almost Cornish with a slight American twang. He had lived alone for 
the past eight years and had three adult children - one son and two daughters. 
He saw at least one of his children every weekend. Sean, his 18 year old son 
accompanied him on the day of the interview which followed a routine clinic 
appointment. Phil walked towards me waving and smiling wearing dark blue 
jeans and a dark terracotta long sleeved shirt. He had put on some weight 
probably due to the steroids. Phil looked pale and tired, but apart from that he 
appeared well. Phil appeared confident and relaxed. He was intelligent and 
knowledgeable about the disease and viewed almost everything as an 
"adventure". Phil's Father died of myeloma (unusual and unproven hereditary 
link) and he felt that his mother was probably more shocked about his own 
diagnosis than he was. He left home when he was 19 and wasn't around when 
his Father was ill so had little knowledge of the impact on his mother or sister. 
Phil was well into the 'internet world', which was natural for him as he was from 
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an IT career background. Phil was a resourceful character and very proactive at 
accessing support and finding ways of helping himself. Phil exercised his 
fingers and stated that his own "physiotherapy" had been very effective. Phil 
believed that typing on his computer was good exercise as he was moving all 
his fingers and thought this helped significantly with his neuropathy. 
Dave's story 
I met Dave (P 023) for the first time when he was newly diagnosed and have 
looked after him when he attended the chemotherapy day care unit on 
numerous occasions. Dave met his wife when he was 19 years old and they 
started dating having known one another for 7 years. They married in 1993 had 
a daughter aged 7 years and a son aged 5 years. Dave was in his early forties, 
tall, fairly slim, had dark hair, wore spectacles, and was smartly dressed in a 
suit when he attended clinic as he was usually on his way to work or a meeting. 
He worked in London and had a passion for politics. He appeared confident and 
well educated with a clear and fairly distinct loud voice. The day of the interview 
he seemed to be his usual cheerful and optimistic self but remained pale and 
slightly bloated in appearance due to steroids. Dave was a local counsellor 
within the community where he lived in Essex and had an interest in Martial 
Arts, which he gave up when diagnosed. Prior to the interview Dave told me 
that his Father had died from lung cancer recently at Christmas time. His Father 
often accompanied him to the hospital and appeared well. Dave's Mother had 
died 5 years previously from breast cancer. I had never met Dave's wife or his 
family except for his Father. Dave attended the chemotherapy day care unit 
regularly because his paraprotein levels had been "up and down like a Yo-Yo 
throughout". According to Dave he had not experienced long periods of time 
when the MBands or paraprotein levels were low. Despite this Dave appeared 
to be very optimistic and full of enthusiasm. He seemed to 'bury his head in the 
sand' although he was knowledgeable about the illness and its outcome. Dave 
appeared to keep his working life, his family life and his hospital life as separate 
entities. The physical impact of the disease was explained in terms of 
"catastrophic lack of fitness" and the pain in his hips was described as "like 
someone had applied sandpaper to the joint". 
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Gloria's story 
Gloria (P 024), was the first patient I interviewed who was not known to me 
previously. We had spoken on the telephone on several occasions prior to the 
interview which took place in her home. She was introduced via one of the'` 
registrars from the clinic and I was told I could call her directly. Gloria was a 67 
year old widow originally from Barbados. She had three adult sons one of whom 
still lived at home and had five grandchildren. Gloria had lived in her 
maisonette in East London for 27 years. She had a kitchen downstairs but 
needed to walk upstairs to the lounge and bedrooms. Gloria described how ill 
she had been and how wonderful she thought the doctors and nurses were at 
the hospital. She talked about her chemotherapy and stem cell transplant. 
Gloria appeared well and was in remission (stable disease). Gloria described 
her treatment as "plain sailing" and seemed aware of other myeloma patients 
who have had a number of set backs and treatment delays. Gloria was also 
aware of patients not responding to treatment and felt thankful that she was 
"fine with it alt'. Gloria had been diagnosed the previous year and had one line 
of therapy which included high dose melphalan and stem cell transplant. Gloria 
had not yet endured the numerous relapses and treatments that other 
participants in this research had. It seemed she had a lot of energy and drive. 
Gloria maintained that she viewed things differently because of the illness. She 
was no longer interested in the material things in life but in the environment of 
her home and family. Her religion and faith in God was very much part of her life 
and significant. Gloria felt grateful that she had "been saved' however she knew 
there was no cure and understood that the myeloma would return in due 
course. 
Maurice's story 
Maurice (P 025) who was originally from Sierra Leone in his mid sixties, lived in 
the UK since 1960 and had two adult sons (ages 26,31 years) living at home. 
Maurice was introduced to me by the consultant haematologist who had given 
him an information sheet and had explained about the research project. 
Maurice appeared reluctant for the interview to be held in his home and 
suggested that we met at the chemotherapy day care unit on his clinic day. He 
was accompanied by his sister who drove him to the hospital as his wife was at 
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work. Maurice's sister waited outside the room during the interview. Maurice 
was attached to his pamidronate infusion (to control bone disease) pump which 
constantly ticked like a clock. The room was small and the noise from the street 
outside was disturbing. The place was thriving and the interview was difficult 
because Maurice spoke very quietly, almost mumbled when speaking and had 
very little if any eye contact. Maurice was not very informative. His answers 
were short and he seemed unable to discuss things in any great depth. He 
appeared very lethargic and 'out of sink'. I do not think he was aware that he 
kept repeating the same things over and over again. Maurice was emotional 
throughout the interview. He has attended the day care unit for several years 
and was described by nursing colleagues as always `cheerful and fine'. He 
seemed to have pent up emotions, spoke a lot about the pain he had suffered 
over the years and did not want to be a burden to anyone. He disclosed that he 
had a "few tears lately" and when his wife asked him what the problem was he 
was not able to talk because he felt as if he was going to be a nuisance to his 
family: "when the bad days they come I just try, as best as possible to ... get 
over it ... and then ... 
but most of it is a nuisance to the family, you just, try to 
just take if'.. Maurice was diagnosed in 1993 and appeared to have limited 
knowledge of his illness. The main topic of conversation evolved around 
Maurice's progressive bone pain and his entire demeanour spoke volumes 
suggesting a man who found his situation intolerable. 
Bill's story 
Bill (P 027) was the first patient I met with multiple myeloma when I first started 
working at the hospital. Bill and his wife Sylvia met on a blind date and had 
been married for 21 years. They seemed devoted to one another. They did not 
have any children but had three small dogs. They both had elderly parents who 
were living fairly close by but independent. Bill's mother had blood cancer of the 
platelets (diagnosed after Bill). His father also had surgery for cancer of the 
colon. Bill was diagnosed in 1997 at the age of 42 and worked as an electrician 
having set up his own company. Bill had been suffering with 'back problems' for 
several years and was working seven days a week until he could no longer 
move. He had driven from Essex to London on his last day at work and was 
unable to get out of his car to do a job. Bill telephoned the people who were 
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expecting him while sitting in his van outside their home and informed them he 
was unwell and then managed to drive home. Sylvia had to lift him from the car 
and help him into the house where he laid on the floor with multiple vertebral 
fractures. Following the onset of the illness Sylvia spent several months 
worrying about their finances and had borrowed money from close relatives as 
Bill was no longer able to work. Sylvia visited her husband every day while he 
was in hospital and she would tell him that everything was fine. The reality was 
that they had very little money and she would not burden him with what she 
considered to be an additional worry or cause him further anxiety. Bill and 
Sylvia were interviewed a second time three years later in June 2007. 
Charlie's story 
Charlie (P 029) was an Afro-Caribbean born in 1965 and had a happy and 
sunny disposition. Charlie was diagnosed in 2006. He had a clear East London 
accent and seemed 'on the ball'. Charlie lived with his partner Christine who 
worked part time. She reduced her working hours when Charlie became ill. 
They had lived together for 16 years. Charlie had fathered four children, the 
youngest of whom was Christine's and Charlie's 10-year-old son Kevin who 
lived with them. Charlie spoke to his consultant haematologist about Kevin 
because he was worried about talking to him and explaining to him about the 
cancer. His son knew that his father was sick but did not know what was 
causing the illness. Charlie stated "I didn't know, we didn't know how to tell him 
about if'. Charlie was introduced by a nursing colleague who had spoken to him 
about the study. I met him for the first time on the day of the interview. Charlie 
had stated that he preferred to come to the School of Nursing (university) for the 
interview and was glad to get out of the house and have something to do. He 
was wearing a white baseball cap, striped tee shirt and track-suit trousers. 
Charlie had travelled by bus, as he did not feel ready to drive again just yet. 
Charlie also thought that he needed more exercise. Charlie told me that he had 
three uncles (mother's brothers) who each died of cancer. Ironically Charlie 
worked as an ambulance driver picking people up from the chemotherapy day 
care unit (hospital transport). He had not been able to work since October 2005. 
He was diagnosed in February 2006. Charlie reiterated a typical presentation of 
an assumed slipped disc as the probable cause of his back pain which was 
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becoming unbearable over a period of time. Initially Charlie was unable to stand 
up and was crawling about on hands and knees, which is not an uncommon 
scenario. 
Victor's story 
Victor (P 030) was introduced by one of my nursing colleagues. Victor, a tall 
Afro-Caribbean age 52 years with greying hair and a small white beard was a 
quietly spoken and articulate gentleman. Victor was teaching adults literacy, 
numeracy, and computer skills. The interview took place at a flat in Homerton 
close to the railway station where Victor had been staying with his partner. 
Victor instructed me to meet him at the entrance of the block of flats and as we 
went up in the lift to the small flat he stated he was very tired which in his view 
was his major problem. He spoke quickly and almost in a whisper; I thought that 
the recording from this interview would not be audible due to Victor's quiet 
voice. Victor lived with his 21-year-old daughter who was currently away at 
university. Since his illness he had been staying with his partner and their son 
who is totally deaf aged 11 years old. Victor has fathered six children. His 
younger sister died of Lupus age 27 and both of his parents had also died. 
Victor was with his sister when she became ill and remained with her until her 
death. She had also been a teacher. They grew up together and spent time 
travelling together. When he lost his sister he said his mother lost the will to live. 
He was the last of 10 children who remained at home looking after his elderly 
parents. His brothers and sisters came to the UK in the 1960s while Victor 
arrived more recently in 2003. Victor's invisible struggle was not understanding 
the system and not knowing what benefits he may be entitled to although he 
was able to search on the internet for the information he required. Victor was 
also having problems with the company for which he worked. His manager 
appeared to be unsupportive, uninterested and unaware of the severity of the 
illness. 
Alice's story 
Alice (P 033) and her two daughters were introduced by the consultant 
haematologist while they were waiting to be seen for a routine check up in the 
outpatient department. Alice was a 'young at heart' elderly Afro-Caribbean lady 
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who appeared well but unable to walk very far. Her daughters (Val and 
Rosemary) pushed her in the wheel chair to the university room where the 
interview took place several weeks following the introduction. Val seemed very 
much in control and although the family came as a complete package I believe 
that the outcome of the interview would probably be very different if I had been 
able to see them individually. The family did not want me to visit them in their 
home and it was decided I could interview them as a group on a day when they 
came for a clinic appointment. When I asked Alice if she could talk about the 
illness and what was happening to her she replied that she "can't understand 
what's wrong" and that she had a pain in her back, which seemed to be 
improving. Alice made a reference to the alteration in her body image explaining 
that on standing she tends to lean forwards because of her back problems. Val 
(F 035), on the other hand, talked openly sitting close to her mother about her 
understanding stating that multiple myeloma was a type of blood cancer and 
spoke of the impact on bone. Val also used the word "terminal" and I watched 
Alice and her younger daughter to see their reactions. Rosemary seemed 
uncomfortable and her mother appeared to display no reaction giving nothing 
away. I understood Alice could hear well and although she might not be familiar 
with the word 'terminal', most people understand the word 'cancer' and it 
therefore suggested that she chose not to hear. I was disappointed with the 
interview as this family responded with very short answers or brief comments. 
They seemed reluctant to talk in any depth or detail. They did not appear to 
have very much to say and I got the impression their responses were staged. I 
asked Rosemary (F 034) if she worried about her mother relapsing and she 
changed the subject by saying "everything will be alright". Was she protecting 
her mother from the knowledge that perhaps she was concerned? Was this her 
way of dealing with the situation? Rosemary did not say very much. She 
seemed 'closed' but 'zoomed in' on the positive aspects. She was keen to tell 
me about the sort of person her mother was, that she was always positive about 
things and would want to carry on the best she could. I wondered how the 
family were dealing with the reality of the situation emotionally and if they talked 
to one another about the cancer. 
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Mike's story 
Mike was a 56-year-old Afro-Caribbean who was diagnosed with multiple 
myeloma in 1993. Like Gloria (P 024), he was of a sunny disposition and deeply 
religious. He had a laid back attitude. Mike walked slowly with a stick to aid him 
and appeared very tired. Mike was still able to drive and relatively independent. 
He had a supportive wife and caring adult children some of whom still lived at 
home. Mike's 19-year-old daughter had grown up throughout the illness 
trajectory. Once engaged in discussion with him his humour shone through. 
Mike was intelligent and articulate although he had not studied the disease to 
the extent that he could be categorised as an 'expert patient', but he was most 
definitely an experienced patient. The interview was held in a room at the 
university. Mike was dressed in a leisure shirt, dark navy jacket, track-suit 
bottoms, trainers and white baseball cap. His hand felt cold when I shook it. I 
asked him if he would like a hot drink and made him a cup of tea. I tried to 
select the most comfortable chair for him to sit on. We sat chatting for a while 
before the interview. He seemed very relaxed and happy to just sit and talk 
before and following the interview. When he was in his teens he was assaulted 
by a gang of youths and kicked in his left lower back repeatedly. It is in this 
same spot that the myeloma tumour emerged several years later. Mike worked 
as a Plasterer and we talked about the possibility of chemicals or toxins in 
industry and their potential association with the disease. Mike had metal plates 
and screws, which were supporting his collapsed vertebral bones. He thought 
the metal plates were creating pressure on the nerves and causing cramps in 
his legs and upper thighs. He had a lot of pain in his legs and ribcage and only 
got partial relief from the medication, which he tolerated. He was very grateful 
for all the help and support he received from the hospital staff and made a point 
of repeating this twice which made me feel that perhaps he felt I was expecting 
him to complain or criticise the care and treatment he had received. The main 
issue or worry that Mike spoke of openly and spontaneously was the swelling or 
tumour on his penis, which has had a monumental impact on his life and sexual 
relationship with his wife 
117 
4.3 Ways of Communication 
"There are a lot of assumptions made by the medical profession, when they're 
talking to you, that you understand their jargonese' and this is one of the 
problems that I think needs to be addressed" Bert (P 001). 
4.3.1 Introduction 
This section of the findings chapter introduces 'ways of communication' the first 
of four main categories, which form an integral part of the core category of 
Contention. The findings are presented addressing each main category and 
associated subcategory headings set out within the context and analytical story 
lines. Extracts from transcripts are used within the text and also displayed in 
trilogies (Tables 3-21) corresponding to the analytical story lines. The analytical 
story lines provide emerging theoretical explanation (Strauss and Corbin 1998). 
`Ways of communication' relates to the ways in which individuals and their 
families interact and behave towards others (and how others behave towards 
them) during illness. Contention in communication may imply emotional conflict, 
disharmony, feeling ill at ease, confused and feeling overwhelmed. The above 
quote (Bert 001) is a reference to healthcare professionals using medical 
terminology when communicating which created difficulty particularly when 
newly diagnosed and unfamiliar with the language associated with multiple 
myeloma and its treatment. The findings suggest that some of the participants 
experienced feeling rushed during consultations and that they might not be 
prepared or able to take on board additional information concerning treatment 
when they are still coming to terms with the diagnosis: 
Shirley (F 002) 
"Things were all falling into place but it was the speed of it and it was Tom 
(consultant) who said undoubtedly you've got multiple myeloma and I think we 
were both.... well lets find out more about it.... He did explain - he came over so 
fast and furious .... that we 
had to stop him half way through because he was 
going into the cycles, and it was just overload".... 
The subcategories of 'ways of communication' include: 'communicating with the 
doctor', 'communicating bad news', 'Using complex terminology', 
'communicating with children' and 'Hidden disclosure'. 
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4.4 Communicating with the doctor 
4.4.1 The context 
The ways in which people communicate with their GPs during the pre-diagnosis 
stage vary considerably from seeking minimal information relating to symptoms, 
(which may be because the onset is often nondescript), to articulating the same 
problem repeatedly, (often bone pain). Some of the patients participating in this 
study had reached crisis points and were admitted to hospital by an ambulance 
requested by the GP during a home visit. A typical period of time between initial 
contact with the GP and confirmation of diagnosis ranges from months to years 
depending on the severity of symptoms. Fred (P 017), for example, frequented 
his GP's surgery with the same problem several times over a period of years. 
He was unable to say exactly how many years but presented with a pain in the 
side of his chest (fractured ribs) and it was assumed that this was a strained 
muscle associated with playing cricket. His GP finally took the initiative and 
investigated the condition: 
Fred (P 017) "1 used to play a lot of sport, particularly cricket and I kept getting 
pains down my left side and this went on for years, not months, years, and 
kept going back to the GP ... and 
in the end they sent me to the hospital, did a 
blood test but that showed nothing because really they wasn't looking for 
anything other than some sort of strain and it went on again for a little while and 
then in the end my GP said I'm not happy with this. He said I'm going to give 
you a cardiograph and a full blood test, which I had at (named hospital) and 
within the same day after having it, I came in and there was a message to say 
would I go back up there because you know that I'd, they'd found out I'd got 
multiple myeloma". 
Others were more assertive and assumed control from the onset. A 
phenomenon which has emerged, and is intrinsically linked through 'ways of 
communication' is 'special knowledge' of an individual who was able to detect a 
significant change or difference in a loved one (close relative or friend) and the 
ways in which they were or were not able to articulate these changes. This 
meant seeing something that the doctor was not able to see even with a 'trained 
medical eye' except in circumstances where the doctor and patient had a 
longstanding relationship. Powers of persuasion were therefore required to 
convince the GP that there was 'something wrong' which ultimately led to 
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investigating the cause of the problem that might not have otherwise been 
investigated at that stage. 
4.4.2 The analytical story line (Table 3) 
It appears that people are driven by stressful circumstances and where normally 
they would not assert themselves; they take control and become propelled by a 
force that would not normally exist within them. They become agitated and 
frustrated which fuels this assertion. The close relationship between mother and 
daughter (Table 3) was fundamental to the tacit and personal knowledge of a 
loved one, which sharpened awareness and sensitivity to any subtle change 
that may go, unnoticed by others. Stella (F 013) who accompanied her daughter 
(Debs P 009) to the GP's surgery had become dumfounded that apparently the 
doctor was not going to act on the information she had given him and reacted 
by confronting him and suggesting that the course of action that he should take 
would be to send her daughter for a blood test. Stella was able to recognise that 
her daughter was ill and had been outside the surgery with her for an hour 
during which time her daughter was vomiting. The GP assumed that the 
sickness was related to pregnancy and was therefore reluctant to investigate 
the vomiting episodes. The GP finally agreed to the request for a blood test to 
appease the patient's mother. 
Communicating with the doctor had become critical for Jack (P 014) following 
previous visits and unsatisfactory outcomes. His condition became steadily 
worse over a period of months. His father (a doctor) had advised him to ask the 
GP to arrange to have a specific scan (MRI) and Jack was told that he would 
have to wait for approximately six months. In desperation Jack decided to take 
matters into his own hands and arranged to have the problem investigated 
through private referral. He was subsequently seen by a consultant, and, as a 
result was diagnosed relatively quickly. 
The GP's perspective (John HCP 021) in this trilogy (Table 3) concerns patients 
who come to the surgery apparently with one aim in mind; which is referral. 
Alternatively, patients demand some form of investigation regardless of whether 
they understand what kind of investigation is required and lack the knowledge of 
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being able to differentiate between various tests or scans and the rationale for 
undertaking these. Patients and their families are not always able to articulate 
what the problem is and, as is often the case of someone with multiple 
myeloma, the onset is usually very non-specific. This means that making any 
form of referral becomes problematic for the GP because the referral needs to 
be appropriate. On the other hand evidence suggests that when situations 
become critical, patients and their families will ask for a specific test because 
they want action, require answers and want to be taken seriously. 
Stella (F 013) - Mother of female patient 
"Anyway it was awful, we got this doctor who just, because Debs was pregnant, just said oh 
more or less patted us on the head and she's pregnant and I, and the next thing was I knew 
Debs wasn't well really because she allowed me to do this. I wouldn't let it go on as, well aren't 
you even going to send her for a blood test, you know, in the end, he said I sound as if, you 
sound as if you're not very happy, and I explained what had happened outside because it was 
an hour before we got in and Debs was sick and everything like that and in the end he 
reluctantly agreed to a blood test. He didn't want to give her one, he just"... 
Jack (P 014) 
As I'm just not getting any better - back to the GP, back to the GP, back to the GP. Finally, 
after, several months of this and it just wasn't getting any better, I said to the GP, my dad said 
get an MRI done, I came back and said to the GP I want an MRI done, just to see what the heck 
this is and he said yes but you're going to have to wait six months, and I said I can't wait six 
months, because I was almost bent double at that point, I could barely get to the GP's office, I 
could barely get anywhere, and it was just absolute agony. I couldn't sleep, I was just in 
constant pain. So I said give me a list of names of all the bone specialists so I'll go private and 
try to find out what this is, since you don't know". 
Dr. John (HCP 021) 
"Some people will come in and they've seen two or three people already and you know that, 
their mission is for a referral, or their mission is for a scan, whatever that means, and they don't 
have any idea, they just know themselves, they need something. So often you'd diffuse it by 
saying OK that, of course that's not a problem but to make a referral to the appropriate person 
or to ask for the right sort of scan, you need a bit more detail; and actually as you go through 
things and you spend a bit more time with them, they may get more confidence that you are 
considering it properly and you're not just fobbing them oft" ... 
Table 3 Communicating with the doctor 
4.5 Communicating bad news 
4.5.1 The context 
Receiving a cancer diagnosis in relation to multiple myeloma may not be the 
same as receiving bad news concerning a cancer diagnosis per se. The 
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difference being that multiple myeloma is an incurable cancer. The bad news 
therefore encompasses two distinct parts, the first being the cancer diagnosis 
and the second being informed that there is no cure for this particular disease. 
The time of diagnosis is usually described in terms of 'a shock' for most people 
and their families (Thomas and Retsas, 1999; Maliski et al, 2002). There are 
instances when patients and their families are relieved to find out the cause of 
the illness especially when they have suffered and worried about onsets of 
recurring infections or unexplained and unresolved bone pain for several 
months and in some cases years. A 'suspected' cancer diagnosis may be in the 
forefront of the recipient's thoughts long before haematological referral and final 
confirmation particularly when there is a family history of cancer. Conversely 
many are completely traumatised and in a state of bewilderment (Davis, 2002; 
Persson and Hallberg, 2004). Such trauma is further exacerbated in family 
circumstances when pregnancy is involved. Debs (P 009) and Mat (F 010) were 
expecting their second child and they were faced with the decision of having to 
terminate the pregnancy. This was an extremely distressing life experience 
which impacted on the whole family. Debs (P 009) was not only trying to come 
to terms with being diagnosed with multiple myeloma, she had to face the 
imminent loss of her second child and the ensuing grief. 
Events leading up to the breaking of bad or significant news in relation to the 
diagnosis is varied and complex in this population of patients for example a 
person may have several bouts of chest infections, rheumatic pain, a history of 
headaches, nose bleeds or cardiovascular problems. Alternatively an otherwise 
fit and apparently healthy individual attends the A/E department with a 
'suspicious' pathological fracture that has occurred in the absence of a fall or 
collision. The following extract represents one such case: 
Geoff (P 011) "but on that day / got up just to go out as normal on Saturday; 
went to play golf with three friends and I hit the ball once on the 5th hole, on the 
tee shot, and it hurt, quite badly, and finished that hole and then when I hit the 
ball off the tee on the next hole, which is the 6th hole of the day, the arm just 
broke, just snapped'. 
Some patients are investigated for other potential diseases when abnormalities 
are detected in routine blood and urine tests. A pre-existing non-cancerous 
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condition is sometimes diagnosed called monoclonal gammopathy of 
undetermined significance (MGUS) introduced previously (1.5.3) might 
transform into multiple myeloma. Patients with MGUS are therefore closely 
monitored and attend the haematology outpatient clinic for regular blood and 
urine tests. The knowledge of a 'benign' monoclonal gammopathy or disease 
can be advantageous as it serves as a prior warning and regular monitoring 
ensures early detection if and when transformation occurs. Patients may not be 
familiar with the term MGUS and therefore will not know that it can potentially 
develop into a haematological malignancy. 'Blood abnormalities' and 'raised 
protein levels' are common terms used (McRobert 2004) and patients may be 
satisfied with this level of knowledge and feel reassured with the regular 
medical checks and routine blood tests. The psychological impact on patients 
who are familiar with the term MGUS and are aware of implications live with the 
anxiety of knowing that this could potentially develop into cancer (Rawstron 
2005). Patients diagnosed with an asymptomatic or smouldering myeloma, on 
the other hand are usually aware that it is a matter of time before the disease 
will progress and treatment is then required. Typically this period of time for the 
disease to progress is 12-32 months (Bradwell 2006) and psychologically very 
unsettling for the individual concerned. The following participant describes this 
period as the "Phoney War" because after receiving the news of her diagnosis 
she was in relatively good health and her condition remained unchanged: 
Sally (P 018) "1 often likened it to, a bit like the phoney war really, that I'd been 
given devastating news but that actually nothing was happening". 
4.5.2 The analytical story line (Table 4) 
Communicating bad news is described as "one of the most difficult 
responsibilities in the practice of medicine" (Vandekieft 2001: 1975). Bad news is 
defined as "news of life-threatening illness, disability or impending or actual 
death" (Farrell 1999: 101). Doctors have not disclosed all the information to their 
patients at times when their greater concern has been the detrimental effect the 
information would have on the patient. Furthermore, Vandekieft (2001: 1976) 
argues, "Physicians do not wish to take hope away from the patient. They may 
be fearful of the patient's or family's reaction to the news, or uncertain how to 
deal with an intense emotional response". 
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Two distinct ways of confirming the diagnosis have emerged from the research 
data; one approach is the swift onslaught of informing the patient that he/she 
has an incurable cancer and is likely to die within two to five years but that there 
is treatment. The second approach is more positive confirming the diagnosis, 
explaining that multiple myeloma is not curable but that there are treatments 
and people can live for several years reaffirming that death is not necessarily 
imminent. The two patients in this (Table 4) trilogy Dave (P 023) and Sally (P 
018) had completely different experiences because of the way in which the 
haematologists approached giving the diagnosis. Nurse Karen's (HCP 022) 
testimony corroborates the disparity in ways in which consultants approach 
breaking bad news to patients. 
Dave (P 023) 
"They gave me a bone marrow biopsy, which is the first bone marrow biopsy I'd ever had and 
they're pretty unpleasant things, I've had four now, they've all been pretty unpleasant but there 
you are, and very shortly after that the Haematologist there, a fellow called Dr. Brown who sat 
me up and said you've got multiple myeloma, you've got about two years to live and we have to 
admit you straight away, and he pretty much said it in those sort of terms which I appreciated 
actually. I would rather somebody give you news like that straight, as opposed to weave around 
with it". 
Sally (P 018) 
"Gill (Dr) was working at (named hospital) at the time and she did my bone marrow biopsy and 
we had a long, long chat, and she gave me a lot of encouragement, there was no room for 
negativity. She gave me an idea of the kind of prognosis, you know that I might have and that 
made me feel really positive that perhaps I might have 8-10 years of life and I, I left really feeling 
OK, that I, I wasn't ready to 'pop my clogs' that early and that it was looking at least quite 
hopeful but I knew at the time it wasn't curable you know that was made quite plain to me. I 
think it was only after maybe three months or so that Dr. Smith gave me lots of booklets from 
the IMF (International Myeloma Foundation UK)" ... 
Nurse Karen (HCP 022) 
"We've got two consultants who are quite different. One would be quite upbeat and quite 
positive about it, so all they talk about, the fact it's incurable, and you know the fact that you can 
treat it and you know, you should, you know, and he will talk about patients who've lived a long 
time and who've survived, he would talk about the long term survivors. We have another 
consultant who will take the other approach and will talk about the fact that actually, you know 
it's probably going to kill you in less than five years, and he'll tell you that up front, and I think 
he's not very good at entering hope". 
Table 4 Communicating bad news 
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4.6 Using complex terminology 
4.6.1 The context 
Terminology in haematological malignancies is complex and foreign to newly 
diagnosed patients and their families (McGrath 2001). For healthcare 
professionals familiar with the language used in haematological oncology, 
complexity of terms is unproblematic because it has become part of their normal 
every day vocabulary. Healthcare professionals from other areas of practice 
and expertise are not familiar with terms such as myelomatosis, 
paraproteinaemia, plasma cell leukaemia and monoclonal gammopathy all of 
which may be used in association with multiple myeloma. The majority of 
malignancies are referred to as cancers for instance, breast cancer, lung cancer 
and prostate cancer; terms that people are usually familiar with. It is evident 
from the narrative in Table 5 that communication, information giving and 
becoming overwhelmed are key issues that have emerged from the data. 
Problems experienced by the study participants such as doctors communicating 
in a way that is difficult to understand because of medical jargon, the speed at 
which it is delivered and the vast quantities of information given are reflected in 
the literature (Berg and Ahmann 2006, Thomas and Retsas 1999). There are 
critical points in time throughout the illness trajectory when patients and families 
are at their most vulnerable. For example having the diagnosis confirmed, 
during periods of relapse and finally when treatment is discontinued because it 
is no longer having the desired effect. This crucial point in time was described 
as "You're living on `Death Row (Fred P 017). Effective communication and 
interpersonal skills are of paramount importance especially during times when 
bad news is given or patients and families are dealing with difficult situations. 
4.6.2 The analytical story line (Table 5) 
The first extract (Bert P 001) exemplifies difficulty in understanding the 
terminology used during consultations with healthcare professionals and the 
speed at which the information is given. The second participant, Bert's wife 
(Shirley F 002) received a phone call from the GP following medical 
investigations stating that they were "going down the myeloma track" and it was 
assumed that the recipient of this news fully understood what was being said. 
Using the telephone may or may not be considered appropriate to convey bad 
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news such as a potential or actual diagnosis of malignancy. Salander (2002) 
argues that it should not be dismissed as a way of communicating bad news. 
Other factors must be taken on board for example how far away people live 
from the surgery or hospital, the relationship between the family and the doctor 
and the previous interactions that have taken place. Shirley is a retired nurse 
and had heard of myeloma but her knowledge was limited. The GP's 
assumption that she understood the telephone conversation may have been 
based on prior knowledge of Shirley's past nursing career. As a couple they 
immediately responded by asking questions in order to understand what was 
happening. 
At the time of diagnosis the majority of patients and family members had heard 
the words multiple myeloma for the first time. The exceptions are Shirley and 
one other patient (Phil P 019) whose father had died with multiple myeloma. 
Using complex and unfamiliar terminology like myeloma represents a common 
pattern in this study. Primarily patients and their families will ask questions in 
order to clarify understanding. Some however will need more time before they 
are able to ask questions, while others misunderstand or think they have heard 
of the disease before. Mat (F 010) for instance spoke of his reaction when his 
wife (Debs 009) was admitted to hospital with high blood calcium levels and 
was informed that she has multiple myeloma: 
Mat (F 010) "when they told her what it was immediately you think oh right I 
know what it is, in a few weeks maybe we'll get sorted out and everyone will go 
home. " 
Nurse Jill (HCP 036) in this trilogy (Table 5) discloses her observations during 
numerous consultations between doctors and patients and implies that the 
terms malignancy, myeloma and blood condition may be deliberately employed 
to replace or avoid using the term cancer. 
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Bert (P 001) 
"I have one or two reservations about the health care system and the problem that I think we 
have largely is that the people who are in charge of such things are very au fait with the detail of 
the condition and therefore they expect you as a person to pick up the details of that condition 
very readily and as I've said to one or two people if I spoke as quickly as you do on electronics 
you would pick up the 10 per cent that I'm picking up from you on myeloma so there is without a 
doubt a communications problem that is not intentional but because they are so with the detail 
that it is easy for them to skip through something which to them is mundane and straight 
forward but to you as the recipient of the information and also the sufferer of the condition who 
may be suffering very badly and they wouldn't know that.... the communication is not that good I 
joke seriously when I say you need some training from me on communication skills". 
Shirley (F 002) Bert's wife. 
"Well the GP rang us at home and I answered the phone and she just said we're going down 
the myeloma track.. . 
just like that... now this was you know following an examination, a meeting 
and appointment with a general surgeon, a general physician and Dr Smith and it was a 
surprise he said we'll run some urine tests and we'll do some blood tests and I'll speak to your 
GP but he gave no indication at all. There is no dire emergency and I've got it written down and 
I just had an envelope on my lap and I was just writing this down and she said right go to your 
local hospital and pick up a 24 hour sample and some blood tests and that was it and nobody 
until we had a telephone call from the GP who said you have been referred to a Haematologist 
at (named hospital) and that was it and we said why? Do you know it was assumed I feel in 
retrospect that we knew you know? " 
Nurse Jill (HCP 036) 
"Well I've been present with lots of different doctors, different consultants and registrars, and 
have found it quite interesting over the years, and we might see the different ways people, 
doctors do handle it and manage that situation, and, and also taking into account that each 
patient, the family of individuals, as well, so there really, there's no real typical scene, I mean, I 
think, more often than not, I would say the consultant, from consultants level, have not 
mentioned the word cancer, and have talked around it, have I feel been, quite, not upbeat 
maybe but have not been as honest as I think they probably could be right at the beginning of 
the diagnosis and they've always talked about a blood condition. Maybe they use malignancy 
because sometimes people don't understand what that means, they might say myeloma, which 
the patient clearly won't understand to begin with". 
Table 5 Using complex terminology 
4.7 Communicating with children 
4.7.1 The context 
Communicating with young children was a common theme emerging from the 
research data. Talking in a way that a child will understand is particularly 
problematic for parents coping with an incurable cancer as complex, diverse 
and unpredictable as multiple myeloma. Some parents therefore require help 
from a healthcare professional to facilitate this communication. Communicating 
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well with children and helping them to cope with cancer in the family enables 
them to learn and understand what is going on around them and this prepares 
them for inevitable changes (Scott et al 2003). Six patients interviewed had 
children under the age of 12 years. This was highly significant and provided 
evidence of an increase in younger patients who ultimately have different needs 
to parents with adult children. The average maternal age is increasing and there 
is a trend towards older parents (Bray et al 2006, Benzies 2008) which impacts 
on the additional numbers of patients with younger families. It is known that the 
majority of patients are over the age of 40 years at diagnosis and that the 
median age of 63 years has decreased (Schey and Pallister 2004); however it is 
still perceived as a cancer that affects mainly the elderly. One participant was 
diagnosed within the first four months of his child's life, which meant that his son 
had grown and was developing at the same time that the disease was 
advancing.. 
Another male patient, Mike, discussed his family support below and stated that 
his daughter had grown up around his illness. Mike (P 040) was diagnosed in 
1993, therefore his daughter was approximately five years of age at the time: 
Mike (P 040) "My wife, my daughter, you know, my sons yeah, two of my sons, 
they are very supportive really. My daughter you know she grew up around my 
illness really, because I think she was, she was going to nursery, you know she 
wasn't that old when / can't remember... She's 19 now, you knout". 
Some parents will get to the stage when they feel confident and knowledgeable 
enough to explain to a child what is happening concerning the illness and 
treatments. While others simply want their children to have a normal childhood 
and do not want to cause what they consider to be unnecessary distress. There 
are those who `bury their heads in the sand' and appear to be in denial or they 
do not cope very well themselves with the situation. Dave (P 023) suggested it 
was unnecessary to inform his children about the disease as they are too young 
and would not understand: 
Dave (P 023) "Well, so far as the children are concerned, I've simply just not 
told them. I'm not, I mean they know that, though I'm unwell, on occasions, and 
I would take a fair amount of pills, and obviously I've given them long lectures of 
not touching daddy's pills under any circumstances and ... because they are 
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intelligent children but they're still too young and they don't know what cancer 
is, they don't really understand that people get sick and they die, though I mean 
obviously my father has just died and I don't think they really knew about that 
but even so I don't see what good it would do, all they need to know really is 
that daddy gets sick sometimes and daddy takes some medication and keep 
their hands off medication, that's pretty much all they need to know I think'. 
4.7.2 The analytical story line (Table 6) 
Examples taken from two of the families interviewed illustrate some of the 
difficulties in communicating with their children in terms of explaining about the 
illness and its implications in a way that their children will understand. The 
mother (Debs P 009) demonstrates her little boy's perceptions of his 'mummy's 
illness'. The child (Ben) is aware that his mother has 'bad legs' and is not able 
to walk. When his mother went into hospital for high dose chemotherapy and 
stem cell transplantation to treat the myeloma, she was still not able to walk 
when she returned home. Ben had understood that his mother was going into 
hospital to get better and became upset and confused because there was no 
improvement in her walking. The father (Charlie P 029) on the other hand, 
recognised that he and his partner needed help to explain to their son about the 
type of cancer he had and reassure him that his father was receiving treatment 
and that he was not going to die immediately. 
Nurse Claire (HCP 038) describes a family and how they coped with 
communicating with their child. The mother was able to talk to the child in a 
language that the child understood. The child was aware of what was 
happening and therefore was prepared and knew what to expect. This was not 
a common pattern, however it represents an isolated but powerful account of 
parents who are able to communicate effectively with their young children and 
highlights the specific supportive care strategies put in place to meet the 
emotional needs of this particular child at the most vulnerable time. 
129 
Debs (P 009) 
"I think the most important one was Ben, our son, who is now three and a half. He was two 
years old when I was diagnosed so he probably has little or no memory of me having been able 
to walk Obviously we haven't told him exactly what's wrong with me, so he mainly thinks that it's 
my hips that are the problem so when I went in (to hospital) for the stem cell transplant and 
came home, he was very angry that I still couldn't walk. He is looking forward to when I can go 
out for a walk with him". 
Charlie (P 029) 
"Mary, my consultant said well because of my son, he didn't really know, he knew I was sick but 
he didn't know what it was, so that was a problem. I didn't know, we didn't know how to tell him 
about it... because you know, I've got a good bond with him, so, you know. There was no easy 
way about it, so Mary, put us on to Joyce (Macmillan nurse). Obviously she's there for, 
obviously if I'm in pain she can help me ease me pain and that and at the same time she could, 
you know, talk to me. So in the end she, you know, she spoke to me and Christine (partner). 
We told him ourselves, in a way where he could understand but he just assumed cancer's, 
cancer, you're going to die. So we had to explain to him and he's pretty good about it now". 
Nurse Claire (HCP 038) 
"A lady and her husband, he died on the ward, and they had a little girl of about 4 or 5, and I 
guess all in the most recent years the girl's memory would be that her daddy had been very, 
very, very poorly. The wife was very, she knew what she had to do and she had a good 
relationship, she was very upfront and open and honest, very. So that little girl knew that her 
daddy was dying and, and knew that he, you know, was very, very poorly and that he wasn't 
going to get better and when he actually did die, she initially said to me that she, she wondered 
whether the daughter was going to need some help and support, so we spoke to the health 
visitor and the health visitor was able to speak to the school but in fact none of that was actually 
needed and they put her in contact with a local bereavement support they have, you know, sort 
of counsellors specifically for children but none of that was needed". 
Table 6 Communicating with children 
4.8 Hidden disclosure 
4.8.1 The context 
Hidden disclosure and managing the reality of the situation emerged in 
numerous forms. Making a decision not to tell the children about the cancer as 
discussed above represents one such form. Glaser and Strauss (1965) use the 
term "closed awareness context' in relation to hidden disclosure and avoidance 
of speaking to patients dying in hospital about their impending deaths based on 
the assumption that the news would be too upsetting. Another type found in the 
data is 'gradual disclosure' especially at the diagnostic stage when one person 
in the family takes on board more information than the other and decides to 
retain some of the information for another time. Alternatively a member of the 
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family will make a decision not to disclose the information because of the 
potential stress or worry it may create. Diamond (1998) discusses the principle 
of 'gradual disclosure' which he maintains the majority of doctors practise; 
although this could be viewed as providing information on 'a need to know' 
basis. John Diamond surmises: "In the case of complicated, possibly fatal and 
emotionally charged illness, never tell the patient more than he is likely to rind 
out for himself, and only ever give the best-case scenario" (Diamond 1998: 63). 
GPs may well be expected to inform patients of the potential diagnosis and will 
make a judgement about the amount of detail and possibly anticipate an 
emotional reaction or anxiety that may ensue by disclosing this information. The 
first GP interviewed talked about the urgent referral procedure of patients prior 
to confirmation of a cancer diagnosis and stressed the importance of preparing 
individuals while not overwhelming them with too much information: 
Dr Sam (HCP 020) "1 usually use the word myeloma and then explain part of 
what it is, and explain that it is a type of cancer. I try not to tell them too much 
because until a diagnosis is made, I don't really want to overwhelm them and 
concern them too much. Yeah we do and to be honest a lot of the forms now 
that we have, asks is the patient aware? ' We've got a lot of two week rule 
forms now for urgent referrals and those always ask is the patient aware that 
their being referred for possible cancer and I think it's a good idea because 
especially if they see a specialist and they start talking about cancers that if 
they're not prepared they're going to go back saying oh my GP never said 
anything about this so / do pre-warn patients". 
Nason (2004) a journalist aged 45 who had multiple myeloma writes about 
hidden disclosure and returning to work following recovery from his stem cell 
transplantation. He did not want people he worked with to know that he had 
been away in what he describes as the 'world of cancer patients' so he 
"invented a cover story' (p 888) because he felt that if people knew they would 
treat him differently and thus he would feel more vulnerable. In a previous 
article Gerson Nason describes how family and close friends were usually very 
supportive, but it was stressful worrying about whether or not to tell individuals 
the truth about how he was feeling to avoid upsetting them (Nason 2003). 
Several of the participants in the study kept things from their partners or close 
family members. For example one of the men I interviewed and met for the first 
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time seemed reluctant for me to come and see him at his home and suggested 
that I came to the chemotherapy day care unit on his clinic day. He was 
accompanied by his sister who drove him to the hospital as his wife was at 
work. Maurice (P 025) was originally from Sierra Leone and in his mid sixties, 
lived in the UK since 1960 and had two adult sons (ages 26,31 years) living at 
home. The interview described previously (Maurice's story 4.2.1) was difficult as 
he seemed extremely tired and emotional. Maurice appeared unable to talk to 
his wife and family about his constant bone pain because he perceived this in 
terms of being a nuisance. 
4.8.2 The analytical story line (Table 7) 
People find ways of keeping information from their loved ones that is considered 
detrimental to their well being. The belief is that they are shielding them from 
harm. The concept of 'protection' emerges from each of these extracts. Alf (F 
004) wanting to preserve his wife's positive frame of mind, going to such lengths 
to avoid having a medical book in the home and telling the family not to disclose 
the potential 'five year' life expectancy. Shirley (F 002) reading out selective 
'bullet points' of information from the website about the disease not wanting to 
alarm Bert (P 001) or overwhelm him with too much detail. Conflicting emotions 
are prominent with wanting to know and not wanting to know the full 
implications of the cancer which is a common pattern in the study. Silvia's (F 
028) hidden disclosure was associated with the struggle and worry about 
finances. She was reluctant to communicate these concerns to her husband 
thus protecting him from further stress during a difficult period. Each of these 
family members therefore kept their true feelings hidden and prepared to take 
on board additional burdens that they themselves found stressful but were not 
inclined to `spill the beans' in order to protect their loved ones. In the literature 
hidden disclosure within the family is addressed in relation to other terminal 
illnesses (Houldin 2007, Copp and Field 2002). In this research hidden 
disclosure is described within the context of living with a cancer that is complex 
and relatively unknown. 
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Alf (F 004) 
"I never had a medical book in the house at Dagenham or here because my sister used to say 
I've got a lovely medical book, haven't you got a medical book and I said no, we'll have to get 
one, and we never told her what this, they told us at the hospital. she never knew it was a five 
year life span she had and I said no she, don't want to know that, we've got her in a frame of 
mind where she's so positive, I said, I don't know what it would do to her. So the kids never 
said nothing, I mean we knew it from the social worker, what she told us from the start". 
Shirley (F 002) 
"I explained to him after reading from the website you know and printing it all off that it was only 
one per cent of all cancers are myeloma based and when I read I said I'll read you out some of 
the bullet points Bert and I did -I think I protected him do you know what I mean? I didn't want 
to go into things that weren't there or say too much because I felt he could take it on board a bit 
at a time but in point of fact of course it took it out of me because I was still trying to take it all on 
board Pat and you're numb at first I think - you want to know - you don't want to know - do you 
know? " 
Sylvia (F 028) 
"You had all the worry of somebody that could die, plus you had all the worry, and I never used 
to tell him anything, you know, I used to, he'd say how's things going? I said yeah OK, but I 
used to try and keep all that side of.. the financial side away from him, because I didn't want him 
to have to worry about something like that". 
Table 7 Hidden disclosure 
4.9 Summary 
'Ways of communication' was the first of four main categories to be addressed. 
This was subcategorised into 'communicating with the doctor', 'communicating 
bad news', 'using complex terminology', 'communicating with children', and 
'hidden disclosure' corresponding to the subheadings above. The relationship 
between Contention (core category) and 'ways of communication' is described 
in terms of difficulties encountered when communicating with other members of 
the family about the illness or during consultations with healthcare 
professionals. The next main category is 'Nature of the disease' which is 
intrinsically linked to ways of communication by rarity, obscure or indistinct 
onset of multiple myeloma resulting in delayed diagnosis; complicated and 
unfamiliar language associated with this cancer; complexity and unpredictability 
of the disease. 
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4.10 Nature of the disease 
"I know that it's just a matter of keep taking stuff to keep it down or find a level 
that you're happy to live with where either the symptoms, like any maintenance 
therapy that your on, or symptoms of myeloma itself causing an adverse effect 
on your wellbeing. I know that's what the disease is so, and I just say give me 
the next one because I know there will be another one but unfortunately that is 
the nature of the beast" (Phil P 019). 
4.10.1 Introduction 
Multiple myeloma may be viewed as the volcanic 'Galapagos' of cancers and 
unlike any other creating destruction and fragility of the human skeletal and 
immune systems. The condition is painful and debilitating because of the 
presence of bone disease which differentiates multiple myeloma from other 
haematological malignancies or blood cancers. There is a general downward 
decline which gradually results in a poor quality of health which manifests itself 
through bone pain, infections, anaemia, fatigue and disability. Quality of life 
varies considerably. Some people are able to continue with their work and 
maintain jobs while others are disabled and are unable to do so. The cancer is 
incurable, difficult to diagnose, difficult to treat and is unrelenting in its 
progression. The disease is unpredictable with numerous episodes of relapse 
and remission resulting in instability and uncertainty. The outcome therefore is 
grim. The rarity, diversity and complexity of the disease lends itself to 
misgivings and misconceptions. Not all patients want to know or understand the 
disease that they have while there are others who study the disease, learn 
about the treatments, have access to websites and keep themselves updated 
and well informed. Some patients' level of knowledge surpasses that of the 
healthcare professional. The subcategories that emerged through the 'Nature of 
the disease' include 'delay in diagnosis', 'living with uncertainty', 'perceptions of 
the disease', and 'novice to expert patient'. 
4.11 Delay in diagnosis 
4.11.1 The context 
The way in which people communicate with their doctor may have a significant 
influence on whether or not the initial symptoms are investigated as illustrated 
above (4.4). Participants were often influenced by others around them for 
example colleagues at their place of work, family or friends recommending 
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alternative treatments from therapists such as acupuncturists, osteopaths, 
physiotherapists and chiropractors: 
Jack (P 014)"In the meantime lots of friends were giving helpful advice about 
going off to see craniosacral people, and chiropractors and osteopaths, and so I 
did that route too, I think from people I've talked to, a lot of people went down 
this route too, and what the devil is wrong with me"... 
Repeated visits to or from the GP appeared frequently in the data from the first 
few interviews (5 out of 9) resulting in the decision to interview GPs and explore 
this issue to establish why multiple myeloma is difficult to diagnose. More 
importantly why were the GPs treating the symptoms and not investigating the 
cause? The need to repeatedly visit the GP seeking help regarding a specific 
problem before a cancer diagnosis is made has been reported by Leydon et al 
(2003). These authors suggest that difficulties encountered are because of 
scarce resources especially in deprived areas, additional pressure on the GPs, 
ten minute consultations, and differences in the GPs in relation to experience 
and knowledge. An important issue highlighted (Leydon et al 2003) was the 
type of cancer for example the patients with breast cancer interviewed in this 
study were relatively satisfied with responses from their GPs immediately prior 
to diagnosis. This comes as no surprise as breast cancer can be detected more 
quickly and easily because it is a solid tumour which is palpable and often 
visible to the naked eye. Other less conspicuous cancers for example 
leukaemia or myeloma may start out with very non specific symptoms such as 
mild anaemia or backache. Alternatively the initial symptoms in myeloma can 
be atypical or obscure causing delay in diagnosis (Bradwell 2006). In the case 
of a symptomatic myeloma the consequences of a delayed diagnosis will 
ultimately lead to delayed treatment and disease progression. Dr Ian (HCP 026) 
disclosed how one of the patients attending his GP surgery finally became 
diagnosed as a result of obscure symptoms: 
Dr Ian (HCP 026) "She had some rib and thoracic upper spinal pain. I was 
worried about her, she presented a little bit atypically, well she had those 
symptoms, plus thyrotoxicosis and I sent her on to a consultant physician, more 
worried about the thyrotoxicosis. He then went on to refer to a rheumatologist 
who did a bone scan and actually it took another rheumatologist, after the first 
one, before the diagnosis came. She actually saw a rheumatologist and think 
was treated for osteoarthritis plus or minus some bone thinning, before the 
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myeloma diagnosis came out. The diagnosis of myeloma came after the 
rheumatology appointment and was picked up through blood changes rather 
than bony changes on MRI and X-rays". 
4.11.2 The analytical story line (Table 8) 
There were two extremes of delay in diagnosis portrayed. The first taking place 
over a prolonged period of several years (4.4.1) and seemingly non life 
threatening; while the second was over a shorter period of a few weeks and life 
threatening. For example admitted to hospital by ambulance in a semi-` 
comatose condition (Pam's story 4.2.1). GPs seeing patients during the first visit 
make the assumption that they are dealing with something common and thus 
the notion of a condition that is rare is not considered. A 'strained muscle' is 
often the assumed diagnosis and a prescription for pain relief appears to be a 
typical pattern. Subsequent visits to or from the GP have often resulted in the 
provision of stronger analgesia and referral to a physiotherapist. If the 
presentation is considered uncommon, abnormal, severe, or there is a family 
history of cancer it is investigated immediately. The policy regarding common 
ailments such as muscle strain and backache is to treat symptoms and not 
investigate the cause which means that the disease, when present, remains 
undetected and is therefore allowed to progress. 
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Fred (P 017) 
"I kept getting pains down my left side and this went on for years, not months, years, and I kept 
going back to the GP. They found it out with a blood test but first of all because I was 
complaining that I'd, I thought it was a muscle because of my sporting days, and things, and it 
used to, I used to keep getting this, what I thought was a muscle, playing me up, and I went to 
physiotherapy, I went and nothing ever seemed to happen and in the end that is when I went 
back to the doctor and they did a blood test but they only did one phial, just a general blood test 
to see what my general health was like. I mean I wasn't looking for cancer and then as I say 
then after that I'd had an ... went 
back again, pestered them and they did a blood test with 
about 4 or 5 phials of blood, and that's when they found it out". 
Pam (P 003) 
"Then I went to the doctor and our one wasn't there he was on holiday and the 'fill in' doctor, he 
just said oh he just didn't even bother to examine me he said you've strained your back he said 
you got a strained muscle. He said just try resting and that will be OK. So then I went back 
after a week and I said it isn't getting any better, I said if anything its getting worse, so he just 
give me another prescription and carried on and then Alf said why don't you have a bed 
downstairs, save you keep going upstairs, he said, everything's down here you have to get your 
drink and everything" ... 
Dr Sam (HCP 020) 
"I think if there's say an abnormal presentation, so if there's a strong family history of cancers, or 
a strong history of cancers, say the patient had prostate cancer, or had breast cancer and you 
were thinking of a secondary deposit, you might do an X-ray at that stage. If the symptoms were 
very severe, so if a sort of simple analgesia or normal analgesia wasn't helping, then you'd do 
an X-ray. If they've had failed treatment, so if they say that they'd been to a physiotherapist on 
their own for six months or a year and that hasn't helped, you'd do it then. So but if it's like I 
started having back pain sort of two weeks ago and it's not getting any better doctor and it goes 
down my left leg or whatever, then we wouldn't necessarily X-ray at that stage". 
Table 8 Delay in diagnosis 
4.12 Living with uncertainty 
4.12.1 The context 
Living with multiple myeloma means surviving with chronic illness that requires 
continuous monitoring and prolonged periods when lines of chemotherapy are 
administered with the aim of a partial or complete remission (stable disease). 
Remission periods typically shorten and the disease becomes refractory or 
unresponsive to treatment (Durie 2000); a major obstacle being drug resistance 
(Schey and Pallister 2004). Patients may attend the chemotherapy day care unit 
or outpatient clinics on a regular basis for monitoring (blood tests) and for other 
intravenous 'supportive' medication required to treat bone disease 
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(bisphosphonates), or blood products to replenish low counts such as platelets 
or red blood cells. 
It is not known why some people die relatively quickly while others survive 
longer. In exceptional cases individuals may live for 20 years or more with the 
disease. People live with the uncertainty of not knowing how long they will 
survive; whether or not their current course of chemotherapy is having the 
desired effect; or how long it might be before they are no longer able to work or 
pursue normal leisure activities. Coupled with these concerns is an awareness 
that the disease will not remain stable for long and that relapse is expected 
although it is not known when this will occur. Living with uncertainty is identified 
and experienced living with other diseases such as heart failure (Winters 1999), 
advanced gastrointestinal cancer (Winterling et al 2004), cardiopulmonary 
disease (Haugh 2005), breast, prostate and colorectal cancer (Shaha et at 
2008) and inflammatory bowel disease (Dudley 1995); it is not therefore unique 
to living with multiple myeloma but the disease prolongs and exacerbates its 
intensity. 
People with other types of cancer live with the 'fear' of potential recurrence. The 
impact of recurrence of ovarian cancer, for instance, is explicated as "living in 
limbo" or uncertainty of the future and feeling threatened by the thought of 
imminent death (Ekwall et at 2007). Recurrence is perceived as a return or 
reappearance of a cancer that was thought to have been eradicated. People 
have therefore moved on with their lives thinking that they have 'beaten' the 
primary cancer and can usually look forward to a future. Relapse, on the other 
hand, is a progression of disease that exists meaning that a person's condition 
has deteriorated or worsened sufficiently to require a further course of 
chemotherapy. The contrast is living with 'repetition of relapse' characteristic of 
multiple myeloma. Patients often refer to life as a 'roller coaster' because of the 
'ups and downs' phenomenon of incurable disease (Carter et al 2004, Nason 
2004, Kessler-Berther 2003, McGrath 2001): 
Dave (P 023) "at one point you're feeling relatively healthy, at another point your 
rather debilitated with chemotherapy, at another point you're popping steroids 
with their interesting side effects and so on. So that has been the real changes, 
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and how you cope with that really is, I mean you have to take a day at a time 
really, you can't do very much else than that, how do you feel today, what do 
you need today really. If somebody had for example been in remission for an 
extended period, I suppose their life is settled to a certain point and then it 
changed, you might get a different answer but mine's been an exciting roller, 
medical roller coaster". 
4.12.2 The analytical story line (Table 9) 
The nature of the disease and living with uncertainty are entwined. Living with 
multiple myeloma means living with uncertainty. Uncertainty refers to an 
unforeseeable future and uncharted pathway associated with the 
unpredictability of the illness (Shaha et el 2008; Bradwell 2006) and its 
treatment (Schey and Pallister 2004).. Participants speak in terms of 'ups' 
(positive) and downs (negative) also described as living on a 'roller coaster'. 
The 'ups' relate to periods of relative normality when the disease is described 
as stable (remission). There are particular times when participants feel more 
secure, positive and confident for example when the disease is responding to 
treatment; or when treatment is still an available option which means death is 
not an immediate threat. The 'downs' correlate with relapse, which is repetitive 
and ongoing. Repetition of relapse is frightening, disruptive and unsettling 
however people learn to cope and become accustomed to these setbacks but 
they also become reliant on them. Death is a real and immediate threat when 
the disease becomes unresponsive to treatment and chemotherapy is no longer 
a viable option. 
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Frank (P 007) 
"It's like living with the sword of Damocles over you all the time. It's like having an albatross 
around your neck because you know your time on this earth is finite, it's limited and that's the 
down side. The positive side is that I've had this condition now 4 years. I'm currently on Phase 
2 (cycle 2) of the PAD (*PS341, Adriamycin and Dexamethasone) Trial and being optimistic, 
there's no reason in the world why I shouldn't go on living for another 3,4,5 or even beyond 
years. So, although one has the negative side, there is also the positive side. So it's a mixture 
of feelings really". *(PS341 was named bortezomib or velcade). 
Penny (F 015) Jack's wife 
"Just the sort of the ups and downs that you go through with this particular disease, and so you 
go for, he would go into remission and he would go into a time of relative normality and then he 
would go out of remission and we'd have to deal with everything again but we got better at 
dealing with it because we, we'd been through it yeah, so ... and 
I guess that brings us up to 
the, the present time which was difficult to deal with too because I guess I got used to the sort of 
him going into, him relapsing and then, and then going into remission and I thought that would 
just continue forever and this one looks a lot more serious". 
Nurse Fiona (HCP 039) 
"As one describes it, it's like a death sentence really, they're looking at a death sentence, they 
know what's going to get them in the end and so that's something they relate it to. So they're 
always living with that and I think that has a big impact, not just on the patient but obviously on 
the relatives as well and the uncertainty of how things are going to happen and how long that 
life, that line of time really is because they're only given averages and they don't know if their 
sentence is average or not. So there's all this uncertainty". 
Table 9 Living with uncertainty 
4.13 Perception of the disease 
4.13.1 The context 
An individual's perception of the disease from which they are suffering may be 
entirely different to the perception of close friends and family. A person can look 
perfectly healthy and normal in appearance and may not choose to talk about 
the illness or dwell on the topic too much. The consequence of having a 'hidden 
disease' and apparently looking well on the 'outside' often portrays a false 
image which can result in misunderstanding and misconceptions about the 
cancer. Stacey's (1997: 138) cultural study of cancer includes two contrasting 
photographs of herself. In the first picture, she is relaxed, smiling, looking 
perfectly healthy not realising at the time that she had a "large and potentially 
lethal tumour" (137); the second picture portrays Jackie Stacey looking like a 
'cancer patient' with new hair growth following treatment with chemotherapy. 
Stacey argues that visions can be deceptive and that people's perceptions of 
what they see are interpreted differently. The implication of a deceptive 
appearance is the assumption that all is well. It may therefore be assumed that 
everything is fine and no additional support is needed. The following extract 
reflects this notion illustrating how family members became more concerned 
when visible manifestations associated with serious side effects from 
medication were apparent: 
Phil (P 019) "In March she (ex wife) and the girls came over and like sorted out 
my house because I live on my own, as I mentioned for 7 or 8 years. I'd had 
rooms piled up with junk and all sorts and they helped me basically go through, 
did it all and now my house is sort of a bit more liveable than it used to be. It 
was at about the time that I got the DVT (deep vein thrombosis) and my 
daughter had seen this sort of cellulitis, like the thing on my leg and so they 
were obviously really worried, so it prompted them to do something, because at 
the time, I was on crutches from the DVT, it was just so painful for about a 
week, I couldn't even put any pressure on my feet at all, unlike on this leg, so 
that's what prompted them to finally be a bit more aware that I really was sick. 
Because that's the other thing, everyone for years, you look great Phil, the fact 
that I feel like shit, and taking all this medication and having all these side 
effects that people don't know about"... 
People's behaviour and body language can also belie the true extent of 
suffering. Patients can be struggling to walk or move with bone pain and severe 
adverse reactions from medication. They may act normally and be 'themselves' 
with their loved ones while in the confinement of their homes, however, they 
often put on a 'show' or act differently in the presence of others. The following 
extract taken from field notes written during a second visit to validate the 
research findings exemplifies this: 
Field notes 12 October 2007. 
P 007, F 008 Study Validation Visit 
1 told Frank that I thought he was looking well knowing that he is suffering with 
bone pain. I felt guilty and said I hope this doesn't make you angry. He smiled 
and said no but you know so many people say this to him. He is almost 70 and 
has very few age lines around his face. He has a nice face and a good head of 
hair. Frank stands up straight and appears to walk normally. He said people do 
not see the `real me' or do not know what is happening inside. The pain around 
his ribs, his back, his arms, his legs and people are not aware that he had a 
morphine patch beneath his jumper sleeve. His legs are so weak that he can 
only walk a very short distance. Maggie said he is lively and chatting while I am 
there but as soon as / have left she knows Frank will be quiet and lay on the 
sofa for hours, and be his `real self. Frank has been on a six month trial of 
revlimid (thalidomide) and he spoke of feeling absolutely wretched while on this 
medication so much that he wanted to go to bed and not wake up again. Yet he 
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knows that he may require more treatment and does not realistically expect that 
he will have too long to wait. For now his disease is stable with an Wand of 9 
and he knows this is likely to start creeping up within a few months or less. He 
is a religious man and he no longer has the energy or the inclination to attend 
Mass. His faith is very important to him. The saddest thing I heard was Frank 
has played golf for over 43 years and he is no longer able to play. He loved 
playing golf. Yet he still has that drive in him and said he was going to visit a 
friend who was sick and in his eighties so he could cheer him up and make 
himself feel better! 
Family perceptions of a disease that is described to them as an incurable bone 
marrow cancer is often interpreted as 'dying' and death is likely to occur at any 
moment. Relatives and friends not seen for a long time appear offering help and 
support only to withdraw at a later stage when it is realised that the 'patient' is 
not going to die immediately: 
Bill (P 027) "Everyone sort of rallied round and they were good with financial 
help. They were there for a little while, and they're sort of, after a while you 
could almost think, we're still here. Was it as serious as made out? They've all 
sort of helped us a bit here and there You felt like a bit of a museum piece at 
times. Uncles and aunts used to turn up and visit, you know come and have a 
sit and have a look at you for a little while". 
From a healthcare professional's perspective multiple myeloma is perceived in 
terms of the "orphan disease" (Dalton 2004) which implies that it has not 
received the kind of media coverage favoured by other more common cancers 
such as breast or lung cancers. Perhaps this is not surprising as multiple 
myeloma represents only 1% of all cancers. In the field of haematological 
malignancies where it represents the second most common cancer it appears to 
'take a back seat' and one of the reasons suggested is association with the 
elderly. The following extract from a myeloma nurse describes different 
perceptions relating to 'headline grabbing' leukaemia and apparently uninspiring 
multiple myeloma: 
Nurse Claire (HCP 038) "Myeloma's not sexy. All the good things that Myeloma 
UK, it should, raising awareness, all the things like study days today, it still 
takes a back seat, I don't care what you say. Leukaemia's sexy, leukaemia is 
headline grabbing. Leukaemia strikes a child and it... myeloma historically, 
unfortunately, has had a label and / think it still has that label. So it happens to 
an older population, it happens, doesn't it, and that doesn't grab the headlines 
as much as a younger population would". 
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The following palliative care nurse maintains that misconceptions and 
misunderstanding surrounding the disease remains. Ellen highlights the point 
that some people are unable to return to work when treatment has been 
completed making the comparison between patients with multiple myeloma and 
patients with other cancers who can resume normal life following treatment: 
Nurse Ellen (HCP 032) "They've still got mobility problems and, you know, 
they've still got all the difficulties of not working, not mobilising well, not being 
able to carry on their normal lives, which they're going to be left with, which I 
think often people aren't so sympathetic with. So I would imagine, although 1, I 
can't say I've had a conversation with anybody recently about this, but I would 
imagine there's still this misconception, this misunderstanding about the 
condition and why people can't go back to work once their treatments finished 
and, you know why they're not, you know, why they can't resume their normal 
life, like a lot of other patients with cancer problems"... 
4.13.2 The analytical story line (Table 10) 
Multiple myeloma is perceived as a cancer that affects mainly the elderly (Kyle 
2002). It is acknowledged that there appears to be a rise in the younger patient 
population (Schey and Pallister 2004). It is also perceived by healthcare 
professionals as an 'unpopular' cancer that takes a 'back seat' because it is not 
as 'news headline grabbing' as a child with leukaemia for example. When 
disability or altered body image is visible, the perception of illness changes and 
becomes more convincing. People who look well for example are perceived as 
healthy and the presence of cancer is less believable. The cancer and the 
language associated with it are complex (McGrath 2001). Patients may have 
difficulty understanding about the nature of the disease and treatments 
associated with it because of the complicated terms of reference used. However 
patients may choose not to acknowledge the condition or deliberately 'block' it 
out as a way of coping with the situation. 
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Alice (P 033) 
"Really and truly I, I can't understand what's, what's wrong. Just the pain in the back, which I 
see, I've seen the doctor, with, about the pain in the back. But other than that, I can't, I just can't 
say. It's, it's in, the pain has been improved". 
Val (F 035) Alice's daughter 
"Well I mean basically it's, it's a form of bone cancer, and it's to do with the bloods. Mum's had it 
in, in her back and it's to do with the crushing of also of the spine as well, so the spinal bone it's 
been crushed, so that's why she walks with a sort of bent. Bent, yea, with a bend, and I mean 
its terminal. Yea I've got a fair idea of what it entails". 
Nurse Lin (HCP 006) ... "I always think myeloma is very much an old people's disease and it's just one of those things 
that you get when you get older and ... now 
it seems that I'm seeing a lot more younger patients 
with myeloma, lot more aggressive treatments and, and patients with young children and 
obviously that the fact that a lot of myeloma patients there are issues about mobility for example 
so it does have a huge impact on their daily life and the family and practicalities of looking after 
children and sorting out childcare and, and school runs and those sort of issues".... 
Table 10 Perceptions of the disease 
4.14 From novice to expert patient 
4.14.1 The context 
Patients and their family members usually enter the world of haematological 
oncology `shattered' by the confirmation of a cancer diagnosis and begin to 
learn about the hospital environment, the hospital staff, hospital appointments, 
hospital procedures, the type of treatment that they will have, and gradually may 
begin the process of familiarising themselves with a new language. The majority 
of newly diagnosed patients and their family members are in a state of shock, 
confusion and bewilderment. As novices they are inexperienced and do not 
have the knowledge or understanding which enables them to ask the right 
questions or empowers them to take control and make decisions relating to their 
treatment options and immediate needs. Many of the participants in this study 
had access to the internet. Patients are usually actively encouraged by 
healthcare professionals to access the Myeloma UK website for information 
(www. myelomaonline. org. uk). Myeloma UK registered as a charity in 1997 and 
provides information, education and support for patients, family members and 
healthcare professionals. 
Patients soon become familiar with terms such as high dose therapy and stem 
cell transplantation especially if that is their first line of treatment and they need 
to understand what this entails. Many patients and family members learn the 
names of various chemotherapy agents and medications some of which are 
lengthy, complicated and often unpronounceable. The knowledge extends to 
how the medication acts and reacts to their bodies through the experience of 
treatment and liaison with healthcare professionals and other patients. Patients 
and healthcare professionals learn through experience and it can be argued 
that both parties go through a period of training. The difference is that the 
healthcare professional training is formalised and structured. Patient expertise 
is different to a healthcare professional although its value is now recognised as 
a potentially useful resource (Department of Health 2001). Previously it was not 
considered relevant. 
There are exceptions and not all patients' progress from the novice level 
satisfied with the confidence they have in the healthcare professionals and 
relying on them to make decisions on their behalf. Patients and their family 
members are given volumes of written and verbal information regarding their 
care and treatment when they attend the outpatient clinics. It is assumed that 
individuals will read the information when they are ready and when they feel 
that they are able to cope with the task. There are pharmacy bags similar to any 
standard sized supermarket edition full of various medications for patients 
during treatment cycles of chemotherapy waiting to be collected at various 
intervals when attending the chemotherapy day care unit. A variety of drugs are 
required for the numerous potential side effects from prescribed chemotherapy; 
drugs for bone pain, drugs for bone disease and drugs for infections. Patients 
quickly learn of their susceptibility to infections and may develop a specialised 
knowledge relating to plasma cells, immunoglobulins (antibodies), neutrophils 
(white blood cells) and neutropenia (decreased white blood cells). The following 
abstract refers to a lady talking about waiting for her neutrophil count (white 
blood cells) to increase sufficiently which would allow her to leave hospital, 
having had high dose chemotherapy which aims to obliterate the diseased bone 
marrow prior to stem cell transplant. Unfortunately the high dose chemotherapy 
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also destroys normal bone marrow resulting in extremely low blood cell counts 
and virtually no immunity: 
Sally (P 018) "The beginning was fine because / had the, you know, high 
dosage treatment, / had the Hickman line put in and then the transplant but it 
was then the waiting. Now the waiting would have been alright ... the waiting for the... what were those blessed, my 'neutrophils' (white blood cells) which I 
nicknamed 'neutropests' because they didn't do what / wanted them to do 
because you know, they were nought then they'd go up to 2 then they'd go 
down to 1, all this sort of thing" 
Patients become familiar with procedural terms such as radiotherapy, skeletal 
survey and bone marrow biopsy. They talk openly about the side effects from 
the various agents that they have had over the years although there is 
reluctance to report them at the time of administration because generally 
patients do not want to have doses of their chemotherapy modified (reduced), 
delayed or discontinued. Peripheral neuropathy (numbness in the feet and 
hands) for example is a common term used by patients, a common side effect 
of velcade or bortezomib and thalidomide. They do not tend to say 'pins and 
needles' or tingling. Individuals (patients and family members) talk specifically 
about Bence Jones proteins and paraprotein levels or M Bands and understand 
these are the markers by which they can assess whether or not the disease is 
responding to treatment. 
4.14.2 The analytical story line (Table 11) 
Many assumptions are made regarding language, terminology, perceptions and 
understanding. As healthcare professionals it is often assumed for instance that 
patients understand the words haematology and oncology. Most people are 
familiar with the terms blood and cancer; they have a better understanding of 
words that are commonly used in everyday language. People living with multiple 
myeloma have prolonged periods of treatment with chemotherapy agents and 
some people experience numerous hospitalisations. Many have access to the 
Internet and vast amounts of information. Some patients will attend education 
seminars and support groups while others prefer not to do so because they do 
not want to be reminded of what may happen to them further on down the line 
by potentially meeting others with a more advanced disease. Patients may 
develop knowledge through experience of illness and treatment. They may 
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simply adopt the language communicating with other patients and healthcare 
professionals within the hospital setting. It is acknowledged that there are 
individuals who do not study the disease in great detail but it appears many 
including family members have a good understanding of the cancer and 
become 'fluent' with the complexity of haemato-oncological terms. The fact that 
patients learn to use this terminology may be a reflection of the way in which 
healthcare professionals communicate. Are the patients learning to understand 
about the illness and management of the disease or are they learning the 
language in order to communicate more effectively with nurses and doctors? 
Phil (P 019) 
Well I know about the different kinds of... not side effects but the way it's detected, through the 
blood, sometimes through the urine. I mean I've got IgG Kappa so that means that I've got 
short chains instead of long chains, I think, so there's no urinary detection, apart from possible 
changes in albumin and stuff like that but I do know exactly how it works and the fact that 
basically it suppresses... your B-cells are totally non functional because they never mature 
properly, whether they kick out the IgG or whatever paraprotein that a particular one does, and 
presuming the IgG is actually used in some form of combatants but it's just on all the time, as 
the cells mature they just pump it out but the other thing is that they suppress T-cells"... 
Frank (P 007) 
"Sure, the pain in the upper spine region developed about, I don't know, 16 months ago, 
something like that and eventually that led to a consultation with a neurosurgeon, Mr. A, and it 
was decided that having looked at the MRI scans, that a procedure known as balloon 
kyphoplasty would be appropriate in my particular case and it was agreed to go ahead with that. 
However, on the morning of the operation, which was January 2005, Mr. A decided that it was 
going to be too dangerous to get into thoracic 4, where the main tumour was located, so he 
decided that in my best interests not to proceed with the particular procedure. Now since then, 
and that's about 15 months ago, the pain level has gradually increased and it's now not only 
localised around the thoracic region, it's now sort of diffused into the area around the right 
shoulder blade and the entire ribcage" ... 
Debs (P 009) 
"We did that with you (clinical trial) for 9 weeks or something and then found out that that hadn't 
been working, so I had to..., they put me on a new course which was.. I can't remember what I 
was having now. Thalidomide and Dexamethasone and the Cyclo' ... That's 
it 
Cyclophosphamide and that did work and that got my M band right down and then I had the 
stem cell transplant, my own stem cells and then I was offered the trial for the donor stem cell 
transplant a few months later. So I've had that and waiting to see if that's worked but I've had to 
have some extra donor stem cells because the M band was sort of rising, so we're just waiting 
at the moment to see how that's gone". 
Table 11 From novice to expert patient 
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4.15 Summary 
This section of the findings chapter introduced 'Nature of the disease' which is 
the second of four main categories relating to the core category of contention. 
The next main category to be discussed refers to the impact that the cancer has 
on the lives of the participants. Thus the nature of the disease and impact on life 
are also intrinsically linked. 
4.16 Impact on life 
"Still telling me `I can't see anything'. They sent me back home on a stretcher, 
tell me to go back and lie down on the floor, it's back pain, yeah. So when my 
wife couldn't take it again because she actually had to drag me when / went to 
use the toilet, you know drag me to put me on the toilet and so then drag me 
back, to lay on the sitting room floor' (Mike P 040). 
4.16.1 Introduction 
Life was viewed as life before and after the onset of illness. Life as it was known 
is disrupted and comes to a sudden halt. Disruption occurs in many aspects of 
life and the impact can be catastrophic. There was the impact of physiological, 
psychological and socio-economic changes that evolved which might have an 
immediate impact or develop as the disease progresses depending on 
circumstances and severity of illness. Multiple myeloma is a cancer that often 
affects the 'breadwinner' of the family, for example, as the incidence is slightly 
more prevalent in males and the majority of patients are over the age of 40 at 
diagnosis. A significant number of the participants (n=1 1) were not able to 
continue working because of disability caused by bone disease which creates 
enormous frustration and anxiety because people struggle to 'make ends meet' 
particularly when they have been earning a good salary. The shock of the 
diagnosis had a substantial psychological impact on the whole family. It was an 
extremely difficult and emotional time for them. Prolonged periods of treatment 
and healthcare presided over existing working life, family life and social life. For 
example some of the participants had to cancel booked holidays, which 
coincided, with the commencement of chemotherapy. Patients and close family 
members had also, at times, isolated themselves from others (friends or 
relatives) or avoided contact with people especially when they were susceptible 
to infection. Relatives for instance were instructed not to visit if they had colds 
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or influenza. The subcategories that have emerged through 'Impact on life' are 
'disrupted life', 'physical impact of disease', 'emotional impact of treatment', 
physical impact of treatment', 'impact on sexual relationships' and 'impact on 
family life'. 
4.17 Disrupted life 
4.17.1 The context 
Disruption to life is defined as major upheaval and normal life as known by the 
participants suddenly coming to an abrupt end (Houldin & Lewis 2006) People 
living with multiple myeloma who continued to work were are not able to provide 
the level of commitment that was apparent prior to the onset of illness. Normal 
working patterns were disrupted due to hospital appointments and treatment 
regimes. These changes, which inevitably resulted in significant periods of 
absenteeism, required understanding from working colleagues and a supportive 
employer, which was not always the case. 
Participants in this research also isolated themselves within the working 
environment and commuted during off peak times to avoid crowded public 
transportation because of their immunodeficiency: 
Geoff (P 011) "The worst thing, well not the worst thing, is coming to the 
hospital so often disrupts the working life. I mean I used to work quite long 
hours from say 8.30 in the morning till 7.00 or 8.00 at night most of the time, five 
days a week, not any more, not any longer than that but since I've been 
diagnosed and made so many hospital visits obviously I have taken plenty of 
time off work and the time I'm at work now because of my immune system is 
quite often very low, I try to travel out of the rush hour. So I get into the office 
just after 10.00 now and leave about 3.30,4.00 o'clock at the latest. I changed, I 
used to manage the group that I work with now but after going through about a 
year, I suppose it's just shortly after the high dose treatment, I said to the 
people in charge I can't really go to meetings and be available as often as 
should be I suppose in the role I had, so I basically stepped down from that and 
let somebody else take over the group, but the company have been very 
good"... 
Life before the onset of illness was the 'benchmark' that the majority of 
participants related to. Redefining life comparing with how it was before and 
reflecting on the consequences is explicated in the literature as 'perceptions of 
normality' (Carter et al 2004: ). Numerous references are made to the life before 
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and after 'myeloma'. Common expressions such as "I just want my life back" 
(Carol F 012); "life won't be the same" (Mat F 010) and "threw our home life into 
chaos" (Penny F 015) are used to articulate the upheaval. The following extract 
represents a common theme in the data relating to a retired person's full and 
active life style disrupted by the onset of the disease: 
Frank (P 007) "Life was good, life was full, I had a good full social life. / did the 
things I wanted to do. I was active; I used to do a little bit of cycling. I played 
golf regularly, and I was involved in church activities. Life to me before the 
onset of myeloma was well balanced and full. I had a part time job in a 
chartered accountants office where I ran the office, I managed things, and / 
found that demanding but very fulfilling. But then the myeloma was discovered 
and it completely changed my life from the point of view that / had to finish work 
at the office, which I did enjoy very much, and I then found that my whole 
outlook, mental attitude, to life changed, for a period of time - and that was a 
time of adjustment, to get used to the idea that / had got an incurable cancer - 
something which was going to, by the law of probabilities, take my life 
eventually"... 
4.17.2 The analytical story line (Table 12) 
Disrupted life means hitting a 'dead stop' and life as it was known potentially 
undergoing a dramatic and unexpected change. This change means that future 
plans may be put 'on hold' or destroyed. Numerous examples of destroyed 
future plans were found in the data. Mat and Debs' plans for the birth of their 
second child were destroyed along with hopes of Debs returning to her work. 
Bill and Sylvia did not have any children but enjoyed a 'comfortable life' while 
Bill was able to work. Bill was self employed and it became a financial struggle 
for this couple as he was unable to continue with his work because of disability. 
The third example given in this trilogy from the healthcare professional's 
perspective (Nurse Ruth) illustrates how the onset of illness and diagnosis of a 
family member had an emotional and disruptive impact on a family business. 
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Mat (F 010) Deb's (P 009) husband 
"You know both busy with our work, we was sort of whizzing in and out of town to pick Ben up 
from nursery and so I was leaving at the crack of dawn to get to work so she could leave early 
and get him and things like that. Busy social life because we had Deb's mum and dad available 
and so we were still able to go out and socialise and things like that and then all off a sudden, 
you know, we, already knowing that Debs was pregnant with our second child it was all, 
everything sort of hit at a dead stop and you were faced, you know faced with a one decision 
which basically there wasn't two answers to because it was, it was like you're at risk we can 
hang it out an extra couple of months, however, the baby is very, very unlikely to mature into a 
sort of a fully developed child or it will have problems even it's born". 
Bill (P 027) Sylvia's (F 028) husband 
"it has affected us quite a lot because I've not worked since. It's a physical job and I've not been 
able to work. What happed was I was self-employed but I had just started work with a new 
company. I'd only been there a couple of weeks. I come straight out from work, I didn't get any 
sick pay, I didn't get anything. It was a massive upheaval you know, I was earning quite good 
money and going to work and being comfortable and living your life - and all of a sudden it was 
a full stop you know. I was out of work; we'd got no money coming in at all and what happen 
really was that Sylvia was doing all the chasing around to try and get help and they didn't want 
to know. They kept saying you will have to wait for the doctor and all that sort of thing .... 
it was a 
massive upheaval at the beginning because we were trying not to get into debt we didn't have a 
lot put aside, we were really at a full stop"... 
Nurse Ruth (HCP 006) 
"I've just got a patient, who was newly diagnosed in November and both herself and the 
husband, they set up a business, this estate agency and everything was planned, and this 
woman as I say, very, is just like a French lady, very classic woman, very pretty lady, and very, 
you know, very slim and elegant, blonde lady, with blue eyes, pretty and they are running the 
business which is in the family. They've got two daughters and one of them is among them, 
doing the business and suddenly this is what happened, diagnosed, multiple myeloma, of the 
lady. It really destroyed them and I had to give them sort of like counselling that I was able to 
give. We had to refer her to counselling people to have a word with her. The palliative care 
nurses were going to see her. It was really very distressful for the family but now I think she's 
accepting it". 
Table 12 Disrupted life 
4.18 Physical impact of disease 
4.18.1 The context 
The physical impact of the disease is determined by classification of myeloma. 
For example patients who have the most common type (Kappa or Lambda light 
chains) IgG (Immunoglobulin G) there appears to be a greater reduction of the 
normal IgG counterparts, more frequent episodes of infections, a higher serum 
MBand or paraprotein level, less amyloidosis, less hypercalcaemia and there 
appears to be slower tumour growth when compared with other types (Foerster 
1993). Common clinical features include bone pain, pathological fractures, 
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anaemia, bone marrow failure, infection resulting from immunodeficiency and 
renal impairment. One of the most common presentations is back pain of which 
there were numerous references found in the data. The following represents the 
physical impact of the disease: 
Phil (P 019): "The year before I was diagnosed I hurt my back, on a fairground 
ride, I was told it was muscular. When I had my full body scan, I actually had 
two collapsed vertebrae. Now, my friend Dr Brown is confident that in fact the 
myeloma has actually softened or affected my spine in some way and this 
fairground ride just, with the extra pressure, collapsed my spine, which it 
probably wouldn't have done if I didn't have the myeloma, that's his theory. So 
that's the only two things, is that I do have lesions and I've got two collapsed 
vertebrae". 
One of the myeloma nurses interviewed differentiated between leukaemia and 
multiple myeloma highlighting the disabling impact of the disease and living with 
chronic bone pain: 
Nurse Claire (HCP 038) "Leukaemia doesn't bring with it the dreadful impact on 
the daily life in quite the same way. You've still got the diagnosis and the 
implications of that and what that does to the family but you haven't got that 
bone pain, the impact, the disabling impact. So, for example, you've got a man 
in his 50's, you know, bringing in the income, supporting the family and he's 
reduced to somebody in a wheelchair and he's still got the cancer diagnosis to 
boot, you don't see that very often do you with leukaemia, it's not painful, the 
pain presents itself, it's a dreadful thing to live with chronic pain, sometimes no 
matter how successful the myeloma treatment will be, people are still left with 
horrible pain, that never goes away, and for me, you see somebody reduced to 
those sort of states, I think it's a very powerful reminder" 
Less common clinical features of the disease include acute hypercalcaemia 
when there is an increased level of calcium in the blood causing nausea and 
vomiting. Symptomatic hyperviscosity is when the consistency of the blood 
changes due to the increased presence of IgGs and thickens sufficiently to 
reduce the flow of circulation to vital organs such as the brain, eyes, heart, 
lungs, kidneys or digits (Foerster 1993); potentially resulting in headaches, 
confusion, visual and hearing disturbances. Eyes may become 'blood shot' due 
to retinal haemorrhages, mucosal bleeding may occur from sites such as nose, 
gums or intestinal tract, loss of consciousness, fatigue, shortness of breath 
(Hemingway et al 2007) and thrombo-embolic events such as strokes (Perez- 
Diaz et al 2007). Neuropathies affecting sensation (sensory) and alteration in 
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muscular tone (motor) may develop in patients with MGUS (Noring et al 1982) 
and are associated with the presence of paraproteins, osteolytic bone lesions 
and amyloids (Foerster 1993). Amyloids are waxy deposits of diverse proteins 
such as light chain immunoglobulins found in organs and tissues gradually 
resulting in organ failure. Systemic AL Amyloidosis is a primary disease 
associated with multiple myeloma. AL is the classification for Amyloidosis Light 
chain. Clinical features are apparent through involvement with the heart, 
tongue, peripheral nerves and kidneys. The patient may therefore present with 
heart failure, a swollen tongue with waxy nodular amyloid deposits, peripheral 
neuropathy or renal failure (Hoffbrand et al 2001). 
4.18.2 The analytical story line (Table 13) 
The presence of bone disease may be extremely debilitating because of pain 
and susceptibility to fractures. Other physical symptoms that participants 
experienced included general fatigue, anaemia, shortness of breath, chest 
infections, nausea and vomiting, headaches, palpitations and nose bleeds. 
Dave (P 023) experienced difficulty in breathing when walking up stairs, fatigue, 
lack of fitness and falling asleep during the day which are common symptoms. 
Description of the intensity of bone pain is variable. Dave (P 023) implied 
soreness and stated that his hips felt as if they had been rubbed down with 
sandpaper which is a stark contrast to Debs (P 009) who was crippled with pain 
and fractured both her hips trying to walk. Much depends on the advancement 
of bone disease; the probability of pathological fractures occurring is relatively 
high especially in an area of bone weakened by the presence of pre-existing 
disease (Schey and Pallister 2004). The physical impact on Charlie (P 029) 
was devastating as he spoke of becoming disabled, unable to stand without a 
surgical back support and crawling up and down the stairs on his hands and 
knees, not an uncommon experience for patients with multiple myeloma. Geoff 
(P 011) on the other hand talked of a "twinge" in his arm and on the day he 
played golf and the bone fractured, "it hurt, quite bad/y' implying moderate to 
severe pain. 
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Dave (P 023) 
"Well, the primary presentation was a sort of pain in the hips but it wasn't like a pain, it was 
almost like someone had applied sandpaper to the joint, so it was a very odd feeling. I'd new 
had anything like that before and then obviously my cardiovascular efficiency was well down 
because of the level of paraproteins. I was getting out of breath walking up the stairs and falling 
asleep on the sofa and this sort of thing. So it, it was primarily those two presentations. It was 
the pain in the hips and just the catastrophic lack of fitness, were the main symptoms". 
Charlie (P 029) 
"Well when I first felt ill, oh I really, you know I, I was frustrated because I thought a slipped disc, 
was a slipped disc. Then they, it wasn't getting no better, it was just getting slowly worse, I 
mean I was literally crawling up and down the stairs with my hands and knees, I just couldn't 
stand up. I was just walking around with a big belt, which if I, when I stood up I had to hold the 
belt just to support me back and that, so I just couldn't do nothing. So that was frustrating but 
when I was diagnosed with can' the myeloma, I was a lot happier because at least I knew, 
obviously it's not a good thing to have but... and at least I knew what was wrong with me"... 
Geoff (P 011) 
"I had a pain in the upper right arm between the elbow and shoulder and I think I'd actually been 
to see someone privately about it. I was aware that we had a small car without power steering 
and if I was turning to the left, as you push the steering wheel over, I'd get a twinge just where 
the arm actually broke - but on that day I got up just to go out as normal on Saturday went to 
play golf with three friends and I hit the ball once on the 5th hole, on the tee shot, and it hurt, 
quite badly, and finished that hole and then when I hit the ball off the tee on the next hole, which 
is the 6th hole of the day, the arm just broke, just snapped". 
Table 13 Physical impact of disease 
4.19 Emotional impact of treatment 
4.19.1 The context 
The emotional or psychological impact is often associated with time and waiting 
in relation to response to treatment. People need to know that the 
chemotherapy is working and want constant reassurances that this is the case. 
Individuals often refer to paraprotein levels or Wands and understand that 
these are measurements which determine the success or failure of treatment. 
Modifications of drug dosage are often necessary because of severe side 
effects and this ultimately affects response to treatment which can have a 
massive emotional impact: 
Phil (P 019) "They reduced my dosage to about half and that was both the 
dexamethasone and the revlimid. The end of my second cycle, I got a DVT; I 
inject myself everyday with Clexane and then 2 cycles ago I really wanted to 
have the dosage come back up till I `plateaued'. Started off with twenty 
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something paraprotein in the blood and it went down to 11; it stayed at 11 for 
like four months, so obviously the dosage was too low, so I wanted to bump it 
up again. Peter and Kate (consultant haematologists) were thinking the same 
thing, so I've had 2 cycles back on full strength, so that was the impact of my 
most recent stuff and then, my neuropathy is a bit worse now than when I'm not 
on anything but if I'm not on anything it's still there because of the permanent 
damage from the velcade" 
A common experience relates to post high dose chemotherapy when patients 
have their stem cell transplants and must wait for the neutrophil counts (white 
blood cells) to return to normal before they can be discharged from hospital. 
The severe side effects from the treatment, the isolation and length of time 
spent in a hospital room is described as horrendous. The treatment is perceived 
as one of the most unpleasant hospital experiences: 
Dave (P 023) "1 was in hospital about a month with that and the other downside 
it didn't work desperately well either. It knocked the disease back a bit but, but it 
came bubbling back of course within a few months. So I went through all of that 
and it wasn't all that effective. That was probably the most unpleasant hospital 
experience I've ever had. I was just sort of sitting there thinking I just want this 
to be over, I want this infection to clear up and I want to be out of here basically 
and the way it works as you know, is that they measure your neutrophils and 
when the neutrophils get to 0.5 you get to go OK, you know, and as soon as my 
neutrophils hit 0.51 was on the phone to the wife, saying look I can escape get 
down here as soon as you can because what I didn't want to do was be in 
another day, phlebotomist turns up takes another blood sample and it drops 
down to 0.4 or something and I'm stuck back, and then I'm barred from leaving 
and so when the count didn't come up it was very, very frustrating, it really was". 
It is sometimes necessary for patients to be treated at other hospitals. For those 
needing emergency orthopaedic surgery for example such as pinning of 
fractured long bones or kyphoplasty (injection of bone cement), a procedure 
used in the treatment of vertebral compression fractures. One of the participants 
in this study had two surgical procedures at a different hospital, which is not 
unusual, but because of the personal circumstances the emotional impact was 
catastrophic. The first procedure was termination of pregnancy and the distress 
experienced by this family was further exacerbated by inappropriate care and 
apparent lack of compassion. The emotional trauma was still evident several 
months later when the second procedure (hip replacement) took place. This 
involved a return visit to the same hospital which was undertaken with dread 
and reluctance but with resignation: 
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Debs (P 009) "When I had to have the termination at (named hospital) that was 
dealt with really insensitively and really badly. It was in a backroom sort of 
abortion place - it was awful wasn't it? (looking at husband Mat). It was really 
dreadful. Well, I mean I'm sure it was going to be dreadful anyway because of 
what I was having done but they just ... the doctors came in and they obviously hadn't read the notes and they just were asking, they weren't even asking, they 
were demanding to know why I was having it and why hadn't I considered 
having something else, this was like just before, you know while I was there and 
they seemed to have absolutely no idea or clue as to my background, why / was 
there and, you know, I was actually having to have it, it wasn't you know, it was 
my choice but I wouldn't have chosen to have it, had I. not had myeloma but 
that was just a very bad experience; and it sort of put me off that hospital and 
I've got to go and have me hips done there". 
Emotional impact associated with waiting for chemotherapy or supportive 
medication on the day of treatment is also common and described in terms of 
frustration and irritation because patients feel that the waiting times are 
sometimes avoidable: 
Bert (P 001) "You have a time set for 9.00 o'clock because the Velcade has a 
half life of only a small amount of time and invariably you sit there for 2 or 3 
hours because the pharmacist can't be bothered to put the stuff together, even 
though they've known that you're coming for weeks in advance and that really is 
unforgivable. The same thing applies equally well where I go in for the 
immunoglobulin infusions. They know I'm coming from one month to the next, 
they know the day, they know that we will be there at 8.00 o'clock in the 
morning because they like us to be in there early and we assist in that respect 
and they are then looking for the doctor to sign off the prescription at ten past 
nine, which is absolutely crazy, it's just down to bad organisation. The way we 
did it, was that we would telephone them at 8.00 o'clock in the morning and they 
would confirm that the blood tests that had been done the previous day, were 
satisfactory for the Velcade to be given. You know, so there's no real excuse 
and it's a ten second injection". 
4.19.2 The analytical story line (Table 14) 
The emotional or psychological impact of treatment is represented in various 
forms. Time and waiting play a significant role especially in relation to response 
and reaction to treatment. Sally (P 018) discussed her experience of being 
confined to a room day after day, unable to concentrate on anything, "grounded" 
because of infection following high dose chemotherapy and stem cell transplant. 
Sally stated that she felt as if she were "going mad". Shirley (F 002) disclosed 
how frightening it felt when her husband was taken off all his current medication 
because of severe liver toxicities. This meant that there was not just the worry 
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of the disease potentially progressing, prophylaxis (preventive medication) was 
also withdrawn and the probability of infection reoccurring was high creating 
feelings of vulnerability, fear and apprehension. Fred's (P 017) emotional 
experience was associated with his medication which caused him to become 
short tempered and agitated stating that he "snaps at people". The physical side 
effects from chemotherapy agents causing neuropathy (numbness) in his 
fingers had resulted in feelings of frustration and angst as Fred was no longer 
able to do his "buttons up". 
Sally (P 018) 
"It was the sensation of, I think the high dosage chemo, because what it did was to make all my 
concentration levels just disappear and it reached the point in the end where I didn't know how I 
was going to get through a day because the day would be in the room, you know, as if I was 
grounded because I was, you know I'd got an infection, so I'd have to be in the room all day and 
I had difficulty in reading, couldn't read. I'd stop... I wanted to listen to my music, couldn't listen 
to that, put on the television and I couldn't concentrate on that until in the end my concentration 
had totally gone and ... My 
last day in hospital, waiting to go home, I was almost out of my head 
waiting for my friend to come and pick me up. I couldn't sit down, I couldn't, I can't explain it, I 
just, it was as though I had gone completely off my rocker. I thought my mind was going. I 
really, really questioned my mentality, because I thought I was going mad ... and 
it stayed with 
me when I got home"... 
Shirley (F 002) 
It was causing you know, toxicity, he's a mystery man as Dr. Brown called him, only the other 
day, you're a bit of a mystery why your liver function... So they said that the Dex', the liver likes 
Dex' and it will relieve the inflammation but it wasn't on this occasion doing this. So of course he 
hits over the 1,000 which was 'their' level and so they (the haematologists) discontinued it. His 
M bands were 10 and he stayed at 10 without any medication at all. They took him off the 
Septrin, the Aciclovir, absolutely everything, with the intent of reintroducing, to see what was 
upsetting his liver function and his liver function improved quite dramatically, all by itself, with no 
other medication so he has been having absolutely nothing. So that's been like living on 
eggshells really, frightened that he'll pick up anything in the way of infection but in point of fact 
he hasn't"... 
Fred (P 017) 
"Well I found I become very much more short tempered. I always prided myself on being pretty, 
kind of, laid back, calm kind of guy really, but I get agitated now and I, and I do believe that is 
the tablets and I snap at people, I can snap at people, and I never, that wasn't me and I don't 
like it, I can tell you. I am aware and I just can't help it. You know I get like ... when me fingers 
are getting a bit funny I even have trouble doing me buttons up and suddenly getting really 
agitated and you know and that, and I had that going back to me first treatment when I was on 
vincristine, because that numbs you, as you know but I seem to be able to cope with it OK then 
but ... oh 
I suppose it, because it's gone on so long now".... 
Table 14 Emotional impact of treatment 
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4.20 The physical impact of treatment 
"Unfortunately the only treatment that we have for patients with cancer in 
general and myeloma in particular is extremely toxic with major side-effects to 
tissues often not affected by the disease itself. This is because the therapy we 
have is very non-specific and attacks normal as well as the cancerous tissue" 
(Marcus in Grummelt 2006: 3) 
4.20.1 The context 
The physical impact of treatment is not the same as the physical impact of the 
disease. The treatment aims to destroy the cancer cells but at the same time 
the chemotherapy agents also target healthy tissue. Side effects can be so 
severe that dose modifications are necessary and consequently the treatment 
becomes less affective. There are newly diagnosed patients who commence 
chemotherapy with very few symptoms if any from the actual disease and find 
the side effects from the medication are creating numerous problems and 
affecting their quality of life. Peripheral neuropathy is a common adverse event 
associated with treatments such as vincristine, bortezomib (velcade) and 
thalidomide. Peripheral neuropathy is also associated with the disease but only 
affects a small percentage of the myeloma population. This side effect may 
have a massive impact on quality of life and may continue long after treatment 
has been discontinued and in some cases is irreversible (Richardson et al 
2006). Participants in this research (n=4) reported permanent damage to 
peripheral nerves affecting their hands and feet induced from medication. The 
following example is a detailed and vivid account of impact on daily living: 
Phil (P 019) "1 have to be very careful that if I stand up I'm not going to fall down 
again, and the other thing is that when I first stand up, I've got to mentally 
collect myself to gain my balance. Once I'm up I'm OK, because I've been 
walking for 58 years and it's a totally automatic response but I do need that 
initial minute or so to get my stability, to get my head round the fact that I can't 
feel a thing, I don't know if I have my shoes on or off. I remember going out to 
get in the car and I was barefoot, I didn't even know it. So I have to be careful 
about stubbing my toes, the same sort of thing problem that diabetics have with 
their circulation problems. Walking upstairs is a challenge because / got no 
feedback and I have to be especially careful about the width of the step 
because on one foot I've got virtually no stability at all. If I'm like near a step I 
have to be really careful that I get my feet all the way to the back just to give me 
the extra stability when I'm standing on the step and taking the next step down, 
and like bumps in the road, kerbs, inclines, I have to use my eyes because my 
feet don't tell me anything. My feet are totally numb; because my hands are 
paff, ! have big problems with my toenails and not because they're toenails but 
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it's the fact that I've got fungal toenails and they're really thick. I have cut them 
before, cut my toes didn't even feel it, but had blood everywhere". 
The high dose melphalan administered as the precursor to the stem cell 
transplant has both short term and long term associated adverse events. The 
usual gastrointestinal toxicities were reported such as nausea, vomiting and 
diarrhoea (short term side effects). A common pattern was a recovery period of 
several months to a year following the stem cell transplant. Fatigue and 
weakness was extremely debilitating and discussed in terms of resting on the 
sofa for a year or not being able to lift the kettle. There is often a reference 
made to the smell of 'sweetcorn' which is the preservative added to the 
harvested stem cells that are prepared for the infusion. Ray Grummett reflects 
on his experience in a hospital lift following his stem cell transplant; the odour 
exuding from his body was so strong that people were "asking what the smell 
was" (Grummett 2006: 36). The next exemplar encompasses common physical 
side effects of high dose melphalan and the psychological impact of the 
'sweetcorn' aroma from the harvested stem cell preservative: 
Dave (P 023) "1 had an autograft (stem cell transplant) and that was bloody 
awful, it really was. An autograft means you start off with some pretty 
unpleasant chemotherapy, melphalan, and that is like being hit with a hammer 
It really makes you feel terrible, makes you feel nauseous, it gives you 
diarrhoea, it just makes you feel... you know it's really not a pleasant 
experience and then the autograft itself, because it makes you smell like sweet 
corn, you know that? I just really hated that and then of course I caught an 
infection afterwards, so I was sitting there sort of on two types of antibiotics 
taking intravenously and so on, and so there I am in a hospital bed, I've got 
fever, I was feeling terrible, I'd got diarrhoea, the sort of diarrhoea when you're 
having to dash to the lavatory by the way and you know you're on a drip so 
you've got to get up and go to the ... and manoeuvre". 
One of the participants spoke of having an allergy to the preservative (not 
uncommon) and how it affected him on the two occasions that he has had a 
transplant. The reaction was instantaneous when the infusion of stem cells 
commenced: 
Bill (P 027) "It's strange and it's instant as soon as they opened the drip and the 
first little bit went in. It started straight away and it felt like putting a weight on 
the chest. 'Oh dear I can't breath' and then that panting for breath so they got 
the old nebulizer, and then more cortisone and more antihistamines and it took 
a long time"... 
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Serious adverse events associated with high dose melphalan such as massive 
internal bleeding where the stomach lining had been destroyed and cardiac 
problems such as atrial flutter were also reported (n=1). Hallucinations 
associated with morphine prescribed for bone pain were experienced by 
participants (n=2) causing one man, for example, to run out of the hospital 
dressed in pyjamas afraid that staff were going to murder him. Bisphosphonates 
such as pamidronate given to treat bone disease and raised calcium levels also 
have numerous potential side effects, one of which is osteonecrosis or 
destruction of bone affecting the jaw (Boonyapakorn et al 2007). One participant 
complained about losing teeth resulting from bone loss in his mouth associated 
with long-term use of pamidronate. 
4.20.2 The analytical story line (Table 15) 
The physical impact of treatment is very prominent in the data and emerges 
frequently. Physical side effects associated with treatment range from minor 
(mild nausea or small skin rash) to severe (massive haemorrhage or deep vein 
thrombosis) and may be temporary, permanent or traumatic (invasive 
procedures such as bone marrow biopsy). Gloria (P 024) described the 
temporary side effects from the high dose melphalan when she started to vomit 
a few days following the stem cell transplant. Gloria was unable to get to the 
toilet because of uncontrollable diarrhoea and had to use a bedpan. Bill (P 027) 
however had permanent peripheral nerve damage resulting from treatment with 
bortezomib (velcade). Walking was difficult because of sensory loss; Bill stated 
"the toes feel like they're not here" and disclosed there were various degrees of 
numbness in his feet, legs and finger tips. Geoff (P 011) referred to the physical 
and psychological trauma of several months of chemotherapy administered 
intravenously involving repeated 'stabs' using a special needle known as a 
trocar and a fine plastic tube or cannula which is inserted and left inside a blood 
vessel usually in the forearm for the duration of an individual administration. 
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Bill (P 027) 
"As you know the Velcade, that really, that's left me almost completely numb. 
I've had to have all tests on that like my feet and leg. I've been back to (named hospital) for 
tests on all that and they said I've got like sensory nerve damage. So I've got... I'd say the tips of 
the hands, me fingers are slightly numb but other than that, I've been lucky with that. It's been 
mainly, it's me toes, the toes feel like they're not there. They're so numb, and the legs, and me 
feet are numb and then going up, it starts to ease off as it gets towards the knees. I can walk 
about a little bit but after a little while my feet, like the underside of my feet, I always feel like I'm 
walking on marbles or golf balls"... 
Geoff (P 011) 
The cannulations got worse. I come out of here with plasters all up my arms and bruises. That's 
what I was worried about, really, this last treatment's gone on for, I had 8 cycles, which probably 
took about 9 months because somewhere along the line I think I had a bit of a delay, and you're 
having needles stuck in you day after day and sometimes if it's in and you have an hour or so 
between your blood test and the treatment starting, you go out and have a cup of tea and come 
back and find its, its come out of the vein and so they try somewhere else, so you're constantly 
being punctured in your arms and so on, you wonder how long they're going to stand up to any 
treatment - so it was a bit of a relief actually to get to the end of the 8 cycles and think oh I'll get 
a break now for a few months hopefully at least". 
Gloria (P 024) 
"You were in the open ward with the other patients when they give you the chemo, the high 
dose of chemo, and when they give you the stem cells. But after a few, after about a week, the 
next week then, you start, you begin to feel this sick symptom, after you have the stem cell, you 
start to have, I start sicking up, you know, I ain't got much to sick up, just water and drink I was 
drinking anyway. You start feeling sick so that's when, as you are going to start, the sickness 
start coming, they move you into a side ward. But on your own because this is when all the 
immune systems is going down low, and you, you ... 
I had diarrhoea for about, I started 
diarrhoea. Think this is when the stem cells ... when they're starting to act and they said the 
chemicals, is what makes you feel sick and the diarrhoea. I was having diarrhoea so then they 
had to bring a bedpan"... 
Table 15 Physical impact of treatment 
4.21 Impact on sexual relationships 
4.21.1 The context 
Disability or altered body image to do with the disease and its treatment can 
have a significant impact on sexuality and sexual relationships. A person may 
be disabled as a result of bone pain, fatigue or may have numerous 
pathological fractures of the ribcage for example. Significant loss in height 
associated with multiple myeloma may seem very unattractive. Rupert (1987) 
for instance was devastated with her altered body image as she gradually 
shrunk in size losing 10 inches from her original height which she likened to the 
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severity of losing a breast. Temporary loss of hair associated with high dose 
chemotherapy and having a bloated appearance due to steroids affects self 
esteem and body image. It is known that chemotherapy and radiotherapy used 
in the treatment of haematological malignancies and other cancers can cause 
injury to reproductive tissue and sexual function (McGrath 2001). There is very 
little in the literature concerning the emotional impact this may have on 
individuals and their partners. 
The very significant issue of impact on sexual relationships surfaced 
spontaneously from four participants. Debs (P 009) sent me an e mail following 
the interview; it was assumed that this was because she was not able to 
disclose her private thoughts to me in the presence of her husband as they had 
been interviewed together. This had been in response to the question 'is there 
anything else you would like to discuss or talk about'? This couple had both, 
individually, communicated by e mail on several occasions and had said that if 
they could think of more to say that they felt was important or they had forgotten 
they would send an e mail in due course. There were two key issues 
mentioned; the first was the physical act of sexual intercourse which had 
become impossible because of the excruciating pain due to multiple lytic lesions 
in the pelvis and fractured hips. The other issue was associated with high dose 
therapy potentially causing infertility through premature onset of menopause: 
(Debs P 009) "1 would have had a very different 18 months if my hips hadn't 
broken for a start, but they did, and that meant that I have not had sex with my 
husband in all that time and i am probably starting the menopause because of 
the high dose melphalan". 
4.21.2 The analytical story line (Table 16) 
When people are no longer able to fulfil their sexual desires or needs this has a 
substantial impact on their lives and that of their partners. Sex is an important 
part of living but a difficult topic for people to discuss; consequently it is an area 
that has been largely neglected in the literature. In this research it appeared that 
individuals wanted and needed to talk about sexual problems. The opportunity 
to discuss the subject privately on a one to one basis was not always an option 
because of the presence of others. When interviewing couples, it transpired that 
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one person wanted to discuss the topic while the other was too embarrassed. 
One man had a penile tumour and was distraught at the prospect of not being 
able to satisfy his wife. This was a monumental issue which dominated the 
interview as it was a subject Mike (P 040) kept returning to. Mike's main 
concern was the impact this had on his wife and their marriage, which 
manifested itself through him as constant mental torture and anguish. 
Participants are aware that the cause of disruption in sexual relationships or 
sexual activity may be associated with the disease and/or the treatment for the 
disease. In order to come to terms with this 'loss' there is the tendency to avoid 
talking about it and therefore avoid dealing with the problem. Frank (P 007), for 
instance, maintained that sex was no longer a concern and that he tended "to 
focus on other things" implying the need to fill the sexual gap in his life. 
Mike (P 040) 
"There is difficulties in my life because one time, you know, I find that, you know, my penis had, 
you know, it had a swelling in the middle of it and then again, you know, I told the doctors and 
they reckon it's the illness caused this, so there was a breakage in my penis and it became, say 
may be a quarter of what it was, you know, it became smaller, shorter. The erection of my penis 
has changed and so yeah my life in that part changed completely because my wife and I didn't 
use that, you know, we never have contact in that, in that like area. It is a big issue and a big, 
and a big loss in a marriage really, you know. I mean most, most of the time my wife will say 
, Well that's not the only thing that we're married for really', which, it is great to hear your, your 
wife saying that"... 
Phil (P 019) 
"I went to my GP and he said yeah it's a bit swollen so then I started going to not proctologist 
what are they called? What are the prostate people? It's part of the urinary specialists ... yeah, 
urologists, I went to the urologists and I was on this medication for about six months and I had 
all these flow tests and stuff like that you know like how loud can you make the tin sound when 
you're weeing into it, or whatever it is, you know and they stopped the medication, but anyway 
but all throughout this time, I couldn't have any sex, I mean physically couldn't, you know I had 
an erectile dysfunction thing, which I now, I still have and so I just don't know how much of that 
is cross related to my treatment or my condition or, or anything like that but so, that's the only 
thing really I suppose"... 
Frank (P 007) 
Well I, lets face it, I lost a testicle. I had, you know, an orchidectomy, the right testicle was 
removed and that was years ago. I've got the diabetes as well, so all in all I'm completely 
impotent. I can't, I've no sexual arousal anymore and that's something I've come to terms with, 
it doesn't bother me anymore. As a young man, I performed well, we've got three children, we 
had a good compatible sexual life, Mary and myself. Our sexual needs were pretty well similar, 
you know. Neither one, nor the other had a sort of a rampaging libido, we were absolutely 
normal in that respect, a couple of times a week perhaps. Now I haven't had sex properly for I 
guess ten years I don't know what it is but as the years go by you tend to focus on other things. 
Table 16 Impact on sexual relationships 
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4.22 Impact on family life 
"Having Ben (son) around has made things so much better for us to cope with 
everything as you don't get time to dwell on things. He is so full of life. But 
constantly feel terrible for the fact that he will never be able to have a brother or 
sister. Also not knowing whether I will be around to be there with him growing 
up" (Debs P 009). 
4.22.1 The context 
The emotional impact on the family at the time of diagnosis is catastrophic. 
Informing family members that a loved one has cancer is extremely upsetting. 
Informing someone that they have an incurable cancer is also devastating for 
the individual and the family. The uncertainty of not knowing how long 
individuals will survive with this cancer means that people are living in 
disharmony (Contention) and are often in a state of feeling 'ill at ease' or 
unsettled frequently described as 'living on the edge'. People living with the 
disease for several years experiencing numerous periods of relapse and 
remission (stable disease) are acutely aware of the potential outcome. They 
become disillusioned with the knowledge that treatment is not always beneficial 
and can cause very unpleasant side effects. The following family member spoke 
in terms of living with a 'bomb' ticking and "living on a knife edge": 
Sylvia (P 028) "It's a ticking thing. Explosion! You're living on a knife edge; 
you're waiting for blood tests; you're saying oh please God don't let it start 
rising, the paraproteins, because you know if it starts to rise there's going to be 
more heavy treatment. So every month when we have to go and have blood 
tests you sit and wait for the results, hoping and praying that it's never going to 
like start to rise again. When he had his transplant, the first transplant for a few 
years it was lovely, you'd wait for the blood tests and they was always low but 
then two years ago it started to rise again and that started all over again. You 
know what that's like, well it's horrible because you know what's coming, the 
transplant, all the treatment, chemotherapy, the trials that don't work but you've 
got to try them you know because one day please God it will work. It is like 
living on a knife edge all the time". 
Hospital appointments and prolonged treatment regimes impact on family life 
and normal routines. For example, arrangements must be made to take the 
children to and from school; the shopping, washing and other domestic 
household chores must be attended to. Difficulties arise particularly when 
couples are working or have additional commitments. Families may suddenly 
realise that they cannot plan ahead: 
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Carol (F 012) "Well it's just uncertainty, isn't it really You just can't, you know all 
the women / work with go out two times a year and all the rest of it. You just 
sometimes think to yourself and then they moan and groan about this that and 
the other. I sometimes think you don't realise how lucky you are just to be able 
to plan these sort of things. Well / don't think it i say it. You don't realise how 
lucky you are to just be able to plan these things. / think that's the thing, when 
this first happened, you kind of spend the first 6 months or so just thinking /just 
want my life back, just want the life / had, you don't realise how good the life 
you had was". 
Family life may alter significantly in various ways because of the onset of 
illness, disability and numerous periods of relapse requiring further 
chemotherapy. Change in domestic roles in the home where a son or daughter 
take on the cooking and housework when a mother is unable; a husband may 
take on the washing and preparation of meals or a wife might take on the 
chores her husband usually took responsibility for such as sorting out the bills or 
changing a light bulb when their prospective partners are incapacitated because 
of illness: 
Alice (P 033) `By that time around six or so, the children, they come in from 
work, so then you know you've got company and all like that. Then my husband 
is there, or he's in the kitchen cooking. He's in the kitchen or sometimes he's in 
the garden, or anything like that, you know. He do the washing. / can go into 
the thing and switch on the washing machine, or anything like that, where they 
put the clothes in, and I would switch on but I can't reach the line to hang 
clothes on"... 
Family members may alter their working patterns or take time off to be with their 
loved ones who are unwell or having to undergo cycles of chemotherapy or 
other hospital procedures. In some cases relatives will put their social lives on 
hold allowing them to be available and provide the support needed at any given 
time. Although not all families and close relatives live in proximity to one another 
or are able to provide emotional support or practical help such as taking care of 
young children: 
Stella (F 013) "I took unpaid leave because although I only worked three days a 
week and I would have needed just nine days, which 1 could have done with 
flexi' and that. They didn't want me to do it flexibly, so I took it unpaid and I just 
looked after Ben and took him in every day, you know to the hospital and then 
when Debs had this man's stem cells we took Ben on holiday to France, which 
was very brave of Debs. I mean / had mixed feelings, I wanted to go with Ben 
but I didn't want to leave Debs but she booked it and made us do it". 
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4.22.2 The analytical story line (Table 17) 
Family members do not always see or recognise the severity of a loved one's 
condition especially when they are in close and continuous contact. Although 
Marian (F 016) was able to recognise that her mother had deteriorated 
significantly using her nursing experience and professional judgement, she was 
not able to convey her true opinion and admit this to other members of her 
family. Psychological distress appears to be prolonged and intensified for family 
members particularly during advanced stages of cancer (Dumont et al 2006). 
Marian's family coped with a difficult situation through a "conspiracy of silence" 
(Brennan 2004: 100) to protect one another from further distress by attempting 
to minimize the seriousness of the illness (Smith and Cox 2007). Other families 
recognise the severity of the situation however not all have the luxury of time 
which allows them to come to terms with the illness and what is happening to 
them. Jack (P 014) was able to talk openly with his wife and family members 
and continue to make realistic plans such as moving nearer to relatives where 
his wife and child would be supported emotionally following his imminent death. 
The timing of the cancer emerging in relation to age and family circumstances 
may have a significant bearing on the lives of those involved. Impact on family 
life and domestic upheaval is exacerbated particularly in families who have 
young children for example. Loss of identity as a parent and being unable to lift 
up a child can have a massive impact on individuals causing high levels of 
anxiety and frustration. 
The healthcare professional's perspective Jill (HCP 036) highlights the ongoing 
and aggressive nature of the cancer and the difficulties families face because of 
the unpredictability of the disease. The cancer is viewed in terms of a `time 
bomb' reflecting the numerous periods of remission (stable disease) and 
relapse eventually leading to refractory disease, terminal stages of cancer and 
death. 
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Marian (F 016) Bereaved daughter 
"When she was close to being discharged and her last discharge my aunt had come over from 
Ireland and you know our aunt's a kind of one of the matriarchs of the family and I really wanted 
her to come because I knew that mum was really quite sick and I wanted her to be there and 
she walked in to the room and you know, she just burst into tears because mum looked so awful 
... and we couldn't almost see, you 
know you couldn't always see it as the family because she 
was skeletal and she just looked like a dying cancer patient but she looked like a dying cancer 
patient from quite early on. Well, you know my family were always, they didn't always see that, 
they would just see that, they always looked to me as well to.. if I said mum was feeling, getting 
better they'd think, they'd believe that, which is fine"... 
Jack (P 014) Penny's (F 015) Husband 
"May be we would another child, may be we would have - you know, all the maybes, all the 
things we might have done, aren't going to happen so you just roll with the punches, you know. 
Things were looking really quite good, Penny's job's going well, everything was going well. So it 
couldn't have come, really at a worse time. Nathan had just been born, he was four months old, 
and I couldn't take care of him, I couldn't help take care - and all the way through his growing 
up there have been times where I haven't been able to help take care of him, or lift him up, and 
often when I have been able to I can't lift him up now because he is such a big boy but that's 
been enormously frustrating. So there's finance, there's the raising the children, there's 
obviously been, you know, just in terms of a relationship, when one partner is ill, that puts a 
strain on the relationship as well, and then there's the yeah, the money worries too". 
Nurse Jill (HCP 036) 
"Pre-treatment to end stage so that's a funny time with their ongoing treatment and it's fairly 
difficult for these patients and families because of all the symptoms and things I've just sort of 
talked about. They can be, they are ill for a long period of time and they're not ever going to get 
better or not ever going to be cured, so that has a big psychological impact on these patients 
and families living with this disease, which is a bit of a, time bomb if you like. .. and the ups and downs emotionally for them with plateau phases and then proteins going up again and the 
anxiety of going to hospital appointments after they've had blood tests, what's it going be? 
and... it just takes over their life really". 
Table 17 Impact on family life 
4.23 Summary 
`Impact on life' introduced above was the third of four main categories which are 
closely linked to the core category of contention. The final of the four main 
categories to be addressed is 'Supportive care needs' which is related to 
`Impact on life'. It is hypothesised that understanding the impact of multiple 
myeloma will help to determine the specific supportive care needs of individuals 
and that of their families. 
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4.24 Supportive care needs 
"I don't think that they (healthcare professionals) think about the families too 
much, the social service part of it and, what they have to go through. That 
sounds very selfish but just to have somebody. . .a counsellor that actually has the logistical, practical information to help people to arrange their lives around 
the disease, that would be really helpful" (Penny F 015). 
4.24.1 Introduction 
Supportive care is defined as an `umbrella' term for all services that may be 
required by patients with cancer and their families at any given point in time 
before (pre-diagnosis stage), during the illness trajectory and following, the 
outcome of which may be cure or death and bereavement (NICE 2004). Table 
18 includes a list of supportive care strategies and services recommended by 
NICE (2004) towards improving supportive and palliative care for people with 
cancer acknowledging the vast disparity in the quality of care throughout the 
UK. 
SUPPORTIVE CARE 
" Self help and support 
" User involvement 
" Information giving 
" Psychological support 
" Social support 
" Rehabilitation 
" Complementary therapies 
" Spiritual support 
" Palliative care (Symptom control) 
" End-of-life and bereavement care 
Table 18 Strategies and supportive care services (NICE 2004) 
Supportive care needs emerged as a main category encompassing numerous 
ongoing problems and difficulties associated with accessing of services. Some 
problems were associated with the rarity of multiple myeloma and lack of 
knowledge relating to the disease. Difficulties experienced by some participants 
however could apply to people being treated for other cancers, for example, 
struggling to complete a lengthy and complicated DHSS application form for 
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incapacity benefit when feeling extremely unwell (Grummett 2006). The 
subcategories of 'Supportive care needs' include 'invisible struggle', 'impact of 
policy and 'decision making'. 
4.25 Invisible struggle 
4.25.1 The context 
Invisible struggle refers to difficulties or problems encountered by patients and 
their family members unseen by the healthcare professionals. Doctors and 
nurses working in a chemotherapy day care unit for instance tend to focus on 
patients' immediate physical needs and might not be aware that the journey to 
the hospital was horrendous or finding a parking space created additional 
stress. Healthcare professionals may or may not be aware of difficulties relating 
to other aspects of peoples' lives. It is not uncommon for healthcare 
professionals to ask patients questions in non-specific ways such as "how are 
things? " or "how are you getting on? " thus it is often assumed the healthcare 
professional is referring specifically to their illness or treatment. The patient and 
family may not perceive the role of nurses or doctors as people who are in 
positions to help with any problems or concerns pertaining to their situation 
outside the hospital environment. Patients may not want to disclose financial 
worries for example with the doctor during a consultation because they may not 
think that the doctor is able to assist them or offer advice except in medical 
matters. The following statement emphasises the importance of appropriate 
assessment and asking the right question: 
Karen (HCP 022) "1 have seen some of these patients, I will have seen, on 
several occasions, and I've not really picked up that there's a particular 
problem, and it's only when they actually, so I don't think you know, even with 
the fact that you know I'm a trained ... psychologist that you can so easily miss 
what is going on in people's lives unless you ask questions specifically, looking 
at that but we actually just assume it is all OK" ... 
People living with multiple myeloma and participating in clinical trials may travel 
to hospitals much further away from their homes in order to access treatment 
regimes involving novel chemotherapy agents that would not be available to 
them locally. In the present research some people struggled with the trips to 
and from the hospital for treatment. Others perceived it was imperative that they 
169 
were transferred to a hospital that specialised in cancer care regardless of how 
far away the hospital was: 
Carol (F 012) "I used to live near the Royal Marsden you know you've got to get 
somewhere like that, you've got to get to a cancer.. . centre of excellence or, you know somewhere where there's going to be the new drugs". 
Distance was not an issue for all and despite the fact that some of the 
participants lived within a short distance to the hospital where they were 
receiving treatment, the journey was problematic because of disability. Practical 
considerations concerning others especially when family members 
accompanied a young child created further difficulties and anxiety trying to find 
somewhere to park the car. Limited parking around the hospital and the costs 
involved were a constant source of worry. Patients generally do not want to wait 
around for hospital transport particularly when they are immunodeficient and 
therefore feeling vulnerable to infection: 
Debs (P 009) "The practicalities of getting to and from the hospital have proved 
to be one of the most difficult things. It's something that no one gives you 
information on, you have to work out for yourself and it doesn't just affect the 
patient, it effects the visitors too, for example getting Ben in to see me when I'm 
in. There is limited parking at (named hospital) and its quite costly, plus the 
congestion charge, it all adds up if you are coming up every day. I was having 
to do that too on my first course of chemo coming up 2 or 3 times a week, not 
knowing exactly how long we are going to be in the hospital, so someone has to 
keep going out to either move the car or put more money in the meter. it's just 
another thing making life more difficult than it already is. I'm aware that there is 
a hospital transport system in operation if you wait for a minibus but it can only 
support a small number of users and hospital waiting rooms are not the place to 
be when you have little or no immune system. The same goes for public 
transport which still has some way to go before the disabled can comfortably 
assume that they may enter or exit at any given stop". 
4.25.2 The analytical story line (Table 19) 
Attempting to access supportive care services particularly when dealing with the 
DHSS has appeared to be problematic and stressful for many of the 
participants. Sylvia (F 028) was unable to convince the people at the DHSS 
office that her husband was extremely ill and incapacitated when applying for 
financial assistance. The evidence suggests that the staff at the DHSS had not 
heard of multiple myeloma and would therefore not be aware of the impact, the 
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consequences or the outcome of the disease. People are not always aware of 
the benefits or allowances that are available to them. Victor (P 030), for 
example, had only been in the UK for four years and was unfamiliar with the 
healthcare system and social services. Not knowing what to do, Victor was 
relying on the healthcare professionals to anticipate his needs. Fortunately he 
had access to the internet and was able to search for the information he 
required. 
Insurance companies have been criticised for misleading consumers and 
suddenly withdrawing cover from patients with cancer at the most vulnerable 
time (CancerBACUP 2004). The decision to `pull the plug' regarding insurance 
cover appears to be activated when the condition is defined as chronic, 
treatment has failed or the illness is terminal (Pallot 2004). Phil's (P 019) 
permanent health insurance cover became invalid following his stem cell 
transplant treatment provided at the expense of the NHS. The support, which 
Phil had received such as help to clean his house, was no longer there at a time 
when he was feeling extremely fatigued and unwell coping on his own at home 
following discharge from hospital. 
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Sylvia (F 028) Bill's (P 027) wife 
"Nine months it took with me fighting and rowing with people to get financial help and thank God 
we did have our family. Our mortgage was protected for a year so I knew I was alright with the 
mortgage but it was everything else, council tax, all the different bills. I knew we were getting 
more and more into debt but as I say we had a good family who were helping us out but the 
fight with Social Security because they just well you know you've got this illness, it's too bad, 
they were always pressing him because he was so young in his early 40s and they were looking 
in books for Myeloma and they mentioned 60s and 70s and they would question well have you 
really got it you know? They didn't believe us at the beginning. I didn't really know anything and 
I would look at a text book and when you look in the text book its all 60s and 70 year olds. Even 
today the 'Bacup Book', they need to update them sort of books because younger people are 
getting it. They weren't really concerned and when you're getting more and more into debt" . 
Victor (P 030) 
"You see I don't know the system. I was hoping somebody would tell me what to do and what is 
necessary. I did search a few things but ... I haven't heard anything. I've just been trying to do things on my own. I applied for housing benefit, ... and I applied to my local council the 
Borough 
of Waltham Forest, that's where I am and I've tried that, I've sent that. That, well, they're waiting 
for some information, from me and my daughter. I've tried to apply for incapacity. I cannot get 
incapacity because my workplace is to give me statutory sick pay. I've had some problems with 
my workplace, they've been sending me a lot of... they've been stressing me out and I just 
decided, well I wasn't going to deal with them. They're stressing me out. They're sending me 
letters, the company that I work with, they're supposed to be a big company but the way they 
treat staff, is like, well they're like dirt we're not, we're not cherish' - we're not, you know... not 
valued". 
Phil (P 019) 
"The biggest change as well I suppose was, once I had the stem cell treatment, my permanent 
health insurance no longer covered me, for multiple myeloma, for anything to do with multiple 
myeloma - because prior to that, they were meeting my travel expenses to London, they paid 
for a gardener, they paid for my house cleaning and stuff like that, not that I used them very 
much but you know like I paid my daughter to clean my house and I sent them a bill and they 
paid it and I had someone do my gardening and they did, they covered all my expenses to here 
(hospital). Any transplant, this was Cigna (Health Insurance Company), any transplant, of any 
sort, immediately invalidates the cover for that disease or condition, that's just part of their 
insurance policy". 
Table 19 Invisible struggle 
4.26 Impact of policy 
4.26.1 The context 
During the course of this research participants became aware of the decision 
taken by NICE to withdraw the availability of bortezomib (velcade) causing a 
great deal of controversy, alarm and anguish. The reason given was that the 
treatment was not considered cost effective. Bortezomib (velcade) was however 
available in Scotland, Wales and Northern Island within the NHS (Martin 2007). 
Following a well supported campaign led by the Myeloma UK and other cancer 
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charitable organisations such as CancerBACUP, Leukaemia Care Society and 
Cancer Research UK, which were instrumental towards a successful appeal, a 
final appraisal report (July NICE 2007) stated the medication would be available 
on the NHS for patients in England and Wales following first relapse, having 
received one prior therapy. This meant that the medication was not going to be 
an option for patients who had relapsed more than once which was 
disappointing and misleading when the preliminary recommendations in June 
(NICE 2007: 1.1, www. nice. org. uk) had raised hopes by stating: 
"Bortezomib monotherapy is recommended as an option for the treatment of 
progressive multiple myeloma in people who have received at least one prior 
therapy and who have undergone, or are unsuitable for, bone marrow 
transplantation".. 
The consequences of changing the wording from "people who have received at 
least one prior therapy" to "people following first relapse" and quantifying this 
statement with "having received one prior therapy" resulted in a massive 
psychological blow for many people living with the disease particularly those 
patients who have had more than one line of therapy: 
Sally (P 018) "This change has radically affected the treatment that I can now 
expect from my clinicians in that velcade will not be available to me. / believe 
that NICE have used ambiguous language that did not state clearly what they 
meant to say/didn't mean to say. This is unacceptable from a body working in 
the public domain and particularly with vulnerable myeloma patients who had 
their hopes raised in June only to be completely shattered noW". 
4.26.2 The analytical story line (Table 20) 
The impact of policy decisions that may determine whether or not a drug is 
made available that can potentially extend life, on the grounds of whether or not 
it is considered financially viable, may have devastating consequences for 
patients with incurable progressive diseases like multiple myeloma. The NHS 
has been legally bound to provide the finance and resources for treatments 
recommended by NICE in England and Wales since 2002. The NHS was 
originally set up in 1948 to provide free healthcare for all and the argument 
today appears to rest on the area in which people live and a form of 
rationalisation dependent on cost effectiveness (McVie 2003). Participants 
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appeared upset and angry at recommendations produced by NICE which meant 
that many of them would not have access to bortezomib (velcade) within the 
NHS that could potentially prolong their lives. 
Dave (P 023) 
"We got this business with Velcade, you know Velcade, where NICE have decided that if you 
want it, you've got to go to Scotland. I mean what's going on here? This is absolutely absurd, I 
mean the thing is, it's used for treatment of myeloma, pretty much across the entire rest of the 
world, except for England and Wales and NICE as, as a body-who are these people? What 
are they in this authority? They are an absolutely black hole as far as information is concerned. 
They just issued this pronouncement and obviously as you're well aware the doctors are spitting 
nails about it, they're absolutely furious about it because of the absurdity of it, and if NICE had 
trotted out, said this is why, this is the statistical information that we have used to arrive at this, 
you know, you form a press release, absolute absurdity. I'm beginning to think who these 
clowns actually are because I haven't much time for them". 
Carol (F 012) Geoff's (P 011) wife 
"The whole drug's thing is a worry as well really. I mean I'd hate to think you weren't getting, 
within the NHS, what you should get, because of cost. You read an article that said this, what 
was it they were going to licence that might be to the detriment of Velcade? (addressing Geoff) 
It's the breast cancer one. You know, it wouldn't be available, because Health Authorities can't 
afford it and the whole thing, working in a GP's surgery, very small compared to this but you stillrealise 
what a massive waste of money there is in drugs across the board and then people can't 
get drugs that are going to save their lives. You know, it's just horrendous I think in the NHS. I 
don't know what the answer is, it's too big. I don't know but it's a worry because you think well 
supposing you did need something and somebody deemed it too expensive to be available and 
you can only get it on some kind of a drug trial, which is another reason for being somewhere 
like this". 
Nurse Karen (HCP 022) 
"It is very difficult because of all the Velcade issue, in that patients, you know, we had two 
patients yesterday in clinic who were saying my disease is relapsing slowly now, I don't need 
treatment now because it's only coming back slowly ... but if I wait 
for three months when I 
need treatment, I'm not going to have Velcade, should I have my treatment now, even though I 
don't need it, and so they're very much of the awareness that actually in three months time is 
there going to be any treatment option for them because they've done all the others, there's 
only Velcade, and then thalidomide, which we won't be able to have from this Trust, if NICE turn 
down Velcade, because they're not allowed to have planning for thalidomide, and those patients. 
are being aware that actually there are drugs out there that could treat them and they can't have 
them" ... 1 
Table 20 The impact of policy 
4.27 Decision making 
4.27.1 The context 
'Contention' in decision-making, relates to the difficulties patients have when 
confronted with the process of making decisions particularly concerning 
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treatment options. Some patients do not want this responsibility, while others 
find their decision making capabilities are weakened as a result of feeling 
overwhelmed with a vast quantity of information especially when newly 
diagnosed. 'Contention' also appears in the form of ethical dilemmas facing the 
healthcare professional aware that some patients are being influenced by 
making certain treatment options appear more advantageous than other 
available options: 
Nurse Karen (HCP 022) "There are some patients who quite categorically right 
up front say 7 don't want to make a decision doctor, you're the doctor, I want 
you to decide, I will do whatever you say', and whatever information you give 
them, they are only ever going to come back to you and say what do you think 
is best doctor and that's what they'll do. You have other patients who want to 
know everything, and will go and research it and who will, you know you'll have 
gone through all the trial options or the other options and giving them lots of 
information and they'll go off and research it and three weeks later they'll still be 
trying to make up this decision because they've got so much information. But 
I'm also aware actually that we have a huge amount of power and that you can 
get patients to do, depending on how you word it, you can get them to do what 
you want almost. So if you want somebody to go into the trial, if you make the 
other options seem less attractive then you can get them to go into the trial. I 
find that quite scary, that you know, that people are not always given entirely all 
the information". 
The issue of power and control regarding decision making and influencing 
patients by suggesting that a particular treatment is, in the healthcare 
professional's opinion, the best option available was further explored as follows: 
R: Have you been present when a suggestion has been made, by say a 
consultant when they're influencing or encouraging patients towards a particular 
treatment, for example, a clinical trial? 
Maura (HCP 037) Yes, / suppose we do, I mean with drugs like Revlimid 
because it's so expensive and the PCT's aren't funding it. We have got a trial 
going on at the moment and so we are saying to patients, well OK we'll apply to 
the PCT's for Revlimid but / don't think we're going to get it but there is this trial 
you can go into and that's, and basically that's the only way you're going to get 
Revlimid. 
Major decisions associated with the illness/treatment that have impacted on the 
entire family creating emotional upheaval or trauma has been elucidated. 
Examples that emerged from the data include Deb's (P 009) termination of 
pregnancy, Jack (P 014) and Penny's (F 015) planned move to Canada from 
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the UK for much needed family support during advanced stages of the disease 
and Alf's (F 004) deliberate attempt to protect his wife from the knowledge that 
she would probably not survive for more than five years. Coping with practical 
day to day situations such as avoiding contact with others who could potentially 
infect an individual who was susceptible because of immunodeficiency was 
dealt with by travelling at off peak times and instructing family members not to 
visit if they had colds. For example Sylvia (F 028) commented "We live in a 
bubble. To build him up I won't let them, no, like I say, obviously you know, but 
if they've got the slightest sniffle ... they 
don't come in". 
Making decisions regarding travelling and taking holidays proved problematic 
for many of the participants. Travel by air, for example is not recommended 
because of the confined space and lack of ventilation on aircrafts; the 
probability of becoming infected, therefore, is relatively high. Suggestions that 
passengers are exposed to contaminated air during flights and pilots 
experiencing ill effects from exposure to fumes (Barnett 2006) have led to the 
commissioning of a "Cabin Air Sampling Study Functionality Test" by the 
Department of Transport (Muir et al 2008): 
Bert (P 001) It is frustration more than anything. Not being able to fly because 
of the chances of infection in the aircraft are quite high and that means that 
going on holiday, or travelling out of the country is prohibited except, unless you 
go by boat. It's the circulation or re-circulation of the air in the aircraft. That's 
where the problem lies, and also the reduced oxygen levels. 
4.27.2 The analytical story line (Table 21) 
There are three distinct groups represented here (Table 21). Firstly the minority 
of participants in this research (n=3) deliberately chose not to study the disease 
and the management of the illness. Like Maurice (P 025) they distanced 
themselves from any control or decision-making and were fully compliant 
allowing the healthcare professionals to take charge. Secondly the majority of 
participants became knowledgeable about the disease and available 
treatments, had access to the internet, kept themselves well informed and were 
able to make well informed decisions like Shirley and Bert were able to do. The 
third group are at the novice stage and are thus inexperienced patients who are 
not yet able to understand enough to be able to make an informed decision. It is 
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not surprising that the consultant is viewed as the expert and therefore is the 
appropriate person to decide that which is best for the patient in these 
circumstances. From the healthcare professional's perspective, there is a moral 
and ethical duty to give the patient and family members all the information 
available in order for them to make informed choices and understand decisions 
that are made. 
Maurice (P 025) 
"I know it was something to do with, with my bones and my bloods but ... all I did was I just go 
for my treatment and as I say, it was a, it might sound funny and strange but I didn't think it was 
such a problem, you know. I don't know, I don't know really. As I say, even though the 
treatment was working and ... 
I don't know it was, it's very hard to describe isn't it. Even, even 
though I don't understand why ... I 
didn't think that I got it but I would go for the treatment, 
whatever they would say I would do ... so that's, that's the way I've been for, over the years I 
think. It might sound strange and funny but ... that's the way 
it is". 
Shirley (F 002) 
"We've got the time to do a lunchtime break. Say right we'll meet for lunch or meet down at 
another little place we go to and we can make 2 or 3 hours of it. Do you know what I mean or 
come back and have a cup of coffee and there's no rush ... 
but 
... you 
know, we would like to 
be busier, wouldn't we, we would like to do a lot more travelling, which is what we had planned 
to do and that's. John (consultant haematologist) said no last year when Bert's paraproteins 
went up, he said we were going to have to cancel those cruises - and I said well what about the 
second one because that was 3 months ahead, he said no and he really wanted us to go into 
the trial just as you were leaving. He would have liked to and we said no we didn't want to 
come up to London again if we could avoid it. We decided that if this was crunch time, we 
wanted to be at home and enjoy more of at home, you know". 
Nurse Claire (HCP 038) 
"They've come to Harry (consultant haematologist) to start treatment and he talks to them, 'Well 
we can do this, we can do that but there's a third way' and you just tell me what you want me to 
have and one or two people have actually got quite angry and they've said 'I don't know, you 
know, you tell me what I should have'. I think sometimes and it's important to give choice, so 
people can go away and make their own decisions. I'm not saying that isn't but some people, 
people just, they just want to, 'Please tell me what is the best road and I will go down it' and I 
can see where they're coming from and I think in this day and age particularly with the Myeloma 
Nine Trial. So you tell people about that, the do's and the don'ts de-de-de-de and you give them 
a whole wedge of info' and then you say Oh there is another way you can go down here or you 
can do this. You can have it here with us, or you can go to your local hospital and you can just, 
and I'm thinking, ah, and you feel for them, I absolutely feel for them". 
Table 21 Decision-making 
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4.28 Summary 
This chapter introduced the core category, main categories and subcategories 
representing the findings of this research within a framework of contextual and 
analytical story lines. 'Supportive care needs' was the fourth and final main 
category to be addressed comprising of three subcategories called 'invisible 
struggle', 'impact of policy makers' and 'decision making'. The core category 
'Contention' is closely related to 'ways of communication', 'nature of disease', 
'impact on life' and 'supportive care needs' which represent all four of the main 
categories mentioned in this chapter and shown in Figure 5. Contention is 
defined as struggle, battle, disruption and disharmony. These defining 
characteristics appear to be present during a life crisis such as relapse or 
disease progression in multiple myeloma. 
Contention is linked to the rarity, complexity and unpredictability of the disease. 
Through ways of communication, for example, Contention arises for newly 
diagnosed patients and their families because of lack of understanding, shock, 
struggling with complex terminology and a cancer that many are unfamiliar with 
or have not heard of before. From the GP's perspective there is the struggle of 
detecting the disease because of its non-specific onset and the fact that it is 
uncommon. From the patient and family perspective repeated visits to the GP, 
addressed previously, epitomizes the concept of Contention. The model shown 
in Figure 6 conceptualises the existence of Contention (core category) and the 
relationship with the categories and participant groups. The cell metaphor 
appearance represents fluidity as the environment is constantly changing as is 
the nature of the cancer, multiple myeloma, itself. It is unstable and 
inconsistent. The outer irregular membranous layer represents the erratic and 
continued pathway of numerous and ongoing periods of relapse and remission 
(stable disease) characteristic of multiple myeloma. 
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Figure 6 Diagrammatic representation of the core category Contention, main 
categories and subcategories within the context of multiple myleoma. 
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Chapter 5 follows with a discussion of these findings and the rudiments of the 
generated theory of Contention. 
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Chapter S. Discussion 
5.1 Introduction 
Chapter 4 presented the findings establishing the foundation for the theory of 
Contention. The core category Contention emerged throughout the data 
identified by frequency of occurrence, explanatory power and close affiliation to 
the four main categories (Strauss and Corbin 1998), 'ways of communication', 
'nature of disease', 'impact on life' and 'supportive care needs'. The concept 
analysis presented in this chapter (5.3) aims to provide a theoretical definition of 
the core category Contention. The purpose of a concept analysis according to 
Walker and Avant (2005: 64) is: 
,, To distinguish the likeness and unlikeness between concepts. By breaking a 
concept into its simpler elements, it is easier to determine its internal structure" 
The name given to the core category is adequately abstract to enable it to be 
used in research in other substantive areas so that it can be developed into a 
more general theory (Strauss and Corbin 1998). There are four suggested 
requisites, which can be used as criteria to evaluate applicability of grounded 
theory to practical situations such as clinical nursing practice. The theory should 
fit the substantive field, be comprehensible, applicable to a variety of situations 
and be flexible in its utility allowing for modifications when necessary (Glaser 
and Strauss 1967). 
This chapter aims to demonstrate how the theory generated from this research 
contributes to the body of existing knowledge. Furthermore it is hypothesized 
that an increased understanding in relation to the impact of this incurable and 
progressive cancer will help to determine the specific supportive care needs of 
individuals concerned throughout the illness trajectory. The core category is 
now discussed within the confines of the findings and within the body of existing 
literature and current policy. Firstly metaphorical sense of meaning' is 
addressed, followed by the concept analysis of 'Contention' in multiple myeloma 
and its relationship to other chronic or progressive illnesses. Contention in 
communication, Contention in the nature of the disease, Contention in its impact 
on life and Contention within supportive care needs are discussed. Limitations 
of the research are also acknowledged. Finally the chapter concludes with 
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working towards a model of supportive care, summary and emerging overall 
theory. 
5.2 Metaphorical sense of meaning 
The aim of using the chosen methodology for this research was to generate 
theory in an area where limited qualitative research had been undertaken. Thus 
it was identified as an area of insufficient knowledge and understanding 
particularly from the patient and family perspective. The theory that emerged 
from the data should be a true reflection of 'reality' (Strauss and Corbin 1998). 
Some discussion on the use of metaphors found in the data is pertinent in order 
to clarify meaning of the core category Contention and how it relates to the 
participants' experiences. The use of metaphorical language enables individuals 
to articulate experiences, which they find difficult to otherwise explain. Using 
metaphors is utilization of an alternative phrase, which closely resembles the 
'unexplained' literal meaning (Lupton 2003). The fundamental issue here is 
communicating in a way that patients and healthcare professionals can both 
understand providing 'common' ground (Penson et al 2004). Contention is 
defined in Webster's Revised Unabridged Dictionary (1998,1996) as a violent 
effort or struggle to obtain, or resist, contest; strife and is synonymous with the 
following: struggle; strife; contest; quarrel; combat; conflict; feud; litigation; 
controversy; dissension; variance; disagreement; debate; competition; 
emulation. 
In relation to metaphors the following is instructive. From Florence Nightingale's 
endeavours during the Crimean war in British military hospitals the modem 
nursing profession has advanced from military metaphors of its historical 
origins. Winslow (1984) argued that nursing was at one time portrayed as part 
of a battle force against disease and the position held demanded obedience 
and loyalty to the higher rank of physician. The military metaphor in this context 
had been superseded by that of the advocacy metaphor strengthening the 
advancement of nursing as a profession in its own right (Winslow 1984). 
Arguments against the rhetorical use of metaphorical language in relation to 
illness are aimed at demythologizing and demystifying irrational beliefs from the 
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past (Sontag 1991). Using metaphorical discourse in illness and nursing is 
criticized as having a "two-edged sword" suggesting ambiguity (Czechmeister 
1994). Metaphors may elucidate patients' experiences on one hand, while on 
the other may provoke negative ramifications such as feeling stigmatized or 
demoralized. For instance, Sontag (1991: 7) postulates: 
"As long as a particular disease is treated as an evil, invincible predator, not just 
a disease, most people with cancer will indeed be demoralized by learning what 
disease they have". 
Sontag (1991) proposes that metaphors associated with disease are eradicated 
and has a particular disliking for military metaphors arguing that the ill human 
body is not a 'battlefield' and society is not at war with disease. The metaphor of 
"backfiring" is one of several encountered in Sontag's writing (p 67) referring to 
'war on cancer', cancer treatment utilizing colossal amounts of government 
money and growing pessimism among the medical profession who are viewed 
upon as: 
"battle-weary officers mired down in an interminable colonial war - these are 
twin distortions in this military rhetoric about cancer" (Sontag 1991: 68) 
The constant reference to military rhetoric is thus understood as having 
potentially negative consequences; in other words the other side of the double- 
edged sword mentioned previously. Others would counteract this argument of 
attempting to separate metaphorical discourse from illness because it would 
mean obliteration of the conceptual foundation of common colloquial language 
and understanding (Lakoff and Johnson 1980; Lakoff 1993). Common verbal 
expressions used by many of the participants were "struggle", "fight' and "battle" 
to describe numerous difficulties and concerns (Table 22). 
Metaphorical discourse continues to be an established and integrated part of 
language applied in nursing science such as meta-ethnography and synthesis 
in qualitative research (Noblit and Hare 1988) and in nursing literature including 
Stacey's (1997) cultural phenomenon of cancer and Skott's (2002) use of 
metaphorical expressions in cancer narratives. Table 22 shows fragments of 
data illustrating common verbal expressions such as battle, fight and struggle 
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used by patients, family members and healthcare professionals and the context 
in which these expressions were used. 
Verbal expression 
Alf (F 004) "it has always been a struggle" 
Maggie (F 008) "we've got a battle ahead" 
Carol (F 012) "we struggle don't we? " 
Jack (P 014) "I see people struggling" 
Fred (P 017) "I'm struggling a bit" 
Sally (P 018) "it took a lot of fighting" 
Karen (HCP 022) "a lot of them will struggle" 
Karen (HCP 022) "1 struggle with it" 
Karen (HCP 022) "patients have struggled" 
Dave (P 023) "husband struggling with cancer" 
Ian (HCP 026) "half won the battle" 
Bill (027) "she did all the fighting" 
Sylvia (F 028) "he's been fighting for his life" 
Victor (P 030) "it's not a fight". 
Pauline (HCP 031) "struggling a little bit" 
Rosemary (F 034) "you've got to always fight" 
Jill (HCP 036) "struggle and do too much" 
Jill (HCP 036) "1 have struggled" 
Claire (HCP 038) "he struggles" 
Claire (HCP 038) "see people struggling" 
Context 
Hospital trips 
Perceptions about surgery 
Travel insurance 
Hospital trips, finance 
Side effects from medication 
Psychiatric referral 
Financial difficulties 
Approaches to bad news 
Taking thalidomide 
Wife's perception 
Reassuring patients 
Financial support 
Internal haemorrhage 
Misunderstanding 
Palliative care referral 
Staying positive 
Patients working 
Meeting patients' needs 
Consultant giving bad news 
Decision-making (treatment) 
Table 22 Use of 'struggle', 'battle' and 'fight' in the data. 
5.3 Concept analysis 
5.3.1 Introduction 
Selecting a concept and determining the purpose of the analysis aims to 
develop a definition for the term Contention; the purpose of which is to clarify 
the meaning of the concept and its utility. A concept analysis provides an 
understanding of the attributes, which are intrinsically linked to the concept 
under investigation. The concept analysis aims to refine and develop terms that 
specifically relate to nursing language. Clarification of meaning will facilitate 
development and refinement of emerging theory derived from data collection. 
Contention is considered in relation to struggle, hostility, discord or feuding, 
(The Collins Thesaurus 1989) between the individual and the disease. The 
individual relates to the person or persons representing the participating groups 
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in this study, and the disease is an uncommon form of cancer affecting red 
bone marrow called multiple myeloma. 
Concept analysis involves exploring the relationships between concepts and 
deciding what it is and what it is not by defining attributes. According to Walker 
and Avant (2005), if a concept is broken into simple elements it is easier to 
determine its internal structure. The aim is to describe and examine the term or 
concept and whether or not it is associated with other words to verify its actual 
and potential utility with regard to its meaning. Walker and Avant's strategies 
for theory construction shown in Table 23 provide adequately structured and 
comprehensible guidelines as the framework selected for the concept analysis. 
The first and second stages of the framework have already been accounted for 
- selection of the concept and the aims of the analysis. The third stage is 
identification of all uses of the concept Contention; followed by stages 4-8 
which include, determining defining attributes; constructing a model case; 
constructing borderline, related, contrary, invented, and illegitimate cases; 
identification of antecedents and consequences; and definition of empirical 
referents. 
1. Select a concept 
2. Determine the purpose of analysis 
3. Identify all uses of the concept 
4. Determine the defining attributes 
5. Construct cases 
6. Identify antecedents and consequences 
7. Define empirical referents 
Table 23 Framework for concept analysis, Walker and Avant (2007). 
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The core category in this grounded theory research was something that all the 
data sources appeared to be confirming. It was seen in every transcript from the 
patients, the family members and from the healthcare professionals. It appeared 
to be linked to the rarity and complexity of the disease and took the shape of a 
struggle, fight, or battle. The core category illustrated previously in Figure 4 
represents the central component of an evolving 'category group model' derived 
from the data in the form of a skeletal rib cage. An example of 'Contention' is 
illustrated in the following extract involving the patient's wife who became angry 
and frustrated dealing with the Social Security personnel. She was unable to 
convince staff at the Social Security office that her husband had a serious 
illness and was unable to work. This impacted on close family members who 
provided financial support during this time. The Contention is the "fighting and 
rowing" that continued for several months: 
028 (Family member) `Contention' in accessing support 
"I had a lot of bother at the beginning with finances 9 months it took with me 
righting and rowing with people to get financial help and thank God we did have 
our family and the only thing that did help us at the beginning was that our 
mortgage 6 months previously our mortgage was protected for a year so I knew 
was alright with the mortgage side but it was everything else council tax all the 
different bills I knew we were getting more and more into debt but as I say we 
had good family who were helping us out but the fight with Social Security 
because they just well you know you've got this illness it's too bad they were 
always pressing him because he was so young in his early 40s and they were 
looking in books for Myeloma and they mentioned 60s and 70s and they would 
question well have you really got it you know - they didn't believe us at the beginning. I didn't really know anything and / would look at a text book and 
when you look in the text book it's all 60s and 70 year olds - even today like the 'Bacup' Book they need to update them sort of books because younger people 
are getting it. They weren't really concerned and when you're getting more and 
more into debt"...... 
5.3.2 Uses of the concept Contention 
The term concept is defined by Meleis (1991: 12) as "a label used to describe a 
phenomenon or a group of phenomena. Concept denotes some degree of 
classification or categorization". In common every day language a 'bone of 
contention' is an argument or a dispute. It is a discussion where there is 
continuing disagreement. The idea stems from a bone thrown to several dogs, 
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which creates a fight between them (Oxford Dictionary of Idioms 2004). The 
colloquial use of the term is metaphorical and the phrase 'I have a bone to pick 
with you' is frequently used at the onset of a disagreement. The term 'a bone to 
pick' when there is a problem or disagreement has been used since the mid 16th 
century (Oxford Dictionary of Idioms 2004). Formal use of contention (noun) is 
seen often and widely used in the literature for example (Osborn et al 2007: 
118): 
"A major contention of this article is that the lack of progress in reducing 
alcohol-related harm among college students during the past several decades 
has been the research community's failure to effectively engage and collaborate 
with undergraduates on shared concerns". 
Walsh's (2007: 26) report in the International section of the Guardian 
newspaper on fighting between Pakistani tribesmen and foreign militants near 
the Afghan Border States: 
"The Pakistan government claims the revolt is proof that local tribesmen are 
finally turning against the al-Qaida-linked foreigners, whose presence has been 
a bone of contention with the US". 
In another article (Chatto 2007: 10) in the `G2' accompaniment of the Guardian 
a tribute is written for Christopher Lloyd who died in 2006. He authored a 
gardening column for 17 years: 
"However, there was a particular bone of contention: Christopher gave begenias 
(different to begonias) short shrift, while I cannot garden without them. These 
large, and some clusters of smooth, simple leaves, suffused with shades of 
wine-red in winter, act for me, as a focal point, a full stop to the end of a busy 
sentence". 
The Contention of the Bards (Celtic poets) from Irish literature of early 17th 
century Gaelic Ireland wrote controversial poetry involving fierce arguments 
against each other and in support of their patrons. The following verse is from 
the "Irish Texts Society" (McKenna 1918: 185): 
"I could say much more but I insist not. I like not that your words force me to 
speak of such things. From you in the North come the rough words that set folk 
against each other. You cannot find in your books the name of any of Eibhear's 
race who swore that oath to forego their ancestral rights. An example that there 
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were those who took no such oath is Meilge, lughoine's grandson. A king of 
Eibhear's race took from him his life and the kingship of Eire too! " 
5.3.2.1 Dictionary definitions 
Contention 1. "Someone's contention is the idea or opinion that they are 
expressing in an argument or discussion" and exemplifies this with "This 
evidence supports their contention that the outbreak of violence was 
prearranged". 2. "If something is a cause of contention, it is a cause of 
disagreement or argument". For example "a particular source of contention is 
plans to privatize state run companies". 3. "If you are in contention in a contest, 
you have a chance of winning it". As in "he was in contention for a place in the 
European championship squad" (Collins Cobuild Advanced Learners English 
Dictionary 2003: 302). The following example is from The Sunday Telegraph's 
article on golf (Reason 2007: 6): 
"But yet again Rose began to pull himself back into contention towards the end 
of the round. He birdied the 13th and 14th and then showed that Faldo grit when 
he holed a 20-foot par putt on the 16w" 
Contention is defined as "strive, tussle, conflict, clash, running battle, 
dissension; combat, fighting, war, warfare; debate, dispute, controversy, 
polemics, ink slinging, argument; altercation, words, war of words, quarrel; 
bone of contention, competition, rivalry, price war, emulation, jealousy; 
competitiveness, gamesmanship, survival of the fittest, rat race, turf war, cut 
throat competition, war to the knife, no holds barred, feeding frenzy, sports, 
athletics, sport, contest; trial, trial of strength, marathon, biathlon, triathlon, 
pentathlon, decathlon, tug-of-war, tug-of-love, exertion; tussle, struggle" 
(Roget's Thesaurus 1987: 297). 
According to The New Shorter Oxford English Dictionary (1993) Contention is 
"Strife, verbal controversy, a dispute or a quarrel. Earnest exertion, endeavour, 
competition, an act of rivalry, or a point contended for an argument". The act of 
contending (verb) is described as "violent effort or struggle to obtain, resist or 
compete" (Webster's Third New International Dictionary (1986). Contention City 
in Arizona was aptly named as a result of unusual rivalry among silver mining 
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claimants in the early 1880's near Tombstone (Wikipedia the free encyclopedia 
2007). http: //en. wikipedia. org 
Contentious (adjective) is defined as (1) "a contentious issue: controversial, 
disputable, debatable, disputed, open to debate, moot, vexed. (2) A 
contentious debate: heated, vehement, fierce, violent, intense, and 
impassioned. (3) Contentious people: quarrelsome" (Concise Oxford Thesaurus 
2002: 170). 
Contention is also used in "a situation in which several independent activities 
simultaneously seek access to the same resource, as when several 
independent transmitters wish to send data across a single communication 
channel. Where contention may arise, it is necessary to provide some form of 
arbitration to determine which activity gains access to the resource" (Oxford 
Dictionary of Computing 2004: 112). An example of this type of contention 
described as "conflict in requests for the use of system resources" arises when 
two or more computer users attempt to print items simultaneously from the 
same printer (Chambers Dictionary of Science and Technology 2002: 258). 
Sending electronic mail (e-mail) using Broadband Asymmetric Digital 
Subscriber Lines (ADSL) in the United Kingdom are subject to 'contention' and 
'contention ratio'. Contention is the availability of network bandwidth that is 
shared between several subscribers. The ratio relates to the available shared 
bandwidth, which means if there are 50 residential users sharing there is a 
contention ratio of 50-1 (IDNet 1966-2007). The architecture of a computer is 
made up with a variety of components referred to as buses (White 2006) 
including pathways along which data are transmitted. 'Bus contention' occurs 
within the communication control system where a device must wait for a time 
before transmitting data. 'Contention delay' is the "length of time spent waiting 
for equipment to become free for use" (Dictionary of information Technology 
2002: 90). A 'contention resolver' is a "device that enables a central processing 
unit, memory, or channel whose attention is being requested over several 
pathways to give its attention to one pathway and ignore all others" (McGraw- 
Hill Dictionary of Scientific and Technical Terms 2003: 473). 
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5.3.3 Defining attributes 
To determine those attributes most frequently associated with the concept 
involves an exploration of the research data and literature to examine as many 
of the different examples of the concept as possible. The defining attributes or 
characteristics may change during the course of development, refinement, 
applicability and clarification (Walker and Avant 2005). Defining attributes of 
Contention identified in the research data and existing cancer literature are 
shown in Table 24. 
Study data analysis CONTENTION Existing Lite 
" STRUGGLE, exertion, 
difficulty, hindrance, 
negative 
" BATTLE, fighting, 
assertion, form of 
defence, positive 
" DISRUPTION to life, 
major upheaval, 
physical and psycho- 
social. 
" DISHARMONY, 
friction, conflict, 
discord, inconsistency, 
ill at ease, alternating. 
" STRUGGLE 
" BATTLE 
" DISRUPTION 
" DISHARMONY 
Table 24 Attributes derived from data analysis and literature 
In the research data there are instances or events where all the defining 
attributes are present and therefore the concept is easily recognizable. 
Searching the cancer literature for the concept proved difficult using the search 
terms struggle, battle, disruption, disharmony and cancer combined yielded 0 
hits. Combining an individual attribute with cancer using the CINAHL database 
1982-2007 proved more productive than other databases, which were searched 
(British Nursing Index, EMBASE Psychiatry 1997-2007, PsycINFO 1806-2007, 
{' 
. 
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Applied Social Service Index and Abstracts (ASSIA), Social Science Citation 
Index, www. thesis. com). Cancer and struggle (80 hits), battle (86), disruption 
(108) and disharmony (2). There are instances where one or two of the 
attributes are presented in the literature but they are not clearly defined. For 
example struggle and battle are commonly seen in the cancer literature and are 
used interchangeably. Disruption is a common term used in relation to 
physiological disfunction that occurs in disease and it also refers to the 
interruption of normal life patterns as a result of chronic illness. Disharmony is 
not commonly seen in its written form but its presence is powerful through 
inference. Conclusions are thus drawn from expressions such as "it's like living 
with the sword of Damocles over you all the time" (research data). In Grummet's 
(2006) book 'Myeloma and Me' numerous statements suggest the presence of 
disharmony for example, "if they picked up my nervousness" (p13), "the slight 
unease returned" (p14), "my first uneasy sensation" (p25), "conflicting emotions 
are at force" (p78), "someone died today, and the atmosphere has physically 
changed, a pall is hanging over the ward and yet nothing has been spoken to 
cause this" (p79). 
5.3.4 Constructing cases 
5.3.4.1 A model case 
When all the defining attributes are present, it is referred to by Walker and 
Avant (2005) as a 'model case' representing a pure example of the concept. A 
model case can be constructed from real life experiences or examples found in 
the literature. It is suggested that using a nursing model may distort objectivity 
concerning the concept and its meanings. The following, therefore, is based on 
the 'London Bombings' that took place on the 7th July 2005. 
Four bombs exploded in London on the 7th July 2005 during the early morning 
rush hour on three underground trains and a bus. Becoming aware of the first 
explosion and working in the City was the type of news that made the hair stand 
out on the back of the neck. As the events unfolded people experienced 
feelings of shock, fear, confusion, and bewilderment. It became difficult to 
concentrate on the task at hand. The City was at a standstill. Public transport 
was crippled due to the closure of the underground system and there were no 
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buses running. Thousands of people finished work early and were seen walking 
in London on their way towards home or to the nearest public form of 
transportation operating outside the affected zone. The atmosphere outside in 
the street that afternoon was strange, eerie, quiet, and ill at ease. Others that 
chose not to walk waited at the railway stations. When the train stations 
reopened there was chaos as passengers ran and pushed to get onto the 
overcrowding carriages. 
The above model case demonstrates 'struggle' in relation to coming to terms 
with the shocking news. The individual becomes bewildered and unable to 
concentrate. Therefore it disables the individual. The 'disruption' is the City of 
London with no transport system. The disharmony is portrayed in the strange 
atmosphere associated with thousands of 'silent' streetwalkers in the City 
following the bomb explosions. People at railway stations can, on such 
occasions, become very aggressive. They tend to fight their way and physically 
push others to get a space on the train, which exemplifies 'battle'. Thus this 
model case includes all four of the defining attributes of the concept. 
5.3.4.2 A borderline case 
A borderline case is one that contains some but not all of the defining attributes. 
Alternatively this may be an example of the concept where all the defining 
attributes are present but one attribute may have a significant difference such 
as an unusual duration or may not appear as frequently when compared to 
other instances resulting in inconsistency. The inconsistency is the distinction 
between the model case and the borderline case. The following is also based 
on the 7th July 2005 London bombings: 
The couple sat in front of the television both having finished work for the day 
with a cup of tea and pleased to be at home together for a change. They were 
watching the news. They were shocked to hear that there had been a number 
of explosions in London that morning. Three bombs on the London underground 
Circle and Piccadilly Line trains had exploded within seconds of each other. 
Then about an hour later the roof was blown clean away from a double-decker 
bus while travelling through Tavistock Square. People had been killed or 
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seriously wounded. It was difficult to get their heads around what was 
happening and they stared at one another both thinking the same thoughts and 
immediately feeling very unsettled. London was like a war zone and their only 
child may be caught up in it all. Their daughter traveled on the underground to 
get to work. They started to worry and were frantically looking for her new 
mobile number when the house phone rang. It was their daughter to let them 
know that she was alright. She had traveled on the earlier train heading for 
Russell Square and she was fine. They were not to worry. 
The above borderline case demonstrates some but not all of the defining 
attributes. There is the 'struggle' to come to terms with the shocking events as 
seen in the model case. Disharmony exists in the sense of feeling unsettled and 
the urgent need to contact their daughter to make sure she was safe. There is 
an element of disruption to their evening while watching the television and 
relaxing. The disruption to their evening is minimal in comparison to the 
disruption in the model case, which is major and catastrophic. There is no 
evidence of a battle taking place. 
5.3.4.3 A related case 
Related cases are those concepts that are considered to be similar or closely 
associated to the concept under investigation. Related cases require close 
scrutiny to find the differences between them and they do not contain all the 
defining attributes. Related cases help to clarify individual concepts and to 
establish their unique identities. The aim is to understand how the "concept 
being studied fits into the network of concepts surrounding it" (Walker and Avant 
2005: 71) The concept assertion will be considered as a related case. Assertion 
(noun) is a positive statement or the act of asserting. To assert (verb) means to 
speak and act forcefully for example to insist upon one's rights. Being assertive 
(adjective) is being confident and direct in dealing with others (Collins English 
Dictionary 2001). The following represents the related case and illustrates the 
assertiveness of Sally Kane's General Practitioner (GP) who she visits prior to 
having major surgery for breast cancer. She was desperate to talk to someone 
and speaks of cancer patients and the "terrifying speed with which they were 
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swept on to the cancer conveyer belt - leaving no time for calm consideration or 
a second opinion" (Kane and Kane 2002: 223): 
"At five o clock on a Friday afternoon, and with two and a half days before my 
scheduled operation, I sat in Dr Joy's surgery, pouring out all my concerns. She 
halted me right there, pointing out that it was unnecessary to proceed at such 
haste, when certain issues about the reconstruction were so unclear. A few 
days would make absolutely no difference to my health and safety. With that 
she grabbed the telephone and made two fundamentally important calls. She 
called my surgeon's clinic and cancelled my surgery on the Monday, until 
further notice. Then she arranged for me to see another plastic surgeon at 
08.00 on the Monday morning" (Kane and Kane 2002: 223). 
The concept assertion is similar to contention when there is disagreement or 
some kind of dispute. The subtle difference is the approach and level of 
forcefulness. Being assertive is successfully negotiating with others while 
disagreement or dispute is often associated with anger and aggression. The 
exception would be a scholarly debate where one team will argue from one 
perspective while another team counteracts the argument with a different point 
of view. The related case contains only one of the defining attributes (struggle), 
which relates to the sentence "pouring out all my concerns" and is associated 
with the fact that things were happening at such a fast pace for Sally who 
needed to talk to her doctor. Sally required more time to think, come to terms 
with what was happening, and make more informed choices regarding the 
reconstruction of her breast. Her GP's assertiveness allowed her this 
opportunity. 
5.3.4.4 A contrary case 
A contrary case is a complete contrast to the concept being examined. It is 
therefore definitely not an example of the concept thus it is something 
completely different. Identifying that something is without doubt not an example 
of the concept will help to establish that which is. The complete absence of all 
defining attributes determines essentially that it is not an example of the 
concept. A complete contrast to the 7th July 2005 London bombings was seen 
the day before on the 6th July when it was announced that London had won the 
bid to host the 2012 Olympic Games: London, on that day, had a 'balloons and 
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party' atmosphere: Crowds of people gathered in Trafalgar Square jumping up 
and down cheering with excitement and jubilation. 
5.3.4.5 An invented case 
An invented case is a way of seeing something that is very familiar outside its 
normal domain. To invent a case involves something imaginary, which is alien 
so that it might actually read like a science fiction. Walker and Avant advocate 
that to get a "true picture of the critical defining attributes, you must take the 
concept out of its ordinary context and put it into an invented one" (2005: 72) 
which is illustrated below: 
They came in their millions (micro-organisms) all shapes and sizes from the air 
and earth. The first team landed on the moist, uneven, quivering and bushy 
surface. They found the entrance camouflaged by sticky twigs. Many had 
difficulty getting through and were unable to pass into the red area where most 
of the fighting was going on. Those who were not successful proceeded to find 
another entry. The resistance was strong and some of them were destroyed by 
the large hot wave of solution that appeared suddenly forcing them away from 
the target and into oblivion. The survivors soldiered on determined to reach the 
place where the invasion had begun. On arrival they appeared to have 
multiplied in numbers and taken over the entire field. It was an easy war. They 
were the conquerors and they settled in to enjoy their spoils. They remained 
there for a prolonged period of time. They liked the red area. The climate was 
perfect to live and breed and so they continued to flourish. Gradually things 
started to change. Slowly the atmosphere and surroundings took on a menacing 
new contour. Boundaries were shifting and the colour had changed from red to 
orange. The 'settlers' did not like these unexpected changes and they started to 
feel perplexed and a little edgy. They did not understand what was happening to 
them. This was not something they had anticipated. Their equilibrium was being 
seriously threatened. Without warning one entire group completely vanished 
resulting in total chaos and disorganization from within the whole colony. 
The invented case demonstrates all of the defining attributes. The struggle 
applies to the difficulty in gaining entrance. The battle is their determination to 
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find another solution and soldier on. The disharmony is the imbalance in the 
'settlers' equilibrium as a result of the unwelcome changes occurring around 
them. The disruption is the sudden chaos and disorganization that occurs when 
a group unexplainably disappears. 
5.3.4.6 An illegitimate case 
An illegitimate case demonstrates improper use of the concept or it is used out 
of context. Bus contention that occurs in a computer for example only contains 
the attribute disruption, which is minimal and does not contain the remaining 
critical defining attributes of struggle, battle, and disharmony. Therefore this 
would not be applicable or appropriately used within the context of living with an 
incurable and progressive disease such as multiple myeloma. An example of 
an illegitimate case follows: 
The young man sat in front of his computer at home trying to access 
Broadband. The usual notice appeared to inform him that he had failed to do so 
and would he 'please try again later'. He grumbled, as he wanted to send e-mail 
before he went out. It was Sunday and he was playing football. He made a 
comment to his brother regarding the fact that other users were probably to 
blame for the inconvenience stating "I guess our contention ratio is 100-1 and 
they are all using the line right now. " 
5.3.5 Identifying antecedents and consequences 
This stage of the analysis helps in the clarification of the concept in relation to 
its general applicability and further refinement of critical attributes. Antecedents 
are situations occurring prior to the event of the concept emergence. 
Consequences are outcomes or factors that are produced as a result of the 
concept appearing thus they occur following the event of the concept. With 
reference to the research data, the antecedents, which precipitate Contention in 
living with multiple myeloma, are: 
" Onset of illness 
" Cancer diagnosis 
" Communication issues 
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" Accessing support 
" Experience of treatment 
" Impact on life 
" Making decisions and plans 
" Uncertainty 
" Unrelenting nature of the disease 
" Time and waiting 
" Relapse and remission 
The consequences are alterations and adaptations. Alterations are of two kinds 
and relate to life style and physiological or body changes. Life changes as a 
direct result of the presence of disease and treating the illness. Receiving 
treatment can mean frequent trips to the hospital for chemotherapy and blood 
transfusions. This often involves seeing specialists at other hospitals, which are 
further away. The resulting far-reaching implications have a significant impact 
on daily life. When the breadwinner in the family is taken ill and is no longer 
physically fit to continue to earn a living, this can lead to all sorts of problems 
associated with financial loss and struggling to support the family. The body is 
altered because of the presence of bone disease and also as a result of side 
effects from medication. Adaptations are the ways in which people adjust and 
learn to cope living with the disease. It also concerns how individuals manage 
and become more knowledgeable about the condition. Figure 7 illustrates the 
relationships between the antecedents, defining attributes and consequences. 
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Antecedents: 
Onset of illness 
Cancer diagnosis 
Communication issues 
Accessing support 
Treatment experience 
Impact on life 
Making decisions 
Making plans 
Uncertainty 
Unrelenting nature 
of the disease 
Time and waiting 
Relapse and remission 
Defining 
attributes: 
Struggle 
Battle 
Disruption 
Disharmony 
CONTENTION 
Consequences: 
Alterations 
Adaptation 
Figure 7 Antecedents, defining attributes and consequences of Contention 
5.3.6 Defining empirical referents 
Empirical referents are the observable indicators linked to the concept that may 
be identical to the critical attributes and which determine characterization of 
phenomena establishing recognition of the concept and proof of its existence 
(Walker and Avant 2005). Empirical referents such as patient behavioural 
patterns, actions, reactions, verbal expressions, and nursing observations serve 
as valuable criteria on which to base assessment and identify an individual 
patient's problems (formation of diagnoses) in nursing practice. It is not always 
possible to measure empirical referents associated with concepts such as 
struggle, battle, disharmony and disruption due to their level of abstraction. 
Qualitative research provides a way of producing evidence of their existence. 
Table 25 displays the empirical referents of Contention under five headings: 
behavioural patterns, verbal expressions, socio-economic, psychological, and 
physiological changes. 
as rterns 
Anger 
Frustration 
Fear 
Panic 
Dread 
Wont' 
Anxiety 
Restless 
Hyperactive 
Tearful 
Tense 
Distress 
Nervous 
III at ease 
Overwhelmed 
Apprehensive 
Withdrawn 
Depressed 
Denial 
Positive 
Negative 
Jocular 
Assertive 
Disillusion 
Verbal 
expressions 
An irritable 
monster. 
Disabled/ cannot 
work. 
Alarm bells. 
The sword of 
Damocles over 
you. 
Running out of 
options. 
Living on Death 
row. 
Fear of 
infections. 
Panic attacks 
Dread of going 
through the 
horror. 
Worry about 
uncertainty. 
Anxious about 
the future. 
Living on the 
edge. 
Telling jokes. 
Speaking 
knowledgably 
and taking 
control. 
Back to square 
Socio- 
economic 
changes 
Unable to work 
Reduction in 
income. 
Change in life 
style. 
Changing roles 
within the family. 
Alteration in 
working 
patterns. 
Becoming an 
outpatient. 
Hospital 
appointments. 
Hospitalisation 
Changes in 
interpersonal 
relationships at 
work and home. 
chances 
Feeling guilty 
receiving income 
support. 
Feeling frustrated 
unable to do 
things/having to 
rely on others. 
Different 
perspective on 
life. 
Feeling isolated. 
Feeling 
depressed. 
Feeling scared. 
Side effects 
confusion/despair 
/hallucinations. 
changes 
Recurrent 
infections. 
Feeling tired. 
Disabled. 
Fractured bones. 
Anaemia. 
Painful back. 
Side effects. 
Altered image. 
Bone pain. 
Unable to walk 
unaided. 
Breathlessness. 
Numb fingers. 
Numb feet. 
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one. 
Ups and downs. 
Table 25 Empirical referents of Contention 
5.3.7 Defining the concept 
A definition of Contention developed from this concept analysis within the 
context of living with a chronic illness, a critical event or life crisis means 
struggle, battle, disruption and disharmony. It is a multidimensional concept 
encompassing sociological, psychological and physiological manifestations. 
These four concepts are closely related but do not necessary happen 
simultaneously or in any specific order. However, they are all present at some 
stage as a result of the concept Contention appearing. In this instance, the 
context is living with an incurable cancer that originates in bone marrow called 
multiple myeloma. For example, there is 'feeling uneasy' (disharmony) at the 
pre-diagnosis stage. Disharmony comes and goes and is therefore referred to 
as alternating. It returns when changes occur and the disease is slowly 
progressing (relapse). By the time a person reaches the Haematologist in the 
Oncology Department many patients begin to realize that the illness is serious 
although they are waiting for the results of investigations to confirm the 
diagnosis and for the consultant to explain what the diagnosis means. 
Following this there is struggle (difficulty) in coming to terms with the diagnosis, 
the treatment, complex terminology, hospital environment, and feeling generally 
overwhelmed with vast amounts of information. Battle commences when the 
individual is able to see things in a more positive light and starts fighting the 
disease by taking medication, making necessary adjustments, learning, gaining 
knowledge and making informed decisions. There is major disruption (upheaval) 
to life style due to the presence of disease, which has sociological, 
psychological, and physiological implications. The previously mentioned 
'breadwinner' who is no longer able to work and support his wife and family 
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results in a form of 'employment contention' causing massive upheaval and 
emotional conflict. 
5.3.8 Concluding remarks 
Contention is a unique concept that has emerged as a core category from the 
data analysis of this grounded theory research project. The defining attributes of 
Contention are frequently seen in the cancer literature but are not clearly 
defined and are sometimes used interchangeably. Disruption as a search term 
appears in the literature more frequently than struggle, battle, and disharmony. 
Disharmony is often apparent although it is hidden within the text and usually 
inferred through expression. Its presence although assumed is powerful and 
instantly recognizable. Contention appears when struggle, battle, disruption and 
disharmony are all present. 
This concept analysis is based on Walker and Avant's strategies for theory 
construction. The definition of the concept Contention has been developed 
within the framework of specified critical attributes, constructing cases, 
identifying antecedents, consequences, and defining empirical referents which 
emerged from qualitative research data. The implications for nursing practice 
are universal clarification of commonly used terms, which have been refined 
and developed through the process of rigorous analysis and a sound theoretical 
base. The results of this concept analysis provide an understanding of the 
defined attributes of the concept Contention and have potential applicability to 
other areas of nursing practice such as chronic illness and trauma or accident 
and emergency nursing. An operational definition of the concept involves 
identification, exploration and measurement of phenomena. Measurement 
requires searching for a tool that accurately reflects the defining attributes of 
Contention. 
5.4 Contention in communication 
Contention in communication implies struggle or difficulty in understanding what 
is being said or explained. Equally the person speaking may 'struggle' to convey 
meaning because they are unable to explain clearly what a problem is. For 
example, a person that attends the GP surgery who has been unwell but is 
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unable to articulate what the symptoms are because the symptoms are vague 
yet there is a belief that something is wrong. Thorne et al's (2004) research 
highlights the experiences of people living with multiple sclerosis and issues 
relating to communication between patients and healthcare professionals. For 
example, participants frequenting the doctor's surgery reporting ongoing 
symptoms which were trivialized in some instances or it was suggested to 
individuals that their symptoms were of a psychosomatic origin. These 
encounters often resulted in fear, anger, frustration, loss of confidence and 
sometimes emotional conflict between spouses (Thorne et al 2004). 
Following numerous or repeated visits to the GP (Leydon et al 2003) 
circumstances may evolve over a period of time which changes normal 
behavioural patterns. An individual may become frustrated or angry and 
demanding (assertive) for example because the situation has become 
intolerable thus the 'struggle' transforms into 'fight' (battle). Contention has to be 
understood in terms of the whole experience, which encompasses emotional 
turmoil and frustration (disruption to normal well being or existence) and feeling 
`ill at ease', confused, frightened or nervous (disharmony). 
5.4.1 Delay 
Repeated visits to or from the GP and delay in diagnosis in multiple myeloma in 
this research had extremely serious consequences for some of the participants. 
This was evident in several narratives: The crucial point here is that participants 
in this research had fractured vertebral bones at the time of diagnosis. Their 
condition had become severely disabling and excruciatingly painful as a result 
of delay in diagnosis. The decision to interview the GPs was theoretically 
sampled based upon data collected and previously analysed concerning the 
issue of delayed diagnosis and repeated visits to GPs. The GPs interviewed, 
however, did not normally see many patients with multiple myeloma despite the 
location being a main referral area. For example: 
Ian (HCP 026) "on my list of approximately 2,300,2,200, something like that, 
actually assigned to me with my name on their notes; we've actually got two. 
One with multiple myeloma and one with some other weird and wonderful 
paraproteinaemia". 
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The GPs acknowledged that it was difficult to diagnose a rare disease such as 
multiple myeloma and appeared to struggle when patients presented with vague 
or unremarkable symptoms. Disharmony appeared in the form of feeling 
`uncomfortable' or frustrated because of inadequate equipment in the surgery or 
learning that patients they (GPs) had seen and examined on more than one 
occasion, were at a later date diagnosed with a malignancy. One GP stated, for 
example, that he "didn't have a crystal ball" (John HCP 021). 
GPs tend to focus on the more common conditions and treat the symptoms 
rather than attempt to investigate all potential causes (Klineberg et al 2007, 
Watts, 2005). A common presentation at the onset of multiple myeloma is 
backache. There were a significant number of patients (n=9) who presented 
with back pain at the time of diagnosis in this research representing more than 
half of the patients' participant group. By concentrating on the common potential 
causes of back pain (albeit an assumption in the absence of an investigation) 
the uncommon or rare diseases like multiple myeloma are not being 
considered. Depending on the severity assumptions made were generally of a 
muscular strain or a prolapsed disc. It appears that individuals accept what GPs 
initially diagnose without question and if symptoms are subsiding with 
medication prescribed, their patients are usually satisfied. Backache is a 
common ailment and according to the GPs interviewed, they saw approximately 
3 or 4 patients a day: 
John (HCP 021) "A ridiculous number of all ages, I would say, everyday 
somebody is coming in with a back problem of one sort or another, and at any 
given time there are probably 2 or 3 people that you'll be seeing regularly 
who've got ongoing back problems". 
R: So as backache's quite a sort of characteristic onset of myeloma how many 
people do you actually see with backache coming into your practice, say on a 
day-to-day basis? 
Ian (HCP 026) "Must be three a day, potentially more". 
According to one GP from South-West London the key is to concentrate on 
several diagnoses including the more rare diseases surmising that there may be 
10 or more possible causes for back pain (Watts 2005). Klineberg et al (2007) 
discuss 15 potential causes of back pain categorizing them into three groups 
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namely 'emergent' for example ectopic pregnancy, 'urgent' such as a duodenal 
ulcer and 'potentially serious' as in pelvic inflammatory disease. Although the 
majority of cases are associated with minor trauma or degenerative changes in 
muscles or vertebral discs, it is important to recognise all potential causes to 
avoid delayed diagnosis which could, in some instances be fatal (Klineberg et al 
(2007). 
There appears to be four contributory factors identified from the data causing 
delay in diagnosing multiple myeloma, which are (a) GP, (b) patient, (c) policy 
and (d) the nature of the onset. Similar findings are found in the literature. 
Mitchell et al (2008) for example maintain there are three possible factors 
influencing delay in diagnosing colorectal cancer. These are: patient, healthcare 
professional and hospital delay. Patients for instance apparently either failed to 
recognise the serious implications of initial symptoms or denied having them. It 
was suggested that delay associated with healthcare professionals resulted 
through misdiagnosing and inappropriate investigations (Mitchell et al 2008). 
The key contributory factor in this research appeared to be the approach taken 
by the patients' GPs. For example participants stated that they were not 
physically examined; prescribed analgesics were ineffective and they didn't feel 
that they were being taken seriously. The notion of being 'fobbed off or not 
taken seriously does not appear to be uncommon (Berg and Ahmann 2006, 
Picardie 1998). Feelings of anger are naturally directed towards doctors 
especially when it is understood that appropriate investigations were not 
undertaken at an earlier stage of the disease (Houldin and Lewis 2006). In this 
research there was an emphasis on treating the symptoms and increasing the 
dose or changing prescribed medication when the pain persisted or worsened. 
Routinely patients with persistent back pain were referred to physiotherapists, 
which took several months. Two participants attended alternative therapists 
such as osteopaths and chiropractors prior to visiting their GP surgeries, which 
may have contributed towards a delayed diagnosis. The nature of the onset of 
the disease, which is often vague such as back pain, tiredness or mild anaemia, 
provides an effective camouflage. The cancer therefore is difficult to detect. 
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It is only when the presentation is considered uncommon, abnormal, severe, or 
there is a family history of cancer that it is investigated immediately. The policy 
regarding backache is to treat the symptoms and not investigate the cause until 
much further down the line when the disease has been allowed to progress. 
This appears to be one of the major factors influencing delay in diagnosis. A 
delay in diagnosis ultimately means a delay in treatment. The lingering question 
is: What difference does this delay make to the patient who has an incurable 
disease like multiple myeloma? As illustrated in the participants' extracts above 
delay in diagnosis allowed the disease to progress and bones to fracture which 
required surgical intervention. Emotionally this had a monumental impact on 
participants, as they were frustrated and angry because it was felt that the 
diagnosis should have been made earlier. This anger was directed at their GPs. 
As a result of the delay the physiological impact had escalated to intense and 
disabling conditions. The implications of delay in detecting myeloma for patients 
with advanced bone disease synonymous with poor quality of life may mean 
exclusion from the more aggressive treatments such as high dose melphalan 
reducing chances of survival even further. 
In contrast to the delay there were instances when participants were diagnosed 
relatively quickly. The following exemplar is an illustration of how an 
investigation was instigated as a direct result of the way in which the individual 
communicated with the GP during the first visit. Using powers of persuasion and 
asserting herself Stella (F 013) challenged the GP and demanded some action 
(Table 3). This 'challenge' was based on personal knowledge and her close 
relationship with her daughter Debs. Stella was able to distinguish between her 
daughter being ill (vomiting) and being pregnant (vomiting). The GP was not 
able to make such a distinction. 
In this case (Debs) the disease was suspected following routine blood tests, 
which showed high blood calcium levels (hypercalaemia). Hypercalcaemia is a 
condition that results from bone destruction and is associated with myeloma 
(Foerster 1993). Elevated calcium levels are also associated with 
hyperparathyroidism which was discussed as a potential diagnosis with the 
participants (Stella and her daughter Debs). Diagnosis of myeloma is confirmed 
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by specialised blood, urine and bone marrow tests (aspirate and trephine 
biopsy). The blood and urine tests (electrophoresis and immunofixation) will 
detect and type a monoclonal protein spike present (Smith et al 2005). Routine 
blood evaluations would not therefore be useful in the absence of 
hypercalcaemia. Professional opinion may sometimes be swayed by pressure 
put on GPs by either the patient or a family member. The difficulty is 
understanding that specific investigations are required for a particular condition 
or 'suspected diagnosis'. When confronted with demanding patients the GP 
may arrange a referral or an investigation such as a blood test at the request of 
the patient simply to provide some reassurance: 
John (HCP 021) "1 think it's perfectly legitimate to refer people for reassurance 
to whoever, whether it's a neurologist, you know this person is worried that they 
have got cancer, this person's worried that they've got, you know, a significant 
back problem. I've examined her, I don't think there is anything but I can't really, 
you know I can't allay their fears". 
5.4.2 Bad news 
Communicating bad or significant news was a primary cause of Contention. A 
diagnosis of multiple myeloma meant informing participants that their disease 
was not only malignant but also incurable. The news appeared to have a 
monumental impact on the recipients causing disruption to life in the form of 
major upheaval; disharmony in terms of feeling confused, unsettled and 
shocked; struggle meaning difficulty in understanding what was happening to 
them and battle or fight which appeared typically in terms of asking questions, 
learning about the nature of the illness, how it will effect their lives and how the 
illness is managed or treated. 
The ways in which this situation was approached varied considerably 
depending on the individual consultant or haematologist involved. Two 
consultants with different approaches implied that patients would have entirely 
different experiences depending upon which clinic they attended or which room 
they sat in. For example one consultant 'painted a bright picture', which could 
be construed as too `glossy', and another consultant simply informed the patient 
that it was unlikely that they would survive for more than five years (Table 4). 
Here we have two extremes neither of which seemed a satisfactory approach. 
Back and Arnold (2006: 4209) compare a "cheerleader mode" which aims to 
deliver hope with a "blunt and sometimes brutal" but more realistic approach 
when discussing a bad prognosis. These authors (Back and Arnold) argue that 
the most common strategies employed by doctors when dealing with 
communicating bad news are realism, optimism or avoidance. 
Berg and Ahmann (2006) reported on significant differences between a surgeon 
and an oncologist regarding their individual approaches to the disclosure of bad 
news to the parents of an infant with a malignant brain tumour (pineoblastoma). 
The surgeon for example informed the parents that an operation was required 
to relieve symptoms of pressure caused by the tumour and to perform a biopsy. 
The conversation took place in a busy and open area by the nurses' desk. A 
detailed, factual rationale for the procedure and potential outcomes was 
explained without showing any signs of warmth or compassion. The oncologist, 
on the other hand, who confirmed the diagnosis, dealt with the situation in a 
quiet room with a more humane and compassionate manner taking on board 
the distraught parents' emotional needs. 
The following account differentiates between a consultant who communicated 
`consistently well' while others appeared to have 'an agenda' and a restricted 
amount of time in which to deal with the situation. Thus there is a desire to act 
swiftly concentrating on information that they feel legally and ethically obliged to 
divulge regardless of the emotional impact this may have on the patient and 
family: 
Fiona (HCP 039) "You do see a big difference in how different people deliver 
bad news, or difficult news, difficult information. We've one consultant who has 
a keen interest in good communication skills and so he consistently does it well. 
He takes time; he gives very relevant information but doesn't give too much in 
the sense that he's not overwhelming. He allows time for information to sink in 
and asks the patient or the family if they want to ask anything about what he's 
just said before moving on to the next bit. But on the other hand I've come 
across consultants who have an agenda and they feel this is the information 
need to give this person, because that, they feel, I've got this amount of time 
and I need to give this information, without really thinking about how the patient, 
whether the patient is even ready for that information". 
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The reality and consequences of dealing with substantial numbers of patients in 
haematology outpatient clinics and meeting government targets has had a 
profound effect on the duration of consultation times. The study centre had 
recently increased clinic days from two to three days per week to meet the 
additional demand. The supportive role of the clinical nurse specialist appears 
to be compromised at the expense of these time constraints 'picking up the 
pieces' and taking the brunt of the emotional impact at the time of the diagnosis: 
Claire (HCP 038) "You know, clinics are just 15 minutes, appointments aren't 
long, they're very busy and frenetic and people are kept waiting, we're no 
different from any other hospital". 
Karen (HCP 022): "Although the doctor would tend to go through their 
diagnosis, they tend to do it probably in 15 minutes and I would then probably 
spend an hour going through the diagnosis in more detail and answering their 
questions and picking up any pieces and" ... 
5.4.3 Emotional labour 
Communicating bad news is exceedingly arduous (Vandekieft 2001) and 
working as an oncologist is deemed "inherently difficult, and racked by 
emotional and psychological traumas" (Lyckholm 2001: 750). The emotional 
impact of disclosing bad, sad or significant news on healthcare professionals is 
monumental yet it has received little attention in the literature (Arber and 
Gallagher 2003). It is particularly stressful for many oncologists who find it 
difficult dealing with patients' emotional reactions (Dias et al 2003). Situations 
vary according to level of expertise, patient's age and whether a relationship is 
well established between patient and doctor (Dias et al 2003). It is surmised that 
in relation to multiple myeloma Contention arises when healthcare professionals 
struggle with difficult situations and intense emotional responses from patients 
and their families. Events associated with bad or significant news, for example 
periods of unstable disease are synonymous with the trajectory of the illness: 
Claire (HCP 038) It's not just an academic brain, it's seeing the individuals and 
seeing them as, as individuals and just appreciating how awful this is for 
them.. . and 
Ed (consultant haematologist) does that very well and you can 
clearly see that he's devastated and that he struggles, as a lot of 
haematologists do, I think". 
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Emotional labour in nursing both in non-specialised and highly specialised 
clinical areas (Mohan et at 2005, Kelly et al 2000) is a salient reminder that 
healthcare professionals may struggle because events they are continually 
dealing with are 'emotionally draining' and often difficult to manage. The 
myeloma clinical nurse specialists interviewed in this research suggested that 
the emotional impact on them was, at times, far greater when seeing newly 
diagnosed patients as this was determined by how positive or negative the 
approach taken by the consultant haematologist was deemed. In other words 
the responsibility of managing 'emotional backlash' from patients and family 
members (when the diagnosis was confirmed) was transferred from the 
consultant haematologist to the clinical nurse specialist. This became 
burdensome depending on how the situation was initially managed: 
Karen (HCP 022) "I struggle with it because I'm much more on the sort of 
positive side" 
Fiona (HCP 039) "It makes me feel uncomfortable and again when I'm in there 
in that situation, I'll often say to patients that this is something we can talk about 
again" 
5.4.4 Complex language 
Complex terminology in haematological oncology, communicating with 
healthcare professionals, communicating with children and hidden disclosure 
were significant issues that emerged from the data. Healthcare professionals 
specialising in this field of practice were so familiar with haematological 
language that it became ordinary. Thus it appeared to `desensitise' healthcare 
professionals when communicating with patients and their families (Berg and 
Ahmann 2006) indicating that communication was at times ineffective because 
of the medical terminology used. From a healthcare professional's perspective 
entering the area of practice for the first time, the language was perceived as 
highly technical, foreign and challenging. McGrath et al (2007) corroborate this 
statement and provide evidence of parents of children with acute lymphoblastic 
leukaemia, also from a healthcare professional background, who appeared to 
have difficulties understanding complex and unfamiliar terminology causing 
significant barriers in communication. An appropriate period of time therefore 
was required to study the terminology and become accustomed to it. From a 
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layperson's viewpoint it is argued that the use of terms such as plasma cells, 
stem cell transplants, myeloma and paraproteins increases anxiety and adds to 
the bewilderment and trauma associated with the diagnosis. This implies 
struggle, battle, disruption and disharmony (Contention). Evidence from this 
research suggests that patients were sometimes given information that they did 
not understand because of the complexity of medical jargon. Furthermore it was 
suggested that the disclosure of the information was sometimes rushed (Berg 
and Ahmann 2006, Ptacek and Ptacek 2001, Thomas and Retsas 1999) and 
overwhelming due to the volume of information devolved. For example 
confirmation of the diagnosis was often followed with a detailed discussion on 
various treatment options. This could however be viewed as a swift move 
towards focusing on the positive aspects, reassuring patients and their families 
that although the cancer was incurable, treatment was available to manage the 
disease and prolong survival. 
5.4.5 Talking to children 
'Communicating with children' as an emerging issue was a reflection on the 
increased number of younger patients diagnosed with myeloma, which was 
mainly perceived by healthcare professionals who participated in this research 
as a disease of the elderly (Kyle 2002). A significant number of patients had 
children under the age of 12 years (n=6) and seven couples had children in 
their late teens. Talking to young children was problematic because the parents 
were uncertain of what to say and how to say it. Participants in Houldin and 
Lewis's (2006) qualitative study about newly diagnosed patients with advanced 
colorectal cancer struggled with how and when to talk to the children about the 
cancer, concerned that the disclosure may interfere with their progress at 
school or socialising with their friends. Alternatively talking to children and 
explaining about the illness was not perceived as a problem because the child 
was considered too young to understand. The consequences of 
underestimating a young child's perception and ability to understand can have a 
detrimental impact on the child's development and well being (Scott et al 2003). 
In this research for example it was explained to Debs (P 009) and Mat's (F 010) 
son Ben aged 3 that his 'mummy' was going into hospital to 'get better' and Ben 
understood that his mother would be able to walk when she returned home from 
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hospital but this was not the outcome he had anticipated which caused him to 
become upset (Table 6). The concept of Contention in communication and the 
way in which that communication is interpreted by a young child for example, 
may provide a useful framework to enhance explanatory power and 
understanding of interactions between parents and their children. . 
5.4.6 Hidden disclosure 
Hidden disclosure and managing the reality of the situation emerged from the 
research data. The disclosure was either 'total' or 'partial and gradual' 
undertaken to protect loved ones from knowledge that was considered 
psychologically injurious. Individuals develop coping mechanisms such as 
'denial' or/'acceptance' (Copp and Field 2002) and some avoid any discussion 
with close family members concerning illness or dying in order to protect one 
another (Smith and Cox 2007). Some people are unable to express their 
feelings without getting distressed and consequently others within the family 
feel isolated (Houldin 2007, Simpson 2005). Some of the participants in this 
research appeared to be unable to disclose their true feelings and talk openly 
with their partners or other family members who were perceived as unable to 
cope. Some participants believed they were a burden to their family 
(McPherson et al 2007, Thome et al 2003) resulting in emotional conflict, 
feelings of abandonment and disharmony. Hidden disclosure also involved 
deliberate attempts to take on board selective information that was viewed as 
positive, while 'blocking out' or not wanting to take on board any negative 
feedback with the aim of sustaining hope: 
Alf (F 004) "It's not a very nice illness.. . you can ask the question how's Pam 
and you might say well that's OK, that's OK but that's not very good and that's 
not very good. Well you don't want to hear the not very good part".. 
5.4.7 Sustaining realistic hope 
Sustaining realistic hope when someone has an incurable and progressive 
illness is problematic (Clayton et at 2007) and was mainly achieved by the 
research participants in relation to short-term goals such as a trip away or 
attending a family wedding. It cannot be predicted how long patients will 
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survive following a diagnosis of multiple myeloma. The medium survival 
remains 3-4 years (Bradwell 2006). Some people may only survive for a year 
following diagnosis but there are those who live for ten years or more. One 
participant discussed the meaning of 'battle' or 'fight' in relation to sustaining 
life: "It's an ongoing fight. I mean.. . you know, the fight is to sustain life; 
it's as 
simple as that, that is the fight" (Frank P 007). 
It is rare for a patient to survive for twenty years. For example, there was only 
one patient at the study centre who had survived for twenty years. Contention 
arises through the uncertainty of the unknown length of time for survival which 
is discussed in the next section. Healthcare professionals realise how important 
it is to remain positive (Dias et al 2003) however it can induce false hope and it 
is misleading to imply that patients can live for the potentially maximum period 
of time: 
Karen (HCP 022) "When I talk to patients I try and stress that you know, we 
don't know but the average survivor lives three to five years but within that, you 
will get some people who will only survive for a year but then we also have 
patients who are 20 years post their diagnosis and that at this stage we can't 
predict". 
5.5 Contention in nature of disease 
Continuing from the previous statement the unpredictability of myeloma is a 
major cause of Contention because of disruption and uncertainty in the lives of 
people living with the disease. Numerous expressions were found in the 
research data such as 'living on the edge', 'living with the sword of Damocles 
over you', 'having an albatross around your neck', 'it is a ticking thing', 'a time 
bomb', 'living on death row', 'a death sentence', 'living with all the uncertainty', 
'a rough old ride', 'the ups and downs' and 'roller coaster'. Many of these 
expressions reflect the struggle and disharmony constantly present. Similar 
expressions are commonplace in the cancer literature. The nature of myeloma 
and living with uncertainty are synonymous. The concept of uncertainty is 
associated with other diseases (Shaha et al 2008, Haugh 2005, Winterling et al 
2004, Winters 1999 and Dudley 1995), In the context of living with a rare and 
progressive cancer such as myeloma, uncertainty is viewed as intensified, 
prolonged and entwined in a linear relationship to the pathway of the disease, 
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which, in itself, is unpredictable with an unforeseeable future. The differences 
between this disease (myeloma) and other cancers are the presence of bone 
disease and the unrelenting and ongoing periods of relapse. Individuals are 
living with an incurable cancer and despite all the novel chemotherapy agents, 
clinical trials and stem cell transplantations, the impact or effectiveness of the 
treatment may only last for days, weeks or months. This does not appear to 
occur with other cancers. 
In a recent review of the cancer literature (Shaha et al 2008) causes of 
uncertainty in common cancers such as breast, prostate and colorectal were 
identified as: inadequate information, decision making in relation to treatment 
options, coping with the cancer and impact on daily living. The 'ups and downs' 
or 'roller coaster ride' terms (Carter et al 2004, Nason 2004) in this research 
specifically relate to the repetition of myeloma relapse. Uncertainty is also 
associated with response to treatment and whether or not the therapy will 
effectively stabilise the disease. It is not unusual for chemotherapy to be 
exchanged following 2-3 cycles due to an escalation in progression of disease 
or severe toxicities (adverse events) that may result from the medication 
administered. Nason (2004) reported on two failed lines of treatment while in 
the meantime the disease progressed unrelentlessly. Although individuals adapt 
and cope with their illness, they tend to cope much better knowing that 
treatment is still an available option (Clayton et al 2007). 
5.5.1 Becoming knowledgeable 
The majority of patients and family members in this research became 
knowledgeable and familiar with the complex terminology which is associated 
with the cancer and the management of the disease (procedures and 
treatments). Gaining knowledge meant having control (Houldin 2007) and being 
able to judge progress (Thome et al 2003) and being able to cope at home as a 
patient or a caregiver (Mok et al 2003). Although in some cases there appeared 
to be interest and enthusiasm to learn, others may have struggled to do so. 
Learning the 'new language' was both challenging (battle) and daunting 
(struggle) and may have been viewed as a necessity to communicate effectively 
with the healthcare professionals. This may also be a reflection on the period of 
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survival, which ranged from 20 months to 20 years allowing time to develop 
from 'novice' to 'expert patients'. Examples of 'expert' patients were previously 
shown in Table 11. With the exception of three participants diagnosed between 
2006 and 2007, two of the patient group could be categorised as experienced 
patients who chose not to become involved with familiarisation of terminology or 
learning about the disease. These participants appeared 'detached' and 
attempted to 'block out' any knowledge associated with the illness as a way of 
coping. Participants aware of the impact of bone disease and potential 
consequences lived with uncertainty regarding their future physical capabilities, 
which had a substantial psychological impact and threatened their quality of 
existence in numerous ways creating disruption and disharmony. This is 
abundantly clear in the following two excerpts: 
Debs (P 009) "They've been very good at work, I'm still, I'm being paid sick pay 
but I don't know how long that's going to go on for, you know, with the 
anticipating of sort of going back but I'm not sure if that's ever going to happen" 
Geoff (P 011) "It's just not knowing what course the disease will take next year. 
You don't know how it's going to affect you. There are people I've spoken to 
who've had severe back problems. I said to, either Tom or Harry (consultant 
and registrar) should I pack up playing golf, is swinging a golf club, I know it's 
how it broke, my arm, broke it in the first place, but will I one day, just have my 
spine go while I'm playing"? 
5.5.2 How others perceive us 
Struggle emerged in relation to perceptions and how others (family and friends) 
viewed the illness particularly when there were no visible signs and the patient 
looked or appeared healthy. Rupert (1987: 21) discussed her myeloma in terms 
of an "assault from within" and objected to others complimenting her on how 
well she looked as this was interpreted as: 
"Because / looked well / must be well" page 22. 
Adverse events or side effects from medication were sometimes so severe that 
these manifested as the only obvious visible symptoms and changed other 
peoples' perceptions of the illness. Visible symptoms signified legitimate 
disease convincing family members that it existed. Newly diagnosed cancer 
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patients with leukaemia and malignant lymphoma experienced difficulties 
convincing others of their illness because they appeared to look well (Persson 
and Hallberg 2004). 
Multiple myeloma is not generally associated with young people or parents of 
pre and school aged children, which was found to be significant in this research 
and a reflection of the decreased median age at diagnosis (Schey and Pallister 
2004) The argument here is understanding that this younger population of 
patients have different issues to that of the elderly population of patients. 
Younger caregivers' experiences of newly diagnosed advanced colorectal 
cancer with children reported higher levels of distress (Houldin 2007). There 
appears to be far greater disruption and disharmony impacting on family life 
when the father of a young family becomes incapacitated and can no longer rely 
on an income to support them. This kind of 'supportive care' needs to be 
recognised by healthcare professionals. Equally pertinent is for patients and 
families to understand that healthcare professionals are in a position to assist or 
refer them to the appropriate person who can advise and support them. The 
discussion continues with Contention in impact on life. 
5.6 Contention in impact on life 
Contention associated with life for the participants and that has been reflected 
in the literature, meant total disruption (Houldin 2007, Houldin and Lewis 2006) 
and chaos (Persson and Hallberg 2004) to normality and life, as it was known 
prior to the onset of the illness. It was described in terms of normal existence 
and daily living hitting a 'dead stop' or "standing still" (Houldin and Lewis 
2006: 722) and dramatically changing. Future plans were either postponed or 
destroyed. In relation to this research, the presence of bone disease can be 
exceedingly debilitating because of constant pain and the fragility of skeletal 
bones predisposes to multiple fractures. Some of the participants were not able 
to return to work because of disability. Others who managed to continue had 
non-manual jobs (information technology, finance and banking) despite 
disruption to normal working patterns caused by ongoing hospital appointments 
and treatment regimes resulting in significant periods of absenteeism. 
Commuting or travelling was viewed in terms of struggle. Participants aimed to 
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avoid crowded public transport to isolate themselves from potential infection 
due to their immunodeficiency. This was a constant source of worry following 
chemotherapy on the day care unit and travelling home during the 'rush hour'. 
The anxiety associated with delay or being detained longer than anticipated is 
viewed in terms of struggle and 'feeling on edge' (disharmony). All cytotoxic 
medications cause bone marrow suppression with the exception of vincristine 
and bleomycin (BNF 2006). Thus the immunodeficiency associated with the 
myeloma is further exacerbated by the chemotherapy. Participants were usually 
acutely aware of the potential consequences and therefore felt vulnerable 
following treatment. 
5.6.1 Impact of treatment 
The physical and emotional impact of treatment was another major source of 
Contention. In this research, as in other research, people not only struggled and 
fought (battled) the disease; they struggled and fought (battled) the physical and 
psychological consequences of treatment they had to endure (Houldin and 
Lewis 2006, Persson and Hallberg 2004, Thome et al 2003). For example the 
physical and emotional trauma dealing with invasive and ongoing cycles of 
intravenous chemotherapy over prolonged periods involving repeated punctures 
from needles (cannulations) resulting in arms full of bruises, abrasions, 
associated anticipatory trepidation and feeling 'ill at ease' (disharmony) in the 
interim period prior to the administration. The dilemma of toxicity of the 
medication has to be weighted against its efficacy and the individual's safety 
and well-being. Patients are sometimes reluctant to report adverse events 
because of the fear that dose of medication will be modified (dose reduction) 
and it is then viewed as less effective; or treatment may be discontinued and 
there is the fear that the disease will progress or worsen. 
The physical impact of treatment ranged from mild to severe and in some 
instances life threatening, for example deep vein thrombosis and substantial 
internal haemorrhage. The haemorrhage, in this instance, may have been 
precipitated by two factors: the use of non-steroidal anti-inflammatory drugs for 
bone pain and the destruction of stomach membranes caused by the 
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chemotherapy. (Sylvia's husband Bill had taken Brufen (Ibuprofen) occasionally 
for his bone pain): 
Sylvia (F 028) "He (surgeon) said it was all the chemotherapy that had burnt all 
the lining of the stomach away and because of all the neutropenia and all of 
that ... as soon as 
they was putting it in (blood), it was just coming out... because 
there was nothing there, you know platelets to clot the blood, and he was the 
one who turned round and said to me make sure your husband never ever 
takes any anti-inflammatory drugs"... 
Ray Grummett's reference to his stomach lining (Grimmett 2006: 87) was related 
to his inability to eat: 
"There are white spots in my stomach and it seems that the stomach lining has 
not grown back after the ravages of the chemo. When / was in Addenbrooke's 
(hospital) the skin on my fingers split and eventually fell off, and was quite 
unpleasant. The doctors also said that the same thing would be happening to 
my gullet and gut, so it is hardly surprising that my insides are a shambles". 
Four participants complained of permanent damage to peripheral nerves 
affecting their hands and feet induced from medication, which had a profound 
and disruptive impact on the quality of their lives. The effects from steroids used 
to treat myeloma such as dexamethasone were particularly troublesome 
causing patterns of unusual behaviour, which was out of character. One 
participant described himself as an "irritable monster" (Dave P 023), which he 
attributed to his dexamethasone. Another (Fred P 017) complained that he had 
become short-tempered 'snapping' at people resulting in emotional conflict and 
disharmony (Table 14). McGrath et al (2007) report on disturbing psychological 
adverse events such as aggression, isolation, confusion and depression 
associated with the treatment of dexamethasone in children with acute 
lymphoblastic leukaemia. This had a substantial impact on family members who 
were described as "exhausted from the prolonged treatment process" (p 90). 
The emotional experience associated with high dose therapy (stem cell 
transplantation) described as one of the most unpleasant hospital experiences 
was due to physical and psychological consequences of this particularly 
aggressive treatment. Carlson and MacRae (2002) include elevated levels of 
stress, anxiety and depression prior to and following the transplant procedure. A 
major theme in the meaning of experience associated with leukaemia and stem 
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cell transplant was the aim of achieving a cure (Haberman 1995) as opposed to 
achieving stability of a progressive and incurable myeloma. This was an 
experience that participants in this research endured more than once knowing 
that it could potentially extend their survival. 
5.6.2 Impact on sexual relationships 
Contention caused as a result of impact on sexual relationships and family life 
emerged in terms of disruption, chaos, upheaval and emotional conflict 
(disharmony). Sexual relationships were disrupted or damaged as a result of 
the disease and the effects from treatment (Thome et al 2004, McGrath 2001, 
Rice 2000). Although sexual support may also be enhanced within a 
relationship during illness (Houldin 2007) sexual activity became intolerable for 
individuals who were debilitated because of pain associated with bone lesions 
or fractures particularly involving the spine, chest, hips, pelvis and upper thighs. 
Sexual disruption was also caused through fatigue, erectile dysfunction and the 
development of one penile tumour creating a private and hidden struggle for the 
individuals concerned. One participant was tormented and agonized over the 
impact this had on his wife despite the fact that as a couple they were able to 
talk about the problem. It remained a concern: 
Mike (P 040) "I cannot really, you know, well make love to my wife, satisfy her 
the way that I should but you know, that is a worry for me in a sense but again, 
worried about it yes, but worry cannot fix it. You know cannot make it better. / 
think about it sometimes but yes try to put it at the back of your mind really 
because that's not going to help". 
5.6.3 Impact on family 
Changed domestic roles within the family home environment (Simpson 2005) 
took place where, for instance the male partner exchanged roles with the 
female who was ill or incapacitated, taking on board the household duties 
traditionally done by the female such as shopping, laundry and cooking. 
Alternatively the female took on responsibilities traditionally done by the male 
such as attending to the household bills or orchestrating assistance from other 
male members of the family for `heavy' work such as furniture moving, 
gardening or repairs. Family life appeared to alter significantly more for those 
with children living at home. Examples included the problem of storing vast 
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quantities of medication in the home away from the children; adult children 
preparing meals for parents; adult children escorting a parent out in a wheel 
chair; and having to rely on other family members or friends to take care of 
infants. In contrast children in their late teens or early twenties away at 
university or living away from home were perceived as `getting on with their 
lives' and doing what they would normally be doing: 
Carol (F 012) "The kids by virtue of the fact that they do live, you know they're 
doing everything that they normally did. I mean since Geoff 's been diagnosed, 
Nancy's been around the world for a year. You know they both finished their 
degrees. Fran's been off travelling to Australia and New Zealand, you know 
Nigel's doing all the things he'd do, which means that they've kind of got an 
inbuilt faith that everything is going to be OK. Do you know what I mean? Which 
is quite reassuring really, you know the fact that it hasn't, we the family life 
hasn't changed. The kids' lives haven't". 
Struggling between the illness and being a parent proved to be a major source 
of contention. Loss of identity as a parent and loss of parental control were 
viewed in terms of frustration, disappointment and anguish. The desire to regain 
parental identity and control became overwhelming. Examples included 
termination of pregnancy, taking care of the child (Table 17), walking with the 
child and carrying the child which the parents were no longer physically able to 
do: 
Debs (P 009) "He (Son Ben) is looking forward to when / can go out for a walk 
with him". 
The monumental impact on the family and psychological distress appeared 
more intensified because of significant life events and the time of life (Houldin 
2007) that the disease struck particularly in relation to the participants with 
young children. Their lives were in a constant state of turmoil and domestic 
upheaval because of the debilitating effects of the disease. Jack (P 014) for 
example was no longer able to take care of his toddler Nathan in the evenings 
while his wife went to work. Hiring a reliable child minder was a constant worry. 
This couple had no extended family members living in the UK and felt that they 
could not continually accept offers of help from friends: 
Jack (P 014) "We can only ask so much of friends, before you feel 
uncomfortable about it and friends offer all the time and we can say thank you 
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very much of course but you don't want to take them up on it all the time". 
In contrast to the lack of family support, taking on shared responsibility of 
younger children when a parent was incapacitated meant that the lives of those 
individual family members involved were also 'on hold' or at a standstill having 
a disruptive impact. For example, other research findings suggest individuals 
rearranged their working lives (Wideheim et al 2002), cancelled social 
engagements, took unpaid leave and made themselves available. Simpson's 
(2005) portrayal of Chinese women with breast cancer reported that their 
partners or family members were constantly with them providing the physical 
and emotional support they needed. 
Hospital appointments and prolonged treatment regimes including the aftermath 
appeared to dominate the lives of participants and their families. Travel between 
local and specialist hospitals and parking the car was problematic in terms of 
finding somewhere to park (a constant battle) and additional expenditure. 
Ways in which families coped during difficult periods such as when the disease 
had progressed significantly or was no longer responding to treatment ranged 
from a "conspiracy of silence" (Brennan 2004: 100) in order to sustain hope and 
protect each other (Simpson 2005) to talking openly and making realistic plans. 
Maintaining a 'conspiracy of silence' may be viewed as a struggle (hindrance) or 
a battle (challenge) when communicating with each other as members of the 
family must be 'on their guard' the whole time or establish ways of creating a 
positive atmosphere. Either way may cause an additional burden, disruption 
and disharmony in normal family communication. Identifying emotional support 
needs such as family counselling would therefore potentially be helpful in 
facilitating openness in communicating within the family who are unable to talk 
or come to terms with a loved one's deteriorating condition and impending 
death. Contention in supportive care needs follows. 
5.7 Contention in supportive care needs 
Similar patterns emerged throughout the data relating to problems or barriers 
accessing supportive care services. Contention was identified through struggle, 
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conflict and fight (battle) experienced by participants as a result of their 
supportive care needs not being adequately met or acknowledged. It is 
suggested that lack of recognition of specific supportive care needs was linked 
to rarity of the cancer, lack of awareness and lack of knowledge. Having a rare 
disease means coping with the illness and with other peoples' ignorance 
(Joachim and Acorn 2003), which represents a challenge for the individual 
family concerned, and for members of the public. Therefore individuals in a 
position to facilitate access to supportive care services were, in some instances, 
oblivious to the impact and consequences of the disease. For example, outside 
the haematological oncological arena participants were dealing independently 
with external agencies such as employers, DHSS and insurance companies. 
Even within other areas of healthcare it cannot be assumed that healthcare 
professionals are familiar with the term multiple myeloma. In a GP's surgery, for 
instance, practice nurses admitted they had not heard of the cancer: 
Pam (P 003) "At times I'd go to... even like a nurse at the surgery or ... if I had to have blood tests or anything and I used to say, I have myeloma, they used to 
go myeloma? What's that"? 
Invisible struggle, impact of policy and decision-making were key issues 
associated with supportive care needs. 
5.7.1 Invisible struggle 
Invisible struggle emerged as problems or difficulties in participants' daily lives 
associated with the illness but not immediately apparent or observable. Various 
reasons may prevent individuals discussing problems they have other than 
medical matters. They may be too embarrassed if issues are of a sexual or 
financial nature (McGrath 2001). It could be that the role of the healthcare 
professional is perceived as 'departmentalised' and can only deal with the 
cancer and its treatment. The outpatient setting may not be a conducive 
environment for such disclosure. Patients and family members may not wish to 
discuss what might be considered as 'private family business' with healthcare 
professionals. Furthermore patients may not be asked a specific question which 
would provide the opportunity to respond and allow discussion concerning a 
particular problem they may be experiencing at home or at work. Examples of 
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invisible struggle included difficulties with completing mammoth and 
complicated DHSS application forms and experiencing difficulties accessing 
support such as incapacity benefit. In one case the struggle, conflict and battle 
continued for seven years during which an annual independent medical 
assessment was undertaken to assess whether the participant was fit enough to 
resume work: 
Bill (P 027) "They (DHSS) used to send their doctor round to assess me. They 
wouldn't take notice of my GP or the hospital, no; they always had to have an 
independent chap come round. But / think it was about four years ago, that I 
finally got a letter from them saying that ... we now recognise that your illness is indefinite and ongoing". 
Financial struggle was a major concern and participants worried about the 
colossal amounts of money spent on travelling to the hospital, petrol and 
parking the car. One participant's invisible struggle was not knowing or 
understanding the healthcare and social system in the UK as he had only lived 
in the country since 2003. He was unaware of what help he may be entitled to 
and had problems convincing colleagues at his place of work that he was ill. 
The consequences of this meant that he had not yet received statutory sick pay 
and was struggling financially (Table 19, Victor P 030). Nine out of eighteen 
Bangladeshi families in East London referred to a community-based palliative 
care facility were reported as having serious financial problems through 
borrowing money from relatives (Spruyt 1999). 
Another participant was very resourceful and had not only studied the disease 
but familiarised himself with approaches to accessing supportive care 
advocated that most individuals did not have the "forcefulness or the 
demeanour or whatever to actually deal with all the flack that you get or dealing 
with disappointment" (Phil P 019). The evidence suggests people struggled and 
battled in their efforts to access help and supportive care. Phil was referring to 
liasing with people at the DHSS and insurance companies. This participant (Phil 
P 019) was disappointed at the sudden withdrawal of his private health 
insurance following his stem cell transplant (undertaken by NHS Trust 
professionals) invalidating the insurance cover. Insurance companies tend to 
base their decision on whether the condition is defined as chronic, unsuccessful 
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treatment or the illness is terminal (Pallot 2004). The withdrawal of private 
healthcare insurance is particularly stressful and disruptive when patients are 
going abroad and may require urgent medical attention. 
5.7.2 Impact of policy 
Recommendations produced by NICE are based on the clinical evidence 
provided and cost effectiveness that is considered appropriate for a modern 
NHS. The policy taken to withdraw the availability of bortezomib (velcade) 
caused a great deal of controversy, alarm and anguish. Contention emerged 
through sheer desperation and the difficulty participants had in coming to terms 
with this decision which caused anger, frustration and disappointment. 
Psychologically patients felt that their lives were undervalued and potentially 
shortened. Uncertainty and disharmony constantly present in the lives of those 
individuals living with multiple myeloma appeared to be further exacerbated as 
a direct result of the decision concerning the availability of bortezomib. 
As stated in the Findings Chapter, following an appeal, a final appraisal report 
(July NICE 2007) indicated the medication would be available on the NHS for 
patients following their first relapse having had one prior therapy providing they 
have had, or were not eligible for bone marrow transplantation. This policy 
excluded a vast number of the myeloma population namely those who have 
relapsed more than once restricting their treatment choices. This decision 
impacted on patients, family members and healthcare professionals. The 
following healthcare professional suggested that patients would be able cope 
better emotionally if everything possible had been tried: 
Nurse Karen (HCP 022) "l think patients actually cope better, we've got some 
patients who you know, they've had velcade, they've relapsed fro m their 
velcade and they're saying you know, there isn't any options now, you know l 
appreciate, I know, we can go back through some of the others but nothing is 
now going to hold it for very long and I'm looking towards palliative care, and 
that's OK because they feel that they've done everything but for these patients 
where there are these other options around and they're just not allowed them, 
it's just so difficult to think that nobody values your life". 
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5.7.3 Decision-making 
Contention in decision-making was associated with the struggle individuals 
faced when confronted with having to make difficult decisions they felt unable to 
make especially concerning treatment options or significant life events. Difficulty 
in making decisions regarding treatment options often coincided with the time 
that the diagnosis was confirmed. Participants were therefore often in a state of 
shock and bewilderment while at the same time struggling to concentrate on 
explanations concerning managing and controlling the disease. It is suggested 
that in some instances participants were encouraged to participate in clinical 
trials undermining their freedom to choose. Some of the participants felt that 
they were being rushed and simply 'swept along with the moment', consenting 
but not understanding everything that was happening to them. Participating in a 
clinical trial may be the only solution for some individuals who have had several 
lines of therapy because of immediate access to novel agents that might not be 
available within the NHS Trust. Struggle in relation to decision-making is often 
transformed into battle or assertiveness particularly when the patient has 
experienced more than one line of chemotherapy. The experience and 
knowledge gained, for example enhances awareness and understanding which 
enables the individual to make a more informed choice. 
However for individuals who are newly diagnosed a clinical trial is an additional 
option to traditional therapy. Decisions should not be made merely to 
accommodate clinical trial recruitment targets. Individuals may base their choice 
of therapy on the method of administration or whether they could be treated 
nearer their home at the local hospital. Oral medication may appear attractive to 
patients compared to the more invasive intravenous therapy. Taking tablets at 
home and avoiding additional trips to the chemotherapy day care unit for the 
administration of intravenous agents was considered a preferable option for 
some: 
Dave (P 023) "The actual experience of getting chemotherapy is not, not really 
fun because you know it's going to make you tired, it's going to make you 
washed out, or whatever, even though medically it's very necessary. I must 
confess / much prefer thalidomide because that's taken in pill form". 
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The majority of participants were in a position which enabled them to make 
informed choices once they had passed the 'novice stage' and had gained an 
adequate level of knowledge and understanding of their illness and how it was 
managed. The consultant haematologist is generally viewed as the expert and 
many will be guided in their decision-making. A minority of participants did not 
actively engage in the process of decision-making and allowed the healthcare 
professionals to take complete responsibility as was found in Thome et al's 
(2003) research. The healthcare professional has a moral and ethical duty to 
provide all the relevant information available so that individuals can make 
informed decisions. However the timing is crucial and if the individual is in a 
state of shock or bewilderment it may not only be considered an unproductive 
exercise but an immoral one. Clayton et al (2007) highlight the importance of 
asking the individual if they can cope with the additional information at this 
particular moment in time. 
Contention that occurred in decisions that related to significant life events varied 
considerably from struggling to get to a family wedding or taking a holiday, to 
moving abroad to be near family and termination of pregnancy which had a 
devastating impact on the family at the time of diagnosis. The intensive 
treatment of combined chemotherapy agents and radiotherapy required for the 
areas of severe bone pain in this case may have resulted in severe birth defects 
(Weisz et al 2001). 
5.8 Applicability of Contention in relation to other chronic illnesses 
The basic premise underpinning the theory of Contention is the assumption that 
it is applicable (fittingness) to other chronic and progressive diseases such as 
Parkinson's or Alzheimer's disease for example. Thus it is suggested that the 
defining attributes of Contention contribute to the understanding and meaning of 
living with other chronic, progressive and debilitating illnesses. 
In contrast to multiple myeloma, Parkinson's and Alzheimer's are relatively well 
known diseases although Alzheimer's (a form of dementia) is far more common. 
There are approximately 120,000 people living with Parkinson's disease (Carter 
2008) many of whom will also develop dementia (Noble 2007). According to the 
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Alzheimer's Society, there are about 417,000 people with Alzheimer's disease 
in the UK (www. alzheimers. org. uk). The figures 10-15,000 people living with 
multiple myeloma appear minuscule in comparison highlighting the rarity of its 
incidence. 
A similarity between Parkinson's disease and multiple myeloma is that they both 
affect more males than females (Bury 2005). Alzheimer's on the other hand is 
more prevalent in females than in males (McCabe 2008). These specific 
diseases will inevitably have different meanings to people, a profound impact on 
the individual who is afflicted and both Parkinson's and Alzheimer's can have a 
devastating impact on family members and friends. For example life was totally 
disrupted for a 17 year old daughter who took on the responsibility of her 
father's care while her mother was at work (Altschuler 1997). The family found it 
difficult to discuss the illness (Parkinson's) and while the condition deteriorated 
and her father's needs increased, the couple's teenaged daughter became 
anorexic and needed professional help (Altschuler 1997). The nature of 
disruption in someone living with Alzheimer's disease and the impact on family 
life can be categorised as catastrophic and relentless. A 73 year old man, for 
example, continued to care for his wife at home with assistance from 
professional nurses. His wife had lived with Alzheimer's disease for 10 years 
and she no longer recognised her husband or their children: 
"This illness didn't just destroy Anna's mind, it has killed something in me, in the 
family too. If anyone asks about Alzheimer's tell them it is a disease of the 
whole family" (Kleinman 1988: 183). 
Regardless of the nature of the illness each family is unique and family 
members will react to illness in their own unique way. Influencing factors such 
as culture, knowledge, education, mass media, personal values and beliefs, 
individual characteristics, circumstances, social and religious orientation may 
determine how an individual family cope and respond to illness (Altschuler 
1997). It cannot be assumed, however, that family members will always be 
compassionate or collaborate in order to provide support when it is most 
needed. Partners may not be able to cope and inevitably relationships can 
deteriorate and end in separation because of the illness (Fleming et at 2004). 
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Contention in the nature of Parkinson's disease, for example, is explicated in 
terms of struggle and fight or battle in relation to the debilitating and progressive 
course of the illness and its impact (Fleming et al 2004, Habermann 2000). 
Disruption to life clearly emerges in the literature: "My world had turned upside 
down" (Fleming et al 2004: 518). A significant decline in attending social events 
or receiving invitations is reported and some individuals deliberately stay away 
from public scrutiny. The disease manifests itself through characteristic and 
unpredictable periods of sudden loss of physical mobility which is disruptive and 
frustrating. From a family member's perspective (spouse or partner) one of the 
key concerns reported was seeing their loved ones struggling with the illness: 
"Watching him struggle is very difficult for me. / have seen him in the worst 
possible stages, barely able to walk, dragging his leg, he has fallen" 
(Habermann 2000: 1410). 
Evidence suggests psychosocial and physiological disruption often resulting in a 
gradual decline from society and the way in which others react during episodes 
of sudden uncontrollable tremors or complete immobilisation. Disharmony is 
associated with the social stigma that exists and the lack of understanding or 
misconceptions of the illness creating growing psychological disturbance and 
discomfort for the person suffering with Parkinson's disease. From the patient's 
perspective alterations in body image and perceptions in relation to how 
individuals viewed themselves with the notion that others also viewed them in a 
negative way appear to have a profound effect on self esteem (Fleming 2004). 
Feelings of incompetence, embarrassment and 'living on edge' (disharmony) 
are embedded in the nature of the disease: For example a person can be made 
to feel misunderstood because they are unable to speak clearly or they are 
capable of walking one minute and not the next (Caap-Ahlgren et al 2002). 
These visible manifestations are a sharp contrast to people living with a 
haematological malignancy and the consequences of apparently looking well 
(4.13.1) which is also misconstrued. 
5.9 Limitations 
As with any research study there were a number of limitations some of which 
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have been addressed previously for example issues associated with the role of 
insider/practitioner researcher and the potential for influencing the data 
collection (3.9.2) In addition more specific issues relating to the study (3.9.3) 
have also been acknowledged such as the appropriateness of returning 
transcriptions to participants for clarification of meaning. 
Returning to the nature of the disease, a limitation existed regarding selection of 
participants and the diversity or multifaceted character of myeloma and its 
classifications. The majority of the patients (n=14) who participated had the 
most common type of myeloma categorised as IgG kappa or lambda light chain 
myelomas. However it would not have been feasible to recruit patients with 
some of the more obscure or uncommon types of myeloma some of which are 
so rare that they represent a minute percentage of the myeloma population. For 
example both IgD and biclonal myelomas represent 1% of the myeloma 
population. The experience of illness would have contrasted with other 
classifications because of the different symptoms and would have enriched the 
study. The study could also be viewed in terms of a 'snapshot' in time as 
healthcare services and treatment are constantly evolving and improving. 
The sample of participants (n=40) was relatively small and patients and family 
members were recruited from one centre. The individual groups of patients 
(n=17), family members (n=11) and healthcare professionals (n=12) 
represented small samples restricting generalisability of the study. The nature of 
qualitative approaches to research tend to focus more on events, circumstances 
and experiences with smaller numbers of participants. However, due to the 
restricted number of Clinical Nurse Specialists in myeloma, the healthcare 
professionals were recruited from various regions in the United Kingdom. The 
patients and families were known to me previously with the exception of six 
patients and two family members. This may have influenced the data collection 
and the way in which the participants responded while participating in the study 
as previously discussed in specific methodological issues (3.9.2). These 
interviews were more productive because of the established relationship and it 
became apparent, that for some of the participants, it was an emotional but 
cathartic experience as it provided an opportunity for individuals to discuss 
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'sensitive' and 'personal' issues that had a significant impact on their lives and 
supportive care needs. 
5.10 Towards a model of supportive care 
Developing a model of supportive care would seem a natural progression 
forward. A basic premise underpinning the model is that human beings all have 
fundamental needs and that nursing and healthcare are directed towards the 
family and not merely the individual. The Arc and Tunnel diagram (Figure 8) 
represents a model of supportive care in its infancy to be developed and refined 
further. The large arc is divided into four domains: 
" Physical needs 
" Psychosocial needs 
" Existential and spiritual needs 
" Informing and educational needs. 
The central components (main interrelating concepts) of the model are 
healthcare, communication; supportive care needs, Contention and illness 
trajectory. The tunnel part of the diagram represents a potential illness 
trajectory. Each continuous black arc relates to periods of unstable or 
progressive disease (relapse, refractory and end of life). The first arc at the 
tunnel entrance labelled `diagnosis' is situated within a three way arrow 
indicating potential course of direction of the disease, for example the patient 
may not make any progress and die shortly following diagnosis. The dotted arcs 
relate to stable disease or remission. Each arc equates to approximately 6 to 12 
months of life. The assumptions underpinning the model of supportive care are 
that healthcare professionals, patients and families work in collaboration to 
establish their immediate and ongoing supportive care needs in light of recent 
policy developments (Department of Health 2007; NICE 2004). The model 
requires an understanding of supportive care needs and how to elicit specific 
information in order to identify and meet the individual requirements of a patient 
and family. The model can be used in conjunction with the nursing process or 
within a framework from other disciplines and is yet to be validated. 
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5.11 Summary and the emerging theory 
This chapter discussed the findings of the research within the context of the 
core category Contention and associated subcategories, which have been 
explicated in relation to existing literature. The elementary components of the 
theory of Contention are further explicated through the undertaking of a concept 
analysis. The theory of Contention is a raw substantive and descriptive theory, 
which has emerged through human struggle and adversity. The overall 
emerging theory of Contention and its rudimentary components are presented 
within the metaparadym concepts of person, environment, health and nursing in 
Appendix 14. The aim of the research was to increase understanding and 
awareness in relation to the impact of multiple myeloma on an individual's life 
and explore the supportive care implications. Consequently a proposed model 
of supportive care needs for patients and their families has also been 
presented. Chapter 6 explores the issues arising from the research, their 
significance and contribution to the body of knowledge. 
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Chapter 6 Conclusion 
6.1 Introduction 
The aim of this research was to explore individuals' experiences and supportive 
care implications living with multiple myeloma, a rare, progressive and incurable 
cancer. The research was also aimed at complementing the increasing amount 
of worldwide biomedical research and clinical trials in existence. The inspiration 
came from my clinical practice working as a clinical trials nurse. The decision to 
take on this investigation was based on the assumption that healthcare 
professionals were not meeting the psychosocial needs of the patients. The 
objective was to generate theory derived from data collected from the research 
participants thus influencing the decision to utilise a grounded theory design. 
This final chapter summarises the findings and their significance in relation to 
the way they contribute to the body of existing knowledge. Implications for 
future practice, education and research are presented. Further 
recommendations are suggested in relation to supportive care needs of patients 
and their families. An overall contribution towards the body of knowledge, 
strategies employed for dissemination of the findings and concluding comments 
complete this thesis. 
6.2 Findings and their significance 
6.2.1 Contention 
'Contention' represented the core or central category that emerged from this 
grounded theory study. The main interrelating categories comprised of 'Ways of 
communication', 'Nature of the disease', 'Impact on life' and 'Supportive care 
needs'. Contention was defined and explicated further through the process of 
concept analysis (5.3). The defining attributes of the new nursing concept 
Contention identified as struggle, battle, disruption and disharmony in the 
context of living with multiple myeloma were all clearly represented in the 
research data but not all appeared together representing a 'model case' in the 
literature. According to Walker and Avant (2005) a 'model case' can be 
constructed from real life experiences or examples found in the literature. 
Contention as a concept helps to explain the nature of the demands associated 
232 
with the diagnosis and contributes to enhancing understanding of living with a 
progressive disease. There is a presentation of the emerging components of the 
theory of Contention (Appendix 14). The theory, as it stands, is descriptive, not 
predictive or explanatory and will evolve in further research and publication 
through the undertaking of postdoctoral study. 
6.2.2 The fundamental issues 
The original aims and objectives of this research (1.10) relating to the meaning 
of living with multiple myeloma in terms of becoming ill and being diagnosed 
(4.4.2, Table 3), impact on personal or family life (4.22.2, Table 17), impact on 
family members (4.17.2, Table 12), impact on professional or working life 
(4.17.1) and perceptions of health care and supportive care services (4.24, 
4.25.2, Table 19) correlate to the findings presented in Chapter 4 and discussed 
in Chapter 5. Delay in diagnosis, for example, represents a fundamental issue 
relating to the meaning of living with multiple myeloma in terms of becoming ill 
and being diagnosed. Complex medical language used in haematological 
oncology was perceived by participants (patients and family members) in terms 
of healthcare professionals communicating in a way that sometimes created 
confusion and misunderstanding. The numerous characteristic periods of 
relapse and remission (stable disease) epitomises the unpredictable and 
unrelenting nature of the disease and the emotional impact on individuals and 
family members. The invisible struggle is explicated in terms of impact on family 
life, sudden loss of income and difficulties experienced when accessing 
supportive care services. 
The issue of delay in diagnosis (a primary cause of Contention) is significant 
because of the monumental impact this has had on the quality of life of the 
participants. It is known that multiple myeloma is difficult to diagnose because of 
the complexity and unremarkable onset of the disease. The findings from this 
research contribute new understanding of the ramifications of delayed diagnosis 
from the patient's and family's perspective. The result of undetected and 
consequently untreated bone disease progressed to the stage where several of 
the participants had broken backs (multiple vertebral fractures). It is argued, 
therefore, that there should be a focus on investigation of cause and not merely 
233 
treatment of symptoms based on medical judgement, biased towards the 
probability that the condition is a common ailment. 
A fundamental issue addressed in this thesis is communication and language 
that is used when healthcare professionals are interacting with patients and 
their families. Haematological oncology is a highly specialised clinical area and 
healthcare professionals naturally converse in haematological terminology, 
which for them is familiar and routine. For many of the participants (patients and 
their families) a diagnosis of an incurable blood cancer was shocking and 
devastating news resulting in disruption and disharmony (Contention). The 
words 'multiple myeloma' represented foreign terminology and the rarity of the 
cancer meant that most individuals had heard the name of the disease for the 
first time. Interactions during this sensitive and vulnerable phase were usually 
emotionally demanding for the healthcare professionals and even more so for 
the recipients of bad news. The use of complex medical language created 
confusion and chaos leaving some of the participants in a state of bewilderment 
exacerbating their distress. 
Contention escalated during periods of relapse (unstable disease) which 
followed a pattern of relative normality meaning reprieve from the long months 
of treatment with chemotherapy. This aggressive and prolonged treatment 
period was replaced with monitoring of stable disease and continued supportive 
therapy such as monthly pamidronate infusions for bone disease and 
analgesics for pain control. During periods of monitoring patients and their 
families struggled with mixed emotions and uncertainty. On one hand it was 
perceived as a monumental relief to return to normality, but on the other relapse 
was anticipated. The uncertainty was not knowing when or how long it would 
be before the next relapse. Participants kept a watchful eye on their blood test 
results especially the Mbands or paraprotein levels (disease markers). Any 
slight elevation created high anxiety because this indicated that the disease was 
probably starting to progress. Participants described living with multiple 
myeloma in terms of `living with a time bomb' and 'living on the edge'. Patients 
who had experienced more than one or two lines of chemotherapy knew what to 
expect. Others who had only experienced one line of chemotherapy and were 
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living with stable disease appeared more optimistic in comparison. One 
participant who had an unusually long period of stability (remission) for several 
years was more shocked about the relapse than the diagnosis having believed 
that the cancer had been cured despite being informed that myeloma was 
incurable. 
The invisible struggle encompassed all the characteristics of Contention and 
related to the difficulties participants experienced and the impact of the illness 
on family life that healthcare professionals were apparently unaware of. Finance 
and sudden loss of income was a major concern for participants who were no 
longer able to work for example. Individuals who were too unwell or disabled 
relied on family members to access support services on their behalf. Dealing 
with external agencies such as the DHSS was problematic for numerous 
reasons and consequently individuals either gave up through exhaustion or 
continued with a battle that lasted for months until the situation was resolved. 
The crucial point here is that if healthcare professions take the initiative in the 
early stages of the illness and appropriate referrals are made families will 
receive the help they need at the earliest opportunity and not have to struggle 
alone. 
The progressive nature of the disease and its trajectory delineate specific points 
in time when Contention may escalate or crescendo which ultimately 
determines periods when emotional support for patients and their families could 
make a significant difference to their psychological well being and adjustment. 
Critical points in time are: 
" Transformation of MGUS to myeloma 
" Confirmation of diagnosis 
" Starting treatment 
" Hospitalisation 
" First and subsequent relapses 
. Interim phase (monitoring and uncertainty) 
. Ending cancer treatment (not having any impact) 
0 End of life (palliative care). 
The generation of findings and grounded theory produced from this research 
underpin the central hypothesis of this thesis explicated below: 
235 
Increased understanding and awareness of the impact of a rare, complex and 
progressive cancer will assist healthcare professionals in the identification of 
patients' and their families' individual supportive care needs at specific points in 
time throughout the illness trajectory. 
6.3 Recommendations for practice 
Findings suggest that the supportive care needs of the participants were not 
always recognised or addressed. Participants were not able to articulate their 
needs until they had time to understand and accept the implications of the 
diagnosis and the impact this would have on their lives. The participants in this 
research attended the chemotherapy day care unit and most were keen to take 
on responsibility for their health and well-being although there are critical points 
in time as mentioned previously when they may require hospitalisation or 
professional care. Patients and their families need to be kept well informed so 
they know what to expect and require adequate time to arrange their lives 
around hospital appointments and treatments. Each family is unique and it may 
not be possible to anticipate all their supportive care needs. 
It was with the outpatient setting in mind and families struggling at home that 
the concept of a Family Self-Assessment and Referral Plan (Appendix 19) was 
developed during the course of this project. This leaflet aims to help patients 
and family members identify their supportive care needs and explain about the 
services that are available to them. It also provides contact details of their local 
clinical nurse specialist who may assist them or make an appropriate referral. 
The main objective is for patients and families to have immediate access to 
professional help and advice when they need it. The leaflet has been designed 
to be handed to the family by a healthcare professional once it has been 
completed with the contact details of the local clinical nurse specialist and 
Macmillan nurse. This may involve liaison between local hospitals and Cancer 
Centres when patients travel further from their homes for treatment. 
The need for the clinical nurse specialist, palliative care and haematological 
oncological teams collaborating at an early stage of the illness is essential and 
must be considered whenever a person is diagnosed with this or any other 
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haematological malignancy. This is applicable to all patients diagnosed with 
cancer and other chronic debilitating and progressive illnesses. 
Patients do not always have access to clinical nurse specialists who have the 
knowledge, expertise and competence to educate, advise and support patients 
and their families throughout their illness trajectory. Macmillan and palliative 
care nurses also have specialist knowledge and expertise relating to accessing 
resources in the community and helping with practical support and finance. In 
the absence of this specialist provision healthcare professionals need to gain 
the knowledge in order to provide the supportive care these patients require. 
6.4 Recommendations for education 
Findings suggest there is a need for healthcare professionals to acquire 
specialist knowledge in relation to the community and its resources available to 
patients and their families. With a greater understanding of these resources 
healthcare prefessionals can be proactive in meeting the psychosocial support 
needs of patients and their families. Providing educational opportunities that 
increase the awareness of resources available within the community is one way 
of increasing the heathcare professionals' knowledge. In addition secondments 
to other clinical areas is one approach to learning and understanding the 
professional roles of others. 
The research demonstrates that communication between patients, families and 
healthcare professions was often problematic because of unfamiliar and 
specialised terminology used in haematological oncology. This often resulted in 
confusion and anxiety. Specialist communication skills workshops may 
encourage healthcare professionals to avoid use of complex medical 
terminology when interacting with patients and their families. Furthermore 
findings suggest the complexity of the illness and its associated specialised 
terminology created problems for parents who needed to explain to their 
children about the illness and what was happening. Educating parents, 
therefore, would prepare them in order to communicate more effectively with 
their children. Gaining knowledge about the disease, how the illness is 
managed and guidance relating to communicating with their children will enable 
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parents to articulate explanations in terms that a child can understand. Parents 
need to be able to explain to their children how the illness is affecting their lives. 
This may help families to adjust and prepare their children for potentially 
disturbing events such as hospitalisation or alterations in appearance such as 
sudden weight gain due to steroids, the insertion of a central venous line or hair 
loss. 
Findings suggest that the rarity of the disease, the complexity of its name 
(multiple myeloma) and lack of awareness in the public domain and other 
healthcare areas indicates the need for wider dissemination and provision of 
education leaflets explaining about the disease, its progressive nature and its 
implications. In the absence of media coverage, educational leaflets could help 
to increase awareness and understanding in other areas or departments of 
health, social care, community and in the workplace. From the GP's perspective 
dealing with the rarity of the disease, findings suggest that assumptions were 
apparently based on what they (GPs) normally expected to find. Back pain, for 
example was often assumed to be a strained muscle or a slipped disc. It is 
recommended that a move towards educating GPs to focus on all potential 
uncommon and common diseases with the undertaking of prompt investigation 
to identify the origin or cause of illness needs to be considered as mandatory 
and standard practice. 
6.5 Recommendations for research 
The following research recommendations relate to the findings of this grounded 
theory research: ways in communication, nature of the disease, impact on life 
and supportive care needs. The research findings are summarised within a 
framework of integrated conceptual hypotheses (Appendix 9) contributing 
towards understanding the nature and impact of the disease and direction for 
further research (Glaser and Holton 2004). The direction recommended from 
this research is: 
" An investigation into delay in diagnosis and further exploration of the 
impact that delay has on the quality of life aimed at providing substantial 
evidence to suggest the need for changing medical practice and 
highlighting strategies towards early detection. 
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"A study that aims to answer the question: Is the shock of a cancer 
diagnosis such as multiple myeloma considered potentially further 
exacerbated because of its rarity, incurability and progressive nature? 
" Exploration of the issue of the way in which healthcare professionals 
communicate and give information in the haematological oncological 
arena where the language is specialised; how that informaiton is 
perceived by the recipients and determine whether or not this impacts on 
individual's decision making capabilities when newly diagnosed. 
"A study that aims to provide an operational definition of the concept 
Contention involving identification, exploration and measurement of the 
phenomenon. Measurement requires a tool that accurately reflects the 
defining attributes of the concept. 
A study to explore the concept of Contention in relation to illness 
trajectory and chronic diseases. 
" An investigation into the effectiveness of treatment for multiple myeloma 
verses the serious, prolonged or irreversible adverse events associated 
with medication or chemotherapy used to answer the question: Does 
treatment improve or impede quality of life? 
An exploration that highlights the impact of the disease, its treatment and 
associated impact on sexual relationships and what healthcare 
professionals can do to help individuals express their concerns and 
initiate approprate referrals. 
A study that determines whether healthcare professionals are doing 
enough to help parents communicate more effectively with their children 
when living with a complex and progressive cancer. 
An investigation into perceptions of whether family members are more 
supportive when visible signs of illness or disease are apparent and 
when individuals appear to look 'normal and healthy' despite the 
presence of disease, whether this is generally perceived as 'normal and 
healthy'. 
An investigation into perceptions of employers and working colleagues or 
associates towards absenteeism associated with illness: Reactions in the 
work place and how supportive colleagues or associates are in the 
working environment. 
An investigation into perceptions of supportive care services from the 
patient and family perspective. 
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6.6 Overall Contribution 
This grounded theory study provides insight through exploration of 
individuals' life experiences living with a complex haematological malignancy 
that is poorly understood impacting on healthcare professionals and the 
provision of supportive care. This study contributes to the body of knowledge 
in the following ways: 
"A unique nursing concept (associated with the experience of living with 
multiple myeloma) named 'Contention' has emerged and developed from 
this grounded theory 
" Increased awareness and understanding of multiple myeloma and the 
impact that the disease has on the individual and on family life 
" Identification that it is important that patients, families and healthcare 
professionals collaborate to identify supportive care needs at specific 
times along the illness trajectory to inform service provision and develop 
effective care pathways. 
6.7 Dissemination of results 
Dissemination of the findings (emerging key issues) commenced soon after 
data collection started as the ongoing analysis immediately followed each data 
collection and return of transcribed interviews. Poster presentations have been 
accepted and exhibited locally and internationally. Numerous oral presentations 
have been given locally and nationally. Through further publications and future 
presentations, the findings will continue to be effectively disseminated. 
Summarised versions of the results have been distributed to participants and 
colleagues. The most recent local presentation took place at a regular evening 
seminar for the medical oncology team and cancer nurses (April 2009). A 
donation of the completed thesis will be contributed to the 'Steinberg Collection' 
at the RCN Library in London and to the Myeloma UK organisation. 
6.8 Concluding remarks 
Undertaking a PhD is a steep learning curve and one which made me realise 
that there is so much more to explore and learn. This grounded theory has 
contributed to enhancing understanding of the impact of a relatively unknown 
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cancer that is progressive, debilitating and unrelenting. More importantly people 
with uncommon cancers or diseases have the same human needs that people 
with common cancers or diseases have. All persons are equally important 
whether well or unwell and every individual's supportive care needs should be 
acknowledged. As healthcare professionals it is our responsibility to probe more 
deeply and reassure patients that we can help them by meeting all their needs. 
'Chair-side' nursing on the chemotherapy day care unit should not focus entirely 
on treating the disease when the impact on life is immense and affects the 
whole family. This study offers insights into the Contention that underpins the 
experience of living with multiple myeloma, and the challenge facing healthcare 
providers seeking to provide effective supportive care. Other cancers will also 
evoke Contention but multiple myeloma requires to be better understood in 
order to minimise the many struggles associated with it. 
"So really you kind of feel like you're living on 'Death Row' / suppose because 
you don't know, you think things ... are OK and then suddenly something 
happens ... 
1 struggle a bit" (Fred P 017). 
"The tight is to sustain life, it's as simple as that, that is the fight" (Frank P 007). 
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Appendices 
Appendix 1 Chair-side nursing - The impetus for the study 
The researcher's perspective 
I feel it's important and pertinent that the researcher's perspective and the 
impetus for the study is taken into account because without the experience of 
working on the chemotherapy day care unit and looking after patients with 
multiple myeloma (bone marrow cancer) I would not have undertaken this 
project. Chair-side nursing is a term that came to me while working on the 
chemotherapy day care unit as a clinical trials nurse. The chair is a reclining 
armchair, which can be extended allowing the patient to rest with feet up if 
required while being treated with chemotherapy or receiving blood transfusions. 
Since the late 1960s when my nurse training began I have from time to time 
experienced nursing sick and dying patients in bed and the idea of people 
coming to a day unit and sitting in armchairs for two, three or up to several 
hours while receiving treatment was at first quite extraordinary. My official role 
title is clinical trials coordinator and I prefer to use the term clinical trials nurse 
because that is what and who I am. The majority of trials I have been involved 
with relate to single and combined chemotherapy agents for patients with 
multiple myeloma. Although the nature of the work lends itself to huge amounts 
of necessary administration with a focus on data collection and record keeping 
there is also a large nursing component. First and foremost I will attempt to 
draw a picture of the working environment, the place, the patients and hospital 
staff who inspired me to undertake this study. 
The chemotherapy day care unit 
The general layout of the chemotherapy day unit as shown in a diagrammatic 
scheme in Figure 1 is one that when filled with people and equipment leaves no 
room to swing a cat and manoeuvrability can be extremely difficult. This not only 
creates frustration for the staff but ethical dilemmas for example privacy and 
confidentiality can become compromised. The atmosphere is very changeable 
and ranges from different levels of stress and sadness to much lighter modes of 
interaction between staff and patients. Laughter for example is often heard. 
Healthcare professionals working in the haematological oncology field appear 
caring and sensitive to the needs of the patients especially during periods of 
despondency. Because of the nature of illness long-term relationships are 
established between staff and patients lasting (in some cases) for several 
years. Many patients are on borrowed time so there is an emphasis on 
treatment starting promptly at the critical moment when disease is progressing 
following a period of stable disease or remission. Consultants and registrars 
appear directly approachable and accessible to the patients by telephone, e- 
mail or make themselves available in person when the patient attends the clinic 
or the day unit without having made an appointment. 
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Patients are treated for leukaemia, lymphoma, multiple myeloma, other 
haematological malignancies and red blood cell disorders. There are 
approximately 30-40 ongoing clinical trials and despite this number those 
patients participating only represent a small percentage of the patients 
attending the day unit. A clinical trials team will specialise in a particular area for 
example the trials relating to lymphomas will have a separate clinical trials team 
to that of multiple myelomas. The clinical trials team consists of the consultant 
or registrar, nurse, pharmacist, and a monitor (clinical research associate) who 
checks the accuracy of the data that has been collected and recorded (source 
verification). During the day on the unit there may be four clinical trial nurses, 
six day unit nurses, four day unit doctors, one receptionist, and one domestic, 
(there are variations in numbers of staff which can get much smaller or fewer). ' 
There are two white working boards hanging on the wall near the nurse's 
treatment room. The large board usually has a long list of patients' names who 
are expected to attend and do not include those who are referred from the 
clinics, or those who just turn up unexpectedly. The work is divided up and 
patients are allocated to a specific nurse whose name also appears on the 
board along side that of the patients they are expected to look after. The smaller 
board consists of short lists of clinical trial patients, and patients having special 
procedures such as bone marrow biopsies or collection of peripheral blood stem 
cells for harvesting (apheresis). The large white board is central to the 
organisation of the work and is used as a gathering point for the day unit staff at 
certain times of the day for updates and communication. 
Dual role of nurse and researcher 
The boundaries that normally exist between the roles of researcher and nurse 
appear to over lap, which makes this particular post (clinical trials coordinator) 
unique. This is partly because clinical trials in oncology have become the norm 
and there is no treading on anyone's toes. Being there as a "research person" is 
acceptable and it is implicitly understood that while attending to the patient I 
take on the responsibility of a trained nurse because I am invariably looking 
after very sick people. Patients living with multiple myeloma may arrive on the 
day unit depressed, distraught or extremely ill and barely able to walk. In these 
circumstances the role of the nurse supersedes that of the researcher and 
research activities or "run of the mill" things are put on hold. 
In a previous job working as a clinical trials coordinator in thrombosis research 
involved with trials which focused on prophylaxis for patients undergoing hip 
and knee surgery, I was made to feel like an intruder and was not very welcome 
on some of the hospital wards. One ward sister finally accepted my presence 
when she saw that I was prepared to stop collecting data and get someone a 
bedpan. The fundamental difference between oncology and thrombosis trials is 
one aims to extend the person's life while the other aims to reduce the risk of 
deep vein thrombosis following surgery, which could potentially lead to a fatal 
pulmonary embolism. The fact that some of the trial medications are 
considered to be experimental has no bearing in the field of oncology where it 
may be looked upon as a potential miracle cure or at best another reprieve. 
Patients are informed of the treatment options. With advice from the 
haematologist they can choose between not participating in a trial and receiving 
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a standard or traditional therapy, or participating and receiving a new 
combination of standard therapies, or participating and receiving a completely 
new therapy (unlicensed drug). Some patients simply run out of options having 
had several lines of conventional therapy and the only path left open will be the 
new treatment. Spending much of my time on the day care unit administering 
chemotherapy to the patients has meant that I have become part and parcel of 
the day unit staff although my role is that of a "research person". Wearing a 
nurse's uniform was something I deliberately chose to do so I could "blend in" 
and not feel like an "outsider" and it was important that I did not appear to be 
different from my nursing colleagues working on the day care unit. It also 
prevents any confusion as to who I am (a patient I met for the first time wanted 
to know if I was a "proper nurse" because I was not in uniform). Furthermore 
there are the practical aspects of the job, issues of hygiene, infection control, 
health and safety when obtaining blood samples or handling cytotoxic drugs 
and the need to wear protective clothing. 
Attending the chemotherapy day care unit 
Patients coming to the day care unit for the first time are usually apprehensive. 
They and their families are not only coming to terms with the diagnosis of 
cancer but are trying to get used to the idea that they are going to receive some 
form of treatment and this will mean making changes to their normal routine. A 
newly diagnosed patient is given huge amounts of verbal and written 
information in a short space of time often during one or two visits to the clinic. 
This can be extremely overwhelming for some while for others it is welcoming 
and reassuring. This can cause high levels of anxiety because of the 
adaptations they must make to their lives. It can be particularly stressful when 
patients have dependants prior to the onset of the illness, young children, 
elderly parents, or a spouse who needs care and would normally rely upon 
them. Receiving cycles of intravenous chemotherapy may involve travelling to 
the day unit twice a week for two out of a three-week cycle. Other supportive 
care may be required between treatments such as blood transfusions or iron 
infusions. The illness, the treatment, and the travelling can cause extreme 
tiredness and fatigue. Getting to the day care unit, receiving the treatment, and 
getting away to spend the rest of the day doing normal things becomes the 
main objective, even if this means resting for long periods at home. The main 
focus for all patients is whether or not the treatment is working. Newly 
diagnosed patients often assume that this will be so but for those who are "fully 
trained" that is they have already received several lines of therapy know that 
this is not always the case and are familiar with the unpredictable path of the 
disease and it's response to treatment. 
The paraprotein levels found in the blood or the urine are the markers that 
inform us as to whether the patients are responding to the therapy or not. 
Although there is always an exception almost all of the patients will take a keen 
interest in the blood test results and will want to know what the paraprotein 
levels are at the end of each treatment cycle. This causes huge excitement 
when the levels have dropped significantly, and huge disappointment when they 
are rising or at a standstill. Rising is a sign of disease progression and 
remaining at the same level over a period of time implies that the therapy is not 
working. Waiting until the following cycle which could be three or four weeks 
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plus the time of several days before the test results are seen means that a 
patient may be on "tender hooks" for more than a month not knowing whether or 
not the treatment is having any effect. Patients appear to pick themselves up 
again and respond to reassurance, encouragement, support, or some optimism 
from a nurse, a doctor, or a friend. It may be a small remark such as "it's only 
risen very slightly, we are just as likely to see a decrease after the next cycle of 
treatment. Lets just wait and see". 
Making assumptions 
I use the word appear because we (healthcare professionals) make many 
assumptions about what we think the patients are going through and what it 
must be like for them. In reality we cannot possibly know what it is like and how 
the illness is affecting them and their lives or that of their families. The 
chemotherapy day care unit is often crammed full with people. Nurses and 
doctors are seen walking backwards and forwards. Nurses are cannulating 
patients, taking blood samples, or setting up infusions. Doctors are examining 
patients; phones are ringing constantly; bleeps are bleeping; patients are having 
treatments or they are waiting to be seen. Patients are treated and then go 
home. Alternatively patients become too ill to go home and are transferred to a 
ward. Amidst the hustle and bustle of the day care unit environment one patient 
waiting may start shouting or burst into tears and it is not until there is such an 
emotional outburst that anyone is aware that there is something wrong. Some 
patients remain quiet while waiting to be seen, while others talk together often 
about their illness, their treatment, and whether or not they feel they are making 
any headway. There are patients who will tell a nurse without being questioned 
that there are problems such as the physical side effects from the medication 
(chemotherapy), or that they have depression. Sometimes patients do not want 
to make a fuss; they see how busy the nurses and doctors are, and as a result 
of this they remain quiet. It cannot be assumed that there are no problems. 
Patients participating in clinical trials are usually keen to report any side effects 
or adverse events because they appreciate the importance of collecting 
information and how it will affect future patients and the way in which they are 
treated. 
It was an emotional outburst from a female patient that made me sit up and 
think about my clinical practice and made me realise that I had made the wrong 
assumptions about this particular lady. It was a very busy period of time and I 
had seven patients waiting to be seen on the day care unit. Unless I have to 
prioritise as in the situation that someone is suddenly feeling very unwell and 
requires immediate attention I work on a first come first serve principle although 
appointment times are arranged in advance people cannot always make it in 
time. So the aim is to get through things as swiftly as possible bearing in mind 
that people are waiting to be seen. I had observed that this patient was 
becoming more demanding over a period of weeks. She would come and find 
me on the unit and make sure that I was aware that she had arrived. This 
would be followed by an occasional nod of the head if I happened to look in her 
direction. I remember thinking about her profession (teaching) and although 
she had retired I had decided that she was assertive and autocratic to the point 
that she was accustomed to making demands. She stopped me in mid flight 
trying to avoid her and asked how long it was going to be before she could have 
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her treatment. I apologised stating that there were other patients waiting. She 
started to cry. She apologised for her attitude towards me and continued to cry. 
I stopped a patient going into the only free examination room to wait for the 
doctor. It was inside this room with the door closed that this lady shared some 
of her life experiences living with her husband who had Alzheimer's disease. 
He had stood on the doorstep of their home that morning shouting, "where the 
hell do you think you are going? " She answered "to the hospital and I will be 
back as quickly as possible". 
If we (healthcare professionals) do not know what is going on in people's lives 
how can we help them? If we do not know what is going on how can we 
understand why they are behaving in a certain way? How in turn do we 
become more sensitive to their needs? It might well be that a person will not 
wish to share these life experiences with healthcare professionals and on the 
other hand patients who do want to share their experiences and emotional 
problems may not have the opportunity to do so. The kind of environment in a 
chemotherapy day care unit may not be conducive because it is open planned 
with reclining chairs almost touching one another; spaces crammed full of 
people and examination rooms constantly in use. 
Assumptions are usually made based upon the outer appearance and what 
people perceive as normal. Patients with multiple myeloma often appear to look 
well which can be deceptive and because of this are able to camouflage or hide 
behind their true feelings when necessary. For example one male patient 
stated that he could not tell his elderly parents that he has cancer and has so 
far kept it from them. A female patient disclosed that she had been invited to a 
formal luncheon and her one fear was that she might have to take a wheel 
chair. Another example, which heightens the layperson's perception, was 
brought to my attention while booking hospital transport for a patient. A 
member of the transport department informed me that there was no room for 
the patient's husband who always accompanied her when she came to the day 
care unit for chemotherapy. The member of staff working in the transport 
department stated that the patient always looked well and did not require an 
escort. The issue was quickly resolved following a discussion with the manager 
of the department. However the situation highlighted the fact that there are 
people employed within the hospital environment who have regular contact with 
patients and their families, and who have little or no knowledge of the illness 
and it's implications. It can be argued therefore that there is a lack of 
understanding and sensitivity towards patients and their families within the 
hospital environment because of this. 
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Figure 1 
Diagrammatic scheme of the chemotherapy day unit 
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Multiple myeloma is a cancer of the red bone marrow and despite modern 
treatments, such as high dose chemotherapy and stem cell transplants, it 
remains incurable with a median survival of between three to four years 
(Hoff brand et al 2001, Bradwell 2003). The aim of this article is to increase 
awareness and understanding of this relatively unknown cancer. 
Multiple myeloma is a disease which is 
often difficult to diagnose and difficult 
to treat. An overview of the disease will 
include clinical features, diagnosis, 
treatment options and likely outcomes. A 
case study will help to illustrate the impact 
of the disease on the individual. 
Multiple myeloma can be simply 
described as bad blood and fragile bones. 
It is a haematological malignancy or bone 
marrow cancer that produces excess 
amounts of plasma cells, osteolytic bone 
lesions, and the appearance of monoclonal 
proteins that may be seen in the blood or 
urine. Plasma cells normally produce 
immunoglobulins (Igs) or antibodies. In 
multiple myeloma the cloned plasma cells 
(myeloma cells) produce monoclonal Igs. 
These appear as a spike in the blood serum 
test called the M Band or Paraprotein level. 
Normally there is only 1 per cent plasma 
cell content in the bone marrow. This 
increases to 30 per cent and can be more 
than 90 per cent in multiple myeloma 
(Bradwell 2003). 
The invasion of myeloma cells (cloned 
plasma cells) results in a significant 
reduction in the normal production of 
plasma cells. This leads to a compromised 
immune system that can result in 
recurrent infections. The most important 
differential diagnosis is a condition 
known as monoclonal gammopathy of 
undetermined significance (MGUS) 
which means a paraprotein level exists 
in the absence of multiple myeloma. This 
can, however, transform into multiple 
myeloma or other associated diseases, for 
example lymphoma, amyloidosis, in 26 
per cent of patients (Singer 1997). 
Common clinical features of multiple 
myeloma are: bone pain and pathological 
fractures; anaemia and bone marrow 
failure; renal impairment; infection due 
to immunodeficiency and neutropenia. 
Less common clinical features are 
acute hypercalcaemia; symptomatic 
hyperviscosity; neuropathy; amyloidosis 
and coagulopathy (Singer 1997). 
Multiple myeloma represents only 1 
per cent of all cancers. It is diagnosed 
in 3,500 people each year and there are 
approximately 10-15,000 people living 
with the disease in the UK (King 2003). 
Most patients are aged over 40 years at 
diagnosis. In recent years, there has been 
an increase in the number of younger 
patients. It is now known that the median 
age of 63 years has decreased (Schey and 
Pallister 2004). 
Myeloma is more common in the Afro- 
Caribbean ethnic groups than Caucasians 
or Asians, but is present in all ethnic 
groups, with a higher incidence in males. 
The cause of the disease has not been 
identified but certain contributory factors 
may be associated with myeloma. These 
are: genetic factors; weakened immune 
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system; exposure to particular chemicals; radiation 
and viruses (Morris 2003). 
Myelomas are usually described in terms of 
secretory and non-secretory, symptomatic and 
non-symptomatic or smouldering. They are also 
classified according to the types of immunoglobulins 
(Igs) and the presence of light chain or heavy chain 
disease. The structure of each Ig molecule is made 
up of two heavy chains and two light chains. The Ig 
molecule itself is normal but sometimes these are 
altered due to disease or separated resulting in a rare 
heavy chain disease or the more common light chain 
disease. Light chains are also known as Bence Jones 
proteins. There are two types of these called Kappa 
and Lambda. Only one or the other is present. The 
monoclonal protein or paraprotein level found in 
the serum is IgG in two thirds of the population of 
myeloma patients; IgA in one third; and IgM, IgD 
or IgE are rarely found but can exist on their own or 
coupled together. The urine contains Bence Jones 
protein (Kappa or Lambda free light chains) in two 
thirds of the myeloma population and in some cases 
is present without a serum paraprotein (Hoffbrand 
et al 2001). 
People diagnosed with multiple myeloma 
are likely to experience a number of physical 
and emotional sequelae that may be as poorly 
understood as the disease itself. Sirohi and Powles 
(2004) describe the activity of the disease as'intricate 
interactions which occur between the bone-marrow 
microenvironment and the myeloma cells, frequently 
causing bone destruction which in turn stimulates 
tumour growth'. 
A number of bones can be diseased with 
myeloma cells but this is not something that can 
be seen or detected easily unlike other cancers. It 
has an unpredictable path with numerous periods 
of relapse and remission. A patient can die within 
days or weeks of being diagnosed on one hand 
and on the other can live for many years with a 
'smouldering' myeloma that does not require any 
medical intervention (Bradwell 2003). 
Diagnosing multiple myetoma 
Diagnosing multiple myeloma is difficult. In its early 
stages it is often asymptomatic and early symptoms 
are usually very non-specific such as lethargy, mild 
anaemia or back pain. According to Watts (2005), 
'myeloma is a victim of its own rarity - difficult to 
diagnose, and even harder to treat, devastating for 
sufferers and their families, yet poorly understood 
by both the public and many doctors'. 
The disease has previously been referred 
to by other names such as paraproteinaemia, 
dysproteinaemia, immunoglobulinopathy and 
myelomatosis (Hoffbrand et al 2001, Schey and 
Pallister 2004) which can add to the confusion. 
Diagnosis is usually based on the presence of a 
paraprotein'spike' (monoclonal protein or M Band) 
in the serum or urine sample, the presence of lytic 
bone lesions and more than 10 per cent plasma cells 
in the bone marrow. 
Treatment options 
Patients with symptomatic myeloma are usually 
treated with chemotherapy. Medical intervention 
prior to the onset of symptoms has not proved to be 
beneficial (Hjorth et al 1993; Riccardi et al 2000). 
Single agents such as melphalan or cyclophosphamide 
are usually used to treat the disease initially. They are 
sometimes used in conjunction with prednisolone 
or one of the common combination chemotherapy 
regimes, for example Vincristine, Adriamycin and 
Dexamethasone (VAD). 
High dose therapy and stem cell rescue 
(autologus stem cell transplant) is recommended in 
newly diagnosed patients up to the age of 65 years 
and may be considered in patients older than 65 in 
the absence of any serious co-morbidity (Smith et 
al 2005). 
The drug Thalidomide was reintroduced for 
treating multiple myeloma in 1999 (Schey and 
Pallister 2004, Weber 2004). Velcade, which started 
out as PS 341 and known as Bortezomib, is a 
proteasome inhibitor that acts by interfering with 
the growth of myeloma cells. Due to the drug's 
expense, it is currently only available in clinical 
trials. It has been available on a restricted named 
patient basis at the discretion of the haematologist 
and pharmaceutical company. 
The aim of the treatment is to slow down the 
disease's progress, the outcome of which may be a 
partial, complete, or no response to therapy; control 
the symptoms and improve the patients quality of 
life (Morris 2003). Treatment is aimed at reaching 
a 'plateau phase' where the paraprotein level falls 
significantly and remains at that level maintaining 
stabilised disease; or for the paraprotein level to 
fall to zero when the patient enters a remission 
period. Many patients are entered into clinical 
trials and have the option of receiving novel single 
and combination therapies. Radiotherapy is used for 
lytic lesions which are at risk of or have fractures and 
is highly effective in treating local symptoms such as 
bone pain or spinal cord compression (Hoffbrand et 
al 2001). Bisphosphonates such as clodronate and 
pamidronate are also given to control bone disease, 
hypercalcaemia, and may have anti-tumour effect 
(Cavenagh and Croucher 2004). Transfusions or 
erythropoietin which stimulates red blood cell 
production are given to treat anaemia. 
Cass study 
John, 38, was diagnosed as having monoclonal 
gammopathy of undetermined significance (MGUS) 
in 1998. In 2000 he started to get back pain which 
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gradually became almost unbearable. A few months 
later John had a CT scan which showed multiple 
lytic lesions; a bone marrow aspirate showed a 
plasma content of 40 per cent; serum paraprotein 
level of 47 (normally there is a level of zero). Bence 
Jones proteins were also present in his urine. He was 
diagnosed with IgG Kappa multiple myeloma. 
John was treated with radiotherapy to his thoracic 
spine which relieved the pain. He commenced 
treatment as an outpatient with combination 
chemotherapy consisting of VAD. The VAD 
was interrupted and postponed twice due to 
hospitalisations because of febrile neutropenia 
and pneumonia. He completed combination 
chemotherapy and had high dose Melphalan and 
a stem cell transplant. Following treatment he 
remained well for almost two years and returned 
to work. In 2002 he relapsed and was treated with 
combination chemotherapy. On this occasion 
John had Cyclophosamide, Thalidomide and 
Dexamethasone (CTD) as the Vincristine had 
previously caused some peripheral neuropathy. This 
was followed by high dose Melphalan and a second 
stem cell transplant. 
Several months later John relapsed again with 
a rising paraprotein level and prescribed a clinical 
trial drug PS 341 (Velcade). His myeloma did 
not respond and instead of having a decreasing 
paraprotein level it rapidly rose from 30 to 70. He 
was taken off the PS 341 after two treatment cycles 
and was again treated with CTD. 
John's remission lasted for a few months during 
which he remained fit and was able to work and 
socialise. In October 2003 he became a man who 
no longer looked well, had a pale yellowish tinge to 
his skin and was unable to walk without the aid of 
a walking stick. This was a marked transformation 
from the tall, slim, healthy looking man who walked 
into a room without effort a few months previously. 
He had a history of worsening back pain which 
was making his walking very difficult. He was 
treated with more radiotherapy to his spine, more 
Thalidomide and Dexamethasone. 
Following several weeks of treatment John was 
admitted to hospital with a six-day history of 
worsening constipation, abdominal distension, 
malaise and anaemia. He received frequent 
platelets and blood transfusions. His liver function 
tests were abnormally deranged and innumerable 
new myeloma lesions were seen on his kidney and 
liver scans. During his hospital stay he reported 
numbness in his lower limbs. 
An MRI scan showed an extensive extra dural 
mass lying predominantly posteriorally to the spinal 
cord extending along several of the thoracic vertebrae 
and the cord was found to be compressed. 
Although his paraprotein levels remained low 
with the current treatment, the changes on the scans 
suggested that there was extra medullary relapse. He 
appeared to be making progress and was transferred 
to another hospital for intensive physiotherapy. 
John had been there for one day when he fell. As his 
left leg gave way, he knocked his arm against a table 
which led to a fracture of his left humerus. He was 
taken by ambulance to an orthopaedic hospital for 
surgery where a nail was inserted. John returned to 
his local hospital looking pale and weak. 
John remained in hospital for three months with 
numerous problems including chest pain, cardiac 
arrhythmias, intermittent fever, general bone pain, 
and small haemorrhages from the nose and mouth 
associated with low blood platelets. His condition 
deteriorated at a steady pace. The myeloma had 
reached advanced stages of the disease and was no 
longer responding to treatment. 
John prepared himself for the news that the 
treatment was no longer effective. The decision 
was made to stop treatment. The myeloma was in 
its terminal phases. Frequent blood transfusions 
were having little or no effect. John was no longer 
able to stand without support and had difficulty 
in breathing. In March 2004, arrangements were 
made for John to be transferred to a hospice where 
he died three weeks later. 
Discussion 
Multiple myeloma can be conceptualised as a 
chronic illness affecting adults from all age groups. 
It is different to other cancers in a number of ways: 
a) it is a haematological malignancy 
b) there is the presence of significant bone disease 
and associated functional problems 
c) there is a median survival of between three to 
four years 
d) there is no cure. 
John's case study illustrates the impact of the 
condition on the life of an individual person. The 
management of the disease is often fraught with 
difficulties such as finding effective solutions for 
the prevention and control of side effects associated 
with the chemotherapy used to treat the myeloma. 
Finding an effective treatment for the myeloma 
itself is often a significant feature that might only 
be achieved through persistent trial and error. 
Multiple myeloma is often referred to as being in 
a state of relapse or refractory which means it is not 
responding to treatment. 
The unpredictable path and numerous periods 
of relapse and remission are typical as seen in the 
above case study. There is a dear pattern of disease 
progression, followed by treatment, a period when 
the patient is well and able to lead a relatively normal 
life. This process may repeat over and over again. 
Only as the disease progresses, and enters the more 
advanced stages, does the quality of life become 
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noticeably poorer. Remission periods may also be 
much longer for some patients. One female patient, 
from the author's (PJS) clinical practice area, had a 
12 year remission following her first treatment with 
chemotherapy; however, this is unusually long. 
It is not uncommon for patients to look perfectly 
well when they attend the chemotherapy day 
care unit for treatment. Rupert (1987) describes 
myeloma as 'assault from within' implying that 
it cannot be seen externally. People's body image 
may however be altered because of steroids and, 
although an unpleasant bloated appearance is likely, 
this is usually a temporary alteration. Alterations in 
appearance such as significant loss in height can be 
devastating as this is irreversible. Osteolytic bone 
lesions cause pathologic fractures and reduced 
mobility (Cavenagh and Croucher 2004). Some 
patients are unable to walk because of bone lesions 
and fractures in the pelvis and thigh bones. 
A patient suffering with back pain or discomfort 
is extremely common in multiple myeloma. 
Collapsed vertebrae and spinal cord compression 
are seen in many patients. Back pain or backache 
is a common ailment and often the first symptom 
that patients present with. However, many people 
complain of `bad backs' and may attend the GP 
practice several times before it is investigated 
further. Often patients attend the hospital for 
other conditions when abnormally high protein 
or calcium levels are detected in the blood which 
may alert the doctor towards the possibility of the 
presence of myeloma. John's abnormal monoclonal 
protein levels were detected while having routine 
blood evaluations. 
The time of diagnosis is usually described in terms 
of a shock for most people and their families (Thomas 
and Retsas 1999, Maliski et al 2002). Many are 
completely traumatized and in a state of bewilderment 
(Davis 2002, Persson and Hallberg 2004). 
Patients with multiple myeloma not only have 
to come to terms with a diagnosis of cancer, but 
they also have to take on board the additional bad 
news that there is no cure. Reassuring patients 
that multiple myeloma can be treated and having 
a positive attitude is very important (Bulsara et al 
2004). 
Conclusion 
The NHS Cancer Plan (2000) and the NICE 
Guidance on Supportive and Palliative Care 
(National Institute for Clinical Excellence (NICE) 
2004) both set out to improve supportive and 
palliative care for adults with cancer. 
Key topic areas include: communication, 
information, coordination of care, psychological, 
social and spiritual support. 
For a variety of reasons patients may not always 
get the support from family and friends that they 
need. Many patients are unable to speak to their 
family and close friends about how they are really 
feeling because they do not want to upset them. As a 
result of compromising, anxiety levels are increased 
at the detriment of their own stress (Nason 2003). 
A preliminary recommendation for practice 
is the importance of accessible psychological 
support. Patients who suffer with anxiety do not 
always have immediate access to professional 
support. It is suggested that psychosocial support 
services are needed to cover all areas within the 
hospital environment and the community. It is 
also suggested that day care units include anon the 
spot' patient and family counselling service to meet 
recommendations specified regarding supportive 
care (NICE 2004). 
Liaison and communication between hospitals is 
vital at all levels and needs to be followed through. 
Face-to-face communication is not always possible 
and written information in the form of hospital 
letters/electronic records concerning patients need 
to be followed up with emails and/or telephone 
communications. Continuous liaison between 
hospitals and hospital departments is a way of 
ensuring that relevant clinical staff are fully 
informed of the patient's condition when receiving 
treatment at other hospitals. 
In conclusion, this article has described the 
features of multiple myeloma and explored the 
individual suffering associated with it. Increased 
understanding into the impact of this particularly 
debilitating disease will determine the way forward 
in developing future management strategies in 
relation to the supportive care needs of multiple 
myeloma sufferers and their families 
Implications for practice 
Future qualitative research studies should focus on 
exploring the experience of living with multiple 
myeloma from the patient and family perspective 
with the following aims and objectives: 
 To increase awareness and understanding of 
multiple myeloma 
  To increase awareness and understanding of the 
impact that the disease has on an individual's 
personal, family, professional or working life 
  To increase awareness and understanding of the 
impact of multiple myeloma on significant others 
(family members, friends or partners) 
  Development of future management strategies 
for planning high quality and effective care 
pathways in this patient group 
  Identification of supportive care needs and 
development of supportive care assessment 
methods and tools 
  Testing of rehabilitation and supportive care 
interventions. 
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A FAMILY'S EXPERIENCE OF COPING 
WITH MULTIPLE MYELOMA 
Patricia Smith, Carol Cox 
This article highlights an 
uncommon cancer that is 
relatively unknown within the 
context of end-of-life care. It presents 
a small part of an ongoing qualitative 
study that was commenced by the 
first author in October 2005 entitled 
'Living with multiple myeloma: a study 
to explore patients' experiences and 
supportive care implications'. The aim 
of this article is to heighten awareness 
Patricia Jean Smith is Research Fellow and PhD 
Student and Carol Lynn Cox is Professor of 
Nursing, Advanced Clinical Practice, Acting 
Deputy Director, Institute of Health Sciences, 
Department of Applied Biological Sciences, 
City University St Bartholomew School of 
Nursing and Midwifery, London. 
Email: Patricia Smith: abbd532@ctyac. uk 
of multiple myeloma and provide some 
insight into the often aggressive nature 
of the disease. An illustrated account of 
multiple myeloma is followed by 
the background story of a mother who 
was diagnosed with this incurable 
bone marrow cancer. The names 
have been changed to maintain 
confidentiality of the patient, the 
informant and the family. 
Context 
The narrative in this article describes 
the experiences of Marian, one of the 
family member respondents from the 
first author's ongoing qualitative study. 
She describes how her mother, Susan, 
became ill with an aggressive form of 
multiple myeloma and died within a 
few months of diagnosis. The interview 
was recorded and took place in a quiet 
room at the university 6 years after 
Susan's death. 
The impetus for the qualitative 
study came from the first authors 
experience of working in a 
chemotherapy day care unit, treating 
patients with multiple myeloma 
participating in clinical trials, Ethical 
approval for the study was granted 
in August 2005 by the local research 
ethics committee, The aim of the 
ongoing study is to explore: the 
meaning of living with multiple 
myeloma in terms of becoming ill and 
being diagnosed; the impact on the 
participant's personal or family life; the 
impact on other family members: the 
impact on the participant's professional 
or working life; and participants' 
perceptions of health care and 
supportive care services. 
Multiple myeloma 
Multiple myeloma is a complex and 
diverse haematological malignancy that 
is poorly understood. It is cancer of 
the red bone marrow that produces 
excess amounts of cloned plasma cells 
(Figure 1), osteolytic bone lesions and 
the appearance of monoclonal proteins 
that may be seen in the blood or 
urine. Plasma cells normally produce 
antibodies called immunoglobulins 
(Igs). In multiple myeloma the cloned 
plasma cells (myeloma cells) produce 
monoclonal Igs that appear as a spike 
in the blood serum test called the M- 
band or paraprotein level. Normally 
there is only I% of plasma cell content 
in the bone marrow. This increases to 
30% and can be over 90% in multiple 
myeloma (Bradwell, 2003). 
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The invasion of myeloma cells 
(cloned plasma cells) means that the 
normal production of plasma cells 
is significantly decreased resulting 
in an immune system that becomes 
compromised leading to recurrent 
infections. It is unrelenting in its 
progression and the development of 
drug resistance is a major obstacle in 
curing the disease (Dalton, 2004). 
There may be a pre-existing 
condition called monoclonal 
gammopathy of undetermined 
significance (MGUS), which means 
insignificant amounts of paraproteins 
are present in the absence of multiple 
myeloma. This can transform into 
multiple myeloma or other associated 
diseases such as lymphoma or 
amyloidosis in approximately 26% of 
patients (Singer, 1997). 
Myelomas are usually described in 
terms of secretory and non-secretory, 
symptomatic and non-symptomatic or 
smouldering. Plasma cell leukaemia is 
a term used when there is peripheral 
blood involvement accounting for 
>20% of cells (International Myeloma 
Working Group, 2003). Myelomas are 
also classified according to the types 
of Igs and the presence of light chain 
or heavy chain disease (for further 
information refer to Hofbrand et 
al, 2001). Numerous bones can be 
diseased with myeloma cells, hence the 
name multiple-The common and less 
common clinical features of multiple 
myeloma are presented in Table I. 
The cause has not been identified but 
Common 
Bone pain and pathological fractures 
Anaemia and bone marrow failure 
Infection as a result of 
immunodeficiency and neutropenla 
Renal impairment 
Less common 
Acute I ypercalcaemia 
Symptomatic hyperviscosity 
Neuropathy 
Amyloidosis 
Coagulopathy 
Source: Singer () 997) 
certain contributory factors may be 
associated with myeloma (Table 2), 
Multiple myeloma has an 
unpredictable path with numerous 
periods of relapse and remission. The 
patient can die within days or weeks of 
being diagnosed, but may live for many 
years with a'smouldering' myeloma 
that does not require any medical 
intervention. It is difficult to anticipate 
how aggressive the disease is going 
to be, A new International Staging 
System, developed by the International 
Myeloma Working Group, has recently 
been published (Durie, 2006), using 
serum B2 microglobulin and serum 
albumin prognostic indicators. 
Previously, the most common staging 
system used (Durie-Salmon) was 
criticised as being too complex and 
cumbersome for clinical practice (Schey 
and Pallister, 2004). 
Despite modern treatments of 
combination chemotherapy and high- 
dose therapies such as melphalan 
used in conjunction with autologous 
stem cell rescue (autograft transplant) 
multiple myeloma remains incurable 
with a median survival of between 
3 and 4 years (Bradwell, 2003). An 
outline of the principles of management 
are given in Table 3. The treatment is 
aimed at slowing down the progress of 
the disease, the outcome of which may 
oe a partial, complete or no response 
to therapy, controlling the symptoms 
and improving the patient's quality 
of life (Morris, 2003). 
The disease and treatment can 
cause extreme tiredness, lethargy and 
depression (Smith et al, 2005). The 
fragility of bones means that patients 
with multiple myeloma are susceptible 
to pathological fractures and movement 
can be particularly painful because of 
the presence of bone disease. Backache, 
back pain and collapsed vertebral 
Weakened immune system 
Exposure to particular chemicals 
Radiation 
Viruses 
Source: Morns (2003) 
bones are common (Hoffbrand et al, 
2001). Figure 2 shows various collapsed 
vertebral bones and prior evidence 
of kyphoplasty, which is injected 
bone cement used to treat vertebral 
compression fractures. 
The NHS Cancer Plan (Department 
of Health, 2000) has set out to improve 
supportive and palliative care for adults 
with cancer, in collaboration with the 
National Institute for Health and Clinical 
Excellence (2004). The key topic areas 
include the following: communication, 
information, coordination of care, and 
psychological, social and spiritual support. 
Background to the family narrative 
Marian is a senior nurse and works as a 
clinical nurse specialist in a large teaching 
\"I 
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hospital. Her mother Susan died of an 
aggressive form of multiple myeloma, 
which left her family completely 
devastated. Her parents had been 
married for 40 years and they had four 
daughters, one of whom was fostered, 
and a brother. During the interview 
Marian indicated that she would 
probably get upset and she did start to 
cry at one point. 
Susan had originally gone to her 
GP with a history of bad headaches. 
Following a number of visits the GP 
eventually took a blood test, which 
showed some abnormality. This 
necessitated a referral to haematology 
and Susan underwent a period of 
monitoring, which lasted 2 years. Marian 
was vague about the abnormality 
detected. However, it can be assumed 
that a monoclonal protein had been 
found in the blood serum. At this stage 
it could have been either a smouldering 
myeloma (asymptomatic) or MGUS. The 
family was aware that Susan's condition 
could evolve into something more 
serious such as a symptomatic myeloma 
but did not understand the implications 
if it did. Unfortunately, the onslaught of 
the disease was aggressive and Marian 
describes the illness as'hell on earth 
with no quality of life in between'. 
Marian appears to be a strong and 
articulate person. She looked upon the 
interview as a cathartic experience and 
although she became really disturbed 
and emotional, she insisted that she 
wanted to carry on. Marian seemed 
unhappy because she had not been 
able to speak to her mother about 
death and dying. 
When her mother had asked am 
I dying? ' Marian had said'no of course 
not'. She says that this was because 
no one in the family wanted to speak 
about Susan's death until she was 
actually dying and then it was not 
discussed with Susan. The family had 
wanted to stay positive. Although 
Marian could see that her mother was 
dying and was rapidly becoming a'dying 
cancer patient', her coping mechanism 
was to push that knowledge aside 
and concentrate on hoping that the 
treatment would be successful. 
Table 3 
Management of multiple myeloma 
Chemotherapy 
High-dose rnelphalan with transplant 
Radiation 
Maintenance therapy: support 
therapy: erythropoietin; 
bisphosphonates; antibiotics: pain 
relief; growth factors; emergency 
treatment, e. g, long bone pinning, 
plasmapheresis, kyphoplasty 
Management of drug-resistant or 
refractory disease 
New medication used in clinical 
trials: thalidomide; bortezomib, PS- 
341 (Velcade); Doxil (long-acting 
doxorubicin); arsenic trioxide ( Ir isenox) 
Further reading: Hjorth et al (I993), 
Riccardi et of (2000). I Iofibrend et of 
(7001), Silverman (2002), Cuvenagh 
and Croucher (2004), Weber (2004), 
Smith (2005), Durie (2006) 
Being monitored 
Susan had been attending a 
haematology clinic for approximately 
2 years. Marian was on maternity leave 
and was able to accompany Susan to 
clinic visits. The family understood that 
there was a blood abnormality that 
required monitoring, The haematologist 
informed them that it might not 
develop into anything further and, 
as the blood count levels remained 
the same, the family avoided any 
contemplation of what might or might 
not have developed. 
Denial is one way that people 
cope with situations that are difficult 
to accept (Copp and Field, 2002). The 
following narrative reflects the denial 
that Susan's family adopted: 
'The doctor had talked about some 
problems with her blood. You know 
I'm a nurse but I didn't really know 
what it was. We had this consultant 
who said maybe it will never ever 
come to anything, so we kind of lived 
for the moment and thought OK, lets 
just live with it and we even used 
to laugh about it. I got to go with 
Mum to all her clinic appointments 
and afterwards we'd be like laughing 
about this consultant because it was 
just our way of managing it. Mum 
was that type of person who would 
manage that. She'd just forget about 
it and get on with life and we'd sort 
of think nothing of it, and it never got 
worse, it was always the same. ' 
Feeling unwell 
Following the 2-year period of 
monitoring Susan suddenly became 
unwell with general weakness and loss 
of appetite. Immediately before this 
period she had complained to Marian 
about her back feeling sore. As Susan 
had bilateral hip replacements this was 
not unusual. It was difficult to describe 
what the problem was: 
`I remember spraying Ralgex on her 
one day and you know we had such 
a laugh about it because this Ralgex 
was so cold, and she said "Ooh yes 
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it's really helped". Quite quickly after 
that mum came down with an illness 
and was very sick. I went to see her 
one day and I looked at her and I 
said mum you look awful go back to 
bed. It was a morning that we were 
going to go to the GP and I was going 
with her. I said "you can't go to the 
GP" because mum could hardly walk. 
It was all very non-specific. ' 
Diagnosis 
The GP was called and knew at a 
glance that Susan required immediate 
hospitalisation. Marian states that the 
GP had been her mothers doctor for a 
long time and knew her well. Susan was 
admitted to hospital in early August 
2000 and was informed of the diagnosis 
relatively quickly. Marian describes 
the shock of the diagnosis and how 
distressing it was informing the family: 
'We were in casualty and the doctor 
said it's your myeloma, it has flared 
up, that's what the problem is. Mum 
immediately said "I've got cancer" 
and she knew and you know, a 
diagnosis of cancer is awful for a 
family. I went home that day after 
casualty and had to tell dad, and 
of course he thought "that's it she's 
going to die" and he was very, very 
upset and so were all the family... 
that-initial shock that you've 
got a cancer. ' 
Treatment was commenced with 
chemotherapy to bring the cancer 
under control. Susan became well again 
fairly quickly following initial supportive 
treatment for hypercalcaemia and blood 
transfusions for anaemia. Marian states 
that within approximately 48 hours 
her mother was feeling much better 
after having felt'so dreadful'. Susan 
was treated with chemotherapy as an 
outpatient and also had several hospital 
admissions. Initially. Susan appeared to 
be progressing well and was responding 
to treatment. Marian's younger sister 
was getting married. Susan's big aim was 
to be well enough to be able to attend 
her daughters wedding: 
`Mum's big aim at that time was 
Mary's wedding. My younger sister 
was getting married and that was at 
the end of August, so you know how 
quickly this happened. So at the end 
ofAugust mum made that wedding 
and she was really well that day, 
really well, like her normal self and 
we look back on photos and think 
wow! But as that day progressed, 
by the end of the night she was 
sick again. ' 
Becoming a dying cancer patient 
In October, Marian went away for a 
week to Ireland with her husband and 
baby son. It was a holiday that had 
been planned originally with Marian's 
parents but Susan was not well enough 
to go. Marian describes the change in 
her mothers appearance when she 
returned from Ireland. The fact that 
her father did not recognise the change 
in his wife's appearance was also noted 
at this time: 
'Quite soon after mum had been 
diagnosed, it was the October and we 
had planned to go to Ireland all of 
us together with our new baby and 
mum and dad and of course mum's 
now dying, so she couldn't go and I 
was away for a week and came back. 
I went into her bedroom and just 
was in tears, you know. I had to leave 
the room in tears because there was 
such a drastic change, she looked 
so skeletal, she looked like a cancer 
patient, you know, quite quickly, a 
dying patient, and I remember being 
in the front room crying and dad 
coming in and saying "Why are you 
crying, she's, she's very well, she's 
looking"... he couldn't see any of it.. ' 
Within several weeks Susan 
deteriorated and was no longer 
responding to the chemotherapy. 
A decision was taken to change 
the therapy: 
`Mum started to deteriorate, so her 
bloods deteriorated, and they called 
us up one day to see them and they 
said we want to move on to another 
class of treatment because things 
are deteriorating and of course we 
agreed. We had to because there 
wasn't really another option. They 
wanted to do it, and I think from 
there on, no treatment was ever 
probably going to work because 
mum got worse and worse and 
then on Christmas Day I remember 
coming, we'd been to Dave's parents 
for dinner, for Christmas Day and we 
came and mum had had a really bad 
day and we called out the emergency 
doctor for some pain relief and she 
was admitted quite soon after that. ' 
Marian was informed that the 
new therapy (thalidomide) was not 
having any effect. Susan continued to 
deteriorate. It was suggested that the 
treatment was discontinued. Marian 
disclosed her feelings and stressed that, 
as a family, they did not acknowledge 
that Susan was dying. Furthermore, it 
was assumed that Susan was not aware 
of her impending death: 
'A new registrar came and he'd been 
around for a couple of weeks and I 
called him at home about something 
and he said... your mum's figures are 
deteriorating, I think we should stop 
treatment. I can't remember what 
else he said but I was horrified that 
he would actually even go there and 
I just said as a family we wouldn't do 
that, we won't stop treatment and 
now 1. I think was that the wrong 
thing to do at that time because 
we as a family never acknowledged 
mum's dying, until right at the end 
when mum was dying and couldn't 
acknowledge it herself He said to 
me, this registrar, that mum would 
be crying at night with the nurses, so 
maybe she did have some knowledge 
of what was happening. ' 
The family believed and hoped for 
a miracle cure. They had seen an article 
on the internet about thalidomide and 
how a particular woman had been 
treated with success: 
'I think it was probably that we as 
a family were never ever going to 
give up. We would always have that 
hope and that we would always try 
and look for this miracle I suppose. 
We were reading something on 
the website about thalidomide. You 
know this woman's story that it 
had worked. She was taking it and 
then wow she had made this great 
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recovery and I suppose l' always 
thought that maybe that would 
happen for mum. ' 
Susan returned from her last 
hospitalisation to the family home 
where she had lived for more than 
30 years. During that time many people 
came to visit. Marian recalls visitors' 
shock at seeing such a drastic change 
in her mother's appearance: 
'Mum was ill but people did start to 
drop in and you know it was just like 
the shock, people knew then that she 
was dying. We never told anyone. You 
know we were so closed about what 
was going on but it must have been 
so obvious to people. She just looked 
like a, you know, a corpse. ' 
Marian talked about two distinct 
changes in her mother. One change was 
in her mother's external appearance 
relating to body degeneration because 
of the disease. The other was'a very 
discrete difference in who mum was', 
implying there had been a subtle 
change in Susan's personality: 
'To me she just looked awful and 
that's how quickly the change 
happened and then you know, awful 
bruising that came on her body. 
You know that's horrible at the end, 
yeah I suppose it wasn't a very long 
time span but she was just bruised 
everywhere. She was so thin, skin and 
bone and, she could hardly get out 
to the commode and everything was 
such an effort It's just awful really. I 
think you know as a family we knew 
there was something different about 
her, that no one else would have 
seen. It was a very discrete difference 
in who mum was and I suppose at 
the time I wasn't really recognising 
it properly. I would just think "oh you 
know mum's ill" but now I think back 
it was the whole period, very discretely 
she was a bit of a changed person. ' 
Marian recognised that her mother 
had an'underlying depression' as she 
had become withdrawn, distant, and 
tearful. Marian's thoughts were that her 
mother was not able to come to terms 
with her diagnosis. Susan was described 
as having been a'funny person' who 
was interested in talking with people. 
During her illness Susan had become 
'distant'. Marian suggests that this was 
because Susan was afraid to talk to her 
family about what was happening to 
her. In addition, the family did not want 
to accept that Susan was dying: 
7 think she was frightened. Mum 
couldn't talk to us about it I don't 
know why. Perhaps it's because we... 
just didn't want to accept that You 
know mum had this very serious illness, 
that she was going to die with but we 
just always hoped she would recover. ' 
End-of-life care 
Susan was treated with morphine for 
bone pain (back pain) and lorazepam 
was prescribed for anxiety attacks. 
Marian maintains that the lorazepam 
was very effective. It helped calm her 
mother, improved her wellbeing, and she 
appeared to be more her normal self: 
'The one thing that mum was 
prescribed, that really did help her 
and I'm sure it was because, she 
did have a fear, was lorazepam. 
We used to laugh about it because 
they were like her little blue pills but 
when she'd had a lorazepam she, it 
really calmed, it calmed her in lots of 
ways and almost brought her back 
to being the mum that we knew 
because she would get a little bit 
panicky or withdrawn. ' 
The whole family was'very pleased' 
that Susan was at home when she died. 
Susan had only been discharged from 
hospital a few days previously. Being at 
home gave the family an opportunity to 
participate in Susan's care and to share 
special moments that would never be 
forgotten. It also gave the family an 
opportunity to begin to come to terms 
with Susan's impending death. However, 
Marian claims that her father could 
not have coped with his wife at home 
for much longer, Marian sums up the 
period of her mother becoming'struck 
down' with the illness and dying: 
`Mum was diagnosed in early August 
and died on the 7th of February. In 
between, you know, it was hell on 
earth, mum didn't have any quality 
of life really because she was either 
in hospital or if at home, was in bed. 
Mum wasn't able to do anymore 
more than that Sometimes she 
could get up and be so exhausted 
but the one thing, I mean, she made 
it to our son's christening. That was 
in the November. Mum had quite 
a good day that day, but, you know, 
making the christening means that 
she got in a car got to my house and 
spent quite a bit of time in bed in 
the spare room, but she was in quite 
good spirits. ' 
Discussion 
Diagnosing people with multiple 
myeloma can be difficult (Watts, 2005). 
Back pain or backache is common and 
is often the first symptom that the 
patient experiences. However, people 
may have to attend the GP practice 
several times before the cause of the 
pain is investigated further. Patients 
may be attending the hospital for 
other conditions and abnormal protein 
or calcium levels are detected in the 
blood, which may alert the doctor 
towards the possibility of the presence 
of myeloma, Others may simply break 
a bone while carrying out household 
chores. These patients are seen in 
accident and emergency departments 
with a'suspicious' pathological fracture. 
The need repeatedly to visit the 
GP seeking help regarding a specific 
problem before a cancer diagnosis is 
made has been reported by Leydon et 
al (2003). These authors suggest that 
difficulties are encountered because 
of scarce resources, especially in 
deprived areas, additional pressure on 
GPs, 10-minute consultations and lack 
of experience and knowledge. With 
regard to this latter point, Leydon et 
al found that the patients with breast 
cancer were relatively satisfied with 
their GPs' ability to facilitate a diagnosis. 
This is not surprising as breast cancer 
can be detected quickly and easily 
because it is a solid tumour that is 
palpable and often visible to the naked 
eye. Other less conspicuous cancers, 
e. g. leukaemia or myeloma, may start 
out with non-specific symptoms such 
as mild anaemia or backache. In the 
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case of a symptomatic myeloma, the 
consequences of a delayed diagnosis 
will ultimately lead to delayed 
treatment and disease progression. 
Susan's abnormal monoclonal 
protein levels were detected after 
having routine blood evaluations as 
a result of several visits to the GP 
initially for severe headaches. The 
abnormal levels were not significant 
enough for treatment but necessitated 
monitoring and it was not conclusive 
that this condition would develop into 
cancer. It is known that a smouldering 
myeloma or MGUS can develop into a 
symptomatic myeloma (Singer, 1997). 
In Susan's case this was advantageous 
as it served as a prior warning and 
thus she was diagnosed quickly. The 
relationship between patient and GP 
is fundamental. Susan was well known 
to the GP. Her doctor was familiar with 
Susan's medical history and knew her 
as a person. One look was enough to 
inform the GP that something was very 
wrong and that immediate medical 
intervention was required. 
The time of diagnosis is usually 
described in terms of'a shock' for most 
people and their families (Thomas and 
Retsas, 1999; Maliski et al, 2002). Many 
are completely traumatised and in a 
state of bewilderment (Davis, 2002: 
Persson and Hallberg, 2004). Susan was 
told'your myeloma has flared up'. She 
instantly knew she had cancer which 
implies a degree of awareness. It is 
assumed that the words'myelomä and 
'cancer had been used in a conversation 
between the doctor and patient at some 
stage. From the interview it is clear 
that this discussion did not take place 
between the patient and her family. 
During the monitoring period both 
Marian and Susan knew that something 
sinister was potentially' brewing' but 
chose not to acknowledge it as a 
way of coping with the situation. It 
appeared to be a case of - why worry 
about something that may or may not 
develop? Being forewarned, however, 
did not lessen the shock and distress 
associated with the diagnosis and the 
impact this had on the family. It can 
take a long time for family members 
to come to terms with a diagnosis 
of cancer (Mellon, 2002). In Mellon's 
(2002) study, cancer survivors and 
family members were so shocked at 
receiving the diagnosis that it was a 
considerable length of time after the 
cancer treatment had ended that they 
finally came to accept it. 
Myelomas are often referred to as 
being in a state of relapse or refractory 
which means that the disease is not 
responding to treatment. Finding an 
effective treatment is often a challenge. 
It might only be achieved through 
persistent trial and error. The disease 
was particularly aggressive in Susan's 
case. In the terminal stages of the illness 
no treatment will alter the course of its 
progression, It is unrelenting. Hope for a 
miracle cure has been identified in the 
literature (Mok et at, 2003) and this 
was apparently very real for Susan's 
family who were influenced by other 
people's experience of successful 
treatment with thalidomide. The 
findings from Mok et al's (2003) study 
are important, despite the differences 
in culture and beliefs, because of the 
implications for nursing practice. This 
research explored family experience 
caring for terminally ill patients with 
cancer in Hong Kong. Hoping for 
a miracle, despite being told that 
the illness was incurable, and trying 
alternative herbal medicine, was 
described as an integral component of 
the process of caring. 
Not all families are able to talk 
openly about death and dying because 
it is too upsetting (Greisinger et al, 1997; 
Copp and Field, 2002). Marian describes 
her mother becoming subdued and 
distant. This was understood as a fear of 
talking to her family about her situation 
and the possibility of dying, 
Marian knew her mother was dying 
but was unable to discuss this with 
her or any other family member. This 
suggests that family members were 
protecting each other and were not 
necessarily in denial. Marian was under 
no illusion that her mother was dying. 
However, denial of impending death is 
conceptualised as an individual coping 
mechanism (Zimmermann, 2004). 
Copp and Field (2002) discuss the 
open awareness culture in a hospice 
setting and the use of denial and 
acceptance of dying as alternating coping 
strategies used by patients at different 
stages of the illness trajectory. Family 
members were seen to be protecting 
one another by not talking about illness 
and dying. While some patients were 
able to discuss issues relating to their 
situation throughout the course of 
their illness, others preferred to have 
periods when they were not constantly 
reminded about their imminent death. 
People cope by not acknowledging that 
a loved one is dying, They cope with 
the now' of the situation and do not 
concentrate on what is about to happen 
because it is too painful. 
Lawton's (2000) work highlights 
strategies employed by dying patients 
such as focusing on the memories of 
their past lives and being reluctant to 
discuss any topic associated with the 
future. Lawson provides an example 
of this within a day care setting, Any 
person showing unrealistic expectations 
concerning future plans was immediately 
excluded from the inner circle of 
patients attending (Lawton, 2000). 
The breaking of bad news is 
described as'one of the most difficult 
responsibilities in the practice of 
medicine' (VandeKieft, 2001). Bad news 
is defined as'news of life-threatening 
illness, disability or impending or actual 
death' (Farrell, 1999). Doctors may 
withhold certain information because 
they have concerns about its detrimental 
effect on patients. Furthermore, 
VandeKieft (2001) argues: 'Physicians 
do not wish to take hope away from 
the patient They may be fearful of the 
patient's or family's reaction to the news, 
or uncertain how to deal with an intense 
emotional response: 
Marian was the recipient of bad 
news when the registrar told her 
on the telephone that her mothers 
condition was deteriorating and that 
the health care team was considering 
stopping the treatment. Marian was 
clearly upset by this comment. The 
doctor could have coped with the 
situation more sensitively by arranging 
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a meeting with Marion to discuss 
the options in person. Effective and 
compassionate communication is not 
just a matter of discussion. Health care 
professionals should be prepared to 
provide the emotional support and 
respond to an individual's reactions to 
bad news (Dias et al, 2003). 
Conclusion 
The aim of this article is to describe the 
disease process of multiple myeloma 
in the context of a dying mother and 
the impact of the disease on the family. 
Susan's family had little time to come 
to terms with the diagnosis of cancer 
before Susan died. The myeloma was 
aggressive, unresponsive to treatment, 
and unrelenting. Within a short period 
Susan became a'dying cancer patient'. 
The narrative content provides 
some insight into the often 
unpredictable nature of the disease. 
The ongoing qualitative study intends 
to increase understanding into the 
impact of this debilitating bone marrow 
cancer, strengthen the evidence base 
for managing the disease and provide 
more supportive care, particularly at 
the end of life, 
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Communication 
Journal/Date 
Sample 
Context 
Data 
collection 
Setting 
Analytical 
approach 
Categories of 
respondents 
Synthesis 
categories 
Friedrichsen & Milberg 
J. P. M 2006 
30 doctors 
Different specialists 
Interviews 
Hospitals 
Sweden 
Phenomenography 
Doctors giving 
bad news to patients 
Communication 
Bad news 
Incurable cancers 
Breaking news 
Losing control 
Demanding task 
Maintaining control 
Choice of words 
Concentration 
Perceptions 
Existential thoughts 
No-one wants to hear 
The healer 
The executioner 
Feelings of guilt 
Disappointment 
Harming patients 
Expectations 
Life and death 
Making judgements 
Relationships 
Showing emotions 
Bad starting points 
Competence 
Time constraints 
Interruptions 
Misinterpretations 
Cultural differences 
Randall & Wearn 
P. M 2005 
15 adults 
Leukaemia and 
Lymphoma 
Interviews 
Haematology 
Clinic UK 
Thematic analysis 
Patients with 
blood cancers 
Communication 
Bad news 
Personal qualities 
Expertise 
Rare cancer 
Friendly 
Spending time 
Sympathetic 
Honesty 
Hope 
Fight 
Simple talk 
Metaphors 
Atmosphere 
Different approaches 
Unrushed 
Rushed 
Right to choose 
Leaflets 
Control 
Written summary 
Medical terms 
Confusion 
Being monitored 
Kept Informed 
Emotional turmoil 
Continuity 
Support 
Byrne et al 
P. E &C 2002 
30 adults 
Different cancers 
Interviews 
Oncology clinics- 
and day unit UK 
Subcategories 
(concepts) 
Page 1 of 6 
Thematic analysis 
Patients with various 
types of cancer 
Communication 
Response 
Hidden disclosure 
Hidden tensions 
Concealing distress 
Rejecting cancer 
Effort and struggle 
Being normal 
Minimising disease 
Accepting cancer 
Shock 
Bewilderment 
Finding cause 
Fear 
Inevitability 
Assimilating Illness 
Life re-evaluation 
Burden 
Brave face 
Impact on others 
Clinical collusion 
Family collusion 
Fighting 
Suppression 
Mixed emotions 
Staying positive 
Confusion 
Protecting others 
Communication 
Journal/Date 
Sample 
Context 
Data 
collection 
Setting 
Friedrichsen et al 
P. M 2002 
30 adults 
Different cancers 
Interviews 
Palliative unit 
Sweden 
Bakker at al Barnes et at 
P. E &C 2001 WJM 2000 
40 females 32 females 
Breast cancer Breast cancer 
Interviews Interviews 
Oncology clinics Breast cancer- 
Canada Centers UK 
Analytical 
approach 
Categories of 
respondents 
Synthesis 
categories 
Subcategories 
(concepts) 
Phenomenography 
Patients with Incurable- 
cancers 
Communication 
Language 
Verbal expressions 
Ending treatment 
Interpretation 
Understanding 
Choice of words 
Indirect warning words 
Forewarning words 
Evasive words 
Vague sentences 
Ambiguous words 
Threatening words 
Fortifying words 
Supporting words 
Maintaining Interest 
Reassurance 
Positive message 
Underlying message 
Decision making 
No-chemo-no-side effects 
Metaphors 
Time focus 
Ultimate message 
Separation focus 
Death focus 
Abandoning words 
Negative feeling 
Thematic analysis Content analysis 
Patients with Mothers of school- 
breast cancer age children 
Communication Communication 
Interactions Talking to children 
Information Timing of disclosure 
Routine check ups Time of discovery 
Doctor mode Time of GP visit 
Medically focused Time of appointment 
"Doctor talk" p 64 Time of diagnosis 
Physical exam' Time of surgery 
Lab' results Decision making 
Treatment Withholding 
Nurse mode Avoidance 
Problem solving Facing questions 
Being listened to Preventing distress 
Individual needs Protection 
Main support Understanding 
Power and control Special occasions 
Fighting the cancer Right to know 
Partnership Child's trust 
Decision making Family discussion 
Continued support The cancer word 
Sustaining hope Appropriate language 
Having confidence Needing guidance 
Gaining knowledge Being honest 
Relationships Child's awareness 
Role expectations Child's coping 
Self help Feeling reassured 
Assertiveness Family counselling 
Connectedness Preparation 
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Impact on life 
Journal/Date 
Sample 
Context 
Data 
collection 
Setting 
Analytical 
approach 
Categories of 
respondents 
Synthesis 
categories 
Houldin 
ONF 2007 
14 Caregivers 
Advanced colo- 
rectal cancer 
Interviews 
Cancer Centre 
USA 
Content and constant 
comparative analysis 
Spouses and friends 
as caregivers 
Quality of life 
Disrupted life 
Johansson et al 
C. N 2006 
5 adults 
Incurable cancers 
End of life 
Focus group 
meetings 
County Hospital 
Sweden 
Content analysis 
Living with 
incurable cancer 
Quality of life 
Patients' perceptions 
Denny 
J. A. N 2004 
15 females 
Endometriosis 
Interviews 
Gynaecological- 
Dept' UK hospital 
Thematic analysis 
Living with- 
Incurable disease 
Subcategories 
(concepts) 
Total disruption 
Changing priorities 
Responsibilities 
Struggle 
Unable to plan 
Change in routine 
Impact on work 
Social Impact 
Life Insurance 
Chemotherapy 
Sperm bank 
Cancer diagnosis 
Helplessness 
Relationships 
Financial concerns 
Medical knowledge 
'We are at war" p326 
Unable to talk 
Staying positive 
Normal as possible 
Being parents 
Cancer word 
Talking to children 
Quality of life 
Delay in diagnosis 
Palliative homecare Being taken seriously 
Ordinariness Intense pain 
Normal things Dyspareunia 
Able to function Sexual relationships 
Alleviate suffering Treatment 
Physical well being Side effects 
Mental well being ineffective treatment 
Living their lives Operations 
Personal strategies Social relationships 
Managing pain Employment 
Positive life Partners support 
Memories Supportive employer 
Feeling needed Fear of recurrence 
Not just an iii person 
Motivation 
Maintaining interest 
Significant relations 
Essential networks 
Communication resonance 
Emotional support 
Positive talks 
Nurse contact 
Contact continuity 
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Journal/Date 
Sample 
Context 
Data 
collection 
Setting 
Analytical 
approach 
Categories of 
respondents 
Synthesis 
categories 
Subcategories 
(concepts) 
Howell et al 
C. N 2003 
18 females 
Recurrent ovarian- 
cancer 
Telephone- 
Interviews 
Cancer Centre 
Canada 
Thematic analysis 
Living with- 
recurrent cancer 
Impact on life 
Eimberger et al 
C. N 2002 
8 males 
Haematological 
malignancies 
Interviews 
Transplant and 
OPD Sweden 
Molassiotis & Morris 
C. N 1998 
28 BMT adults 
Acute myelold- 
Ieukaemia 
Written narrative 
BMT Centre 
UK hospital 
Interpretative 
description 
Fathers living 
with cancer 
Quality of life 
Waiting for recurrence 
Fear 
Ups and downs 
Ongoing treatment 
Side effects 
Tumour markers 
Watchful waiting 
Devastation 
Hopelessness 
Changed attitudes 
Communication 
Struggle 
Becoming assertive 
Taking control 
Options 
Being monitored 
Progressive disease 
Drug resistance 
Gaining knowledge 
Demanding treatment 
Making decisions 
Prolonging life 
Content analysis 
Survivors 
Quality of life Quality of life 
Impact on family pre and post 
transplantation 
Transition 
Changed Image 
Changed role 
Burdensome 
More time at home 
Daily treatment 
Not taken seriously 
Family perceptions 
Misunderstandings 
Isolation 
More family time 
Childrens' reactions 
Gaining control 
Using metaphors 
Gaining knowledge 
The Internet 
Hidden disclosure 
"Going to fight it" p481 
Balance emotions 
Fear of relapse 
Hidden tensions 
Protecting children 
Sharing knowledge 
Value of family life 
Family support 
Struggle 
Normality 
Fulfillment 
Independence 
Being able 
Being supported 
Fatigue 
Loss of work 
Restrictions 
Family problems 
Re-evaluation 
No difference 
Coping with family 
Returning to work 
Disabled 
Fears of recurrence 
Infertility 
Socialising 
Future plans 
Finance 
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Supportive care needs 
Journal/Date 
Sample 
Context 
Data 
collection 
Setting 
Analytical 
approach 
Categories of 
respondents 
Synthesis 
categories 
Bottle et al 
C. N 2006 
15 nurses 
Haematological- 
oncology 
Focus groups 
Haematology cancer- 
ward. Australia 
Thematic analysis 
Experienced nurses 
working in cancer ward. 
Psychosocial support 
Barriers 
Workload 
Time to talk 
Inexperienced 
Lack of knowledge 
Good time to talk 
Building relationships 
Gaining trust 
Working part-time 
"Band-Aid fill-in" p312. 
Continuity of care 
Struggle 
Competence 
Understanding 
Complex medical history 
Primary nurse 
Emotional labour 
Personal boundaries 
Providing support 
Key times 
Difficult times 
Communication 
Approach to bad news 
Feeling uncomfortable 
Feeling isolated 
Clarke et al 
C. N 2006 
16 adults 
Melanoma and- 
Breast cancer 
Interviews 
Cancer Centre 
UK Hospital 
Thematic analysis 
Cancer patients 
Psychosocial support 
Gender differences 
Formal system 
Informal system 
Support networks 
Different needs 
Access 
Less common cancers 
Emotional support 
Gender 
Busy clinics 
Consultations 
Time pressure 
Breast care nurse 
Wives' support 
Support for wives 
Perceptions 
Specialist nurses 
Coping 
"Internal struggle" p71 
Men's support needs 
Women's support needs 
Support for partners 
Burden of support 
Ziebland et at 
P. E &C 2006 
43 females 
Ovarian cancer 
Interviews 
DIPEx. org 
UK 
Subcategories 
(concepts) 
Page 5 of 6 
Thematic and constant 
comparative analysis 
Participants from 
the DIPEx project 
Psychosocial support 
Treatment decisions 
Feeling overwhelmed 
Treatment choices 
Unable to cope 
Out of control 
The modern patient 
Right to choose 
Right choice 
Wrong choice 
The responsibility 
Medical uncertainty 
"Went along with" p363 
Doctor's choice 
Doctor's expertise 
Unable to choose 
Asking questions 
Second opinion 
No 'real' choice 
Recommendations 
Searching the Internet 
Time to research 
Becoming familiar 
Able to discuss 
More active role 
Burdensome choice 
Contradictory advice 
Struggle 
Supportive care needs 
Journal/Date 
Sample 
Context 
Data 
collection 
Setting 
Analytical 
approach 
Categories of 
respondents 
Synthesis 
categories 
Furness 
B. J. N 2005 
38 adults 
Facial surgery 
Focus groups 
and interviews 
Surgical unit 
UK Hospital 
Grounded theory 
Patients and 
significant others 
Psychosocial support 
Categories of support 
Informational support 
Practical help 
Material help 
Emotional support 
Psychological support 
Shock 
Unprepared 
Time to talk 
Seeing my face 
Unexpected emotions 
Needing support 
Support groups 
Specialist nurses 
Physical changes 
Prostheses 
Reconstruction 
Loss of teeth 
Assertiveness 
Accessing help 
Unable to speak 
Family support 
Emotional adjustment 
Staff awareness 
Availability and need 
Staff approachability 
Long-term follow-up 
Chapple et al 
B. J of G. P 2004 
45 adults 
Lung cancer 
Interviews 
At home 
UK 
Thematic analysis 
Living with 
lung cancer 
Murray et al 
BMJ 2002 
40 adults 
Lung cancer- 
Cardiac failure 
Interviews and 
Focus groups 
Community 
Scotland 
Subcategories 
(concepts) 
Thematic analysis 
Patients, carers 
and professionals 
Psychosocial support Psychosocial support 
Financial benefits Prioritisation 
Accessibility 
Stigmatisation 
Barriers to obtain 
Reluctance to seek help 
Justification 
Feeling ashamed 
Being a man 
The provider 
Having cancer 
Wanting to be normal 
Barriers due to Illness 
No backdated benefit 
The benefits system 
Uninformed 
Barriers due to failure 
Bureaucratic barriers 
Complicated forms 
Misinformed 
Macmillan nurse 
Welfare rights officer 
Fight and tussle 
Being acknowledged 
Struggle 
Better access 
Immediate access 
Macmillan grant 
Accessibility 
Different trajectories 
Written Information 
Sound understanding 
Poor understanding 
Protecting patients 
Hidden disclosure 
Decision making 
"Time bomb" p3 
Persistent threat 
Struggle 
Side effects 
Feeling useless 
Social Isolation 
Comorbidity 
Increased disability 
"Knacker's yard" p3 
Uncertainty 
Support service barriers 
Needing support 
Clinical nurse specialists 
Hospital car parking 
Palliative care services 
voluntary agencies 
Service provision 
Misunderstanding of roles 
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Appendix 6 Ethic committee approval 
25 July 2005 
Miss 5............ 
Acting Committee Administrator 
Barking and Havering Local Research Ethics Committee 
Room 7,2"d Floor, Beckett's House 
2/14 Ilford Hill, Ilford 
Essex, IG1 2QZ 
Dear Sandra 
Full title of study: Living with Multiple Myeloma (MM): A study to 
explore patients' experiences and supportive 
care implications. 
REC reference number: 051QO602155 
Many thanks for your letter dated 21 July 2005 informing me of the information 
and clarification required to enable the Committee to give an ethical opinion 
regarding the above mentioned study. I am enclosing the following documents 
for further review by the Committee: 
a) The patient information sheet and the information sheet for member of family 
or friend have been rewritten and simplified reducing the technical jargon as 
advised by the Committee. All information sheets were corrected to indicate 
that the research was reviewed by the Barking and Havering LREC. 
b) The GP Letter has been written and will be used to inform the patient's GP 
of the patient's participation. (Attached to Patient Participation Information 
Sheet). 
c) Page 2 of the Patient Participation Information Sheet has been amended to 
include "With your permission the researcher will invite a family member or 
friend to participate in the study" 
d) If a patient agrees to participate and their family member or friend declines 
the patient will still be included in the study. 
Please do not hesitate to contact me if any further clarification is required 
Yours sincerely 
Patricia J Smith 
(Clinical Trials Coordinator) 
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Barking and Havering Local Research Ethics Committee 
Room 7.2nd Floor 
Becketts House 
2/14 Ilford Hill 
Ilford 
Essex 
IG1 2QX 
Telephone: 
Facsimile: 
7'" August 2005 
Mrs Patricia Jean Smith 
Clinical Trials Coordinator 
Barts and The London NHS Trust 
St Bartholomew's Hospital, 
Haematology Dept, 1st Floor, PathBlock 
West Smithfield 
ECIA 7BE 
Dear Mrs Smith 
Full title of study: Living with Multiple Myeloma (MM): A study to explore 
patients' experiences and supportive care implications. 
REC reference number: 05/00602/55 
The Chair of the Barking & Havering Local Research Ethics Committee reviewed the 
additional documentation on the 3rd August 2005, and was able to approve the 
commencement of this study by Chair's Action. . 
Conditions of approval 
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully. 
Approved documents 
The documents reviewed and approved at the meeting were: 
Document Version Date°.. 
_ Covering Letter 25 July 2005 
Participant Information Sheet 2 22 July 2005 
Participant Consent Form 2 22 July 2005 
Response to Request for Further Information (None Specified) 
Information sheet for Family member or friend 2 22 July 2005 
Management approval 
The study should not commence at any NHS site until the local Principal Investigator has 
obtained final management approval from the R&D Department for the relevant NHS care 
organisation. 
--ý The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet. 
05/Q0602/55 
Notification of other bodies 
The Committee Administrator will notify the research sponsor that the study has a favourable 
ethical opinion. 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
05/Q0602/55 Please quote this number on all-correspondence 
With the Committee's best wishes for the success of this project, 
Yours sincerely 
J c:, ^c3ý-Cýýý 
Chair 
yJ 
Emal: janetcarter©redbridge-pct. nhs. uk 
Enclosures: 
Standard approval conditions 
Site approval form (SF1) 
Page 2 
SF1 list of approved sites 
Appendix 7 Participant information sheet and consent 
PATIENT PARTICIPANT INFORMATION SHEET 
Study title 
Living Multiple Myeloma (MM) -A study to explore patients' experiences 
and supportive care implications. 
Introduction 
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss 
it with others if you wish. Please ask if there is anything that is not clear or if 
you would like more information. Take time to decide whether or not you wish 
to take part. 
Thank you for taking the time to read this. 
What is the purpose of the study? 
This study will explore the meaning of living with an uncommon form of bone 
marrow cancer called Multiple Myeloma. Patients who have MM may be treated 
by various specialists including doctors known as Haematologists who 
specialise in blood disorders, Orthopaedic surgeons who deal with bone 
problems, and Nephrologists who treat abnormalities of the kidney or bladder. 
There is at present no cure and common treatments consist of chemotherapy, 
steroid medications and high dose chemotherapy followed by stem cell 
transplant. Stem cells are primitive cells found in bone marrow and blood which 
are taken from the patient or a donor and reinfused at a later time to stimulate 
the production of new blood cells and allow the bone marrow to recover 
following the high dose chemotherapy. MM can be unpredictable and there 
may be numerous periods of unplanned hospital visits. The purpose of the 
study is to gain an insight and to increase awareness of the problems these 
patients encounter which will have major implications for the nursing care of 
patients with MM and future research and education. 
Approximately 30 participants will be recruited from within the (named) NHS 
Trust. The objectives of the study are to explore the meaning of "Living with 
Multiple Myeloma" in terms of the impact on an individual's personal or family 
life, professional or working life, close family members or friends, and to try to 
understand what health care and supportive care patients feel they require. 
Examples of supportive care are psychological, social and spiritual support. 
Whv have I been chosen? 
You are being asked to consider taking part in this study because you have 
Multiple Myeloma. 
Do I have to take part? 
it is up to you to decide whether or not to take part. If you decide to take part 
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you will be given the information sheet to keep and be asked to sign a consent 
form. If you decide to take part you are still free to withdraw at any time and 
without giving a reason. A decision to withdraw at any time or a decision not to 
take part will not affect the standard of care you receive. 
What will happen to me if I take part? 
If you agree to take part in this study I would like to interview you about your 
illness. This interview will be recorded and arranged at a time and place that is 
most convenient to you. The interview will be very informal and will give you 
time to tell me about your experiences and needs. You will be given the 
opportunity to tell me what it is like living with Multiple Myeloma in your own 
words. For example the first question might be "please tell me what it was like 
when you were diagnosed with Multiple Myeloma". This then allows you to tell 
your own story. With your permission the researcher will invite a family member 
or friend to participate in the study. Your GP will also be informed about the 
project and your participation should you decide to take part. 
How Iona will I be involved? 
It is anticipated that the interview will take approximately 60-90 minutes. You 
may be contacted again for clarification of meaning to avoid misinterpreting any 
of your comments which have been transcribed from your recording. 
What are the Possible benefits of taking part in the study? 
The information that we get from this study may help us to manage future 
patients with Multiple Myeloma better. 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research 
will be kept strictly confidential. Any information about you that leaves the 
hospital will have your name and address removed so that you cannot be 
recognised from it. Your name will not appear on the transcript and you will 
remain completely anonymous. For the duration of the study only your initials 
and a number will be assigned to your interview so the researcher can identify 
you. For the writing of the final report only the number will remain so it will not 
be possible for any party reading the report (thesis) to identify you. Any 
information you give will be treated with complete confidentiality at all times. 
Your recording will be stored on the researcher's computer and this will be 
erased at the conclusion of the study. 
What will happen to the results of the study? 
Following completion of the research study the results will be widely distributed to all 
participants, patients, families, and NHS Trust personnel via written summaries, 
pamphlets, teaching materials, guidelines and care pathways. Results will also 
be 
circulated to myeloma associations and healthcare professionals via websites, 
journal publication, and conference presentations. 
Who is organising and funding the research? 
The research is being organised by myself, a full time PhD university student 
who is also a Registered General Nurse, sponsored by the City University and 
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funded by the (named) NHS Trust, and the (named) Charitable Foundation. 
Who has reviewed this study? 
This study has been reviewed by the Barking and Havering Local Research 
Ethics Committee. 
Contact for further information 
Pat Smith 
University: 
Mobile: 
Home: 
E mail address: 
Thank you for participating in this research study! 
Version 2. Revised 22 July 2005. 
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Study Number: 
CONSENT FORM 
Title of Project: Living with Multiple Myeloma (MM): A study to explore patient's experiences 
and supportive care implications. 
Name of Researcher: Patricia J Smith 
Please Initial box 
1. I confirm that I have read and understand the information sheet dated 22 July 2005, 
Q 
version 2, for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, F-1 
without giving any reason, without my medical care or legal rights being affected. 
3. I understand that relevant sections of any of my medical notes and data collected during 
the study, may be looked at by responsible individuals from City University, 
Q 
from regulatory authorities or from the NHS Trust, where it is relevant to my taking 
part in this research. I give permission for these individuals to have access to my records. 
4.1 agree to my GP being informed of my participation in the study. 
Q 
5.1 agree to take part in the above study. 
Q 
Name of Participant 
Name of Person taking consent 
(if different from researcher) 
Researcher 
Date 
Date 
Date 
Signature 
Signature 
Signature 
When completed, 1 for patient; I for researcher site file; 1 (original) to be kept in medical notes 
Appendix 8 Letter to patient (example) 
02 March 2006 
Dear Jack and Jill 
Re study "Living with multiple myeloma (mm): A study to explore patients' 
experiences and supportive care implications 
It was nice to see you recently Jack and glad you have almost completed this 
lot of treatment. I expect you are too! I hope you are not feeling too bad or too 
tired out. I am sending you a couple of information sheets one for you both if 
you would like to consider taking part. It is of course not something that you 
have to do but I would just ask you to think about it and let me know. Below is a 
list of items from my interview guide but I am interested in the issues that are 
most important to you as a family: 
" Life before 
" At the time of diagnosis 
" Impact on personal or family life 
" Impact on professional or working life 
" Healthcare system 
" Supportive care 
I can come to you if that is o. k. or if you would prefer to see me at the hospital 
that is not a problem and I can see you any day (including weekends) whatever 
is convenient for you. My office number is above just at the School of Nursing 
around the comer close to the hospital. My mobile number is...... and my home 
number is.... It would be lovely to see you again. I must say I do miss the 
clinical work much more than I had anticipated but at the same time I appreciate 
how lucky I am to do my own study, be a student full time, and still receive my 
full salary! It's great that I have my job to come back to when I have finished the 
project. 
Best wishes to you and your family 
Pat Smith 
Enc. 
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Appendix 9 Integrated conceptual hypotheses 
"Classic grounded theory is simply a set of integrated conceptual 
hypotheses systematically generated to produce an inductive theory 
about a substantive area" Glaser and Holton (2004: 2) 
The research findings are summarised within a framework of integrated 
conceptual hypotheses contributing towards understanding the nature and 
impact of the disease and direction for further research. 
Integrated conceptual hypotheses: 
Diagnosing multiple myeloma is difficult because of its rarity and non- 
specific onset. Routine blood and urine tests do not detect monoclonal 
proteins associated with the disease therefore specialised tests are 
required. 
Delay in diagnosis ultimately leads to delay in treatment and potentially 
impacts on prognosis. Where there are bone lesions, the probability of 
pathological fractures occurring is relatively high especially in an area of 
bone weakened by the presence of pre-existing disease (Schey and 
Pallister 2004). The probability is likely to be higher in undetected pre- 
existing bone disease. Bone pain is likely to intensify and extend to other 
areas. This will ultimately have a significant impact on quality of life and 
may mean exclusion from aggressive treatment such as high dose 
therapy (stem cell transplantation) restricting options. 
" The shock of the cancer diagnosis (Thomas and Retsas, 1999; Maliski et 
al, 2002) and the emotional trauma that this significant disclosure evokes 
(Davis, 2002; Persson and Hallberg, 2004) is likely to have an impact on 
concentration levels and decision-making capabilities of the individuals 
concerned. 
" The shock of a cancer diagnosis such as multiple myeloma is considered 
potentially further exacerbated because of its rarity, incurability and 
progressive nature. 
Decision-making capabilities are probably further weakened as a result 
of feeling overwhelmed with the vast quantity of information available 
concerning treatment options particularly when newly diagnosed. 
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" Contention in communication occurs through lack of understanding the 
medical jargon used (diverse discourse), the speed at which the 
information is delivered and the volume of information given. 
" If the speed at which the information given is accelerated and the 
terminology used by healthcare professionals is 'foreign' or unfamiliar to 
individual recipients, levels of shock, bewilderment and psychological 
trauma are likely to be increased. 
" Common colloquial language applied by healthcare professionals when 
communicating and discussing medical issues associated with a complex 
cancer may enhance understanding and lessen the degree of confusion 
or bewilderment. 
" Living with multiple myeloma is synonymous with living with uncertainty. 
Uncertainty is likely to be more prolonged and intensified when 
compared to other diseases. Uncertainty in multiple myeloma is closely 
linked to the unpredictable nature of the disease, repetition of relapse 
and an unforeseeable future. Uncertainty is also associated with 'living 
on the edge', fear of refractory disease and fear of disability with 
advancing bone disease. 
" Serious adverse events associated with treatment such as peripheral 
neuropathy may be prolonged or irreversible (Richardson et al 2006) and 
can have a monumental impact on the quality of life and daily activities of 
living. 
" Individuals with sexual problems associated with their treatment or 
cancer are more likely to struggle on their own than seek counselling or 
advice from a healthcare professional as this is a difficult topic for people 
to discuss. 
" Disruption to family life appears more intense for those with children still 
living at home. 
" Parents knowledgeable and aware of the consequences of myeloma are 
more likely to be able to communicate with their children more effectively 
so that they can understand what is going on around them and prepare 
them for significant life changes (Scott et al 2003). 
" Family members appear more supportive when 'visible signs' are 
apparent. Patients' 'visible signs' are often associated with side effects 
from medication and not from the disease. When individuals appear to 
look normal and healthy this is generally perceived as 'normal and 
healthy'. 
Disruption to working life can involve significant periods of absenteeism 
caused through hospital appointments and treatment regimes. The 
individual is more likely to maintain employment if the job is non-manual 
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(white collar) and employertworking colleagues provide continued 
support and understanding. 
" Contention in accessing support services appears to be experienced by 
participants as a direct result of their supportive care needs not being 
adequately met or recognised. 
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Appendix 10 Original interview schedule 
PATIENT INTERVIEW SCHEDULE GUIDE 
Pre-interview phase 
Follows initial contact - time taken to establish rapport and gaining trust 
Explanations concerning aims of study 
Explanations concerning participants involvement 
Reassurances given regarding confidentiality and anonymity. 
Explanations regarding both verbal and written consent. 
Obtaining verbal and written consent from participant 
Completing participant record and demographic sheet 
Recording name, address, contact number in private and confidential record 
book. 
Interview phase 
Inform participant that the recorder has been switched on 
The following open-ended question will be asked : 
"What's it like living with multiple myeloma? " 
"What's it like living with someone who has multiple myeloma? " 
Further subsequent neutral or nondirective probes as suggested by Polfit and 
Hungler, (1991) p 291 may be used where necessary: 
" Is there anything else? 
" Go on 
" Are there any other reasons? 
" How do you mean? 
" Could you tell me more about that? 
" Why do you feel that way? 
" Would you tell me what you have in mind? 
" Could you please explain that? 
" Could you give me an example? 
Concluding interview 
The interview will continue until the participant shows signs of tiring or has 
exhausted the flow of conversation. It is anticipated that the interview will last 
for approximately 60-90 minutes. 
Examples of questions for participants who found it difficult to talk without 
questions: 
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(1) Please tell me what it was like when you were first diagnosed 
(2) What impact has Multiple Myeloma had on your personal life or family life? 
(3) What impact has this had on your professional or working life? 
(4) What difference does it make to your life? 
(5) Describe how you view yourself and your illness. 
(6) Describe how others view you and your illness. 
(7) Describe the issues that are most important to you regarding the health care 
system 
(8) Describe the issues that are most important to you regarding the supportive 
care system (explanation of what supportive care means giving examples). 
Appendix 11 Topic guide 
Topic Guide 
Life before - Redefining life comparing with how it was before and reflecting on 
the consequences called perceptions of normality (Carter, H Macleod, R 
Brander, P and McPherson, K 2004) 
At time of diagnosis - "Like a bolt out of the blue" and the feeling of life being 
turned upside down" (Persson, L and Hallberg, IR 2004). "It was too much to 
cope with and I felt in physical pain with the shock and trauma of this 
devastating news" (Davis, K 2002). Choosing not to tell the family and carrying 
on as normal - "I apparently have something funny with my blood and I need to 
take tablets for it" (Lewando, S 2003). Disassociation and denial - "when I got 
my diagnosis I felt as though it didn't concern me" (Thome, B Dykes, AK 
Gunnars, B and Hallberg, IR 2003). 
Impact on personal/family life - Becoming the caregiver and the process of 
caring seen as a duty and not a burden. Hoping for a miracle cure and seeking 
alternative medicine. (Mok, E Chan, F Chan, V and Yeung, E 2003). "You start 
to think and worry about how the family is going to cope - who is going to do 
this and who is going to do that"? (McRobert 2004). "While reassuring my mum 
that things would be o. k. I was having recurring dreams about her funeral" 
(Davis 2002). 
Impact on professionallworking life - "I had been averaging five and a half to 
six hours of work per day, five days a week. This has recently become too 
demanding so I have reduced it by 1-1.5 hours per day" (Duffy, J 2002). "I 
wanted to be a normal person, not a cancer patient. I was forced to give in to 
my illness - to give up work and tell people I was ill" (Nason, G 2004). 
Healthcare system - Encounters with healthcare professionals - they felt they 
were being listened to and their autonomy was respected while others felt 
neglected and pushed aside. Adopting a passive role and showing no interest in 
illness. Or a proactive role and being in control (Thome, B Dykes, AK Gunnars, 
B and Hallberg, IR 2003). Letting go and handing over the care to the 
healthcare professional (Mok, E Chan, F Chan, V and Yeung, E 2003). 
Supportive care. - Receiving help and support from family members and 
friends. Not receiving any help and support from family members and not 
wanting to bother them by requesting help (Mok, E Chan, F Chan, V and 
Yeung, E 2003). "Family and close friends are almost always very supportive, 
but are often the reason I feel under stress - will I upset him/her if I tell them 
how I actually feel"? (Nason, G. 2003). 
Appendix 12 Specific questions (analysis driven) 
How long had you been unwell for before you were diagnosed? 
Are you able to work? 
Have you had any problems accessing support services? 
Can you talk to me about the myeloma - what it is, how is it affecting your body, 
how is it affecting you as a person? 
Are there any particular difficulties in your life - or what are the challenges of 
daily living? 
Can you talk to me about the experience of undergoing chemotherapy or other 
treatment? Stem cell transplant? 
Do you feel you are well informed and able to make decisions about treatment 
options? 
Can you talk to me about the experience of relapse? 
Can you talk to me about the experience of remission (knowing that the disease 
will return at some point? ) 
What's it like being monitored? 
How do you cope? 
What sort of support network do you have around you? 
What do you worry about, what are your main concerns? 
Is there anything that has been a struggle for you? 
Can you describe changes as your illness evolves and the best ways of meeting 
your needs at different points in time? 
If I was setting up a service for myeloma patients what would you like to see in 
that service if you were at home alone? 
Is there anything you would like to talk about concerning your illness? 
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Appendix 13 Demographic data 
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Appendix 14 The emerging theory of Contention in multiple myeloma 
Defining Contention 
The theory of Contention is a raw substantive and descriptive theory, which has 
emerged through human struggle and adversity. A definition of Contention in 
multiple myeloma developed from the concept analysis (5.3.7) relates to 
experiences involving struggle, battle, disruption and disharmony. It is a 
multidimensional concept encompassing sociological, psychological and 
physiological manifestations. These four concepts are closely related but do not 
necessarily happen simultaneously or in any specific order. However, they are 
all present at some stage as a result of the concept Contention appearing. For 
example, there is 'feeling uneasy' (disharmony) at the pre-diagnosis stage. By 
the time a person attends the Haematologist in the Oncology Department many 
patients begin to realize that the illness is serious although they are waiting for 
the results of investigations to confirm the diagnosis and for the consultant to 
explain what the diagnosis means. Disharmony comes and goes and is 
therefore referred to as alternating much like osmosis or diffusion in relation to a 
cell. It returns when changes occur and the disease is slowly progressing 
(relapse). Following this there is struggle (difficulty) in coming to terms with the 
diagnosis, the treatment, complex terminology, hospital environment, and 
feeling generally overwhelmed with vast amounts of information. Battle 
(forcefulness) commences when the individual is able to see things in a more 
positive light and starts fighting the disease by taking medication, making 
necessary adjustments, learning, gaining knowledge and making informed 
decisions. There is major disruption (upheaval) to life style due to the presence 
of disease which has sociological, psychological, and physiological implications. 
The 'breadwinner' for example who is no longer able to work and support his 
wife and family results in a form of 'employment contention' causing 
monumental upheaval, emotional conflict and frustration. 
Person 
Person relates to patients, family and healthcare professionals. All participate in 
the provision of health and supportive care services. Person relates to role and 
identity such as being a parent, a spouse, a journalist or teacher. The individual 
person is considered in terms of size, age, gender, culture, ethnicity, outer 
appearance, inner character or behaviour, and role in society. The person is a 
unique and dynamic individual whose culture and life patterns have been 
influenced through family values, religion, education, society and surrounding 
environment. The person has cognitive thoughts, intelligence, memories, 
experiences, knowledge, various talents, capabilities and expertise. 
Human beings have the power of resourcefulness and resilience when 
managing difficult and challenging situations. Disruption of normal existence 
through illness will have various consequences for individuals. The way in which 
the person responds and adapts to the disruption and the illness is determined 
through physical, emotional, cultural, spiritual and socio-economic ramifications. 
The person is a sociable human being and part of a family. Illness affects the 
family and not just the individual. Incurable and chronic disease has a 
279 
monumental impact on working and family life. Individuals are aware of their 
surroundings and sensitive to change or a threatening environment. The 
individual is growing and developing constantly within the environment. The 
person and the environment are closely associated but each is separate and 
interchangeable for example airborne transmission of disease, 
Environment 
The immediate environment consists of the hospital, community, work place, 
home and includes people, pets and general surroundings. The hospital is 
viewed in terms of an inpatient ward and clinical outpatient settings. Hospitals 
are located locally or further distance away (centres of excellence). 
Environment also relates to atmosphere and situations. For instance home may 
be perceived as a safer environment following hospitalisation in light of recent 
reports regarding outbreaks of clostridium difficile infections in hospitals (Carvel 
2008). Experiences associated with medication can result in a different 
perception of surroundings and environmental imagery through hallucinations 
unique to the individual causing psychological disruption and disharmony 
(Contention). 
Environments are constantly changing and one of the most crucial 
responsibilities of the family member (carer) or healthcare professional is to 
maintain safe and healthy surroundings for the sick or disabled person. Many 
people living with multiple myeloma appear acutely aware of their changing 
environments and take precautions to avoid crowded places so that they have 
minimal contact with others who may transmit harmful bacteria. They are 
constantly susceptible to infection because of their immuno-deficiency. 
Contention sometimes exists when situations are out of control and individuals 
are struggling to travel home by train during the rush hour or other public 
transport, for example having spent a long day on the chemotherapy day care 
unit receiving treatment. 
Health 
Maintaining optimal health is synonymous with promoting and maintaining a 
good quality of life. Health in the context of living with a symptomatic myeloma 
cannot be considered in terms of "a state of complete physical, mental, and 
social well-being and not merely the absence of disease, or infirmity' as broadly 
defined by the World Health Organisation (www. who. int 2003). The physical, 
psychological and social well-being of the whole family need to be taken into 
account. There are substantial variations along the illness trajectory in 
myeloma; optimizing health is challenging and maintaining a good quality of life 
is seriously threatened depending on the severity of bone disease and disability. 
Treatment in multiple myeloma aims to stabilize the disease, prolong life and 
where possible promote and sustain a good quality of life. Health is viewed by 
many as a "roller coaster" ride with periods of "ups and downs" that is, being in 
a state of wellness with relative normality (stable disease), or relapsing and 
recommencing another line of chemotherapy. Maintaining health and a good 
quality of life while on treatment is problematic because of the toxicities 
associated with the chemotherapy agents. There exists a physical and 
emotional Contention that is associated with the impact of the disease and the 
impact of the treatment of the disease. Numerous prophylactic medications are 
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taken throughout the entire duration of treatment, some of which may be 
ineffective. The duration of treatment often continues for several months at a 
time. Stable disease may last for several months or years but is unlikely to 
extend beyond several years. Depending on the type of treatment, how the 
individual responds and the stage of disease, the median progression-free 
survival ranges between 3-54 months (Kyle and Rajkumar 2008). Between 
treatment periods when the disease is stabilized the psychological well-being of 
the individual is significantly affected. Individuals and their families are living 'on 
the edge'. They know that the disease will progress but they do not know how 
long it will be before the next relapse and this creates emotional discord and a 
feeling of 'ill at ease' or disharmony which is constantly present in their lives. 
Nursing 
Nursing has moved beyond the realms of vocation, commitment, duty and 
caring. The discipline has evolved into a science and technology of multiple 
specialist units and areas of expertise. Nursing is a culture and a skilful art that 
consists of a community or society of persons providing care within the 
environment. Modern nursing has become a global network of people 
communicating, interacting and collaborating through links with the Internet and 
attending conferences. The individual nurse or person who is trained in the 
profession of providing nursing care aims to be knowledgeable, compassionate 
and competent. Nursing is a technology of highly skilled professionals involved 
in the arts and crafts of nursing, teaching and educating, researching and 
ongoing professional development. Nursing strives for creativity, innovation and 
change in order to enhance the provision of nursing service and improve the 
quality of nursing care. Nursing is reparative and restorative. The ultimate goal 
is to provide the physical, emotional, spiritual and social support during illness 
and disability. The personal characteristics of the nurse caring for the disabled 
or unwell person are a fundamental component of nursing. The individuals 
receiving nursing care require a professional who is compassionate and 
trustworthy. A positive connection or engagement during interactions is 
essential in order to communicate effectively. Nursing requires effective 
communication and interpersonal skills in order to (a) establish a rapport, (b) 
work towards establishing a trustworthy partnership and (c) recognise and meet 
the needs of the individuals requiring assistance. Nursing is a process of 
bonding, nurturing and sharing during times of human struggle and disharmony 
(Contention). Furthermore there is the commitment of providing information and 
educating the disabled person so that the responsibility of care is shared. The 
objective of nursing is directed towards empowering the unwell or disabled 
individual when possible to regain control and independence; reduce the risk of 
complications during illness; assist in the recovery and rehabilitation of the 
unwell person; maintain the dignity, comfort and quality of existence for the 
dying person; inform and educate those undertaking the responsibility of caring; 
and educate the well individual and family in order to maintain fitness, well 
being and supportive care. 
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Appendix 15 Validation narratives (examples) 
Shirley (F 002) 
Struggle: "This struggle was the slow realisation that Bert would probably die within 
the next five years. I had to come to terms that we were offered a place on a clinical trial 
using a new drug called velcade. We were quickly prepared; lots of tests and x-rays, 
blood tests and ultrasounds and an MRI scan. This was all to commence in two weeks 
approximately, followed by a complicated regime of medication. How did we do this? 
Travel from home? Live in London? A hotel? Endless struggle! Daily treatment? 
Weekly treatment? I could barely cope at this stage, I can tell you. But we were so 
pleased to be offered this trial. So happy and very relieved and anxious to get going. 
Battle: We both had to be assertive and confident to ask the many queries re' 
how to cope with everyday traumas. Bert was determined from day one that he 
would beat multiple myeloma. He was constantly asking and questioning his 
progress. Fatigue was a big problem but this did not stop him. He always 
approached every situation from an engineering perspective. It is an up and 
down situation, forward and back, but never giving up. My support never 
wavered. If I became negative 1 could never have coped. During the 10 months 
of remission the battle eased, we relaxed a lot, we laughed, went on holiday 
even. The family support continued strongly especially our daughter (a nurse) 
who kept us up to speed with lots of good advice. 
Disruption: The disruption was massive, the biggest in our forty years of 
marriage. There was the total change in daily life and leisure by 
comparisons/trends. I kept my own daily diary of events. It kept me sane and it 
reminded me of my own career (nursing). It created my own sense of 
homeostasis. Bert also found it helped him to be involved in his care and 
management. He interfered but once we had returned to our local hospital for 
treatment etc he relaxed and found life less disruptive. 
Disharmony: He was moody. No doubt this was due to the effect of the 
diagnosis and the drug regime and the toxicity. He fought hard but he became 
irritable at times and physically fatigued. There was disharmony because we 
tried too hard to carry on as if there was nothing wrong. Slowly we slowed down 
and had to accept that the intervention of multiple myeloma was inevitable. I felt 
on edge at times and we were very jealous of close friends who were not 
plagued by illness. The effect of this caused us to become irritable with each 
other. We dealt with this with chats and hugs; we had such a strong 
relationship. Perhaps we should have asked for help, but we did not, we coped. 
There was disharmony with our son who had difficulty with the acceptance of 
his father's illness. He said we should be more positive! I now find 18 months 
later (after Bert's death) he is still terribly upset and grieves to date. He is 
improving and relating slowly with the rest of the family. Our daughter is as 
supportive as she has always been". 
Sally (P 018) 
Communicating bad news in a good way or in a bad way 
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"So far my experience has been good. My GP handled the task of telling me he 
suspected myeloma in a very thoughtful and sensitive way, even though it was 
me who actually said the words 7 think you are trying to tell me that I have 
cancer. ' I was of course stunned, numb and completely unable to think beyond 
being diagnosed with a potentially life-threatening illness and that / was going to 
die. Nothing can prepare or save the patient from having to experience the 
awful shock that diagnosis brings however well or badly it has been conveyed. 
However, my GP's swift referral meant that within 2 days I was contacted by 
phone with my hospital appointment and within a week I was seen by the 
consultant. I found this really reassuring and, along with on-line research on 
myeloma by the family, it saved the agony of going through the not-knowing and 
not-doing phase which adds to the already high levels of distress". 
Using complex terminology 
"I have found that clinicians will often use terminology that / don't always 
understand and I have to ask them to `use English'. 1 get a better 
understanding when I talk to professionals from outside of the hospital setting Je 
Myeloma UK, hospice doctors and nurses etc. I do feel that / get the time 
need with my clinicians but I constantly come away from an appointment not 
entirely sure what has been said because I am anxious and they use the 
language they know. This is where it helps to have someone else accompany 
you". 
Living with uncertainty 
"This is one of the biggest issues for me - the not knowing what is going to 
happen. Because myeloma is such a complex disease it makes life very 
uncertain. The need to live for the present is a way of coping but the nagging 
uncertainty of living with myeloma is never far behind and for me life is like a 
roller-coaster, the highs and the lows. At times it becomes very difficult to live 
with and / become prone to mood-swings". 
Perceptions of the illness (others' reactions towards you and your illness) 
"I don't hide my myeloma as 1 have long ago accepted that it is now part of me 
and we come as a package. However, I am still a person in my own right with 
or without myeloma and I try to present myself in that way. I have had no 
awkward situations with other people but I am constantly amused by people 
feeling the need to tell me how well I look even when / often feel unwell. 1 think 
it is their way of coping with the discomfort they feel when confronted with an 
illness that they dread for themselves". 
Novice to expert patient 
"Having had no knowledge of myeloma before my diagnosis it was important 
that I learnt about it but I found it almost impossible in the beginning as I really 
did not want to know anything that had to do with myeloma. / was just too 
terrified to know what was going to happen to me. I was given bookletsAeaflets 
from the hospital but could only read them some months after diagnosis and 
when I started treatment. lt was then that i began to acquire some knowledge. 
My inclinication to want to know more about myeloma only comes at each stage 
of the illness and treatment. I think I will only become an 'expert' when I truly 
am dying. My expertise in myeloma only evolves when I have to face every 
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new stage and although I am an active member of Myeloma UK I struggle with 
the discussion boards because of other peoples' experiences which / know 
won't necessarily apply to me but I am still afraid to face". 
Disrupted life 
"I suppose any illness will cause a disruption to life so I don't think that myeloma 
disrupts more than any other really". 
Physical impact of disease 
"Currently my illness does not restrict me from leading a near-normal life when 
am off-treatment other than fatigue which comes from my low blood counts after 
the stem cell transplant. This requires me to have weekly blood tests and blood 
transfusions when needed. I did have to give up work but as I was at 
retirement age and once / had come to terms with it, I realised that I would not 
have had the energy to continue working". 
Emotional impact of treatment 
"lt is emotionally exhausting because the physical impact leaves me unable to 
lead anything like a normal life and I often become low or even depressed by it. 
The fear of wondering whether or not it will work, the physical side-effects and 
not being able to function properly all play a big part in emotional distress. 
Also, the drug Dexamethasone plays havoc with my mental health to the point 
where I can only tolerate low levels of the drug. This obviously has an effect on 
my treatment". 
Physical impact of treatment 
"This is a big issue and often requires a lot of tinkering with drugs by the 
clinicians before getting medication right to relieve some of side-effects (see 
comments on Dexamethasone above). The biggest impact is the chronic 
fatigue which seriously affects mobility, which in tum affects my domestic and 
social life". 
Social/economical impact of disease 
"My social life is heavily affected when I am receiving treatment but when off- 
treatment it is less so. However, the need for regular hospital check-ups, blood 
tests and transfusions severely restricts how far and long I can be away from 
home which means no holidays abroad and limits stays in the UK. Financially, 
as I am now retired I have a small corporate pension, the state pension and 
DLA, which allows me to make ends meet. I did not anticipate giving up work at 
60 if I had been well, so it has affected me economically in restricting my ability 
to carry on working". 
Support needs 
"I attend the Day Care Unit at my local hospice where they support me through 
my treatment and / also have counselling and complementary therapies at the 
(named centre) `Cancer Centre. Whilst I have been caring for myself since first 
diagnosed 4 years ago, I sometimes have to be cared for during or after 
treatment and / do worry about how / will cope when my disease becomes more 
disabling". 
Sexuality 
"I can only comment that chemotherapy drugs cause a very decreased libido 
and that affects an individual's sex life". 
Invisible struggle 
"I think my biggest struggle is dealing with my own feelings and emotions on my 
own and without causing anxiety to family and friends. This is where I find my 
counselling so invaluable". 
Impact of policy/legislation 
"This for me and / am sure other patients is a really big issue. So far / have not 
been denied the drugs recommended because of being on clinical trials. 
However, I think it will only be a matter of time before I am affected by 
government policies on cancer drugs and NICE's appraisal system which works 
on cost-effectiveness rather than clinical need. This can be hugely stressful for 
patients and families alike. There should not have to be this stress at a time 
when living with myeloma causes its own stress. I can only hope that Lord 
Darzi's recent recommendations for the next 10 years of the NHS eliminates 
this and makes these drugs available on an equal basis". 
Decision-making 
The very nature of myeloma and its unknown prognosis makes it very difficult - 
if not almost impossible - to make any decisions in the short and long term. 
Treatment can make me feel so ill that I am quite incapable of making a rational 
decision. Other times when not on treatment my rational thinking is better but 
the ever present threat of relapse and more treatment means that decisions 
other than normal day to day decisions are difficult to make. I think that is the 
best way that I can describe it. 
Frank (P 007) 
Struggle: "Going back to the beginning of it, I wasn't obviously even aware that l 
had this myeloma and to me life was pretty good five and a half years ago, and 
there hadn't been any struggle from the time that I was told that I had this 
problem. I just went about my life in the normal sort of way, there was no 
struggle at that time. I reckoned / was pretty fit for my age in those days but the 
struggle was something that developed as the years went by, and / would say 
that ºeally the last two years have been a bit of a struggle, from the point of view 
of physical deterioration and because of the physical deterioration, there was a 
concomitant frustration mentally that evolved from not being able to do the 
things I wanted to do. The pain began to assert itself in the joints and life was 
becoming pretty difficult and pretty miserable because of the impact of all the 
ongoing medication and all of the side effects produced by the medication. So 
yeah, struggle, the last two years have definitely been a struggle, as the 
condition has got worse, so the struggle has become more severe"". 
Battle: "Oh yes, oh yes, it's a fight. It's an ongoing fight. I mean... you know, the 
fight is to, to sustain life it's as simple as that, that is the fight". 
Disruption: "Well the disruption is that I no longer have the energy to get on and 
lead what I would say is a normal days activities. I am so much lacking in 
energy that there is a complete different way that I fill the day. I don't walk as 
much as / would like to, I don't cycle as much as I would like to, I can't play golf 
anymore, to me the condition is totally restricting my lifestyle, totally". 
Disharmony: "Lets open it up and encompass the whole of the family. Way 
back five and half years ago I got the whole family together and told them that I 
had multiple myeloma and it was a very tearful scene when, when they realised 
that this, this was an incurable form of cancer. I told them in such a manner as 
to be gentle with them because it's a, it's a terrible thing to have to tell the entire 
family that this is an incurable condition. There was a great deal of upset ... a 
great deal of emotional, there were floods of tears, cuddling and all that. Now 
that was five and a half years ago. Now during the five and a half years there 
has never been any embarrassment with the family members. My own three, 
our own three children, the grandchildren, life has gone on pretty normal 
because I've never dumped my lot on them, they have their own lives to lead. 
They're getting on in the world, with their careers, with bringing up their children 
and to be honest, my condition has had no impact on their lives at all". 
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Appendix 16 Project administration file 
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Appendix 16. Project administration file. 
Original 
interview 
guide for 
patients 
2004 
Original 
HCP 
interview 
guide 
01 /2006 
Dear HCP 
invitation to 
participate letter 
Demographic 
data forms for 
patients and 
HCPs 
Project administration 
file 
Potential 
topic 
guide for 
patients 
01/2006. 
Updated 
HCP 
interview 
guide 
01/2007 
Dear Family 
member 
invitation to 
participate 
letter 
Sample 
characteristics 
record 
Updated 
interview 
guide for 
patients 
08/2006 
GP 
interview 
guide 
Updated 
interview 
record 
letters (your 
patient is 
participating in 
a study) 
Registration 
for Health 
Advocacy 
(Interpretati 
on service) 
Participant 
Information 
sheets and 
consent forms 
Dear Patient 
invitation to 
participate letter 
Research Steering 
diary and group docs 
record of 
events 
Dear GP 
invitation to 
participate letter 
KEY: HCP = Healthcare Professionals; LREC = Local Research Ethics Committee 
Appendix 17 Time plan 
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Appendix 19 Family self-assessment and referral plan 
Page (1) Introduction. 
Patients and their families may need help at specific points in time during illness. They may not 
be aware of their supportive care needs especially during difficult periods when they are unable 
to think or concentrate clearly. For example newly diagnosed patients and their families need 
time to come to terms with the news of a cancer diagnosis. They may, therefore, need someone 
to explain about the cancer at another time when they feel more prepared to take on board this 
information. The information in this leaflet is based on research involving patients, families and 
healthcare professionals to help others identify their needs. The contact details inside will give 
families access to a healthcare professional who can advise or make a referral to the 
appropriate person who can help. 
Page (2) Helping you to identify your supportive care needs. 
When you are diagnosed with a blood or a bone marrow cancer like multiple myeloma you and 
your family will require time to get over the initial shock. At this distressing time you may not be 
aware of the kind of help you may require at any particular moment in time. This leaflet has 
been designed to help you identify your supportive care needs such as practical help in the 
home, emotional support, or family counselling. It will also help you by providing contact details 
of the local Clinical Nurse Specialist and Macmillan Nurse who can advise you or refer you to 
the appropriate person. 
When am I likely to need help? 
Newly diagnosed 
Starting treatment 
Having a stem cell transplant 
Times of relapse 
Times of remission (being monitored) 
Following hospitalisation 
Times of uncertainty 
Page (3) What kind of help do I need? 
Is there someone i can speak to concerning: 
Feeling depressed or anxious? 
Helping me to explain my illness to the children? 
Helping me to understand my illness? 
Treatment options? 
My current medication and side-effects? 
Financial concerns? 
Benefits and allowances? 
Childcare? 
Preparing meals? 
A local support group? 
Introduction to someone who has the same 
cancer as my own so I can talk things through? 
Travel insurance? 
Private health insurance? 
Getting a wheelchair? 
Modifications to my home for easy access? 
Page (4) Contact details 
Clinical Nurse Specialist 
Name .................... Phone ..................... 
